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Summary 
 
Mycobacterium tuberculosis, the causative organism of tuberculosis (TB), is a major cause for mortality and 
morbidity world-wide with a death toll only second to HIV among infectious diseases. Drug resistance is wide-
spread and cases of multiple drug resistant TB (MDR-TB) and extensively drug resistant TB (XDR-TB) have 
emerged in several countries. Drug treatment is problematic and new drugs are not developed rapidly 
enough to offset the rapid drug resistance mutation rate of M. tuberculosis. Simple and effective diagnostics 
are required to contain the spread of the disease as current routine diagnostics are not fulfilling this role. 
Additionally, current rapid TB diagnostics are out of reach to resource poor settings due to infrastructure, cost 
and skill requirements. Novel TB diagnostics are thus required that meet these requirements. 
Mycobacteriophages are phages that infect mycobacteria and could offer a viable and cost effective 
alternative rapid TB diagnostics. In this study, an affinity-tagged fluorescent reporter mycobacteriophage is 
described, which was engineered to act as a TB diagnostic. Its performance proved favourable and superior 
to current existing mycobacteriophage-based TB diagnostics.  
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Opsomming 
Mycobacterium tuberculosis, die organisme verantwoordelik vir tuberkulose (TB), is `n groot bron van 
mortaliteit en morbiditeit wêreldwyd en slegs HIV is verantwoordelik vir groter getalle sterftes as gevolg van n 
aansteeklike siekte. Middelweerstandigheid is algemeen en gevalle van meervoudigemiddelweerstandige 
tuberkulose (MDR-TB) en uiters weerstandige tuberkulose (XDR-TB) kom in verskeie lande voor. Antibiotika 
behandeling is problematies en nuwe anti-TB middels word nie vinnig genoeg ontwikkel om die antibiotika 
weerstandigheid mutasie spoed van M. tuberculosis te bekamp nie. Doeltreffende diagnostiese toetse word 
benodig om die verspreiding van die siekte te beheer en bestaande roetine diagnostiese toetse voldoen tans 
nie aan hierdie vereiste nie. Behalwe hiervoor, is huidige vinnige TB diagnostiese toetse buite bereik van arm 
instansies weens vereistes aan infrastruktuur, meegaande kostes en werknemervaardigheid. Nuwe TB 
diagnostiese toetse is dus nodig om aan hierdie vereistes te voldoen. Mikobacteriofaage is fage wat 
mikobacteria infekteer en kan moontlik 'n lewensvatbare en koste-effektiewe alternatief bied vir 
vinnige TB diagnostiese toetse. In hierdie studie word 'n affiniteitgekoppelde fluoreserende 
rapporteringsmikobakteriofaag beskryf wat ontwerp is om op te tree as `n nuwe vinnige TB diagnostiese 
toets. Die werking hiervan vertoon gunstige en beter resultate as die huidige, mikobacteriofaag-
gebaseerde TB-diagnostiese toetse. 
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Chapter 1: Introduction 
1.1 Mycobacterium tuberculosis epidemic background  
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tb), is a major cause of death worldwide 
with a death toll of 1.7 million people in 2009 (World Health Organization, 2009a). In the same year, 
9.4 million new TB cases were detected, exacerbating the state of the epidemic. Multiple drug 
resistant (MDR) (defined by resistance to isoniazid and rifampicin, with or without resistance to other 
first-line drugs) as well as extensively drug resistant (XDR) TB) (defined by resistance to isoniazid and 
rifampicin, and any fluoroquinolone as well as resistance to a second-line injectable such as 
capreomycin, amikacin, and kanamycin) have also emerged in recent years making treatment difficult 
and expensive. The WHO stated that 2010 had been the year in which the highest rates of MDR-TB 
and that XDR-TB had been detected in at least 58 countries (World Health Organization, 2010). 
Clearly, there is a drastic need to address the spread of the TB epidemic through rapid diagnostics 
and effective treatment regimens, as the current methodology is not suitable to effectively address and 
contain the disease. 
 
1.2 Infection and treatment 
TB is transmitted through inhalation of aerosolized respiratory droplets containing M. tb bacilli, 
commonly spread through coughing (Strull & Dym, 1995). Aerosolized M. tb particles can stay 
airborne for a long period of time, remaining infective and potentially exposing many people to the 
disease (Wells, 1955). The WHO estimates that one third of the world's population is infected with M. 
tb (Corbett et al., 2003, World Health Organization, 2009a). Exposure results in a 5-10% lifetime 
chance of developing active TB (Harries & Dye, 2006), a figure which rises dramatically to 10% per 
year if the individual is HIV infected (Decker & Lazarus, 2000). 
 
As M. tb manifests itself in the lungs, the body fends off the disease by forming granulomas to contain 
the bacterium (Saunders & Britton, 2007). M. tb can stay dormant and viable for extensive periods of 
time inside granulomas. These granulomas can spontaneously rupture at a later period to expose 
viable bacteria into new areas of the lung, culminating in drastic disease progression (Saunders & 
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Britton, 2007). If the disease is allowed to persist, it can lead to disseminated tuberculosis during 
which the bacteria spread throughout the body causing further morbidity. As the body forms 
granulomas in order to contain the bacteria, it inadvertently shields the M. tb bacilli from the 
bacteriostatic and bactericidal effects of antibiotic treatment since current anti-TB drugs cannot 
permeate granulomas. A further complication in drug treatment of TB, is the slow replication rate of the 
organism of 12 to 18 hours (Strull & Dym, 1995), and its ability to enter a dormant non-replicating 
state. Almost all classes of antibiotics currently in use require replicating targets for effective drug 
action (Saunders & Britton, 2007). Drug treatment regimens thus span over extensively long periods in 
order for a patient to be considered as cured, 6-8 months for drug sensitive TB and 18-24 months for 
MDR-TB (which is also much more costly) according to the WHO recommendations (World Health 
Organization, 2009a). Despite the long drug treatment period, cured patients still have a risk of relapse 
after drug treatment due to reactivation of dormant M. tb (Saunders & Britton, 2007), which also 
carries an increased risk of drug resistance (World Health Organization, 2009b).  
 
The WHO currently recommends a standard 6-8 month drug regimen for new, previously untreated, 
TB patients which consists of four drugs: isoniazid, rifampicin, pyrazinamide, and ethambutol. 
Isoniazid and rifampicin is used for two months followed by a continuation phase of 4-6 months 
consisting of isoniazid and rifampicin (ethambutol is added in high rifampicin resistance settings) 
(World Health Organization, 2009b). Such a combination therapy is given to avoid drug resistance 
associated with mono-therapy (David, 1970). If resistance to isoniazid and rifampicin is encountered, 
the patients are considered to have MDR-TB which is treatable only with second line drugs. If 
additional resistance to quinolones and an injectable aminoglycoside (kanamycin, capreomycin or 
amikacin) is encountered then the infection is considered XDR-TB, in which case the amount of 
remaining effective drugs is drastically reduced (World Health Organisation, 2006). The WHO 
recommends that patients that have been previously treated require drug susceptibility testing (DST) 
to confirm or exclude MDR-TB since MDR is prevalent in 15.3% of retreatment cases (World Health 
Organization, 2009b). However, most high burden TB countries lack the necessary DST facilities and 
funding to perform DST, which leads to incorrect drug regimens and poor patient outcomes (Parsons 
et al., 2011). In the case where DST is available, a specific drug regimen can be selected to best suit 
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the patient to improve patient outcome. A further problem with TB treatment is patient non-compliance 
or fallout where patients either take their drugs irregularly, or do not complete their treatment cycle 
(Parsons et al., 2011). There are several reasons why patient fallout occurs, such as loss of financial 
income, adverse side-effects of drugs and patients stopping due to the fact that they feel better etc 
(Parsons et al., 2011). The outcome of patient fallout is troublesome; if the patient has interrupted 
treatment for longer than 2 months, the WHO recommends DST to be performed, which is not readily 
available to low resource settings (World Health Organization, 2009b). The problematic TB treatment 
process stresses the importance of diagnostics in early detection and prevention of TB. 
 
1.3 TB diagnostics 
Routine TB diagnosis typically starts with clinical examination, followed by chest radiography if the 
patient presents with typical symptoms of TB such as persistent cough, night fever and weight loss 
(Zaman, 2010). If pulmonary TB is suspected, the tuberculin skin test (TST) is performed on the 
patient and a sputum sample is taken for smear microscopy as well as culture testing in most high 
burden TB countries (Parsons et al., 2011). This is however not the case in resource-limited settings 
which often use smear microscopy as definitive indicator for TB infection (Parsons et al., 2011). The 
following section contains a summary of existing routine diagnostics currently in use, as well as new 
emerging TB diagnostics.  
 
1.3.1 Chest radiography 
Chest radiography is widely used in the diagnosis of patients with active TB since infection typically 
leads to distinct patterns such as upper lobe infiltrates, cavities, hilar and mediastinal 
lymphadenopathy (Trinker et al., 1996). Chest radiography is typically used if a clinician determines 
that the patient presents a positive skin test and/or symptoms such as persistent cough, night swears, 
weight loss, fever or chills(). However, radiographs are only suggestive of TB and do not offer a 
definitive test. Radiographs may show abnormalities from previous TB infection as well as similar 
radiograph features due to other diseases, which require further testing to validate, and which means 
that radiographs are mostly useful to rule out TB. Due to the poor performance (reader bias, poor 
sensitivity and specificity) of chest radiographs, the WHO discouraged its use since 1974 for two 
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decades in favour of sputum microscopy (see Section 1.3.2) for symptomatic patients (World Health 
Organization, 1974). The WHO continued to discourage their use in 1994 with the implementation of 
DOTS (directly observed treatment short-course) (World Health Organization, 1994).  
 
1.3.2 Microscopy-based TB diagnostics  
Mycobacteria have a particularly thick lipid layer which causes them to retain certain chemical stains 
despite de-staining steps with acidic reagents (Brennan & Nikaido, 1995). They are thus called “acid-
fast” bacteria. Smear microscopy involves spreading clinical samples onto a glass slide followed by 
staining the sample with one of several staining techniques followed by analysis using microscopy 
(Steingart et al., 2006). The three most widely used staining techniques are Ziehl–Neelsen, auramine–
rhodamine fluorochrome and Kinyoun stains (Attorri et al., 2000, Gordin & Slutkin, 1990). Smear 
microscopy has several drawbacks. Firstly, it is not specific to M. tb, since it will detect all acid fast 
bacilli, which decrease the specificity of the test. The sensitivity of the test is also low due to its 
detection limit, as at least 5000 to 10 000 bacilli/ml of sputum is needed for detection (Hobby et al., 
1973). This results in the test only detecting an estimated 45% of active pulmonary disease (Dinnes et 
al., 2007, Dye et al., 1999, Dye et al., 2005). Smear negative TB is higher in HIV positive patients, 
than in HIV negative patients which decreases sensitivity below the estimated 45% (Steingart et al., 
2006) to as low as 10-30% (Vittor et al., 2011). Furthermore, the test cannot distinguish between 
viable and nonviable cells and also cannot provide drug resistance information (Dinnes et al., 2007). 
Despite the drawbacks of smear microscopy, it is still widely used, since the test is relatively rapid, 
inexpensive, does not require much equipment compared to culture and because it detects the 
patients with the highest bacillary load (i.e. the individuals who are the most infective) (Steingart et al., 
2006). However, with the drawbacks of low sensitivity as well as the need for further validation for 
strain, species and drug resistance information, light microscopy is a less than ideal diagnostic.  
 
Recent improvements in microscopy have led to an improved performance through alterations to 
sample processing and use of fluorescence microscopy and LED microscopy. Specimen processing 
has been shown to increase sensitivity in comparison to direct sputum smears (Steingart et al., 2006). 
It has also been shown that using bleach and centrifugation on HIV positive patient samples results in 
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a 15% (5% for HIV negative) increase in sensitivity for smear microscopy and a 17% (2% for HIV 
negative) increase for fluorescence microscopy (Eyangoh et al., 2008). Fluorescence microscopy 
could potentially increase the sensitivity of smear microscopy and improve the efficiency of facilities, 
since these microscopes allow a larger area of the smear to be visualized, resulting in improved 
sample processing time. Fluorescence microscopy has been shown to have superior diagnostic 
capacity compared to conventional microscopy, especially in HIV positive patient samples. 
Fluorescence microscopy has an average of 10% more sensitivity than conventional smear 
microscopy (Steingart et al., 2006). LED lamps are, however, not readily available in all countries. 
Although these improvements will increase the usefulness of microscopy, results still need to be 
confirmed by other diagnostics, most commonly through culture.   
 
1.3.3 Culture-based TB diagnostics 
Culture is currently the definitive routine diagnostic and it is the gold standard for TB diagnosis as well 
as DST (Kalantri et al., 2005). This method relies on culturing clinical samples on solid or liquid media, 
and in the case of DST, in conjunction with various anti-TB drugs. Solid media is based on egg or agar 
such as Löwenstein-Jensen, Ogawa, Middlebrook (Saito, 1998). The slow replication rate of M. tb 
limits the speed of culture-based detection and drug susceptibility testing with results available in only 
about 6-8 weeks (Dinnes et al., 2007). During this extended period of time the patient has the potential 
to contribute to the spread of the epidemic until an effective drug regimen is administered to the 
patient. Culture results are not always reliable since not all clinical samples can be cultured. 
Additionally, patients may have multiple strains of TB which may have varying drug resistance profiles 
and may represent varying amounts of the total M. tb bacterial population in the patient. Drug 
treatment provides a purifying selection against drug suseptable strains and provides grounds for 
positive selection for drug resistant strains. However, it is also possible that a drug sensitive strain may 
be the predominant strain amidst drug resistant strains which could lead to false diagnosis of drug 
susceptibility if the ratio is less than 1%. Sensitivity is also reduced by the initial decontamination step 
during which many M. tb bacilli are killed. Culture based TB diagnosis requires a specialized 
biohazard level 3 area and skilled workers, which is unsuitable for resource limited TB centers. 
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There have been various attempts to improve culture, as exemplified by the BACTEC, MGIT 
(Mycobacteria Growth Indicator Tube) and CONTAS systems. The BACTEC method makes use of 
media containing radio-labled carbon-14 and works on the principle that mycobacterial growth is 
proportional to radio-labeled CO2 released, which can then be detected (Roberts et al., 1983). This 
means that mycobacterial growth can be detected before colonies are observed, shortening the 
detection time. Despite the improvement in time to detection, the assay still requires a lengthy 5-15 
days for a positive result (Rusch-Gerdes et al., 1999). Furthermore the BACTEC system cannot 
perform speciation of mycobacteria and cannot culture all isolates, thus certain isolates will still have 
to be cultured on solid media (Roberts et al., 1983). The BACTEC system is also labor intensive and 
expensive, making it unsuitable for use as a routine TB diagnostic (El Sayed & Goda, 2007).  
 
The mycobacteria growth indicator tube (MGIT) makes use of liquid culture in Middlebrook 7H9 broth 
as well as a fluorescence quenching-based oxygen sensor. A UV source is used to take fluorescence 
readings which are proportional to mycobacterial growth (El Sayed & Goda, 2007). The assay has 
similar sensitivity and specificity as the BACTEC culture method and the same pitfalls. The MGIT 
system requires 3 to 15 days for a positive result, is incapable of speciation and drug susceptibility 
testing capabilities are limited (El Sayed & Goda, 2007, Rusch-Gerdes et al., 1999). Based on this, 
attempts have been made to develop simplified culture techniques.  
 
The nitrate reductase assay (NRA) is a culture based rapid drug resistance diagnostic for M. tb. Media 
containing potassium nitrate (such as Löwenstein-Jensen) turns pink as M. tb reduces potassium 
nitrate to nitrite and this signal in conjunction with the presence of rifampicin or isoniazid in the media 
is indicative of drug resistance. The assay has a sensitivity and specificity of 97% and 100%, 
respectively, for rifampicin resistance testing and 96% and 99% for isoniazid resistance testing. The 
assay requires 6.5 days for liquid media growth detection and 7-12 days for solid media. Based on 
these results, the WHO has also endorsed the method for rapid drug resistance testing (Vittor et al., 
2011).  
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TK MEDIA® is a colorimetric detection system for TB detection where the media also changes color in 
response to mycobacterial growth (Baylan et al., 2004). The media changes into different colors for 
either M. tb growth, no growth or contaminated growth. Mycobacterial growth is detectable within 2 
weeks, whereas conventional testing with Lowenstein-Jensen (LJ) medium requires a minimum of 4 
weeks to obtain results (Baylan et al., 2004). TK MEDIA® offers the advantage of a simplified visual 
readout more suitable for low resource settings and the ability to distinguish between M. tb growth and 
contamination (Pai et al., 2006b). However, contaminant gram-positive bacteria can give color 
changes similar to mycobacteria and would require further testing to confirm (Baylan et al., 2004). 
Additionally, the media is pH sensitive and samples that have not been sufficiently neutralized thus 
affect the time of media color change (Baylan et al., 2004). However, the media has been shown to 
have similar sensitivity and specificity to LJ culture (Baylan et al., 2004). TK MEDIA ® currently only 
offers drug resistance testing to four drugs (isoniazid, rifampicin, streptomycin and ethambutol) and 
does not support speciation (Baylan et al., 2004). TK MEDIA® offers advantages over other culture 
methods but its shortcomings described above, combined with a 2 week waiting period, makes it 
unsuitable for wide-spread use.  
 
Microscopic Observation Direct Susceptibility (MODS) assay is a culture-based TB diagnostic 
developed to reduce the time to detection of culture. Micro-wells are filled with liquid media and 
inoculated with the bacterial sample, with some wells also containing rifampicin and isoniazid. 
Bacterial growth leads to colony formation which is detected using an inverted microscope. Growth in 
the wells which contain drugs are indicative of drug resistance. MODS have a growth detection time of 
7 days and simultaneously tests for rifampicin and isoniazid resistance (in comparison to ~13 days for 
LJ and additional culture time requirement for drug resistance detection). The assay is relatively rapid 
for a culture-based diagnostic and is also accurate and cheap. Two studies have evaluated the 
performance of the test on HIV positive patients and the sensitivity was 87-98% with a specificity of 
93-94%. The test also had a diagnostic time of 7-8 days in comparison to 11 days for liquid culture 
and 21 days for solid media (Arias et al., 2007, Ha et al., 2010). The assay has a reduced biohazard 
risk, since the cultures are sealed in a transparent bag. Additionally, the assay is less prone to 
contamination than conventional culture (Ha et al., 2010). Due to these favorable aspects, the WHO 
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has recently endorsed MODS as TB diagnostic (World Health Organisation, 2010). Although the assay 
has a favorable performance in comparison to conventional culture, there are a few drawbacks. 
Colonies of non-tuberculous mycobacteria (NTM) could be difficult to distinguish M. tb from other 
mycobacteria and thus skilled operators are required (Parsons et al., 2011). The assay is also more 
complex than smear microscopy and requires biosafety culture facilities which are not feasible for low 
resource settings (Parsons et al., 2011). 
 
The thin layer agar method is another method of microscopic observation which is performed on solid 
media. M. tb is grown on plates containing a thin layer of agar, some also containing rifampicin or 
isoniazid for DST, followed by microscopic observation for growth. Standard microscopes are suitable 
for microscopic observation using the thin layer agar method.  The assay, when performed on smear 
positive samples, has a reported diagnostic time of 10.6 days with a sensitivity of 97.3% (Martin et al., 
2009a). The thin layer agar method has also been tested on smear negative samples, which had a 
reported median time to growth detection of 14 days with a sensitivity of 74% (Martin et al., 2009b). 
The assay has the same advantages as other solid media based assays, but with a slightly lower 
sensitivity and slower diagnostic time. However, further studies are needed to validate the diagnostic 
assay. The long waiting period for growth detection and requirement for biohazard facilities and 
trained staff, results in this method not being suitable as a routine diagnostic.  
 
1.3.4 Nucleic acid amplification assays 
Nucleic acid amplification tests (NAAT) are polymerase chain reaction (PCR) based methods and 
includes in-house and commercial assays as well as nucleic acid probe amplification assays. NAAT 
diagnostics have become a frequent diagnostic tool for TB, mainly due its rapid and sensitive results. 
NAAT based TB diagnosis are based on TB-specific DNA amplification, which targets genes such as 
IS6110, MBP64, rpoB and hsp65, and can be done directly on clinical samples such as sputum 
(Cheng et al., 2004, Noordhoek et al., 2004, Pai et al., 2006b). NAATs are also very suitable for high 
throughput, especially if automation is possible. A systematic review of 106 NAATs (commercial and in 
house assays, on respiratory samples) have shown that the overall sensitivity and specificity is 86% 
and 97%, respectively, in the pooled analysis (Dinnes et al., 2007). Smear positive samples had a 
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sensitivity of 97% and smear negative samples had a sensitivity of 73%. The study also showed low 
sensitivity for extrapulmonary samples. The high smear positive sensitivity, low smear negative and 
extrapulmonary sensitivity has also been reported in other studies (Cheng et al., 2004, Nahid et al., 
2006, Pai et al., 2006b). The high specificity of NAAT allows for a preliminary early diagnosis to help 
set up appropriate drug regimens while waiting for culture confirmation results (Cheng et al., 2004, 
Greco et al., 2006). The high sensitivity on smear positive samples allows for ruling out of TB, 
however, this is not the case of smear negative samples due to the lower and varying sensitivity 
(Greco et al., 2006, Pai et al., 2006b). Thus PCR can also not replace culture and can only be used to 
help interpret the results (Nahid et al., 2006). PCR also cannot distinguish between dead and live 
mycobacteria and is susceptible to amplicon contamination, both of which could lead to false positives. 
Further drawbacks of PCR are that it is expensive (especially the commercial kits), and requires skilled 
staff and infrastructure, which is not suitable for use in the field (Dinnes et al., 2007). PCR-based TB 
detection currently only acts in conjunction with other less rapid tests. There is thus a need to improve 
PCR methods for TB detection and the Xpert®MTB/RIF and LAMP TB diagnostic tests are two 
examples of recent improvements. 
 
The Xpert®MTB/RIF is an automated cartridge-based NAAT system which concentrates and purifies 
sputum, followed by PCR amplification of M. tb genomic and rifampicin-resistance genes. The assay 
requires relatively minimal training, has a detection limit of only 5 genome copies or 131 cfu/ml, and 
generates results in less than 2h (Van Rie et al., 2010). The performance of the Xpert® MTB/RIF 
assay was tested in a multi-country study consisting of 1730 patients (Boehme et al., 2010). The 
assay has a high specificity of 98% but with a variable sensitivity of 98.2% for smear-positive TB and 
72.5% for culture positive smear-negative TB (Boehme et al., 2010). The assay also has the drawback 
of requiring a constant electrical power supply, biosafety facilities, annual calibration and trained 
personnel (Van Rie et al., 2010). 
  
Loop-mediated isothermal amplification (LAMP) is a simplified nucleic acid amplification method that 
makes use of uninterrupted isothermal DNA amplification, followed by visual fluorescence detection, 
and has recently been applied to Mycobacterium detection (Iwamoto et al., 2003). LAMP makes use of 
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Bst DNA polymerase, enabling auto-cycling strand displacement and production of large amounts of 
product DNA at a constant temperature (Iwamoto et al., 2003). The use of Bst DNA polymerase also 
confers a relatively high specificity of primers at 67°C (Boehme et al., 2007). Isothermal DNA 
amplification saves time in comparison to normal PCR, since there are ramping steps while cycling 
through temperatures. The primers used are species-specific for the gyrB gene and consists of four 
primers that recognize six regions of the gyrB gene, giving the assay high specificity (Boehme et al., 
2007, Iwamoto et al., 2003). DNA is extracted from sputum samples and the DNA and LAMP reagents 
are mixed in one tube followed by amplification and detection (Boehme et al., 2007). In the latest 
version of the assay (developed by Eiken Chemical Company together with the Foundation of 
Innovative New Diagnostics (FIND)) the reaction mixture contains calcein and manganese ion, and 
this allows fluorescence detection only in the case of DNA amplification (Boehme et al., 2007). Calcein 
is a fluorescent chelating reagent which is quenched by manganese ion. However, pyrophosphate is 
produced by the LAMP reaction which binds to manganese ion to restore the fluorescent properties of 
calcein in the case of a positive LAMP reaction. Fluorescence (from calcein) is detected by the naked 
eye using a UV-source and combined with the turbidity caused by manganese pyrophosphate, creates 
an easy to detect positive result. The assay’s capability for detection of M. tb has been shown to 
outperform microscopy in both smear positive and smear negative (culture positive) samples (Boehme 
et al., 2007). The assay also takes about the same amount of time as smear microscopy to perform, 
with negligible reader to reader bias (Boehme et al., 2007). The assay has the advantages of needing 
little laboratory equipment (UV source and heating block), being relatively rapid (about 60 min), and 
requiring a low level of technical skills. However the assay shares various downfalls with other PCR-
based TB diagnostics. For example the sensitivity is low (48.8%) in smear negative, culture positive 
samples. Non-specific amplification also occurs if the LAMP reaction is not stopped (by incubating for 
2 min at 80°C) within 70 min after the end of amplification, and the assay currently lacks diverse 
speciation capability (only M. tb, M. avium and M. intracellulare cannot be differentiated). The assay 
also does not have an internal amplification control, making the results questionable for routine TB 
diagnostics. Another drawback of the assay is the lack of the ability for drug susceptibility testing in its 
present format, so that it would still require subsequent culturing of clinical samples. Thus the LAMP 
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assay for TB clearly offers advantages over microscopy, but cannot replace current diagnostics and 
only acts as an adjunct to culture. 
 
Nucleic acid probe assays are based on detection of DNA through hybridization to a probe. The 
assays generally make use of initial culture and cell lysis, followed by hybridization to probes of 
specific design for strain speciation and in some cases drug resistance detection. The AccuProbe 
assay is a nucleic acid probe speciation test that can detect M. tb complex, M. avium complex, M. 
intracellulare, M. kansasii and M. gordonae from lysed culture in about 1-2 hours (Dinnes et al., 2007). 
However, a separate test must be performed for each organism. An improvement on this assay is the 
Line probe assays which are PCR-based reverse hybridization assays. Two prominent line probe 
assays for TB are in use, the INNO-LiPA Rif for use on solid culture isolates and the Genotype 
MTBDR (and Genotype MTBDRplus) assay for use on solid culture, liquid culture and smear positive 
samples. Line probe assays are based on PCR amplification of bacterial DNA, followed by detection 
through hybridization to a probe-containing strip. Regions of the bacterial DNA are amplified, which 
allow detection of the M. tb complex, as well as drug resistance. The INNO-LiPA Rif assay amplifies 
the rpoB gene (conferring rifampicin resistance) and the Genotype MTBDRplus amplifies both the 
rpoB gene as well as the isoniazid resistance genes by detecting mutations in the katG gene and inhA 
promoter. A recent study which focused on the application of the line probe assay for DST showed a 
sensitivity of 99% (for both rifampicin and isoniazid) and a specificity of 99% with a turnaround time of 
1-2 days (Barnard et al., 2008). The line probe assays share the downfalls of conventional PCR such 
as the requirements for a DNA extraction room and separate PCR room, the sensitivity of the assay 
for amplicon contamination (causing false positives), the requirement for skilled operators and 
expensive equipment and the need for initial culture (except in the case of smear positive samples for 
the Genotype MTBDRplus). It is thus necessary to culture smear negative samples, leading to 
diagnostic delay. Despite the high accuracies, the Accuprobe, INNO-LiPA and MTBDRplus tests have 
costs, equipment and staff requirements that limit their diagnostic use. 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
12 
 
 
1.3.5 Antigen-based assays 
There are various TB diagnostics that make use of antigen detection as well as sensitization to 
antigens. These tests are used in conjunction with other TB diagnostics for a definitive diagnosis, 
since they can only diagnose latent TB (except for the skin patch test) and are incapable of DST. The 
tests can be subdivided into skin- and blood-based tests. The skin-based tests are the Tuberculin Skin 
Test (TST) and skin patch TB tests. The blood tests are the QuantiFERON™-TB Gold test (QFT-GIT; 
Cellestis Ltd, Carnegie, Australia), QuantiFERON-TB Gold In-Tube test (QFT-GIT; Cellestis Ltd, 
Carnegie, Australia) and T-SPOT.TB test (Oxford Immunotec, Abingdon, UK). The main difference 
between the skin and blood tests (other than antigen compositions) are in the way the antigens are 
administered and measured. In the skin patch test the antigens are placed on top of the skin, eliciting 
an immune response on the skin. In the TST method the antigens are injected below the epidermal 
layer, causing an inflammatory reaction, where after the resulting indurated area is measured 
(Andersen & Heron, 1993). In the blood tests, the T-cells are stimulated in vitro to produce Interferon-γ 
which is measured by ELISA in conjunction with a plate reader (Pai et al., 2006a).  
 
The tuberculin skin test (TST) is one of the oldest TB diagnostics, yet is still frequently used (Andersen 
et al., 2000, Richeldi, 2006). It has low sensitivity and specificity and this limits its use as a diagnostic 
(Andersen & Heron, 1993, Richeldi, 2006). The antigens used in the test is obtained from a purified-
protein derivative (PPD) of a culture filtrate of heat-killed tubercle bacilli (Richeldi, 2006). PPD contains 
over 200 antigens that are not only present in M. tb, but also many other species of mycobacteria, 
including the vaccine strain M. bovis BCG (Bacille Calmette ét Guerrin) (Andersen et al., 2000, 
Richeldi, 2006). This gives the test a low specificity. Patients in contact with mycobacteria other than 
M. tb and patients with prior BCG vaccination could falsely test positive for latent M. tb infection 
(Richeldi, 2006). HIV infected and other immune-compromised patients have a substantially reduced 
immunologic response to PPD and thus a lower sensitivity to TST (Vittor et al., 2011). The test also 
has a boosting effect whereby the patient becomes increasingly sensitized to the various antigens in 
the PPD each time the test is taken, creating false positives (Richeldi, 2006). Following PPD injection 
into the patient’s skin, an inflammatory response is measured after 3 days (Andersen et al., 2000). 
The test is easy to administer and suitable for field use, however experienced workers are needed to 
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accurately interpret the results. Furthermore, patients have to come back to the diagnostic center for 
the result to be read and this leads to patient fall out. Compounding the problem, the reading of the 
induration is subject to reader bias. These factors make the test unreliable and inefficient. 
 
An improvement on TST is the Sequella TB skin patch test, a trans-dermal patch that elicits a 
distinctive skin response in patients with active TB. The test is currently being developed as a 
commercial diagnostic. The test makes use of mycobacterial antigen MPB64, an antigen secreted by 
M. tb, M. bovis and certain strains of BCG during active growth (Andersen et al., 2000, Nakamura et 
al., 2001). The patch has been shown to distinguish between active and latent TB and cured TB 
(Nakamura et al., 1998, Nakamura et al., 2001, Pai et al., 2006a). The skin patch test has previously 
been shown to have high sensitivity and specificity and the results are available within 3-4 days 
(Nakamura et al., 1998, Nakamura et al., 2001, Pai et al., 2006a). The test also has the advantage 
that it does not require skilled staff or expensive infrastructure. However, the test is not without 
problems. Concerns of false diagnosis of TB in patients with M. bovis infections or BCG vaccinated 
individuals have been raised, which would require further testing to confirm results. The diagnostic 
also requires a repeat visit, leading to patient fallout, and it is unknown what the performance of the 
test will be in HIV patients. As with the TST, tests that rely on healthy immune responses to antigen 
challenge are of concern in HIV infected and other immune-compromised patients. Performance is 
also of concern in children, patients with a dark skin color and drug treated patients (Nakamura et al., 
2001, Pai et al., 2006a). The TST and skin patch tests are minimally invasive tests, yet also have 
disadvantages. TB diagnostics based on assays of blood samples offer alternative diagnostic 
methodologies.  
 
Blood tests rely on measurement/quantification of interferon-γ production by T-cells in response to M. 
tb antigens (Dinnes et al., 2007, Richeldi, 2006). Patients with an M. tb infection are sensitized to the 
antigens used in the blood tests (Dinnes et al., 2007). When their blood samples are exposed to these 
antigens, interferon-γ is produced by the lymphocytes (Dinnes et al., 2007). Early blood tests made 
use of PPD and consequently also had trouble distinguishing between M. tb and atypical mycobacteria 
(yet could distinguish between M. tb and M. avium) and gave false positives due to BCG vaccination 
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(Dinnes et al., 2007, Pai et al., 2006a). The QuantiFERON™-TB Gold,  QuantiFERON™-TB Gold In-
Tube test (QFT-GIT) test and the T-Spot TB test, however, are blood tests that make use of specific 
antigens from region of difference 1 (RD1) in the M. tb genome (Dinnes et al., 2007, Richeldi, 2006). 
The antigens used are the 6kDa early secretory antigenic target (ESAT-6) and the 10kDa culture 
filtrate protein (CFP-10) as well as TB7.7 (Dinnes et al., 2007, Pai et al., 2006a, Richeldi, 2006). 
These antigens are not present in non-tuberculous mycobacteria, except for M. kansasii, M. szulgai, 
and M. marinum (which could lead to cross reactions in the case where patients are infected with one 
these strains). Although the interferon-γ release assays are based on the same antigens they have a 
few differences in the way that they detect their antigens. The The QuantiFERON™-TB Gold test uses 
whole blood with an unknown amount of leukocytes and measures the amount of interferon-γ in the 
supernatant of the blood sample (Richeldi, 2006). In contrast, the T-Spot TB test quantifies the amount 
of interferon-γ producing T-cells and reads the amount of individual T-cells producing interferon-γ 
(Richeldi, 2006). These tests require 1-2 days for results (Pai et al., 2006a). The blood tests are not 
subject to reader bias, as is the case with the TST test, since they make use of automated equipment 
(Dinnes et al., 2007). There is also no need for a return visit and there is no “boosting” effect where 
the patient is sensitized by repeat tests as is the case with the skin tests (Dinnes et al., 2007, Richeldi, 
2006).  
 
The blood tests are thus a valuable asset for rapid screening of TB patients and for advising on which 
patients to further screen for TB with conventional tests. A meta-analysis by Pai and co-workers 
determined that the pooled sensitivity was 78% for QuantiFERON-TB Gold, 70% for QFT-GIT, and 
90% for T-Spot TB (Pai et al., 2008). However there is no gold standard for latent TB detection, 
making comparison studies indefinite (Pai et al., 2006a). The drawbacks of the blood tests are that 
they cannot confirm active TB and only indicates a likelihood of TB infection (Pai et al., 2006a). 
Furthermore, samples must be processed within 12-16 hours and the test and interpretation of results 
require skilled staff, (Dinnes et al., 2007, Pai et al., 2006a, Richeldi, 2006, Vittor et al., 2011). The 
tests also uses infrastructure not ideal for use in the field or low resource settings with limited staff (Pai 
et al., 2006a). Furthermore, there is still a chance for tuberculosis mycobacterial cross reactivity or 
cross-reactivity due to BCG vaccination, as a large number of tuberculosis mycobacterial species 
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contain homologs of ESAT-6 and CFP-10. Interferon-γ release assays are expensive to process and 
require a 24h waiting period to generate results. These attributes make IGRAs less than ideal as TB 
diagnostics. As an alternative to detecting antigens by means of blood or skin tests, the Capilia TB 
assay (TAUNS Laboratories, Inc.) is performed directly on culture isolates. The assay is a lateral-flow 
immunochromatographic assay which, as with the skin patch test, detects the MPB64 antigen 
(Muyoyeta et al., 2010). Following initial MGIT culture (how many days) a small amount of the culture 
is added to the sample wells which contain a strip. The culture is incubated with the strip for 15 min 
after which readout from the strip is taken. In one study the Capilia assay had a sensitivity and 
specificity of 99.6% and 99.5% respectively compared to a DNA strip test (Muyoyeta et al., 2010). A 
further study found that the assay had a sensitivity and specificity of 98.4% and 97.9% respectively 
with results available in 20 min (Muchwa et al., 2012). Despite the rapid time for results generation, 
the assay relies on initial culture which is time consuming and requires specialized biohazard facilities 
which is not suitable for field settings.  The assay has also been shown to be liable to false negatives 
for M. tb complex samples as well as false positives for non-tuberculious mycobacterial isolates due to 
mutations in the mpb64 gene (Muchwa et al., 2012, Muyoyeta et al., 2010).  
 
1.3.6 Mycobacteriophage-based TB diagnostics 
1.3.6.1 Mycobacteriophage replication assays 
Mycobacteriophages are Mycobacterium-specific phages, the first of which was identified in 1947 
(Gardner & Weiser, 1947). Since then, over 250 mycobacteriophages have been isolated (Hatfull & 
Jacobs, 1994, McNerney, 1999). Mycobacteriophages isolated to date have double stranded DNA and 
are of the siphoviridae or myoviridae morphotype (Hatfull et al., 2008). Initially, mycobacteriophages 
were considered for use in taxonomic studies and phage typing (see Section 1.5.3.1) (Redmond & 
Ward, 1966). David and coworkers developed a bacteriophage replication assay for mycobacteria 
which makes use of sensor cells to overcome the slow replication rate of M. tb (David et al., 1980, 
Jones & David, 1971), In their assay, the M. tb sample is incubated with mycobacteriophage D29, 
treated with an antiviral agent and then plated onto a lawn of M. smegmatis. Progeny phages are 
detected by plaque formation which is possible since D29 can infect both M. tb and M. smegmatis. 
The role of the antiviral agent is to kill off excess phages that did not take part in the initial infection, to 
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avoid false positives due to mycobacteriophages remaining in the culture media. Inactivation of excess 
mycobacteriophage is possible by treatment by acid, sodium hydroxide as well as ferrous (iron II) salts 
(ferrous iron is less harsh to the cells harboring the mycobacteriophage and thus preferable) 
(McNerney et al., 1998). Bacteriophage replication assays have been tested in various studies with 
varying performance outcomes as shown in Table 1. Bacteriophage replication assays offer the 
advantage of detecting smear negative culture positive samples and indicates successful drug 
treatment since killed cells are not detected despite positive smear results (Prakash et al., 2009). 
However, the detection limit of bacteriophage replication assays has been estimated to require at least 
100-300 bacilli/ml for a positive result (Albay et al., 2003). This is 10 fold higher than for culture. 
 
Table 1. Bacteriophage replication assay studies highlighting varying levels of sensitivity and 
specificity.  
Sensitivity (%) Specificity (%) Samples Setting Reference 
75.2 99 1618 South Africa  (Albert et al., 2002) 
81.6 97.7 514 Pakistan  (Muzaffar et al., 2002) 
87.5 96.9 192 Turkey  (Albay et al., 2003) 
58.3 99.1 2008 Spain  (Alcaide et al., 2003) 
63.6 82.6 38 Egypt  (Marei et al., 2003) 
44.1 92.4 496 Zambia  (McNerney et al., 2004) 
93 96 370 India  (Hemvani et al., 2012) 
 
Mycobacteriophages gained popularity when shown capable of screening antibacterial agents and 
discerning between drug resistant isolates and drug sensitive isolates to streptomycin (Tokunaga & 
Sellers, 1965), kanamycin (Nakamura et al., 1967), rifampicin (Jones & David, 1971), clofazimine, 
colistin, dapsone and (to a lesser extent) isoniazid (David et al., 1980). This is possible since the 
above listed anti-tuberculosis drugs block phage replication in susceptible strains and allow replication 
in drug resistant strains, allowing grounds for detecting drug resistance. Screening for ethambutol and 
isoniazid resistance, however, require several days incubation of the sample with the drugs, since 
these drugs do not block phage replication directly and they are only active in certain cell growth 
stages (David et al., 1980, Wilson et al., 1997). 
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Several studies have investigated the use of bacteriophage replication assays for M. tb drug 
resistance screening. A review which included 11 studies of bacteriophage replication-based DST 
showed a 100% detection rate of rifampicin resistance for 10 of the 11 studies when compared to 
culture (McNerney & Traore, 2005). Shortly thereafter, a bacteriophage replication assay for drug 
resistance screening was performed in South Africa, which included 133 samples and had a sensitivity 
of 100% and specificity of 98.8% (Albert et al., 2004). A meta-analysis on bacteriophage replication 
based DST included 14 studies which showed that bacteriophage replication assays have a high 
sensitivity and specificity. The majority (58%) of the studies had more than 95% sensitivity and 
specificity when used to test culture isolates (Pai et al., 2005). However, concerns over false positives, 
potential for contamination and indeterminate results were raised, since they hinder use of 
bacteriophage based DST assays.  
 
A variation on the bacteriophage replication assay is the use of a micro-well format for drug resistance 
testing (Gali et al., 2006, McNerney et al., 2000). The assay makes use of initial incubation of M. tb 
samples with anti-TB drugs in a micro-well format. This requires 24h incubation for rifampicin and 72h 
for isoniazid. The sample is then mixed with mycobacteriophage D29 and incubated. Ferrous 
ammonium sulfate (FeNH3SO4) is then added to inactivate excess mycobacteriophage. Aliquots are 
then placed onto a lawn of M. smegmatis and the plates are observed for plaques. Plaques would thus 
indicate successful mycobacteriophage replication and thus the presence of viable mycobacteria in 
the sample. In the case of plates containing drugs, plaque presence would also indicate drug 
resistance in the mycobacterial sample. A study on 70 isolates showed that the sensitivity and 
specificity of the assay was 86.1% and 92.6% for isoniazid resistance and 100% sensitivity and 
specificity for rifampicin resistance detection (Gali et al., 2006). The format of the assay has the 
advantage of decreased potential operator exposure to M. tb due to the small volumes handled, and is 
more suitable for handling large amounts of samples. McNerney and co-workers also modified the 
micro well assay end point measurement to make use of a colorimetric redox reaction (McNerney et 
al., 2007). Excess mycobacteriophages are inactivated by sulfuric acid, followed by a neutralization 
step using sodium hydroxide. The samples are then transferred to a microplate together with M. 
smegmatis and incubated overnight. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
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bromide) is then added to each well and incubated for a further 16h. A colour change from yellow to 
purple indicates successful M. smegmatis growth, which is indicative of a drug resistant M. tb isolate. 
A purple sample similarly indicates a susceptible strain, since phage replication was not possible. The 
MTT microplate assay had a sensitivity and specificity of 90.9% and 98.8% when tested on 96 clinical 
samples with sequencing used as gold standard (McNerney et al., 2007). The microplate assays 
share the problems of low specificity for low level drug resistance detection with other bacteriophage 
replication assays and also requires extensive time for DST. 
 
A follow-up meta-analysis investigated bacteriophage replication DST assays which consisted of 31 
studies (Minion & Pai, 2010). The analysis determined that the commercial assays had an overall 
sensitivity and specificity of 96% and 95%, respectively, in-house assays had a sensitivity and 
specificity of 99% and 98%. The contamination rates were 0-36% (higher in direct sputum samples), 
which leads to indeterminate results. The assays have since been updated to include an antibiotic 
which reduces indeterminate results by 68%, without reducing the sensitivity and specificity (Minion & 
Pai, 2010). With the current performance of bacteriophage replication assays it is clear that they 
cannot replace culture methods, due to inadequate sensitivity, specificity and minimal variety of DST. 
Bacteriophage replication assays do however offer a rapid alternative to microscopy for low resource 
settings where microscopy is less feasible (Albert et al., 2002, Kalantri et al., 2005, Minion & Pai, 
2010, Traore et al., 2007). The bacteriophage replication assay has the advantage of only detecting 
viable cells, in contrast to PCR, which makes it less prone to false positive case detection. However 
false positive drug resistance is problematic. The assay requires an extensive 2 days for diagnosis, 2-
4 days for DST and also requires specialized culture facilities and skilled operators, which are less 
feasible for field use. 
 
1.3.6.2 Reporter Mycobacteriophages    
1.3.6.2.1 Luciferase Reporter Phage assays 
Luciferases are enzymes that catalyze light producing reactions in the presence of ATP, O2 and the 
substrate luciferin (Meighen, 1991). Jacobs and co-workers initially developed a luciferase bearing 
mycobacteriophage for the detection of mycobacterium tuberculosis (Jacobs et al., 1993). This was 
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performed by cloning the M. bovis BCG hsp60 promoter together with the firefly luciferase gene (Fflux) 
into the lytic mycobacteriophage Tm4. The recombinant mycobacteriophage was able to express 
luciferase in M. smegmatis and M. tb. The luciferase reporter phage (LRP) assay makes use of 7-8 
days culture of M. tb samples followed by 48h incubation of the samples with anti-TB drugs. The 
cultured samples are then infected with the LRP for 1-5h and the substrate (luciferin) is added. A 
luminometer is used for detection of light production, yielding a detection limit of 104 bacteria/ml 
(Jacobs et al., 1993). Several studies have subsequently investigated and improved luciferase 
reporter mycobacteriophages for use as TB diagnostics and for DST. The first attempt to improve 
upon the LRP assay made use of a recombinant mycobacteriophage L5, which utilized the same 
promoter and reporter gene as the initial LRP (Sarkis et al., 1995). The L5 based LRP assay showed 
an improved sensitivity for M. smegmatis detection, however was unable to infect M. tb (Sarkis et al., 
1995). Similarly, a recombinant mycobacteriophage D29 was constructed and applied to detection of 
M. bovis BCG (also utilizing the same promoter and reporter gene as the initial LRP) (Pearson et al., 
1996). Despite the D29 based LRP having an increase in relative light units of one log above the initial 
Tm4-based LRP assay, the assay still had a poor sensitivity (Pearson et al., 1996). One of the 
problems with the initial Tm4-based LRP assay was the detection limit, which could be improved by 
increasing control of when the LRP replicates and subsequently leads to cell lysis. This would leads to 
a build-up of reporter enzyme before cell lysis and thus an increased detection limit. To achieve the 
goal of gaining control over the timing of cellular lysis, mutations were introduced to the 
mycobacteriophage Tm4-based LRP which led to the production of a temperature sensitive and 
conditionally replicating LRP (Carriere et al., 1997). The conditionally replicating LRP had an improved 
detection limit of 120 bacteria/ml, however this detection limit was achieved using a 12h LRP infection 
and was performed on BCG. For DST the assay required 24h incubation of the bacterial sample with 
the anti-TB drugs followed by a 2h LRP infection step. The improved detection limit was attributed to a 
decreased rate of bacterial lysis, leading to prolonged build-up of luciferase and increased levels of 
light production (Carriere et al., 1997). Another problem with the initial Tm4-based LRP assay was the 
wide host range, which include several species of mycobacteria. In order to adjust the host range a 
selective growth inhibitor was investigated (Riska et al., 1997). Riska and co-workers tested the use of 
a growth inhibitor to differentiate between luciferase production due to the presence of non-
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tuberculous mycobacteria in the sample and that of M. tb following infection with the luciferase 
mycobacteriophage (Riska et al., 1997). p-nitro-α-acetylamino-β-hydroxy propiophenone (NAP) has an 
inhibitory effect to the M. tb complex (but not to nontuberculous mycobacteria). NAP was incorporated 
into the luciferase reporter assay to achieve an assay capable of discerning between M. tb and non-
tuberculous mycobacteria within 24h. The assay also investigated the use of a Polaroid film box 
(named the “Bronx box”) as an alternative light detection method to the expensive luminometer (Riska 
et al., 1999). The LRP assay was performed in a microwell plate format and light production was 
measured by both a luminometer and the Polaroid film (“Bronx box”) method. Despite the cost 
reduction that the Polaroid film method offers, it still requires use of a biohazard unit to perform the 
assay which limits its use. Limited reports of testing of the LRPs on clinical samples have been 
published. A study on 71 Mexican sputum samples showed that the LRP assay had a poor sensitivity 
of 76% on culture positive samples and a specificity of 93% (Banaiee et al., 2001). The low sensitivity 
was attributed to a high contamination rate. The same study also investigated the use of NAP to 
distinguish between M. tb complex and M. tb strains, of which 94% were correctly identified. Drug 
susceptibility required a median time of 2-4 days and was in agreement with BACTEC 460 results in 
98.5% of the cases tested.  A further modification of the LRP assay was the use of the LRP phAE142 
(Bardarov et al., 2003). Mycobacteriophage phAE142 was constructed to utilize the Pleft promoter from 
mycobacteriophage L5 to drive Fflux expression. Propagation of phAE142 required a special strain of 
M. smegmatis which expresses a repressor protein for the Pleft promoter in order to avoid mutations in 
the Fflux gene (Bardarov et al., 2003). The phAE142 based LRP assay was tested in several studies, 
which showed a high sensitivity and specificity (Banaiee et al., 2003, Bardarov et al., 2003, Hazbon et 
al., 2003). The assay was performed on cultured samples, required a median of 3 days for DST and 
had a detection limit (for accurate DST) of 0.5X105 to 1X105 cfu/ml (Banaiee et al., 2003, Bardarov et 
al., 2003). Dusthackeer and co-workers evaluated the potential to detect both dormant and active M. 
tb bacilli by testing various mycobacterial promoters that are potentially active during dormancy in LRP 
assays (Dusthackeer et al., 2008). The promoters of hsp60, isocitrate lyase (icl) and alpha crystalline 
(acr) genes from M. tb were cloned to drive Fflux expression in both mycobacteriophage Tm4 and 
Che12. The authors reported success in detecting dormant and active M. tb in clinical samples using 
mycobacteriophage Tm4 based constructs and could detect as low as 105 cfu/ml in clinical samples 
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(Dusthackeer et al., 2008). The ability of Tm4 to infect dormant cells has been attributed to motifs in 
the Tm4 structure (Mt3 motif in the tape measure protein) allowing infection of stationary phase cells 
(Piuri & Hatfull, 2006). 
 
Luciferase reporter phages have several drawbacks that limit their use. The means of detecting light 
production is problematic since the LRP assays require luminometers which are expensive and 
require skilled operators and biohazard facilities, which is non-viable for use in the field studies 
(McNerney & Traore, 2005). The “Bronx box” which uses a Polaroid film offers a lower cost alternative, 
but has the same problems as the luminometer based assays. LRP assays tested to date have good 
sensitivity and specificity when performed on cultured samples, but little is known of their performance 
directly on sputum samples (Pai et al., 2006b). The LRP assays require a high cfu/ml for DST, which 
necessitates initial culture in addition to the minimum of 2-3 days for the LRP assay (McNerney & 
Traore, 2005). Despite the problems with the LRP assays, they are currently the fastest option for 
phenotypic drug susceptibility assays (Banaiee et al., 2003). 
 
1.3.6.2.2 Fluorescent mycobacteriophages  
Piuri and co-workers created recombinant Tm4 mycobacteriophages that expresses fluorescent 
proteins for the detection of M. tb (Piuri et al., 2009). A modified green fluorescence protein (EGFP) as 
well as ZsYellow fluorescence protein was cloned into mycobacteriophage Tm4, together with the M. 
bovis BCG Hsp60 promoter. The diagnostic was performed by incubating the fluorescent 
mycobacteriophages for 16-30h together with cultured samples. The samples were then fixed with 2% 
paraformaldehyde and washed with buffer, before finally evaluating them using fluorescence 
microscopy. DST was similarly performed, however it required that the samples be incubated in the 
presence of antibiotics and recombinant mycobacteriophage, whereafter fluorescence indicated drug 
resistance. The assay could detect drug resistance to several antibiotics, including kanamycin, 
isoniazid (requires additional 24h incubation), rifampicin, streptomycin and ofloxacin (ciprofloxacin and 
sparfloxacin according to preliminary results). The sensitivity was 94% for isoniazid, rifampicin and 
streptomycin and the specificity was 90%, 93% and 95%, respectively, for the listed drugs using the 
proportion method as reference (Rondon et al., 2011). The time to detection was 2 days post culture 
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for rifampicin, streptomycin and ofloxacin and 3 days post culture for isoniazid resistance detection 
(Rondon et al., 2011). The assay has not yet been adapted for clinical material and has insufficient 
sensitivity and specificity to warrant large scale application (Rondon et al., 2011).  
 
One concern for use of mycobacteriophages as TB diagnostic is the possibility of host phage-
resistance. Common mechanisms for phage-resistance is through restriction, CRISPRs (clustered 
regularly interspaced short palindromic repeats) and alteration of the cell surface or cell membrane 
(Labrie et al., 2010). However, little is known of the mechanisms involved for resistance to 
mycobacteriophages by mycobacteria. It has been shown that CRISPRs are present in M. tb, however 
with little sequence homology to the current collection of mycobacteriophage genomes (Hatfull 2010). 
It has however been shown that overexpression of the M. smegmatis wild-type mrp gene leads to 
resistance to mycobacteriophage D29 and that M. smegmatis lipid extracts have been shown to be 
able to inhibit the binding of certain mycobacteriophages (Hatfull 2010). One possible means to 
circumvent the possibility of mycobacteriophage resistance would be to implement the use of a 
mycobacteriophage cocktail strategy in which various mycobacteriophages with different cell receptor 
regognition and infection mechanisms are employed.  
 
Reporter mycobacteriophages could potentially act as a point of care diagnostic suitable for use in low 
resource settings. However, this would require that the biohazard risk be minimal and that detection of 
the reporter signal be possible using low-cost equipment. As reporter mycobacteriophage based 
assays are capable of DST, it is also possible that these diagnostics could provide low-cost DST tests. 
If these problems could be addressed, it would be possible for reporter mycobacteriophages to act at 
the forefront of TB diagnostics in the form of a cheap diagnostic with wide spread use. Implementation 
of such diagnostics would render other diagnostics redundant with the exeption of cases where 
extensive DST testing is required or where the diagnostic speed similar to the Xpert®MTB/RIF is 
required. As a means of quality assurance, it would also be nessisary to reduce or remove the 
possibility of false positives which would be possible through selective culture, use of of M. tb specific 
mycobacteriophages or use of M. tb specific promoters.  
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1.4 TB diagnostics conclusion 
The need for rapid, simple, cheap and effective TB diagnostics remains largely unmet. Each of the 
discussed TB diagnostics has limitations that cause them to inefficient for wide-spread TB detection 
and an optimal diagnostic thus remains elusive. Recent advances in TB diagnostics have broadened 
the options; however they are in their infancy and require further refinement. The downfalls of the 
current routine TB diagnostics are highlighted in Table 2. 
 
Table 2. Drawbacks of current TB diagnostics 
Diagnostic Drawbacks 
Culture Expensive, time consuming, requires biohazard facilities, 
not suitable for low resource settings 
Chest radiography Inaccurate, not suitable for field use. 
Microscopy  
Limited throughput, requires experienced staff,  limited 
sensitivity and specificity, cannot perform DST or 
speciation 
NAAT  Expensive, requires skilled staff, requires equipment 
unsuitable for low resource settings. 
Antigen based assays  Not an accurate indicator for active TB, cannot perform 
DST or speciation 
Bacteriophage replication 
assays  Requires a biohazard facility, prone to contamination, time consuming 
Luciferase reporter phage 
assays 
Time consuming, requires initial culture, increase 
biohazard risk due to substrate addition, requires 
expensive luminometer, not suitable for field use 
Fluoromycobacteriophages 
Requires expensive fluorescence microscope, utilizes 
suboptimal promoter, no-means of signal or bacterial 
concentration 
 
Each of these issues could be addressed to produce a superior diagnostic tool. In order to fully 
comprehend the current drawbacks as well as to grant insight as to potential improvements, it is 
prudent to perform a comprehensive literature review on all phage based diagnostics as a whole. The 
following is a review of bacteriophage based diagnostics with specific application to pathogen 
detection. 
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1.5 Phage-based detection of bacterial pathogens  
1.5.1 Introduction 
Pathogenic bacteria pose a global health threat and cause extensive morbidity and mortality each 
year. Salmonella infection, for example, was estimated at 1.4 million cases annually in the USA with 
numbers potentially much higher in third world countries (Voetsch et al., 2004). Increased spread of 
drug resistance among pathogenic bacteria and multiple drug resistance, best exemplified by the drug 
resistant M. tb epidemic, is a cause for concern. Transmission of drug resistance has also been 
observed among various pathogens such as the gram negative Citrobacter freundii, Klebsiella 
pneumoniae, Acinetobacter, Proteus mirabilis, Pseudomonas aeruginosa and Escherichia coli as well 
as the gram positive Staphylococcus aureus and Enterococci (Centers for Disease Control and 
Prevention (CDC), 2010, de Costa & Mavalankar, 2010, Krishna, 2010, Walsh & Fanning, 2008). A 
recent example of the alarming rate at which drug resistance spreads is the spread of NDM-1 (New 
Dehli Metallo-β-lactamase) between clinical isolates of the Gram-negative Enterobacteriaceae from 
India to Europe, USA and to Japan (Mazzariol et al., 2012, Yong et al., 2009). The NDM-1 enzyme is 
particularly problematic since it is resistant to almost all β-lactams and easily transfers resistance 
between bacterial species (Poirel et al., 2010). The rise in drug resistance and dwindling drug 
treatment options emphasize the dire need for rapid and effective diagnostics to contain the spread of 
bacterial pathogens. The requirements for these novel diagnostics may fluctuate between individual 
applications for pathogen detection. For example, a diagnostic for Bacillus anthracis requires utmost 
priority on speed, since infection may prove fatal within hours. In contrast pathogen detection in food 
and water requires that the sensitivity be the highest priority. Generally though, diagnostics need to 
strike a balance between their speed, sensitivity, specificity, ease of use and cost. Although culture 
has been a wide-spread method to detect bacterial pathogens, as well as determine their drug 
resistance, the method is inefficient. Culture is limited to viable and culturable cells which is 
problematic for sensitive detection of pathogens since viable but not culturable (VBNC) cells, such as 
pathogenic E. coli, is common in water (Liu et al., 2010). Furthermore, culture of certain pathogens 
requires specialized biohazard facilities, such as for M. tb and Bacillus anthracis, which is not 
applicable for field use. Molecular methods provide a rapid alternative to culture yet are expensive and 
are also not applicable for wide-spread use, due to cost and the need for skilled operators. 
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Bacteriophages offer key features that could provide simple solutions to the diagnostic needs for 
bacterial pathogens.  
 
1.5.2 Bacteriophage background 
Bacteriophages are naturally occurring viral particles that infect and replicate in their bacterial hosts. 
Bacteriophages are the most abundant organisms on earth above all other species and it has been 
estimated that 1025 phages commence a new infection cycle every second, (Pedulla et al., 2003). 
Bacteria and bacteriophages are thus under immense selective pressure to continuously evolve 
accordingly in order to survive in each other’s presence. The vast pool of bacteriophage biomass 
offers a wealth of tools to understand and combat bacteria. Of particular importance are the potential 
tools that may arise from bacteriophages of pathogenic bacteria. Bacteriophages offer several unique 
properties to be exploited to create superior diagnostics that could fulfill the criteria required to 
effectively detect pathogenic bacteria and curb the spread of epidemics. Bacteriophages are generally 
host-specific, capable of infecting only a specific species or even strain, with some exceptions such as 
Listeria phage A511 (which can infect an entire genus) (Loessner et al., 1995).  
 
The life cycle of bacteriophages are visually illustrated in Figure 1. The life cycle starts with the phage 
tail fibers and attachment proteins recognizing specific receptors on the surface of the host cell, 
followed by binding (adsorption) of the bacteriophage to its host. The receptors include outer 
membrane proteins such as cell-surface proteins, polysaccarydes, lipopolysaccharides, flagella, sex 
pili and lipoproteins (Neufeld et al., 2003, Neufeld et al., 2005). Adsorption to the host is followed by 
either insertion of the entire phage particle, or more commonly, the phage DNA into the host. 
Bacteriophage infection and replication is however influenced by factors such as bacterial growth 
stage, co-factor concentrations (such as Ca+ and Mg+) as well as temperature (temperature sensitive 
phages can only replicate at specific temperatures). Under favorable conditions that permit infection, 
bacteriophage genes are subsequently expressed by the host’s own cellular machinery. Several 
bacteriophages even express genes that code for their own tRNA to order to compensate for codon 
usage biases and the genetic differences between host and bacteriophage (Bailly-Bechet et al., 2007).  
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Figure 1: Bacteriophage reproductive cycle. 
 
 
 
 
 
 
The bacteriophage carries out 
specific recognition of its host and 
injects its DNA into the host cell. 
The DNA of lysogenic bacteriophages 
integrates into the host genome to later 
enter the lytic stage. Lytic 
bacteriophages immediately inter the 
lytic stage which consists of replication 
of the bacteriophage DNA and 
expression bacteriophage structural 
components.  
Expression of lysis genes during the 
lytic stage leads to cellular lysis and 
the release of progeny bacteriophages 
which are able to infect new host cells 
leading to an escalating infection and 
replication cycle.  
Bacterial genomic DNA 
 Mycobacteriophage genomic DNA 
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The amount of phages that infects or adsorbs to a single bacterium is referred to as the multiplicity of 
infection (MOI). If the MOI is greater than the threshold of adsorption, a phenomenon called “lysis from 
without” (LO) occurs. LO leads to cellular lysis without the production of progeny phage. In the case of 
a lower MOI, infection leads to successful expression of bacteriophage genes. Some of the first genes 
to be expressed in several bacteriophages are those responsible for superinfection immunity. 
Superinfection immunity refers to the ability of certain bacteriophages to block infection and replication 
of additional bacteriophages that enter the bacterial cell. This is possible by expression of repressor 
proteins. For example mycobacteriophage L5 expresses a 183-amino-acid product that confers 
superinfection immunity against additional L5 mycobacteriophages (Donnelly-Wu et al., 1993). 
Following bacterial infection, bacteriophages have differing life cycle potentials. Certain 
bacteriophages are lytic in nature, incapable of entering the lysogenic phase, whereas other 
bacteriophages are temperate, capable of both lytic and lysogenic phases. Lysogenic bacteriophages 
can integrate their genomes into the host genomic DNA to create what is called a lysogen. This 
lysogen can stay dormant and be copied along with the bacterial genomic DNA in cellular division or 
be activated, usually from bacterial stress responses, and enter the lytic phase. Lysogens can also 
alter the bacterial phenotype and even increase pathogenicity (Eklund et al., 1971, Figueroa-Bossi et 
al., 2001, O'Brien et al., 1984). During lytic growth the phage genome replicates and its lytic genes are 
expressed to also produce its head and tail proteins. The phage DNA is packaged into the phage 
heads, followed by attachment of the phage tails. In addition to the phage capsid genes, holin and 
lysin genes are also expressed during the lytic cycle. Holins and lysins control the timing of cellular 
lysis. Holins alter or degrade cytoplasmic membranes, granting lysins access to the peptidoglycan 
leading to cell lysis (Tanji et al., 2004). Holins and lysins are thus under immense genetic selection 
pressure to achieve the optimal progeny phage production in order to assure an optimal burst size. 
The burst size varies widely between individual bacteria, mycobacteriophage D29, for example, has 
been observed to have an average burst size of 98 phage particles and is affected by both culture 
conditions and growth stage (Sellers et al., 1962). The progeny released following infection of one 
bacterial host cells leads to an enormous phage amplification culminating in a potentially exponential 
escalation of bacteriophage progeny in the presence of viable bacterial hosts. In summary the unique 
features that bacteriophages present are their extreme host specificity, and sensitivity, and their ability 
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to rapidly replicate in their host (producing escalating progeny numbers). The following section 
provides a summary of how these unique properties of bacteriophages have been exploited to create 
bacteriophage-based diagnostics for several bacterial pathogens.  
 
1.5.3 Bacteriophage-based diagnostics 
1.5.3.1 Plaque-based assays  
Initially, bacteriophages were only utilized to determine bacterial taxonomy and phage typing. Phage 
typing is a method of bacterial characterization by susceptibility testing to various bacteriophages, 
which enables the bacterial genus and species to be determined (Redmond & Ward, 1966). The 
method is based on detection of plaques on bacterial lawns and has been applied to several bacteria, 
of which a few are listed in Table 3.  
 
           Table 3. Examples of phage typing assays 
Bacterial species  Reference 
Bacillus anthracis  Abshire,T.G. 2005 
Bacillus cereus Ahmed,R. 1995 
Brucella spp Corbel,M.J. 1987 
Campylobacter spp Khakhria,R. 1992 
Clostridium spp Sell,T.L. 1983 
Escherichia coli 
Grif et al., 1998, Nicolle et al., 1952, 
Khakhria,R. 1990 
Enterococci spp Caprioli,T. 1975 
Listeria spp Loessner,M.J. 1990, Gasanov et al., 2005 
Salmonella spp 
Scholtens, 1962, Hickman-Brenner,F.W. 1991, 
Castro,D. 1992, Kuhn,J. 2002,  Majtanova & 
Majtan, 2006,  
Shigella spp Slopek,S. 1969 
Staphylococci spp  Sekaninova,G. 1998 
Proteus spp Sekaninova,G. 1998 
Vibrio cholerae Chakrabarti,A.K. 2000 
Yersinia spp  Baker,P.M. 1982 
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The main caveat of using phage typing assays as a diagnostic, is that they rely on the host bacterial 
replication rate and lawn formation rate, which although fast for E. coli or B. anthracis, is slower for 
other bacteria such as Mycobacteria (Abshire et al., 2005, McNerney & Traore, 2005). The assays 
also have the potential for contamination and have a specificity which is subject to the infection range 
of the bacteriophages (Kalantri et al., 2005, Pai et al., 2005). Plaque formation is however not the only 
diagnostic avenue that bacteriophages offer. Bacteriophages have several unique features which can 
be exploited to create novel diagnostics, one of which is the highly specific binding affinity for their 
host. 
 
1.5.3.2 Detection of host lysis 
The specificity with which bacteriophages infect their hosts grants specificity as to which cells 
subsequently undergo cell lysis. Detection of the release of host intracellular components due to 
bacteriophage cell lysis is the basis for several diagnostics (Blasco et al., 1998, Neufeld et al., 2003). 
Bacterial cell lysis releases several cellular components that can be detected or measured, such as 
adenosine triphosphate (ATP), adenylate kinase (AK) and β-D-galactosidase (Blasco et al., 1998, 
Neufeld et al., 2003). Specific detection of host lysis can be performed in mixed bacterial populations, 
since bacteriophages are strain specific (Blasco et al., 1998, Neufeld et al., 2003, Yemini et al., 2007). 
Detection of host lysis and release of ATP has previously been performed in industry by the addition of 
luciferase and luciferin (Blasco et al., 1998). However this method has a low detection limit of about 
103 to 104 cells (Blasco et al., 1998). An improvement on the method is to detect adenylate kinase 
(AK) released by host bacteria following bacteriophage cell lysis. AK is an essential enzyme in most 
bacterial cells that catalyzes the equilibrium reaction:    
ATP + AMP  2ADP 
Addition of ADP drives the reaction to produce ATP and this can be used to fuel light production in 
bioluminescence reactions, creating a sensitive detection assay for AK. Blasco et al investigated the 
use of bacteriophage for specific bacterial lysis in combination with the AK detection assay (Blasco et 
al., 1998). The assay, when applied to E. coli detection, could detect fewer than 104 cfu/ml in less than 
1h and 2h for Salmonella newport detection. This was later improved to 103 cfu/ml for E. coli as well as 
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Salmonella, with a detection time of less than 2h, by optimizing the MOI, bacterial growth stage and 
duration of infection (Wu et al., 2001).  
 
β-D-galactosidase is another common cellular constituent which is released following host lysis by 
bacteriophages. Neufeld et al developed an electrochemical assay that detects the release of β-D-
galactosidase amperometrically (Neufeld et al., 2003). β-D-galactosidase is released by E. coli K-12 
MG1655 as it is undergoes cell lysis by bacteriophage lambda vir gene. The target sample is then 
filtered to separate the lysed cellular components from intact cells which potentially also contain β-D-
galactosidase. The current resulting from the activity of β-D-galactosidase, is measured 
electrochemically in real-time as it hydrolyzes p-aminophenyl-β-D-galactopyranoside to produce p-
aminophenol (which is oxidized at the carbon anode). Use of filtration of the target sample (and pre-
incubation) allowed the assay to detect as low as 1 cfu per 100 ml in 6-8h. The assay has the 
advantage of detecting enzymatically active cells which are not necessarily culturable, in contrast to 
phage replication assays which can only detect viable cells. The assay requires a pre-incubation step 
for concentrations of bacteria lower than 2.5X103 cfu/ml, for example detecting 100 cfu/ml requires 3-
4h pre-incubation. The electrochemical assay was later also adapted for detection of Bacullus cereus 
and M. smegmatis (Yemini et al., 2007). The assay consisted of filtering of the target samples, 
infection of the target bacteria with bacteriophages, incubation with the substrate until lysis was 
complete, filtration of the sample followed by electrochemical analysis. The bacteriophage B1-7064 
and substrate para-amino-phenyl-α-D-glucopyranoside was used for B. cereus. Mycobacteriophage 
D29 and substrate para-amino-phenyl-β-D-glucopyranoside was used for M. smegmatis. The modified 
assay could detect 10 cfu/ml in 8h. Assays based on host cell lysis detection have the inherent risk of 
background signal from non-target bacteria that possess similar reporter signals. One means to 
circumvent the background risk is through methods that focus on the specificity that phage binding 
provide without utilizing reporter signals from host lysis.  
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1.5.3.3 Specific binding and adherence to host 
Currently, specific bacterial antigen detection is based on antibodies, due to the high specificity that 
they offer. Bacteriophages bind to their bacterial hosts with similar high specificity, however they have 
the added advantages of having a reliable specific binding and a significantly cheaper large scale 
production cost. This has led to the investigation of the diagnostic uses of the phage particle in a 
bacterial detection assay as well as assays that make use of phage binding proteins. 
 
1.5.3.3.1 Bacteriophage biosorbents 
Immuno-PCR is based on antibody capture of a specific antigen followed by PCR amplification. In 
general, the method relies on covering a surface with host/antigen specific antibodies followed by 
wash steps to remove unbound antibodies. The sample to be probed is then added which potentially 
contains the target organism followed by wash steps to remove excess material which is unbound to 
the antibodies. The sample is then PCR amplified to detect target DNA. A variation on the method is to 
use bacteriophage as antigen capture particle, or rather biosorbent. In principle the method consists of 
immobilization of bacteriophage onto a surface, removal of excess bacteriophage, addition of the 
sample potentially containing the target host bacteria, followed by wash steps and various detection 
methods. An example of this method was the use of Sapphire phage (Amersham Inernational) for 
detection of Salmonella (Bennett et al., 1997). The Sapphire phage was immobilized (by overnight 
incubation) onto microplates with various surface properties as well as onto a dipstick format. The 
bacterial detection assay for the plate format involved adding the crude bacterial sample to the plate 
wells followed by an incubation step, a wash step, a PCR of the lysate and finally visualization by gel-
electrophoresis. In the dipstick format, detection was based on addition of a fluorescent dye followed 
by fluorescent microscopy. The authors reported poor performance due to inefficient phage 
immobilization, stating that their method allowed both head and tail to immobilize onto the solid 
surface due to passive absorption (Bennett et al., 1997). The authors also stated that active 
immobilization of the phage head, exposing the phage binding proteins, would be necessary for 
optimal bacterial capture and that this would require knowledge as to the structure of the phage 
surface chemistry. As such, an improvement on this method would be through the use of 
bacteriophage binding proteins instead of the entire phage particle. 
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Investigation of one such binding protein followed the discovery that the C-terminal region of a binding 
protein from γ-phage specifically binds to the cell wall of Bacillus anthracis (Fujinami et al., 2007). This 
particular binding protein is called Phage-Lysin-Gamma (PlyG) and is a lysin protein. The region of 
PlyG conferring the binding activity was cloned to contain a Glutathione S-transferase (GST) tag and 
the recombinant protein was designated PlyGB-GST. The bacterial detection assay consisted of 
blotting bacterial suspensions onto a nitrocellulose membrane, blocking the membrane and exposing it 
to the PlyG-GST fusion proteins. Horseradish peroxidise-conjugated mouse anti-GST and a 
tetramethylbenzidine membrane peroxidise substrate was added and the resultant signal was then 
visualized using an imaging system.  This assay is more rapid (about 3 hours) and is more sensitive 
than the plaque-based detection methods using γ-phage (Fujinami et al., 2007). The specificity was 
similar to γ-phage methods with a detection limit of 103 cfu/ml (Fujinami et al., 2007). The authors also 
stated that the method is cheaper and simpler to perform compared to PCR and immunological 
assays. The authors speculated that the assay could be improved by labeling the recombinant PlyG 
protein with stable quantum dot nanocrystals (Fujinami et al., 2007). To this goal, a recombinant 
biotin-tagged PlyG together with streptavidin-conjugated quantum Dot nanocrystals was investigated 
for use as an improved diagnostic for Bacillus anthracis (Sainathrao et al., 2009). The assay consisted 
of incubating biotin-tagged PlyG with bacterial samples, followed by addition of streptavidin-
conjugated quantum dot nanocrystals. Fluorescence was measured by fluorescence microscopy or 
fluorometry using a micro-plate reader. The assay was very rapid and showed high sensitivity. It was 
able to detect single cells, yet the technique requires fluorescence microscopy or fluorometry 
(Sainathrao et al., 2009). In contrast to using bacteriophage binding proteins, use of bacteriophages in 
their entirety have also been investigated as cell-markers for bacterial detection.  
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1.5.3.3.2 Labeled phage 
The specificity with which bacteriophages bind to their hosts has led to the investigation of using 
stained and labeled bacteriophages for bacterial detection. Horseradish peroxidase (HRP), a common 
enzymatic reporter for various assays such as in ELISA (enzyme-linked immunosorbent assay) has 
been utilized as enzymatic label for bacteriophages for E. coli detection (Willford et al., 2011). The 
Shiga toxin producing E. coli specific bacteriophages CBA120, AR1 and bacteriophage 56 were 
selected for chemical labeling using a commercial HRP labeling kit. The detection assay consisted of 
taking a swab which is used to inoculate selective media containing immunomagnetic beads. The 
immunomagnetic beads, which are specific for shiga toxin producing bacteria, are then incubated for 
8h together with the swab. The beads are then washed to remove excess bacteriophage and are 
incubated with the HRP labeled bacteriophages followed by another wash step to remove excess 
bacteriophage. At this stage one of two substrates are added, a colorimetric substrate or a 
luminescent substrate. The colorimetric substrate leads to a colour change to yellow and the 
luminescence substrate resulted in light production which was measured with a luminometer. The 
assay`s sensitivity without enrichment was between 6.8x104 cfu/ml to 3.85x105 cfu/ml which decreased 
to 1 cfu/ml with 8h enrichment (Willford et al., 2011). A similar method combined immuno-separation of 
E. coli O157 with detection of fluorescently labeled bacteriophage binding to bacteria (Goodridge et 
al., 1999a). The method consisted of immuno-separation of the target bacteria by means of magnetic 
beads (Dynal Inc., Lake Success, N.Y.) a wash step to remove excess bacteria followed by incubation 
with labeled bacteriophage. The bacteriophage used in this study was bacteriophage LG1, which had 
been stained with the nucleic acid dye YOYO-1 (Molecular probes, Inc., Eugene, Oreg.). The beads 
were subsequently magnetically separated and washed to remove excess labeled bacteriophage 
followed by flow cytometry. The assay was able to detect 104 cfu/ml in 8h (Goodridge et al., 1999a). 
The assay was also adapted to detect E. coli O157 in food samples such as ground beef and raw milk 
(Goodridge et al., 1999b). The assay was able to detect 2.2 cfu/g in 7h in ground beef and could 
detect between 10 and 100 cfu/ml in raw milk in 12h. In contrast to utilizing stained bacteriophages, a 
means to reduce production steps (and cost) is to utilize recombinant bacteriophages that express 
fluorescent proteins which are fused to structural proteins. An example of this was the use of a 
recombinant T-even type PP01 bacteriophage for detection of enterhemorrhagic E. coli strain 
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O157:H7 (Oda et al., 2004). The recombinant PP01 bacteriophage was engineered by homologous 
recombination to contain a green fluorescent protein (GFP) tag to a structural protein – the small outer 
capsid protein (Oda et al., 2004). The research team found N-terminal fusions of GFP to the small 
outer capsid protein to have optimal fluorescence intensity post host infection, indicating functionality 
of the fluorescent fusion protein. Furthermore, the GFP-small outer capsid protein fusion increased 
phage binding affinity to their host but decreased stability in acidic and alkaline solution in comparison 
to wild type phage. The detection assay consisted of incubation of the bacterial sample with the 
recombinant bacteriophage for 10 min and a wash step to remove excess bacteriophage, after which 
labeled bacteria could be detected by fluorescence microscopy. The assay showed increasing 
fluorescence intensity due to bacteriophage replication after 1h incubation of E. coli O157:H7 with the 
recombinant phage and reached maximum fluorescence at 3h (Oda et al., 2004). The assay could 
detect culturable cells as well as viable but non-culturable (VBNC) cells by modifying the MOI and 
incubation time. A low MOI and incubation time of greater than 1h was used to detect culturable cells 
using a fluorescent microscope, since this allowed for expression of the reporter gene. VBNC cells 
were detected by using a higher MOI to detect the adsorbed fluorescent phages on bacterial host cell 
membrane using a fluorescent microscope. In lieu of the lytic nature of PP01, which could potentially 
decrease sensitivity in microscopy based bacterial detection, a recombinant T4 bacteriophage 
incapable of lysis was investigated for use for E. coli detection (Tanji et al., 2004). The bacteriophage 
T4 was engineered to have a mutation in its lysozyme gene (named Gpe). The recombinant T4 was 
also created to have a GFP fusion to the small outer capsid protein. The recombinant bacteriophage, 
named T4e-/GFP maintained infectivity and host fertility without the ability to lyse the host. The T4e-
/GFP assay consisted of incubation of the recombinant bacteriophage with the bacterial sample, a 
wash step to remove excess bacteriophage, followed by fluorescence microscopy. The assay required 
a detection time of 10-30 min for detecting both viable E. coli as well as viable but non-culturable E. 
coli and could discern between the two cellular states in less than an hour (Tanji et al., 2004). The 
assay was also applied to the detection of E. coli in sewage influent, which showed that the 
recombinant bacteriophage T4e-/GFP could not infect all strains of environmental E. coli indicating the 
need for a bacteriophage with a wider host range (Namura et al., 2008). This lead to the investigation 
of a variety of bacteriophages that infect environmental E. coli, of which two were found to be superior 
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in their host range (Namura et al., 2008). The two bacteriophages, IP008 and IP052, were modified to 
replace their lytic genes with a GFP gene in addition to a GFP fusion to their small outer capsid genes 
(Namura et al., 2008). The combined host range of the recombinant bacteriophages allowed the assay 
to detect 35 out of 70 strains of E. coli in a few hours using fluorescence microscopy (Namura et al., 
2008). It has been suggested, however, that the use of GFP is problematic since it has a low signal to 
noise ratio due to background and cellular auto-fluorescence, as well as stability and photo-bleaching 
problems (Edgar et al., 2006). The advantages of streptavidin-tagged quantum dot nanocrystals in 
conjunction with biotin-tagged bacteriophages was investigated as a departure from stained and 
fluorescent protein tagged bacteriophage methods (Edgar et al., 2006). A recombinant E. coli phage 
T7 was constructed for detection of E. coli by fusing a biotinylation peptide tag to the T7 major capid 
protein (named gp10a). The assay consisted of incubation of the recombinant bacteriophage with the 
bacterial sample together with streptavidin-coated quantum dots. Following infection of viable bacterial 
cells, the recombinant bacteriophage T7 becomes biotinylated by the native E. coli biotinylation 
enzymes. The biotinylated bacteriophages subsequently bind to the streptavidin-coated quantum dots, 
which can then be visualized by fluorescence microscopy. The researchers found that visual detection 
of target bacteria was possible within 1h and that the detection of as low as 10 cfu/ml of sample was 
possible. Individual cells, labeled phage as well as individual quantum dots could be visualized (Edgar 
et al., 2006). The lytic nature of bacteriophage T7 has, however, been suggested to hamper the 
sensitive detection of single cells (Yim et al., 2009). To circumvent this problem the use of a non-lytic 
or conditionally replicating bacteriophage is necessary. To achieve this goal, bacteriophage lambda 
gt11 was chosen since it contains mutations which make it temperature sensitive. Bacteriophage 
lambda gt11 was engineered to contain a biotin-binding peptide fusion to the bacteriophage major 
coat protein gpD (Yim et al., 2009). The biotin-tagged bacteriophages were harvested following 
temperature induced replication. The progeny bacteriophages are then biotinylated by the E. coli host 
biotinylation enzymes, after which the bacteriophages could be purified. The purified and biotinylated 
bacteriophage lambda gt11 was then added, together with streptavidin coated quantum dots, to the 
bacterial sample and incubated at room temperature. Since lambda gt11 is temperature sensitive, the 
bacteria do not undergo lysis at room temperature, intact cells could be visualized using fluorescence 
microscopy or flow cytometry. Although the fluorescent properties of quantum dot nanocrystals are 
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potentially superior to common fluorophores, the assay could be simplified, and potentially be made 
more versatile, by making use of phage-based expression of a reporter signal, which does not 
necessitate addition of substrate or dyes for detection. Although single cell detection is possible, the 
main drawback of the assay is that it requires addition of substrate (streptavidin-coated quantum dots) 
and the fluorescence signal is thus not self-driven as in the expression of reporter proteins. 
Additionally, the use of flow cytometry and fluorescence microscopy does not lend itself readily for 
field use. This warrants the investigation of not only fluorescent proteins as reporter signal, but the 
investigation of all potential reporter proteins or signals. 
 
1.5.3.4 Reporter gene expression 
Reporter bacteriophages are specific as to which bacterial hosts they infect which also grants 
specificity as to which bacteria express the reporter gene(s). Considering reporter bacteriophages that 
do not make use of incorporation of the reporter signal into structural components, as discussed in the 
above Sections, certain benefits become apparent. These reporter bacteriophages have the inherent 
advantage of only infecting viable cells and thus do not give false positives for drug-killed cells as with 
PCR (Dinnes et al., 2007). Furthermore, the reporter signal can also be expressed in dormant bacteria 
(Dusthackeer et al., 2008). To date, several bacteriophage reporter assays have been developed 
which will be explored in this section.  
 
1.5.3.4.1 Ice Nuclease  
Supercooled water can remain liquid below 0°C, but can rapidly undergo a chain reaction of freezing 
when ice nuclei, or a nucleating agent is introduced to it (Franks, 2003). Various organisms have the 
ability to cause nucleation of ice in supercooled water, such as Pseudomonas, Erwinia and 
Xanthomona (Corotto et al., 1986). The first recombinant bacteriophage to make use of ice nucleation 
as reporter signal utilized the inaW gene from Pseudomonas fluorescens (Wolber & Green, 1990). 
The inaW gene was transferred to bacteriophage P22 for specific detection of Salmonella. Expression 
of the inaW gene causes ice nucleation at temperatures below -9.3°C which allows the cells to freeze. 
Detection of ice formation is aided by making use of a fluorescent freezing-indicator dye (Wolber & 
Green, 1990). When tested on Salmonella, the assay could detect less than 10 cfu/ml in mixed 
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bacterial populations indicating that an enrichment step is not required (Wolber & Green, 1990). The 
assay was later shown to be able to detect as low as 2 cfu/ml (Wolber, 1993). A commercial assay 
based on the ice nuclease reporter bacteriophage P22 was also developed called the Bacterial Ice 
Nucleation Diagnostic (BIND) assay which could detect less than 3 cfu/ml in 3h (Irwin et al., 2000). 
Assays based on ice nucleation have the advantage that background bacteria are unlikely to contain 
similar gens to inaW which makes the assay specific. Sadly, no further ice nuclease reporter 
bacteriophage assays have since been developed, perhaps due to the need of accurate temperature 
control devices which would be less than ideal for field use as well as due to favorable performance of 
other reporter proteins.  
 
1.5.3.4.2 Enzymatic reporters  
The utilization of enzymes as reporter genes has the advantage that a small amount of enzyme can 
produce a relatively large amount of reporter signal. To date, several studies have investigated the 
use of enzymes as reporter genes for reporter bacteriophages. One study investigated the use of 
alkaline phosphatase as reporter enzyme for detection of E. coli TG-1 (Neufeld et al., 2005). The 
researchers utilized helper bacteriophage M13KO7 to deliver a commercial plasmid which leads to 
expression of alkaline phosphatase. Although not a true reporter bacteriophage (since it lacks a 
bacteriophage genome), the assay is an example of how bacteriophages can deliver enzymatic 
reporter genes to their hosts and lead to expression in target bacteria. The diagnostic assay is based 
on infecting E. coli with the helper bacteriophage which then leads to the expression of alkaline 
phosphatase (AP). AP reacts with p-aminophenyl phosphate to produce p-aminophenol in an 
oxidation reaction which is measured using an electrochemical cell. The assay could detect 1 cfu/ml in 
2-3h (Neufeld et al., 2005). The phagemid assay is, however, not a true reporter bacteriophage since 
the phasmid cannot replicate and thus the only beneficial bacteriophage feature that it offers is 
through specificity of host infection.  
 
The prokaryotic LacZ gene is a more widely used reporter gene and the activity of its product enzyme 
can be monitored using various fluorogenic and chromogenic substrates. The LacZ gene comes from 
the lac operon and encodes β-galactosidase, which catalyzes the hydrolysis of β-galactosides such as 
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lactose into monosaccharides. When used as a reporter gene, its product is forced to hydrolyse easily 
detectable substrates such as the chromogenic substrate X-gal (5-bromo-4-chloro-3-indoxyl-beta-D-
galactopyranoside). During X-gal hydrolysis, subunits are formed that have a deep blue colour 
generating a signal easily detectable to the naked eye. The enzyme, in its active form, is a tetramer of 
four identical monomers creating a protein of around 465kDa with a conformation that makes fusion 
proteins possible on the N-termini (Juers et al., 2000). Since several bacteria express β-galactosidase, 
it is important to make sure no background expression leads to false positives when using the LacZ 
gene as reporter gene. One means to increase specificity is to make use of immuno-magnetic 
separation in order to first specifically capture the target organism before substrate is added. 
Unpublished results have reported on the development of a recombinant β-galactosidase expressing 
bacteriophage T4 for E. coli detection (Goodridge & Griffiths, 2002). The assay consisted of adding 
the recombinant bacteriophage together with a chemiluminescent substrate (GalactoStar) to the 
bacterial sample. The recombinant T4 bacteriophage was reported to have a detection limit as low as 
102 cfu/ml and as low as 1 cfu/ml using an 8h incubation (Goodridge & Griffiths, 2002). Although the 
use of enzymes allow a very low sensitivity, the assays that make use of them are liable to 
contamination. These assays require the addition of substrate and the potential that background 
bacteria contain similar enzymes are high which would lead to false positives.  
 
1.5.3.4.3 Bioluminescence 
Bioluminescence is the emission of light in living organisms from enzyme-catalyzed reactions. 
Luciferase is an example of an enzyme that catalysis a yellow-green light-producing reaction in the 
presence of both ATP and a suitable substrate such as luciferin. The prokaryotic lux and eukaryotic 
luc bioluminescence genes have been extensively investigated and utilized as reporter genes. Several 
luciferases have been isolated and cloned which provide tools for bacterial detection. Luciferase 
genes have also been cloned into bacteriophages to offer specific light production in target bacteria. 
An example of this was the construction of an auto-inducer expressing bacteriophage for the detection 
of viable E. coli cells (Ripp et al., 2006). The assay is based on the luxCDABE operon of Vibrio 
fischeri. The luxAB component synthesizes luciferase and is under control of the regulatory genes luxI 
and luxR. luxI codes for a regulatory protein called an autoinducer which interacts with luxR which in 
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turn stimulates transcription of luxCDABE and luxI. As the concentration of autoinducer rises so too 
does transcription of luciferase, luxI and luxR binding which creates an auto-amplified loop generating 
increasing levels of bioluminescence. The assay makes use of a recombinant bacteriophage lambda 
which expresses the regulatory luxI gene following infection of E. coli (Ripp et al., 2006). The assay 
consists of adding recombinant bacteriophage lambda to the bacterial sample together with additional 
bacteria which contain the luxCDABE and luxR genes (but not the luxI gene). The expression of luxI 
following the specific cell infection and host lysis by bacteriophage lambda creates an auto-amplified 
bioluminescent signal. The assay was capable of detecting 108 cfu/ml within 1.5h and could detect 1 
cfu/ml with a pre-incubation step in 10h. This method was also applied to the detection of E. coli 
O157:H7 in food samples using a 96-microwell format (Ripp et al., 2008). The microwell assay could 
detect 1 cfu/ml in 6 to 6.5h following a pre-incubation step of 6h and could detect 102cfu/ml in 5h 
without pre-incubation. The luxI expressing bacteriophage lambda assay was also tested on E. coli 
K12 variant XL1-Blue (Birmele et al., 2008). The lux expressing strain used in this assay was E. coli 
OHHLux which expresses luciferase in the presence of LuxI and which is resistant to bacteriophage 
lambda. The modified assay could detect 1cfu/ml in 24h in spite of bacterial starvation or the presence 
of lactonase producing bacteria indicating that the assay is resilient to contamination. 
 
In contrast to utilizing only regulatory proteins to drive lux expression in trans, the entire lux operon 
has also been transferred to create a reporter bacteriophage that does not need helper bacteria for 
signal production. In fact, the very first luciferase reporter bacteriophage was constructed to use the 
entire lux operon from Vibrio fischeri which was cloned into bacteriophage lambda Charon 30 (Ulitzur 
& Kuhn, 1987). To do so the lux operon was first cloned into a plasmid and subsequently cloned into 
the lambda Charon 30 chromosome. The recombinant bacteriophage was capable of detecting 10-100 
cfu/ml of E. coli in 1h (Ulitzur & Kuhn, 1987). Since then several luciferase bacteriophages have been 
constructed to express luciferase in their natural hosts as shown in Table 4. 
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Table 4. Luciferase reporter bacteriophage assays 
Bacterial species Reference 
Bacilus anthracis Schofield,D.A. 2009 
E. coli Ulitzer Kuhn 1987 
E. coli Duzhii zavilgelskii 1994 
E. coli O157:H7 Waddel & poppe 2000 
Enterobacteriaceae Kodikara 1991 
Listeria monocytogenes Loessner 1996 
Listeria monocytogenes Loesner 1997  
M.bovis BCG Pearson,R.E. 1996  
M.bovis BCG Carriere,C. 1997 
Mycobacterium avium Subsp 
Paratuberculosis Sasahara,K.C. 2004 
Mycobacterium smegmatis Sarkis,G.J. 1995  
Mycobacterium tuberculosis Jacobs,W.R.,Jr 1993   
Mycobacterium tuberculosis Riska,P.F. 1999 
Mycobacterium tuberculosis Banaiee 2003 
Mycobacterium tuberculosis Riska,P.F. 1997 
Mycobacterium tuberculosis Bardarov,S.,Jr 2003  
Mycobacterium tuberculosis Dusthackeer,A. 2008 
Salmonella Steward 1989 
Salmonella Kuhn 2002 
Salmonella spp Chen Griffiths 1996 
Salmonella typhimurium Turpin et al 1993 
Staphylococcus aureus Pagotto 1996 
 
A luciferease reporter bacteriophage for Listeria monocytogenes detection was developed by utilizing 
the Vibrio harveyi luxAB genes (Loessner et al., 1996). The luxAB genes were cloned into 
bacteriophage A511 downstream of the major capsid protein by means of homologous recombination. 
The luxAB based assay enabled bioluminescence detection in 2h with a detection limit of 5X102 to 103 
cfu/ml in 2h and 1 cfu/ml in 24h by means of enrichment. The researchers later also adapted the 
technique for microwell use as well as for enumeration of bacteria in food samples (Loessner et al., 
1997). Another means in which luciferase reporter bacteriophages have been constructed was by 
means of transposon mutagenesis (Waddell & Poppe, 2000). A 3.6kb insertion containing the luxA 
and luxB genes was transferred to the chromosome of bacteriophage ΦV10 by means of transposon 
mutagenesis which was investigated for the detection of E. coli O157:H7. The reporter bacteriophage 
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assay was dependent on n-decanal substrate addition for bioluminescence and could detect E. coli 
cells in approximately 1h. A luciferase reporter bacteriophage was developed for the detection of 
Mycobacterium avium spp paratuberculosis based on mycobacteriophage Tm4 (Sasahara et al., 
2004). A recombinant mycobacteriophage Tm4 was constructed to express the firefly luciferase (fflux) 
gene under control of the BCG hsp60 promoter post host infection. In the assay, the substrate D-
lucifersin was added and incubated with the bacterial sample together with the recombinant 
mycobacteriophage after which luminescence was measured using a luminometer. Detection of 
luciferase activity was possible after 4h with a maximum peak after 48h when tested on 106 cfu/ml 
culture. The assay had optimal performance when results were measured 24-48h after infection of 
more than 1000 cells. Luciferase assays have also yielded the necessary diagnostic speed needed for 
detection of certain bacterial pathogens such as Bacillus anthracis (Schofield & Westwater, 2009). The 
Vibrio harveyi luxA and luxB genes were cloned into bacteriophage W β. Following infection of the 
sample containing target bacteria and addition of the substrate, n-decanal, the assay could detect 103 
cfu/ml in 1h. The researchers also transferred the same genes, by means of homologous 
recombination to the plaque-diagnostic phage A2211 for the detection of Yersinia pestis (Schofield et 
al., 2009). The luciferase genes were cloned downstream of the A1, A2 and A3 promoters. The phage 
diagnostic was applied to diagnosis of attenuated Yersinia pestis cultivated isolates and positive 
bioluminescence was detected using a bioluminescence multiplate reader. Bioluminescent signals 
were detectable 12-15 min after phage and substrate (n-decanal) was added to the sample in a dose 
dependent manner. The assay could detect 100 cfu/ml in 1h. Luciferase assays have the common 
problem of requiring substrate addition. This can only be circumvented by cloning the entire lux 
operon, however, the listed assays that make use of the entire operon have a lower sensitivity than 
those that make use of substrate addition. Luciferase assays also require expensive luminescence 
detection equipment such as a luminometer, in addition to biohazard facilities and skilled staff which is 
not suited for low resource settings.  
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1.5.3.4.4 Fluorescent protein expression 
Fluorescent proteins have been used extensively in molecular biology to study cellular mechanisms 
such as cell division, localization of proteins, quantification of protein expression levels, timing of 
expression etc. Fluorescent proteins have also served as a means of bacterial detection, often through 
fusion proteins to bacteriophage structural protein. A GFP expressing bacteriophage was developed 
for the specific detection of E. coli XL1-blue by cloning GFP into bacteriophage lambda TriplEx 
(Clonetech Laboratories Japan, Ltd) (Funatsu et al., 2002). The assay made use of fluorescence 
microscopy to detect fluorescing cells which required 4-6h hours for flourophore expression and 
maturation. The authors concluded that the optimal phage concentration (for maximal host infection) 
should be 109 pfu/ml in this system. The system showed strain specificity, by infecting E. coli but not 
M. smegmatis in mixed bacterial cultures. Similarly, reporter bacteriophages have been developed for 
the detection of mycobacteria which is discussed in Section 1.3.6.2. The benefit of using fluorescent 
proteins as reporter genes in reporter bacteriophages is that only viable hosts become infected and 
subsequently express the fluorescent protein (Funatsu et al., 2002). A further advantage of fluorescent 
proteins is that the fluorescent signal remains detectable for weeks after the diagnostic assay is 
performed in contrast to bioluminescence which has a time-dependent reporter signal (Piuri et al., 
2009).   
 
1.6 Conclusions 
Assays that are based on luciferase production and fluorescent protein detection have been shown to 
be relatively simple and have the best performance in being rapid, with a high sensitivity and 
specificity. However, the means of detection are the main drawbacks. The luciferase assay makes use 
of a costly luminometer and the fluorescence-based assays make use of costly fluorescence 
microscopy, both of which require skilled staff. Furthermore, the luciferase assays involves working 
with live M. tb bacilli, which requires specialized biohazard facilities. Refinement of the reporter 
mycobacteriophage assays seem to be the best option for development of a usable TB diagnostic.  
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1.7 Problem statement 
Several reporter bacteriophage assays exist that utilize various combinations of bacteriophages, 
promoters, reporter genes and means of bacterial concentration and signal concentration methods. 
Many of these assays are of relevance to diagnostics, however, for detection of M. tb several specific 
requirements need to be met. Specifically, a TB diagnostic is needed that can reach even into 
resource-poor settings. This requires rapid, simple to perform and relatively cheap assays, that 
perform at high sensitivity and specificity and no not require highly skilled staff or expensive 
infrastructure. 
 
1.8 Hypothesis 
We hypothesize that a rapid, simple, specific and low cost TB diagnostic could be developed utilizing 
mycobacteriophages which express affinity-tagged reporter proteins using strong promoters 
specifically active when infecting M. tb. 
 
1.9 Aim 
The overall aim of this study is to develop a reporter mycobacteriophage that could be utilized in future 
as a rapid, specific and low cost TB diagnostic. 
1.10 Objectives  
1) To isolate suitable mycobacterial promoters to drive expression of reporter genes. 
2) To construct and evaluate affinity-tagged reporter constructs 
3) To construct and evaluate reporter mycobacteriophages 
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1.11 Study design 
1.11.1 Promoters 
M. tb promoters will be isolated and compared to promoter activity of the Hsp60 promoter by means of 
β-galactosidase assays. The most suitable promoter will be selected and evaluated as a promoter to 
drive expression of various reporter constructs.  
   
1.11.2 Reporter constructs 
Reporter constructs will be created using the promoter identified in 1.11.1, as well as the Hsp60, 
pSmyc, p19K and pACE promoter. mRFP1, DsRed and LacZ will be used as reporter genes, and 
histidine and biotin affinity tags will be used as tools for signal concentration. The expression vectors 
pSD21, p19Kpro, pDMN1 and pACE will be investigated in various combinations to find optimal 
expression. The expression and functionality of these constructs will be tested in the laboratory strain 
M. smegmatis. 
 
1.11.3 Mycobacteriophages 
The most suitable reporter constructs from 1.11.2 will be cloned into suitable mycobacteriophages. 
These reporter mycobacteriophages will be evaluated in M. tuberculosis. 
 
1.12 Rationale 
1.12.1 Promoters 
The Hsp60 promoter is a problematic and suboptimal promoter. Despite over 130 mycobacterial 
promoters being characterised over the years, the Hsp60 promoter still remains one of the most 
popular promoters to drive mycobacterial gene expression (Gomez & Smith, 2007). The Hsp60 
promoter has the befit of promoter activity in M. smegmatis, M. bovis BCG and M. tb (Al Zarouni & 
Dale, 2002). The Hsp60 promoter has long been considered a strong mycobacterial promoter, 
however recent studies have cast doubt over its stability and usefulness (Al Zarouni & Dale, 2002). It 
has been shown to cause unstable constructs and that constructs containing the Hsp60 promoter, 
which drives expression of a foreign gene, cause frequent deletions within the promoter itself 
(Haeseleer,F. 1994, Kumar,D. 1998, Al Zarouni,M. 2002, Al Zarouni & Dale, 2002). The authors of this 
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study hypothesised that the deletions are due to excessively strong promoter activity leading to cell 
death, creating a selection pressure for constructs with mutated, deleted or non-functional promoters 
(Al Zarouni & Dale, 2002). It is thus necessary to make use of a more consistent and reliable 
mycobacterial promoter when constructing reporter mycobacteriophages. 
 
We propose to use promoter screening methods to compare novel and existing mycobacterial 
promoters. There are various mycobacterial promoter screening methods available and they 
commonly make use of reporter genes to indicate promoter activity, for example the β-galactosidase 
gene, chloramphenicol acetyltransferase (CAT) reporter gene and GFP expression (Mulder et al., 
1997). During promoter screening the candidate promoter region is cloned into the promoter probe 
vector containing the reporter gene and this enables a quantitative comparison of different promoter 
strengths (Mulder et al., 1997). Various promoter isolation attempts have used cloning of random 
mycobacterial genomic DNA (Triccas et al., 2001). However, screening of targeted regions can 
increase the likelihood of discovering promoter elements and also grant insight into the regulatory 
mechanisms of the region. Previous promoter isolation studies in our laboratory focused on the 
promoters situated in the M. tb ESAT-6 gene clusters and utilized β-galactosidase assays (Botha, 
2006, Gey van Pittius, 2002). It has been shown that these regions contain promoter elements of 
varying strength (Botha, 2006, Maciag et al., 2009). The ESAT-6 gene clusters contain various 
promoters that might offer mycobacterial promoters more suitable than the Hsp60 promoter.  
 
1.12.2 Reporter genes 
There are several choices for a reporter gene; however we propose the use of a fluorescent protein or 
enzymatic reporter to be superior. GFP, originally isolated from the jellyfish Aequorea victoria, is 
currently one of the most well-known fluorescent proteins and has widespread application as a cellular 
marker and reporter gene (Tsien, 1998). It has a fluorescence absorbance / excitation peak at 395nm 
and another minor peak at 475nm, the corresponding emission peak is at 508nm (Phillips, 1997). GFP 
has relatively strong resistance to photo-bleaching; however the protein has shown some limitations 
and drawbacks. The short wavelength of GFP creates problems with light scattering and background 
due to cellular auto-fluorescence (Tsien, 1998). GFP fluorescence is also sensitive to pH (Tsien, 
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1998). Since the initial discovery and cloning of GFP there has been a considerable increase in the 
amount of available fluorescent proteins for use as reporter protein (Chudakov et al., 2010). Mutants 
of GFP have been made to emit blue, cyan, and yellow light (Rodrigues et al., 2001). Recently, a red 
fluorescent protein called DsRed has been isolated, which offers vast improvements as reporter 
protein (Baird et al., 2000).  
 
DsRed is a 28-kDa polypeptide made up of four monomers that form a tetramer which has bright red 
fluorescence (Yarbrough et al., 2001). This protein was recently isolated from a corallimorpharian of 
the Discosoma genus (Yarbrough et al., 2001). DsRed fluorescence has a longer wavelength than 
GFP with an excitation maxima at 558nm and emission maxima at 583nm, which minimizes problems 
with light scattering and cellular autofluorecence (Rodrigues et al., 2001, Yarbrough et al., 2001). 
Unlike GFP, DsRed has a negligible pH dependence of absorbance or fluorescence through a wide 
pH range of pH 5 to pH 12 (Baird et al., 2000). It has also been found that DsRed is quite resistant to 
photobleaching at exposure intensities of typical spectrofluorometers and microscopes (Baird et al., 
2000). DsRed does, however, have a few drawbacks as genetic marker. It is an obligate tetramer as 
proven by analytical ultracentrifugation. Thus, it is possible that interaction between proteins to which 
DsRed is fused could interfere with normal DsRed tetramerization. DsRed also requires over 24h of 
maturation for optimal emission (Yarbrough et al., 2001). After 24h the red fluorescence is at 50% of 
its maximal peak and requires more than 48h to reach more than 90% peak (Baird et al., 2000). This 
could pose a problem if used in a rapid TB detection assay since it could slow down the time to 
detection. The DsRed crystal structure shows that it is a dimer of dimers (Yarbrough et al., 2001). 
Figure 1 shows a diagram of the interaction between the dimers.  
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Figure 1. Ribbon diagram of DsRed tetramer (figure taken from Yarbrough et al.2001).  
Uppercase A-D indicate monomers and lowercase a-d indicate carboxy termini. 
 
In its tetramer form the surfaces of the A and C chain as well as the carboxy termini makes contact. 
The carboxy termini of tetrameric DsRed are different from those in GFP. In GFP they are free 
whereas in DsRed the a- and c-carboxy terminus are interacting (Yarbrough et al., 2001). The 
chromophore-containing region is situated in the interacting region of the A and C monomers, thus 
suggesting that proper chromophore function requires the protein to be in its tetrameric form. It has 
been suggested that the Leu-225 at the carboxy termini will likely interact with a protomer inherent to 
the tetramer and thus potentially create non-functional caboxy-terminal protein fusions (Yarbrough et 
al., 2001). However, various amino-terminal fusions have been made successfully (Baird et al., 2000, 
Yarbrough et al., 2001). A monomeric version of the DsRed gene, called mRFP1, has been developed 
in order to circumvent some of the problems with DsRed. 
 
mRFP1 was generated by inserting amino acids in key regions of the DsRed subunit to create a stable 
monomeric red fluorescent protein (Campbell et al., 2002). This monomer has an excitation peak of 
584nm and an extinction peak of 607nm, which are about 25nm red-shifted from DsRed, and which 
confer less cellular autofluorescence than DsRed (Campbell et al., 2002). Since it is a monomer, it 
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does not require such an extensive time period to fully mature and is estimated at 10 times faster to 
maturation than DsRed (Campbell et al., 2002). The monomeric state makes the protein much more 
suitable for protein fusions (Campbell et al., 2002). mRFP1 has a similar brightness to DsRed despite 
a lower extinction coefficient, quantum yield, and photostability than DsRed (Campbell et al., 2002). 
These benefits of mRFP1 over DsRed deems the protein more suitable for a rapid TB detection assay. 
 
In a previous study which compared the usefulness of GFP and DsRed as a reporter, it was 
demonstrated that luciferase can be detected more rapidly than DsRed and GFP due to the slow 
maturation times of the two fluorescent proteins (Hakkila et al., 2002). The study also stated that 
luciferase-based cellular detection is deemed more sensitive, since there is no luminescent 
background signal, whereas cellular auto-fluorescence requires more fluorescent protein for detection 
(Hakkila et al., 2002). Although both these statements are true for rapidly growing hosts like E. coli, it 
is not really relevant in the case of M. tb detection. In the case of M. tb detection, high concentrations 
of host bacteria are required for luciferase detection (at least 105 cfu/ml according to the Tm4-based 
luciferase mycobacteriophage assay discussed in Section 1.3.6.2.1). Since this concentration of 
bacteria is not common in sputum samples, a culture step is required, which extends the diagnostic to 
2-3 days (see Section 1.3.6.2.1). This necessitates a specialized biohazard facility, which limits the 
usefulness of luciferase based assays. Additionally, luciferase assays make use of a lumometer and 
sample reading during a specific timeframe, which would not be ideal for use in the field. In contrast, a 
fluorescent protein remains detectable up to months after expression and fixing of M. tb by means of a 
fixative such as paraformaldehyde (Piuri et al., 2009). DsRed and mRFP1 both offer superior 
wavelengths compared to GFP, and confer far less cellular auto-fluorescence (Campbell et al., 2002). 
These properties make DsRed and mRFP1 suitable reporters for M. tb detection. We thus propose the 
use of the fluorescent proteins DsRed and mRFP1 for use as reporter signal in a mycobacteriophage 
based diagnostic.  
 
Enzymes such as β-galctosidase have previously been shown to grant high sensitivity for bacterial 
detection (Neufeld et al., 2003). The main problem with its use was due to the high prevalence of 
similar enzymes in other bacteria which could lead to false positives (Yemini et al., 2007). We propose 
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to circumvent this problem by means of a purification step which is possible by creating an affinity tag 
fusion to the β-galctosidase gene.   
 
1.12.3 Affinity tags 
The final area for improvement on the current reporter mycobacteriophage assays is with regards to 
amplification/condensation of the reporter signal, which we propose to do through the use of affinity 
tags. Affinity tags make isolation of almost any protein possible, as long as a soluble fusion protein is 
possible and the fusion tag is exposed to the external protein milieu. Use of affinity tags on reporter 
proteins allows for separation and purification of the reporter as well as condensing the reporter signal. 
This effectively increases the reporter signal strength and can lead to a higher sensitivity. 
Furthermore, this decreases the potential background signal from contaminant bacteria. There are 
various affinity tags available, a popular choice is histidine tags (typically made up of 6 histidines 
placed at either the N- or C-terminus of the protein (Arnau et al., 2006). Histidine tags readily bind to 
immobilized transition metals like Ni+2, yet can also be eluted to derive a purified protein eluate 
(Kimple & Sondek, 2002). Biotin tags are another good option since they are capable of more efficient 
protein capture and greater yield due to its extremely strong interaction with streptavidin (Arnau et al., 
2006). Since the bond is so strong, a denaturing elution step, often using heat, is involved (Kimple & 
Sondek, 2002). Thus, diagnostics that make use of biotin tags should use detection methods that do 
not require elution to observe a reporter protein signal lest the reporter protein also be denatured.  
 
1.12.4 Conclusion 
In conclusion, the improved reporter mycobacteriophage we intend to construct will make use of a 
strong and stable mycobacterial promoter and a reporter protein with simple detection abilities such as 
fluorescent proteins or a colorimetric reaction, as well as a signal amplification method such as an 
affinity tag.  
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Chapter 2 Materials and Methods 
2.1 Bacterial strains and culture conditions 
2.1.1 Bacterial strains 
Escherichia coli (E. coli) strain XL1-Blue (Stratagene), Mycobacterium smegmatis (M. smegmatis) 
strain mc2155 (ATCC 700084) and Mycobacterium tuberculosis (M. tb) strain H37Rv (ATCC 35734) 
was used in this study. 
 
2.1.2 Bacterial culture 
2.1.2.1 E. coli liquid cultures 
E. coli liquid cultures were grown overnight in 10 ml Lysogeny Broth (LB), (Appendix A.2.6), at 37°C in 
a shaker at 200 rpm with the appropriate antibiotics (Appendix A.1). Freezer stocks were made as 
described in Section 2.1.2.5. 
 
2.1.2.2 E. coli solid media culture 
Cells were plated out on LB agar plates (Appendix A.2.7) containing the appropriate antibiotics 
(Appendix A.1). Once the plate(s) dried enough to not allow running drops of liquid, the plate(s) was 
(were) inverted and incubated overnight at 37°C.  
 
2.1.2.3 M. smegmatis liquid cultures 
M. smegmatis liquid cultures were grown for 2 days in 11 ml 7H9 media (Appendix A.2.1) at 37°C on a 
shaker at 200 rpm with the appropriate antibiotics (Appendix A.1). ZN staining (Section 2.1.2.6) was 
done on M. smegmatis cultures to determine if contamination was present. Freezer stocks were made 
of pure cultures (Section 2.1.2.5). 
 
2.1.2.4 M. smegmatis solid media culture 
Cells were plated on Middlebrook 7H11 plates (Appendix A.2.3) containing the appropriate antibiotics 
(Appendix A.1). The plates were sealed with parafilm, inverted and incubated overnight (or up to two 
days depending on the colony size) at 37°C. 
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2.1.2.5 Freezer stocks  
Freezer stocks of bacterial liquid cultures were made by transferring 150 µl sterile glycerol and 750 µl 
of the cell culture to a fresh 2 ml Eppendorf tube. The freezer stock was then mixed using a vortex and 
stored at -80°C. 
 
2.1.2.6 Ziehl-Neelsen (ZN) staining 
ZN stains were performed to confirm pure cultures of M. smegmatis. An aliquot of 150 µl of 
mycobacterial culture was spread onto a microscope slide and allowed to air dry. The slide was 
intermittently heated by flaming 3-4 times to heat-fix the cells. The slide was flooded with Carbol 
Fuchsin (Appendix A.3.8) and heated intermittently, carefully as to not boil the liquid, for 2-5 min until 
steam formation was visible. The slide was then washed with H2O and decolorized with 3% acid 
alcohol (Appendix A.3.1) and then washed with H2O. Thereafter the slide was counterstained with 
methylene blue (Appendix A.3.19) for 1-2 min and washed with H2O. After drying, the slide was 
examined under a microscope using oil-immersion and 1000 times magnification. Red/pink cells 
indicated mycobacterial cells and blue cells indicated non-acid fast cells (indicative of contamination). 
 
2.1.2.7 Electrocompetent E. coli 
Electrocompetent E. coli was made for electroporation of vectors. A starter culture was made by 
inoculating 1 µl of stock E. coli competent cells into 50 ml LB media (Appendix A.2.6) containing 500 µl 
tetracycline (Appendix A.1.4). After overnight growth at 37°C with shaking at 200 rpm, 2 ml of the 
starter culture was inoculated into fresh LB media containing tetracycline to selectively culture the 
tetracycline resistant XL1-Blue strain of E. coli (section 2.1.1). This was grown until the optical density 
(OD) at 600nm, measured in a LKB Biochrom Ultrospec 4051, was between 0.7 and 0.8, at which 
point the cells were at the exponential growth stage. The cultures were spun down for 10 min at 4°C in 
a Sorvall RC-5B refrigerated centrifuge (Du Point Instruments) at 4000 rpm, using a GSA rotor. The 
cell culture pellets were washed with 10% glycerol (Appendix A.3.15) in an amount equal to the 
original culture volume. The spin and wash step were repeated two more times and after the last step 
the cells were pooled into a 50 ml centrifuge tube. The cells were spun down in an Eppendorf 
Centrifuge 5810R at 4000 rpm for 10 min and resuspended in 10% glycerol using 2 ml per liter of 
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initial culture. Cells were aliquoted (100 µl) into Eppendorf tubes, flash frozen using liquid nitrogen and 
stored at -80°C. 
 
2.1.2.8 Electrocompetent M. smegmatis 
Electrocompetent M. smegmatis was made for electroporation of vectors. A starter culture was made 
by inoculating 1 µl of M. smegmatis competent cells into 100 ml Middlebrook 7H9 (Appendix A.2.1) 
and grown to an OD measurement at 600nm, in a LKB Biochrom Ultrospec 4051, of 0.5. The cells 
were then placed on ice for 1h and centrifuged at 3000g for 5 min at 4°C in a Sorvall RC-5B 
refrigerated centrifuge (Du Point Instruments). The cell pellet was washed twice in 30 ml ice cold 10% 
glycerol (Appendix A.3.15) after each centrifugation. The cell pellet was then resuspended in 4 ml 10% 
glycerol and 200 µl cells were aliquoted into into Eppendorf tubes, after which it was stored at -80°C. 
 
2.2 PCR 
2.2.1 PCR Primers 
A list of all primers used in this study is shown in Table 5. The descriptions of these primers can be 
found in subsequent Sections. Primers were designed using Primer Premiere software to obtain the 
theoretically optimal primer pairs where possible. Primers were diluted to 50pmol/µl using nuclease 
free H2O. 
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Table 5. List of primers and oligonucleotides 
Primer name     Sequence (5`3`) Tm (°C)  Purpose 
LambdaCosF ACGCGTGAGCTCCCCGGTGGTGTTATCTGGC 70 
Construction of 
pDMNLCosmRFP, Section 
2.6.4.4 
LambdaCosR TCTAGAGGTACCTTAATTAATTGTTGACTTCCATTGTTCATTCC 61 
Construction of 
pDMNLCosmRFP, Section 
2.6.4.4  
D29repF CATATGTGTGCGTTCGCACGCACAGGCCCGG 70 
Construction of 
pYub412mRFPNdeIBglII, Section 
2.6.4.3  
D29repR AGATCTCTAGGCGCCGGTGGAG 62 
Construction of 
pYub412mRFPNdeIBglII, Section 
2.6.4.3 
DsRed-Hisr TCTAGACTAGTGGTGGTGGTGGTGGTGCAGGAACAGGTGGTG 70 
Construction of 
pSD21Hsp60DsRedCHis, Section 
2.6.3.3 
ESAT6-f GGATCCTTGTTGTCGTTGGCGGTCA  78 
Construction of 
pSD21Hsp60DsRedCHis, Section 
2.6.3.3  
Hsp60mRFP1
f2   
TAAGGTACCCATGGCCTCCTCCG
AGGACGTCATCA 67 
Construction of 
pSD21Hsp60mRFPNHis, Section 
2.6.3.7  
Hsp60mRFP1
r2  
GCAGTCGACTCAAGCTTCGAATTC
TTAGGCGCCG 67 
Construction of 
pSD21Hsp60mRFPNHis, Section 
2.6.3.7  
HSP60PROM
HISR3 
GGTACCGCGTGGTGGTGGTGGTG
GTGCCACTGCTGCTCCAT 75 
Construction of 
pSD21Hsp60DsRedNHis, Section 
2.6.3.1, Construction of 
pJem15Hsp60NHis, Section 
2.6.3.11, Construction of 
P19KproHsp60DsRedNHis, 
Section 2.6.3.2 
Int1LacZF  AGATCTTGCTCAGCATATTCGTGGGC 61 
Construction of pJem15Int1NHis, 
Section 2.6.3.12 
Int1LacZR  AGATCTGTGGTGGTGGTGGTGGTGCTCCATTGTATACCGTCTCAC 70 
Construction of pJem15Int1NHis, 
Section 2.6.3.12 
INT1RFPr GGTACCUCGTGGTGGTGGTGGTGGTGCTCCATTGTATACCGTCTCAC 71 
Construction of 
pSD21Int1DsRedNHis, Section 
2.6.3.5 
mRFPreporter
1-f  
CGATCGTGTGCGTTCGCACGCAC
AGGCCCGG 739 
 Construction of 
pYub412mRFPPvuI, Section 
2.6.4.1 
mRFPreporter
1-r CGATCGCTAGGCGCCGGTGGAG  66 
Construction of 
pYub412mRFPPvuI, Section 
2.6.4.1  
p19kmrfpf2 CTAAAGCTTGACCACAACGGTTTCCCTCT 62 
Construction of 
p19KProp19KmRFPNHis, Section 
2.6.3.8  
P19kmrfpr3 ATCGATTTAGGCGCCGGTGGAGTGG 64 
Construction of 
p19KProp19KmRFPNHis, Section 
2.6.3.8  
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RepNdeFixF 
AAGCTTGGATGCATCATCATCATC
ATCATGCGATGGCCTCCTCCGAG
GACG 
71 
Construction of 
pYub412mRFPNdeIBglII, Section 
2.6.4.3  
Rep4EcoRVR GATATCCTAGGCGCCGGTGGAG 61 Construction of pYubmRFP, Section 2.6.4.5  
Rep4SalIF GTCGACTGTGCGTTCGCACGCACAGGCCCGG 73 
Construction of pYubmRFP, 
Section 2.6.4.5 
RepTm4SapF GCTCTTCCTGTGCGTTCGCACGCACAGGCCCGG 73 
Construction of 
pYub412mRFPSapI, Section 
2.6.4.2 
RepTm4SapR GGAAGAGCCTAGGCGCCGGTGGAG 67 
Construction of 
pYub412mRFPSapI, Section 
2.6.4.2  
RCMRFPF  AAGCTTGGCATCATCATCATCATCATATGGCCTCCTCCGAGGACG 67 
Construction of 
pDMN1mRFPNHis, Section 
2.6.3.10 
RCMRFPR  GTTAACCTAGGCGCCGGTGGAG 62 
Construction of 
pYub412mRFPNdeIBglII, Section 
2.6.4.3  
Rv1779-80f GGATCCTGCTCAGCATATTCGTGGGC   73 
Construction of 
pSD21Int1DsRedNHis, Section 
2.6.3.5, Construction of 
pSD21Int1DsRedNHis, Section 
2.6.3.5, Promoter screening 
Rv1779-80r GGTACCTGTATACCGTCTCACGTCAC   63 Promoter screening 
Rv1781-82f     GGATCCTCGGGCAAGTTCGACCAG   72 Promoter screening 
Rv1781-82r GGTACCGCCACGCTAGATCACCT   66 Promoter screening 
Rv1783-84f GGATCCCAGCGGGTTGCCCACATT   75 Promoter screening 
Rv1783-84r        GGTACCATGGTGTCGGTCCGGCTA   71 Promoter screening 
RV178384f2 CCTCGGTTCGTGAGTTTGC 64 Promoter screening 
Rv1786-87f        GGATCCGAAATGGCGCTCATCCT   70 Promoter screening 
Rv1786-87r        GGTACCCAACCAGTCCTCCCTCTC   66 Promoter screening 
Rv1787-88f  GGATCCCACAGTGTGGTTGCCCG   72 Promoter screening 
Rv1787-88r        GGTACCCATGCGATCTCCTGCTTA  66 Promoter screening 
Rv1789-90f        GGATCCATGGCTCGCCCACCCTTC   75 Promoter screening 
Rv1789-90r        GGTACCGTCCATTCCGAACCCTTT  68 Promoter screening 
Stellenbosch University  http://scholar.sun.ac.za
55 
 
 
Rv1790-91f        GGATCCGTCTCCGTCGGCGGGATA   75 Promoter screening 
Rv1790-91r        GGTACCGACATGCTGTCTTCCTCT  64 Promoter screening 
Rv1791-92f GGATCCGAGGCGGCCAACGCAG   76 Promoter screening 
Rv1791-92r        GGTACCCATGTTGCCTGTCTCCTTA   65 Promoter screening 
Rv1793-94f        GGATCCACAGCGCCGTCGGCTCCA   79 Promoter screening 
Rv1793-94r        GGTACCGATCCATCGCTACCTCAGC 69 Promoter screening 
Rv1794-95f        GGATCCAGTGGAAAACACACAGCA 66 Promoter screening 
Rv1794-95r   GGTACCCATCGTCCTGTACCCCCT 68 Promoter screening 
SapF2 GCTCTTCCGCTTTGTGCGTTCGCACGCACAGGCCCGG 74 
Construction of 
pYub412mRFPSapI, Section 
2.6.4.2 
SapR2 AAGCGGAAGAGCCTAGGCGCCGGTGGAG 70 
Construction of 
pYub412mRFPSapI, Section 
2.6.4.2 
Sp6 ATTTAGGTGACACTATAG 48 Sequencing primer for pGem-T-Easy 
T7 TAATACGACTCACTATAGGG 56 Sequencing primer for pGem-T-Easy 
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2.2.2 PCR conditions 
PCR amplification was done in an Eppendorf Mastercycler Gradient Cycler using the ROCHE 
Faststart PCR kit using the following PCR program and reaction mixture shown in Table 6 and 7. 
                   
         Table 6. PCR reaction mix composition       Table 7. PCR cycling conditions        
Component Amount 
H2O 57.2 µl 
10X PCR buffer 10 µl 
GC mix 20 µl 
dNTPs 8 µl 
Forward primer 2 µl 
Reverse primer 2 µl 
Faststart Taq 
(Roche) 
0.8 µl 
DNA 1 µl*** 
 
*Where X is equal to the lowest thermal melting point (Tm) between the two primers minus two 
degrees (primer Tm as indicated in Table 5). 
**Where Y is the amount of minutes allotted for product extension (1 min extension time per 1kb of 
product length was used, for example 2kb would require 2 min extension).  
 
2.2.3 PCR colony screening 
After each electroporation into competent cells (E. coli, Section 2.3.13.1 and M. smegmatis, Section 
2.3.13.2), a PCR colony screening was done to confirm the presence of the plasmid containing the 
desired insert. Single colonies were picked with a pipette tip, mixed by pipeting up and down in the 
PCR reaction mixture and the pipette tip was then placed into 200 µl LB media (Appendix A.2.6) until 
the PCR results were known. Colonies which were PCR positive for the insert (following gel 
electrophoresis (Section 2.3.1) were then grown in liquid media (Section 2.1.2.1 for E. coli colonies 
and Section 2.1.2.3 for M. smegmatis colonies). The PCR method used was the same as described in 
Temperature Time 
95°C 4 min 
95°C   1 min 30sec 
*X°C     1 min 
72°C    **Y min             
72°C 10 min 
4°C ∞ 
38 cycles 
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Section 2.2.2, however only 1/10th of the reaction mix was used and a shorter PCR program was used 
as shown in Table 8 and 9: 
 
   Table 8. PCR reaction mix composition      Table 9. PCR Program composition     
 
 
 
 
 
 
 
 
 
 
 
 
 
*Where X is equal to the lowest thermal melting point (Tm) between the two primers minus two 
degrees (primer Tm as indicated in Table 5). 
**Where Y is the amount of minutes allotted for product extension (1 min extension time per 1kb of 
product length was used, eg. 2kb would require 2 min extension) 
 
2.3 DNA Manipulations 
2.3.1 Gel Electrophoresis 
Agarose gels were made and run as follows: In the case of small DNA fragments, in general a 0.7% to 
1% agarose gel was made by dissolving 0.7 to 1g D1-LE agarose (merk) in 100 ml 1X Sodium Borate 
buffer (SB, Appendix A3.39) using a microwave. Five microliters of Ethidium Bromide (Appendix 
A.3.14) was added to the gel before casting the gel. In the case of larger DNA fragments (or when 
higher resolution was required) a lower agarose concentration (down to 0.5%) as well as TAE buffer 
(Appendix A.3.44) was used instead of SB buffer. DNA samples were loaded with 6X loading buffer 
(Fermentas) and run with either roche DNA Molecular Weight Marker X, Fermentas “Generuler DNA 
Ladder Mix”, “Generuler 100bp DNA ladder plus” or Generuler 1kb DNA ladder. Gel electrophoresis 
was generally done at 6.5V/cm for large DNA molecules. Gel electrophoresis for PCR colony 
Component Amount 
H2O 5.72 µl 
10X PCR buffer 1 µl 
GC mix 2 µl 
dNTPs 0.8 µl 
Forward primer 0.2 µl 
Reverse primer 0.2 µl 
Faststart Taq 
(Roche) 
0.08 µl 
DNA 1 µl 
Total 10 µl 
Temperature Time 
95°C 4 min 
95°C   45sec 
*X°C     45sec 
72°C    **Y min             
72°C 2 min 
4°C ∞ 
30 cycles 
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screening was generally performed using 11-22V/cm. Gels were visualized and using a UV 
transilluminater  and documented with a digital camera. 
 
2.3.2 Field Inversion Gel Electrophoresis 
Field Inversion Gel Electrophoresis (FIGE) was applied for the resolution of very large DNA fragments 
such as mycobacteriophage genomic DNA. For optimal resolution, Fermentas LE GQ Agarose was 
used at a concentration of 0.4% using TAE buffer (Appendix A.3.44) and was cast and run at 4°C. In 
the case where subsequent DNA recovery from the gel was required, Cambridge Seakem low melting 
point agarose was used. Low melting point gels were to 0.5% agarose by adding 0.5g Cambridge 
Seakem low melting point agarose to 100 ml TAE. The agarose was fully dissolved by heating in a 
microwave and cast at 4°C. Samples were mixed with loading buffer as described in Section 2.3.1 and 
the FIGE gel was run on a Hoefer Scientific Instruments (HSI) PC750 Pulse Controller using the 
following settings: 60V (3.15V/cm), 18h run length, 50 msec. pulse, forward:reverse pulse ratio of 
2.5:1 at 4°C. Following FIGE, the gel was stained with ethidium bromide (Appendix A.3.14), by placing 
the gel in a container with 500 ml TAE and 40 µl ethidium bromide under (very) gentle shaking for 20 
min (Staining is performed after electrophoresis since ethidium bromide hinders the migration of very 
large DNA particles). Photos of gels were taken using a transilluminator and digital camera. 
 
2.3.3 DNA purification 
DNA purification of ligations, digests and of gel slices (following electrophoresis) was done using the 
Promega Wizard® SV Gel and PCR Clean-Up System according to the standard protocol. In the case 
of purification from gels: DNA fragments of interest were excised from agarose gels using a scalpel, 10 
µl membrane binding solution (supplied with the Promega kit) was added per mg of gel slice. The gel 
slice and membrane binding solution mixture was heated at 65°C until dissolved. In the case of 
ligations and digests: An equal amount of membrane binding solution was added to the volume of the 
sample. The DNA/membrane binding mixture was then placed into a spin column (supplied with the 
Promega kit) and incubated for 1 min. The spin column was attached to a vacuum adapter to pull the 
liquid through the spin column. 650 µl membrane wash solution was added and also sucked through 
the spin column. This was followed by adding 500 µl membrane wash solution and a repeat of the 
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vacuum step. The spin column was transferred to a collection tube and centrifuged at maximum speed 
in an Eppendorf centrifuge 5415D for 5 min. The spin column was placed into a new Eppendorf tube, 
20-35 µl H2O (heated to 65°C) was added to the membrane and incubated for 2 min at room 
temperature. The spin column was then centrifuged for 1 min at maximum speed to elute the purified 
DNA into the Eppendorf tube. The DNA concentration was determined (Section 2.3.7) and the DNA 
was stored at -20°C until further use. 
 
2.3.4 DNA purification from agarose by phenol extraction 
A phenol extraction method was used for recovery of very large DNA fragments from low melting point 
agarose gels following gel electrophoresis and FIGE (Section 2.3.2). Gel slices were placed into 2 ml 
Eppendorf tubes (or larger tubes in the case of larger gel slices) and weighed. For each mg of gel 
slice, 5 ml of TE (Appendix A.3.43) was added. The tube was incubated at 65°C until the gel slice was 
fully melted. The tube was allowed to partially cool and an equal amount of equilibrated phenol 
(Appendix A.3.28) was added. The tube was then centrifuged at 4000g in an Eppendorf centrifuge 
5415D for 15 min at room temperature. The aqueous phase was drawn off and placed into a new tube 
containing an equal amount of phenol followed by another centrifugation step. This was repeated until 
the aqueous phase was clear. The final aqueous phase was transferred into a new Eppendorf tube 
containing an equal volume of phenol:chloroform (Appendix A.3.29), the tube was then centrifuged for 
15 min at room temperature. The aqueous phase was then placed into a tube containing an equal 
volume of chloroform and centrifuged for 15 min at room temperature. The aqueous phase was then 
placed into a new Eppendorf tube and 3M Sodium acetate (Appendix A.3.38) was added to give a 
concentration of 0.3M. Two and a half volumes of 95% ethanol (Appendix A.3.13) was added and the 
tube was then placed at -80°C for 5-10 min. The tube was centrifuged at maximum speed for 15 min. 
The tube content was carefully decanted so as not to disturb the DNA pellet, 500 µl 70% ethanol 
(Appendix A.3.12) was added and centrifuged for 15 min. The ethanol was removed by careful 
pipetting and the pellet was allowed to air dry overnight at room temperature. The pellet was 
resuspended in a volume of 10-50 µl nuclease free water (warmed to 65°C), the DNA concentration 
was determined (Section 2.3.7) and stored at -20°C. 
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2.3.5 Plasmid DNA isolation 
Plasmids were isolated using the Promega Wizard Miniprep Kit. Cell cultures were centrifuged in an 
Eppendorf Centrifuge 5810R at 3000 rpm for 10 min. The cell pellets were resuspended in 300 µl 
resuspension solution (supplied with the kit) and transferred to a 2 ml Eppendorf tube. Three-hundred 
and fifty microliters of cell lysis buffer (supplied with the kit) was added and the tubes were inverted 3 
times. Ten microliters of alkaline phosphatase (supplied with the kit) was added, the tube was inverted 
3 times and incubated for 3 min. A total of 400 µl neutralization solution (supplied with the kit) was 
added and the tubes were inverted 3 times. The tubes were centrifuged in an Eppendorf centrifuge 
5415D for 10 min at max speed (132 000 rpm). The supernatant was transferred to a spin column 
(supplied with the kit) and vacuum was applied to suck the supernatant through the membrane. An 
amount of 600 µl membrane wash solution (supplied with the kit) was added and sucked through, 
followed by 500 µl membrane wash solution. The spin column was then centrifuged in an Eppendorf 
centrifuge 5415D for 5 min at 13 200 rpm. The spin column was placed into a new 1.5 ml Eppendorf 
tube and 20-50 µl H2O, heated to 65°C, was added to the membrane and incubated for 2 min. The 
tube containing the spin column was then centrifuged for 30sec, the spin column was discarded, the 
DNA concentration was determined (Section 2.3.7) and the DNA was then stored at -20°C until 
needed.  
 
2.3.6 Cosmid DNA isolation  
Cosmid DNA isolation was done using the nucleobond® AX 100 cosmid extraction kit. A 100 ml 
culture was grown overnight as described in Section 2.1.2.1, the cells were pelleted by centrifuging for 
10 min at 4000 rpm in an Eppendorf Centrifuge 5810R at 4°C. The cell pellets were resuspended in 8 
ml Buffer S1 with added RNAse (supplied with the kit). An amount of 8 ml Buffer S2 (supplied with kit) 
was added, the suspension was inverted 6-8 times, and incubated for 5 min. Thereafter 8 ml Buffer S3 
(supplied with the kit) was added, the tube was inverted 6-8 times and incubated on ice for 5 min. The 
lysate was then loaded onto a H2O moistened filter and the flow through was collected. The flow-
through was loaded onto a cartridge (equilibrated with 2.5 ml “buffer N2” (supplied with kit)). The 
cartridge was then washed 3 times with 4 ml “buffer N3” (supplied with kit). The DNA was eluted by 
adding 5 ml buffer N5 (pre-warmed to 50°C, supplied with the kit). An equal volume of isopropanol 
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was added to the purified cosmid and the tube was centrifuged at 16000g for 30 min, 4°C in an 
Eppendorf centrifuge 5415D. The DNA was then washed with 70% Ethanol (Appendix A.3.12, 4°C) 
and centrifuged 10 min at 16000g in an Eppendorf centrifuge 5415D at room temperature. The pellet 
was then air dried and dissolved in DNAse free H2O. The DNA concentration was determined using a 
Nanodrop (see Section 2.3.7) and the DNA was stored at -20°C. 
 
2.3.7 DNA concentration determination 
DNA sample concentrations were measured with a Nanodrop ND-1000 spectrophotometer at 260nm 
absorbance using H2O (Promega, nuclease free) as blank. 
 
2.3.8 Sequencing 
DNA samples for PCR products, plasmids and cosmids were sent for sequencing at the sequencing 
laboratory of the central analytical facility at the University of Stellenbosch (www.sun.ac.za/saf). PCR 
products were sent undiluted (approximately 50ng/µl), plasmid sequencing samples were diluted to 
100ng/µl, cosmid DNA was not diluted and was used at concentrations of higher than 600ng (ethanol 
precipitation was used to concentrate the DNA if needed) and primer concentrations were diluted to 
1.1pmol/µl. 
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2.3.9 Restriction enzyme digests 
Restriction enzyme (RE) digests were incubated for 16 hours at 37°C (except in the case of BclI which 
was incubated at 55°C). The RE digest mixture composition shown in Table 10 was used. 
Table 10. Restriction enzyme mixture composition 
Component Amount 
DNA xµl (1-10 µg) 
RE 2 µl 
10X RE buffer 3 µl 
H20 25-xµl* 
Total 30 µl 
 
*Where X is the amount of DNA required for the given digest. 
Samples that required an additional digest were purified by a DNA clean up step (Section 2.3.3) 
followed by elution with 20.5 µl H2O. Two microliters RE and 2.5 µl 10X RE buffer was added and 
incubated as above. Once the digests were complete the samples were mixed with 6X loading buffer 
(Fermentas) and run on a gel as described in Section 2.3.1. 
 
2.3.10 Partial restriction enzyme digests 
A 100 µl reaction mixture was made up containing the DNA to be digested and 1X restriction enzyme 
buffer. The reaction mixture was divided up into five tubes, with tube 1 containing 30 µl, tube 2-4 
containing 20 µl each and tube 5 containing 10 µl. All tubes were kept on ice. The first tube received 
3U/µg of RE which was mixed. From the first tube, 10 µl was transferred to tube 2 and mixed. 
Subsequently, 10 µl from tube 2 onwards was transferred up to tube 5 using a different pipette tip 
each time. The tubes were incubated at 37°C for 15 min and analysed by gel electrophoresis (Section 
2.3.1). 
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2.3.11 Dephosphorylation 
Vector RE digests were followed by dephosphorylation prior to ligations to decrease background due 
to self-ligation of vectors. Eight microliters of DNA sample was mixed with 1 µl of Shrimp Alkaline 
Phosphotase (SAP, ROCHE) and 1 µl 10X SAP buffer (Roche) and incubated at 37°C for 10 min. This 
was followed by a deactivation step of 15 min at 65°C. 
 
2.3.12 Ligations 
A vector:insert ratio of 1:3 was used for ligations. The amount of insert required was calculated with 
the following equation shown below and the reaction composition shown in Table 11. Ligation 
reactions were incubated at 4°C, overnight followed by a 15 min deactivation of the ligase enzyme by 
incubating at 65°C  
 
Vector (100ng) * (size of insert (in bp))  X    3         = ng of insert needed 
 
           (Size Vector (in bp))                          1 
   
Table 11. Ligation reaction composition 
Component Amount 
Vector yµl (100ng) 
Insert xµl (varies according to formula 
as indicated above) 
T4 DNA ligase 1 µl 
10X Ligase buffer 1 µl 
H20 8 - x - y 
Total 10 µl 
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2.3.13 Bacterial Transformation 
2.3.13.1 Transformation of competent E. coli 
Transformation was performed by electroporation using a Bio-Rad Gene Pulser. Forty-five microliters 
of competent E. coli (Section 2.1.2.7) was mixed with 2 µl ligation product (Section 2.3.12), or 15ng 
vector DNA in the case of vector amplification, in a Bio-Rad Gene Pulser Cuvette using a Bio-Rad 
electroporater at 2.5kV, 200Ω, 125 µF. Cells were resuspended in 600 µl super optimal broth with 
“catabolite repressor” (SOC), (Appendix A.2.10) and incubated 1h at 37°C with shaking at 200 rpm. 
Seventy-five microliters of the cells were then plated out on LB plates (Appendix A.2.7) containing the 
appropriate antibiotics (Appendix A.1) according to each vector’s antibiotic resistance (Appendix B). 
 
2.3.13.2 Transformation of competent M. smegmatis 
Frozen M. smegmatis competent cells (Section 2.1.2.8) were thawed on ice before use. The cells were 
then centrifuged in an Eppendorf centrifuge 5415D at 1.7g for 2 min. The cells were resuspended in 
ice cold 10% glycerol (Appendix A.3.15). The centrifuge and resuspension steps were repeated. Two 
micrograms of DNA was mixed with 200 µl competent M. smegmatis and placed in a Bio-Rad Gene 
Pulser Cuvette. Electroporation was done using a Bio-Rad electroporator at 2.5kV, 1000Ω, 125 µF. 
Time constants between 10 and 20 were deemed acceptable, otherwise a further DNA cleanup was 
performed (Section 2.3.3) and an additional glycerol wash step was performed. After electroporation, 
the cells were incubated in 1 ml Middlebrook 7H9 (Appendix A.2.1) with OADC (Appendix A.2.8) for 3h 
at 37°C with shaking at 200 rpm. Seventy-five microliters of the cells were plated onto 7H11 (Appendix 
A.2.3) plates with the appropriate antibiotics (Appendix A.1) according to the vector’s antibiotic 
resistance (Appendix B). 
 
2.3.14 Lambda packaging of cosmid DNA 
2.3.14.1 Packaging reaction 
The Epicentre MaxPlax Lambda Packaging extract was used to efficiently transform large cosmids into 
E. coli. A MaxPlax Lambda Packaging extract was thawed on ice and 25 µl of the tube contents was 
mixed with 10 µl substrate DNA (about 0.2 µg) in a 1.5 ml Eppendorf tube. The tube was incubated for 
90 min at 30°C. Twenty-five microliters additional packaging reagent was added to the tube and 
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incubated a further 90 min at 30°C. Five-hundred microliters phage dilution buffer (Appendix A.3.27) 
and 25 µl chloroform was then added to the tube and briefly vortexed. The lambda packaged cosmid 
was then titered using the E. coli host strain LE392MP (host strain was prepared as described in 
Section 2.3.14.2 and titered as described in Section 2.3.14.3). 
 
2.3.14.2 Preparation of host strain bacteria 
LB agar (Appendix A.2.7) was made up and cooled to about 40°C. An amount of 48.5 ml was 
transferred into a sterile 50 ml tube and 1 ml 1% Maltose (Appendix A.3.18) was added (giving a 0.2% 
w/v concentration) and 500 µl 1M MgSO4 (Appendix A.3.22, giving a 10mM concentration) was added, 
the tube contents were mixed and plated out. E. coli bacterial strain LE392MP (Stratagene) was 
streaked out onto the LB agar plates (containing 10mM MgSO4 and 0.2% Maltose) and incubated at 
37°C overnight. Single colonies were picked and grown in 10 ml LB media (containing 200 µl 1% 
maltose and 100 µl 10mM MgSO4 at 37°C with shaking till  the culture reached an OD (measured at 
600nm in a LKB Biochrom Ultrospec 4051) of 0.8. The cells were then stored at 4°C until use. 
 
2.3.14.3 Titering of the packaging reaction 
A serial dilution range from 10-2 to 10-9 was made of the packaged phage in phage dilution buffer 
(Appendix A.3.27). The initial dilution was made by adding 10 µl of the packaged phage to 990 µl 
phage dilution buffer to create a 10-2 dilution. A dilution range from 10-3 to 10-9  was then made by 
serially taking 100 µl of the previous dilution and adding it to the next Eppendorf tube containing 900 µl 
dilution buffer (with thorough mixing in between dilutions and using a new tip for each titer). One-
hundred microliters of each dilution was placed into a new Eppendorf tube and incubated with 100 µl 
of the E .coli host strain (Section 2.3.14.2) for 15 min at 37°C. The content of the tube was then plated 
out on LB agar plates (Appendix A.2.7) containing the appropriate antibiotics (Appendix A.1) 
depending on the cosmid used for packaging.  
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2.4 Mycobacteriophage Isolation, purification and DNA extraction 
2.4.1 Mycobacteriophage isolation from soil 
Soil samples were collected in universal tubes (Sterilin), by filling the tubes halfway with moist soil. MP 
buffer (Appendix A.3.23) was added to the samples to the point where the buffer covered the top of 
the sample (about 8-10 ml). Fifty microliters concentrated M. smegmatis was added to the samples 
and incubated overnight at 37°C in an incubator with mixing every 30 min for the first 4h. After the soil 
settled at the bottom of the samples, 2 ml of the liquid was transferred to a 2 ml Eppendorf centrifuge 
tube and centrifuged at 2000g for 5 min in an Eppendorf centrifuge 5415D. The supernatant was 
filtered through a Millipore MILLEX®-GV polyvinylidene difluoride (PVDF) 0.22 µm filter unit. One-
hundred microliters of the filtered phage solution was incubated with 250 µl M. smegmatis for 30 min 
at 37°C. Between 7-10 ml of preheated (about 45°C) top agar (Appendix A.2.4) was mixed with each 
sample and immediately plated onto a 7H10 agar plate (Appendix A.2.2). The plate was incubated at 
37°C for 24-48h and plaque presence was indicative of mycobacteriophages with M. smegmatis as 
part of their host range in the soil sample. Plaques were picked using a pipette tip and placed into 50 
µl MP. A serial dilution was made of the phage isolate ranging from 10-2 to a 10-6 dilution. This was 
done by placing 10 µl from the 50 µl initial mycobacteriophage dilution into 990 µl MP buffer to yield a 
10-2 dilution. 100 µl of the 10-2 dilution was then placed into a fresh Eppendorf tube containing 900 µl 
MP buffer to yield a 10-3 dilution. 100 µl of the 10-3 dilution was then added to a new tube containing 
900 µl MP buffer to yield a 10-4 dilution, the process of serial dilution was similarly continued until a 
dilution of 10-6. The various dilutions were mixed with 250 µl competent M. smegmatis and incubated 
for 30 min at 37°C. The samples were then mixed with 10 ml preheated top agar and plated onto 7H10 
agar plates and incubated 24-48h at 37°C. To ensure the plaques contain only one type of 
mycobacteriophage, a single plaque was picked among one of the plates with the best plaque 
separation, placed into 50 µl MP buffer and the above-mentioned titration and plating was repeated 
about 4-5 times. After the final plating step, the plate with the most confluent plaques, creating the 
best “web-like” pattern was selected, 10 ml MP buffer was added and the plate was incubated at 4°C 
overnight. The MP buffer was removed by pipetting and subsequently filtered through a Millipore 
MILLEX®-GV polyvinylidene difluoride (PVDF) 0.22 µm filter unit. The filtrate was collected and a final 
dilution range was created as mentioned above. The optimal dilution was then selected which created 
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the best “web-like pattern” (most confluent plaque pattern). This phage dilution was used for 
preparation of large scale phage stocks as described in (Section 2.4.2).  
 
2.4.2 Preparation of large-scale mycobacteriophage stocks 
A large mycobacteriophage lysate was made in order to ensure that a sufficient amount of 
mycobacteriophages were produced to enable visualization following CsCl ultracentrifugation. For this 
purpose 30 large plates (145mm X 20mm) with optimal plaque confluence (as determined by titering 
as described in Section 2.4.1) was prepared as follows. Competent M. smegmatis was created as 
described in Section 2.1.2.8 and 15 ml competent M. smegmatis was placed into a 50 ml conical tube. 
The appropriate amount (and titer) of purified mycobacteriophage (prepared as described in Section 
2.4.1) for confluent plaque formation was multiplied by 30 and this amount was placed into the 50 ml 
tube containing the M. smegmatis cells. The tube was gently mixed by inversion a few times. The tube 
was incubated for 30 min at 37°C with mixing every 5 min. Approximately 270 ml top agar (Appendix 
A.2.4) was added, together with the contents of to the 50 ml tube, to a sterile 500ml flask, gently 
mixed, and immediately plated onto 30 large petri dishes (about 9 ml per plate). The plates were then 
incubated at 37°C for 24-48h (until complete lysis was observed on the mycobacterial lawn) without 
turning the plates upside down to allow droplets of moisture to aid in plaque dispersal. Between 10 
and 15 ml MP buffer (Appendix A.3.23) was pipetted onto each plate and incubated at 4°C overnight. 
The phage buffer was then removed by pipetting, placed into 50 ml conical tubes, centrifuged at 
3000g using an Eppendorf Centrifuge 5810R for 20 min at 4°C. The supernatant was filtered through a 
Millipore millex®-GV polyvinylidene difluoride (PVDF) 0.22 µm filter unit. The volume of the filtrate was 
determined and NaCl was added to make a 1M solution. Polyethylene glycol (PEG 8000) was then 
added to create a 10% solution, followed by overnight stirring at 4°C. The solution was then 
centrifuged at 5500g in a GSA rotor for 15 min at 4°C. The supernatant was discarded and the pellet 
(containing the precipitated mycobacteriophages) was carefully transferred to a 50 ml TPP centrifuge 
tube and resuspended in 10-15 ml MP buffer. The pellet was slowly inverted overnight at 4°C to 
resuspend the mycobacteriophages in the buffer. The tube was then centrifuged at 3000g in an 
Eppendorf Centrifuge 5810R for 30 min at 4°C and the supernatant, containing the resuspended 
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mycobacteriophage, was transferred to a new conical centrifuge tube. The supernatant was then 
purified by CsCl ultracentrifugation as described in Section 2.4.3.   
 
 2.4.3 Ultracentrifugation of mycobacteriophage  
Ultracentrifugation was used to separate intact mycobacteriophages from debris, following large scale 
amplification as described in Section 2.4.2. Fifteen grams of CsCl (United States Biochemical corp, 
Cleveland Ohio, ultrapure quality) was added per 10 ml of phage supernatant and gently mixed until 
fully dissolved. The supernatant was then transferred into an ultracentrifuge tube, weighed, carefully 
balanced by the addition of 15g/ml CsCl and sealed. The tubes were then placed into a type 50 Ti 
ultracentrifuge rotor. The rotor was placed into a Beckman ultracentrifuge and was run under vacuum 
at 35000 rpm for 24h at 4°C. The resulting phage band(s) were then carefully removed by pipetting 
and placed into Eppendorf tubes and then purified by dialysis as described in Section 2.4.4. 
 
2.4.4 Mycobacteriophage dialysis 
About 2 ml of the CsCl purified phage sample was pipetted and sealed into a pierce10000 MWCO 
pleated snakeskin dialysis tubing and dialysed in 1L MP buffer (Appendix A.3.23). The dialysis tube 
containing the phage sample was slowly stirred using a magnetic stirrer bar for 6h at 4°C. After the 
initial 6h, the buffer was replaced with 2L of MP buffer followed by a further dialysis overnight at 4°C 
with stirring. The dialysed samples were transferred into 2 ml Eppendorf tubes and stored at 4°C. 
Dialysed mycobacteriophage samples where then used for electron microscopy (Section 2.4.5), as 
well as DNA extraction (Section 2.4.6). 
 
2.4.5 Electron microscopy of phage particles 
A dilution range of the mycobacteriophage samples were made using MP buffer (Appendix A.3.23) as 
described in Section 2.4.2 for optimal phage concentration for visualization on the electron 
micrograph. Phage samples were sent to the Department of Physics at the University of Cape Town 
(UCT) for transmission electron microscopy (TEM). Head and tail length were recorded and the TEM 
image was documented. 
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2.4.6 Phenol:Chloroform:Isoamyl alcohol DNA extraction of mycobacteriophage DNA  
The dialysed mycobacteriophage sample was diluted by transferring 1 ml of the sample to a fresh 
Eppendorf tube containing 1 ml MP buffer (Appendix A.3.23) and by gentle pipetting. One-hundred 
microliters 10X proteinase K buffer (Appendix A.3.34), 50 µl proteinase K (Appendix A.3.33) and 900 
µl of the diluted mycobacteriophage sample were mixed in an Eppendorf tube and incubated at 55°C 
overnight. Five-hundred microliters of the proteinase K digested phage sample was added to 500 µl 
Phenol:Chloroform:Isoamyl alcohol (PCI, Appendix A.3.30). The tubes were mixed by inverting and 
centrifuged at 13000 rpm in an Eppendorf 5415D centrifuge at 4°C for 15 min. The supernatant was 
removed and fresh PCI was added and the tubes were centrifuged again. This process was repeated 
until the white interface disappeared (after about 3-4 cycles of PCI and centrifugation). An amount of 
1/10 of the volume of the sample of 3M Sodium Acetate (Appendix A.3.38) was added as well as 2.5 
times the sample volume of 95% ethanol (Appendix A.3.13). The samples were mixed by inverting and 
incubated at -80°C for 15 min. The tubes were then centrifuged at 13000 rpm in an Eppendorf 5415D 
centrifuge for 30 min at 4°C and the supernatant was carefully decanted. The pellet was washed by 
adding 500 µl 70% ethanol (Appendix A.3.12), briefly vortexed, and then centrifuged at 13000 rpm for 
15 min at 4°C. The liquid was decanted and the pellets were air dried at room temperature. Based on 
the size of the pellet, 50-200 µl TE buffer (Appendix A.3.44, heated to 65°C) was added to the pellet 
and incubated at 37°C for 15 min and then stored at -20°C until further use. 
 
2.5. Protein isolation, separation and detection 
2.5.1 Disruption of M. smegmatis cells 
Cell lysates were derived by ribolysing using a FastprepTm FP120 Bio101 Savant. Ten milliliters cell 
culture was centrifuged using an Eppendorf Centrifuge 5810R at 4000 rpm for 15 min. The cell pellet 
was resuspended in 500 µl PBS (Appendix A.3.26). The resuspended cell pellets were ribolysed in a 
QSP 2 ml conical screw microtube with 0.5mm glass beads (1/10th filled with glass beads) for 45sec 
at a speed of 6.5. This was followed by a cooling step on ice for 1 min. This was repeated 4 times in 
total. 
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2.5.2 Magna His purification 
His-tagged proteins were purified using the Promega Magna His tag purification kit. Thirty microliters 
Magna-His Ni-particles were mixed with 200 µl cell lysate in a 1.5 ml Eppendorf tube. This was 
incubated for 2 min at room temperature. The tube was then placed in a magnetic stand for 30 sec 
and the supernatant was removed. The tube was removed from the stand and the lysate was 
resuspended with 150 µl Magna His binding/washing buffer. The tube was then placed in the magnetic 
stand again for 30 sec and the supernatant was removed. This wash step was repeated for a total of 3 
washes. The last elution step used 50 µl elution buffer. The tube was placed in the stand and the 
eluate was removed and placed into a new tube. The eluate was kept at -20°C until use. 
 
2.5.3 Modulus microplate readings 
Fluorescence readings of samples containing red fluorescent protein were taken using a Modulus 
Microplate Reader (Turner Biosystems) with the fluorescence module labelled “green” with excitation 
at 525nm and emission range of 580-640nm. A 5 sec integration time was used. One-hundred 
microliters of each sample was loaded into a 96 well fluorescence microplate together with positive 
and negative controls.  
 
2.5.4 Bio-Rad Protein assay 
The Bio-Rad Protein assay was used to determine protein concentrations of samples intended for β-
gal assays as well as for Western blotting. A dilution range of Bovine Serum Albumin (BSA) dissolved 
in H2O was used to create a standard curve. Sample readings were compared to the standard curve to 
calculate the protein concentrations. The BSA dilution range was made from a 2mg/ml stock as 
indicated below in Table 12.  
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                         Table 12.  BSA dilutions for standard curve 
BSA dilution 
(mg/ml)
2 mg/ml BSA stock (µl) H2O (µl)
0 0 10
0.2 1 9
0.4 2 8
0.5 2.5 7.5
0.6 3 7
0.8 4 6
1 5 5
 
 
Each standard received a volume of 10µl Kircheners medium (Appendix A.2.5). The Bio-Rad reagent 
was mixed with H2O in a 1:4 ratio (1 part reagent to 4 parts H2O). An amount of 980 µl of the mixture 
was added to each standard and sample as well as a blank (Kircheners and H2O). The tubes were 
incubated at room temperature for 5 min and the absorbance was measured at 595nm in a LKB 
Biochrom Ultrospec 4051 absorbance reader. 
 
2.5.5 β-galactosidase assay 
β-galactosidase (β-gal) assays were performed using pJem15 promoter probe constructs (Section 
2.6.2) to compare promoter strengths of various promoters. Following electroporation of the constructs 
into M. smegmatis (Section 2.3.13.2), single colonies were picked and grown in 10 ml 7H9 (Section 
2.1.2.3) containing kanamycin (Appendix A.1.2). The cell culture was centrifuged at 4000 rpm for 15 
min in an Eppendorf Centrifuge 5810R. The cell pellet was re-dissolved in Kircheners medium 
(Appendix A.2.5). Centrifugation and resuspention in Kircheners was repeated for a total of 4 times. 
One-hundred microliters of resuspended cells was inoculated into 10 ml Kircheners medium 
containing Kanamycin. The culture was grown until an OD reading of 1 (measured at 600nm in a LKB 
Biochrom Ultrospec 4051 absorbance reader). The cells were centrifuged and the cell pellet was 
resuspended in 500 µl PBS (A.3.26). The cells were then lysed (Section 2.5.1). The resulting cell 
lysate was centrifuged in an Eppendorf centrifuge 5415D at 13000 rpm for 10 min and the supernatant 
was transferred into a new tube. The protein concentration of the supernatant was then determined 
using the Bio-Rad protein assay (Section 2.5.4). Equal amounts of protein samples were made up to a 
volume of 30 µl in triplicate. The β-gal reaction was set up as in Table 13. 
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             Table 13. β-galactosidase assay reaction composition 
Component  Amount (µl) 
100X Mg solution (Appendix A.3.20) 3 
1XONPG solution (Appendix A.3.24) 66 
Protein sample  30 
0.1M Phosphate buffer (Appendix A.3.31) 201 
 
 
The reaction mixture was shaken and incubated at 37°C for 30 min. To stop the reaction, 500 µl 
sodium carbonate (Appendix A.3.40) was added. The OD was measured at 420nm as well as at 
550nm. To calculate the amount of units of β-galactosidase the following equation was used: 
 
1 unit of β-galactosidase = 200 * (OD420-(1.65 X OD550)) / mg of protein / minute 
 
2.5.6 SDS Polyacrylamide Gel Electrophoresis (PAGE) 
2.5.6.1 Sample preparation 
Protein concentrations of ribolysed samples were measured using the Bio-Rad Protein assay (section 
2.5.4) and samples were diluted to the same concentration. Twenty microliters of each ribolysed 
sample was placed into an 1.5 ml Eppendorf tube, mixed with 20 µl 2X sample reducing buffer 
(Appendix A.3.35) and boiled at 100°C for 5 min. The samples were then loaded onto a gel prepared 
as described in Section 2.5.6.2 and was run as described in Section 2.5.6.3. 
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2.5.6.2 Gel preparation 
A Bio-Rad gel apparatus was assembled as per manufacturer’s instruction (Bio-Rad). A 1% separating 
gel was made, reserving the top 2 cm for the 3% stacking gel. The gel consisted of the components 
listed in Table 14 and 15. 
   Table 14. Components for a 10% acrylamide separating gel 
Component Amount 
Acrylamide/bis-acrylamide 30:0.8 (% w/v), (Appendix A.3.2) 3.33 ml 
1.5 M Tris-HCI pH 8.8 (Appendix A3.47)  2.5 ml 
10% SDS (Appendix A.3.36)  100 µl 
H20  4 ml 
Tetramethylethylenediamine (temed, sigma)  10 µl 
10% ammonium persulphate (Appendix A.3.3) 50 µl 
 
                  Table 15. Components for a 3% acrylamide stacking gel 
Component Amount 
Acrylamide/bis-acrylamide 1.3 ml 
1M Tris-HCI pH 6.8 (Appendix A3.45)  1.25 ml 
10% SDS   (Appendix A.3.36) 100 µl 
H20 7.4 ml 
Tetramethylethylenediamine 20 µl 
10% ammonium persulphate (Appendix A.3.3) 50 µl 
    
 
2.5.6.3 Running of samples 
Fifteen microliter of each sample (as described in Section 2.5.6.1) was loaded into the gel (as 
described in Section 2.5.6.2) wells and run along with 5 µl “Prestained Protein Ladder” (Fermentas) 
protein ladder at 200V for 50 min using SDS-PAGE running buffer (Appendix A.3.37). Gels were run in 
duplicate, in order to have one for protein size analysis as well as one for Western blotting. One gel 
was stained with Coomassie Blue (Appendix A.3.9) for one hour, followed by overnight destaining with 
destaining solution (Appendix A.3.10). The other gel was used for Western blotting as described in 
Section 2.5.6.4. 
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2.5.6.4 Western blotting 
After SDS polyacrylamide gel electrophoresis, the protein samples on the gel were transferred to a 
polyvinylidene difluoride (PVDF) membrane by Western blotting. The gel was placed on a pre-wet 
PVDF membrane. A Whatman sheet was placed on either side of the gel and membrane (one on the 
gel side and one on the membrane side.). A foam pad is then added to either side of the Whatman 
sheet. This “sandwich” was then placed into a Western blot apparatus filled with transfer buffer 
(Appendix A.3.42). A frozen icepack and magnetic stirrer were added and the transfer was allowed to 
take place at 100 V for 60 min. Following this, the membrane was stained with Ponceau Red dye 
(Appendix A.3.32) and the positions of visible protein ladder marker bands were marked with a pen 
(along the edge). 
 
2.5.6.5 Antibody-based His-tag detection 
For antibody-based detection, the membrane was blocked overnight with blocking buffer (Appendix 
A.3.5). The membrane was rinsed well with Tris Buffered Saline Tween (TBS-T) buffer (Appendix 
A.3.41) and incubated with the primary antibody, mouse anti-His (Invitrogen). The mouse anti-His 
antibody was diluted 1:5000 in TBS-T buffer. From this dilution 1 µl was used and placed onto the 
membrane. The membrane was incubated for 60 min at room temperature with gentle shaking. This 
was followed by a wash step by rinsing twice with TBS-T buffer followed by three 10 min wash steps in 
TBS-T buffer with shaking. The membrane was then incubated with the secondary antibody, goat-anti 
mouse (Caltag Laboratories). The secondary antibody (goat-anti-mouse conjugated to Horse Radish 
Peroxidase (HRPO)) was diluted 1:10 000. One microliter was diluted in 10 ml TBS-T buffer and 
incubated with the membrane for 60 min at room temperature with gentle shaking. This wash step was 
repeated followed by an incubation step with enhanced chemiluminescent (ECL) detection fluid (5 ml 
“solution 1” mixed with 5 ml “solution 2”) for 1 min. The membrane was then incubated along with an 
auto-radiographic film in a X-ray film cassette for periods of 10 sec, 30 sec, 2 min, 5 min and 20 min to 
vary the intensities of the visual result on the film. 
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2.5.6.6 HRP Western blot detection colorimetric-based His-tag detection 
The KPL His Detector Western Blot Kit was used to detect certain His-tagged proteins. Following 
Western blotting the membrane was blocked with 10 ml of 1% BSA blocking buffer (Appendix A.3.7) in 
TBS-T buffer (Appendix A.3.41) for 1 hour at room temperature with gentle shaking. One microliter 
His-Detector Nickel-HRP conjugate (KPL) was added directly to the blocking solution and incubated 
with the membrane for 1 hour with gentle shaking. The membrane was washed with TBS-T buffer 3 
times for 5 min each with gentle shaking. Ten millilitres TMB Membrane Substrate (KPL) was added to 
the membrane and allowed to react for 15 min. The membrane was rinsed for 30sec to stop the 
reaction and allowed to air dry. The membrane was then photocopied to keep a permanent record. 
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2.6 Cloning 
2.6.1 Cloning of PCR products 
PCR amplification products intended for cloning were first cloned into the Promega T-vector, pGem-T-
Easy (Appendix B.5). Following a PCR cleanup (Section 2.3.3) and elution with 40 µl H2O, the purified 
PCR product was used in a ligation reaction with pGem-T-easy as described in Table 16. 
 
Table 16. Ligation components for ligation of PCR products to pGem-T-Easy. 
Component Amount 
Purified PCR product 3 µl 
2X Ligation buffer (Promega) 5 µl 
pGem-T-Easy vector (Promega) 1 µl 
T4 DNA Ligase (Promega) 1 µl 
Total 10 µl 
 
This ligation mixture was incubated at room temperature for 1h. Two microliters of the ligation was 
electroporated into E. coli. (Section 2.3.13.1) and plated onto LB agar plates (Appendix A.2.7) 
containing ampicillin (Appendix A.1.1) along with 100 µl X-gal (Appendix A.3.49) and 100 µl IPTG 
(Appendix A.3.16). White colonies were picked, PCR screened for the correct insert (Section 2.2.3), 
grown overnight in LB (Section 2.1.2.1) with ampicillin. Plasmid DNA was extracted and purified using 
the Promega SV-Wizard Miniprep kit (Section 2.3.5). The DNA concentration was then determined 
(Section 2.3.7) and the DNA was then sent for sequencing (Section 2.3.8) using the sequencing 
primers Sp6 and T7 (Section 2.2.1, Table 5) to confirm the sequence of the insert.  
 
2.6.2 Cloning of promoter elements into pJem15 
Ten intergenic regions were chosen from M. tb ESAT-6 gene cluster region 5 (Rv1782 to Rv1798). 
Based on promoters detected in other ESX gene clusters, this region potentially contains several 
strong promoters (Gey van Pittius, 2002). Two online promoter prediction software programs were 
used to identify ten intergenic regions selected from the M. tb H37RV ESAT-6 gene cluster 5. The first 
is the “Neural Network Promoter Prediction” (NNPP) software, 
(http://www.fruitfly.org/seq_tools/promoter.html) and the second is the “BPROM” software 
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(http://softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfindb). A minimum 
promoter score of 0.2 was used for both programs. Regions larger than 35bp were chosen to be 
cloned into a promoter probe vector to detect promoter activity. Table 17 lists the details of the various 
regions chosen to screen for promoter activity and Appendix E.1 lists the sequences of the selected 
promoter regions that were screened. 
 
Table 17. Details of the selected intergenic regions of the ESAT-6 gene cluster region 5 
and their location in the M. tb H37Rv genome 
Intergenic 
region
Size of 
intergenic 
region (bp)
Size of PCR 
product (bp)
Location in  
H37Rv genome 
(bp)
Primer pairs 
(details in Table 5 
Section 2.2.2)
Int1 or 
(Rv177980)
420 254 2014379-2014799 Rv1779-80f and 
Rv1779-80r
Int2 or 
(Rv178182)
464 319 2017376-2017840 Rv1781-82f and 
Rv1781-82r
Int3 or 
(Rv178384)
670 529 2020464-2020734 Rv1783-84f and 
Rv1783-84r
Int4 or  
(Rv178687)
470 323 2024931-2025401 Rv1786-87f and 
Rv1786-87r
Int5 or 
(Rv178788)
279 128 2026298-2026577 Rv1787-88f and 
(Rv1787-88r
Int6 or 
(Rv178990)
654 498 2027871-2028525 Rv1789-90f and 
Rv1789-90r
Int7 or 
(Rv179091)
627 462 2029377-2030004 Rv1790-91f and 
Rv1790-91r
Int8 or 
(Rv179192)
344 187 2030103-2030447 Rv1791-92f and 
Rv1791-92r
Int9 or 
(Rv179394)
288 135 2030878-2031166 Rv1793-94f and 
Rv1793-94r
Int10 or 
(Rv179495)
472 312 2031868-2032340 Rv1794-95f and 
Rv1794-95r
 
 
Each promoter element was PCR amplified (Section 2.2) with the corresponding primers listed in 
Table 17, the products were run on a gel (Section 2.3.1). The correct size band (as listed in Table 17) 
was purified from the gel (Section 2.3.3) and cloned into pGem-T-Easy (Section 2.6.1). The plasmids 
were then digested with BamHI and KpnI (Section 2.3.9) and the digests were run on a gel. The 
correct size bands (Table 17) were purified from the gel. Vector pJem15 was digested with BamHI and 
KpnI, run on a gel, the large molecular size band was purified from the gel and dephosphorylated 
(Section 2.3.11). The digested intergenic region promoter elements were ligated (Section 2.3.12) to 
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the digested and dephosphorylated pJem15 to create the constructs named pJem15int1, pJem15int2, 
pJem15int3, pJem15int4, pJem15int5, pJem15int6, pJem15int7, pJem15int8, pJem15int9 and 
pJem15int10. The ligations were electroporated into E. coli (Section 2.3.13.1) and plated onto LB agar 
(Appendix A.2.8) containing kanamycin (Appendix A.1.2). A PCR colony screening was done (Section 
2.2.3) using the relevant primer pairs from Table 17 and the colonies testing positive for the plamid 
with the correct size inserts (as listed in Table 17) were grown in liquid media (Section 2.1.2.1) 
containing kanamycin. The plasmid DNA was extracted (Section 2.3.5) and sequenced (Section 2.3.8) 
using the relevant primer pair from Table 17 to verify the insert sequence. The promoter strengths of 
the promoter constructs were then assayed using the β-galactosidase assay (Section 2.5.5) and the 
strongest promoter construct was selected for use in constructing reporter plasmids as described in 
Section 2.6.3.  
 
2.6.3 Cloning to create reporter plasmid constructs 
As a proof of concept for the mycobacteriophage reporter system, plasmid reporter constructs were 
made for evaluation of expression in M. smegmatis. Several variables play a role in the expression 
levels of a given reporter protein. It was thus necessary to establish the optimal reporter construct, and 
in so doing numerous plasmid reporter constructs were created and evaluated. The constructs made 
use of various promoters, reporter genes, affinity tags and expression vectors. Table 18 lists the 
various reporter constructs that were created. The methodology for creating each of the reporter 
constructs is referenced in Table 18.  
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Table 18. List of reporter plasmids. 
Construct Name
Reporter 
Gene Promoter Affinity tag
Expression 
vector
Antibiotic 
resistance Section
pSD21Hsp60DsRedNHis DsRed Hsp60 N-term His tag pSD21 Kanamycin 2.6.3.1
p19KProHsp60DsRedNHis DsRed Hsp60 N-term His tag p19KPro Hygromycin 2.6.3.2
pSD21Hsp60DsRedCHis DsRed Hsp60 C-term His tag pSD21 Kanamycin 2.6.3.3
pACEHsp60DsRedCHis DsRed Hsp60 C-term His tag pACE Hygromycin 2.6.3.4
pSD21Int1DsRedNHis DsRed Int1 N-term His tag pSD21 Kanamycin 2.6.3.5
pACEInt1DsRedCHis DsRed Int1 N-term His tag pACE Hygromycin 2.6.3.6
pSD21Hsp60mRFPNHis mRFP1 Hsp60 N-term His tag pSD21 Kanamycin 2.6.3.7
p19KProp19kmRFPNHis mRFP1 P19k N-term His tag p19KPro Kanamycin 2.6.3.8
pSD21Int1mRFPNHis mRFP1 Int1 N-term His tag pSD21 Kanamycin 2.6.3.9
pDMN1SmycmRFPNHis mRFP1 Smyc N-term His tag pDMN1 Kanamycin 2.6.3.10
pJem15Hsp60LacZNHis LacZ Hsp60 N-term His tag pJem15 Kanamycin 2.6.3.11
pJem15Int1LacZCHis LacZ Int1 N-term His tag pJem15 Kanamycin 2.6.3.12
  
 
2.6.3.1 Construction of pSD21Hsp60DsRedNHis  
The Hsp60 promoter as well as the first 3 amino acids from the M. tb ESAT-6 gene was previously 
cloned into the vector pMB154Hsp60 (Appendix B.8). The promoter and ESAT-6 segment was PCR 
amplified (Section 2.2) with primers ESAT6-f and Hsp60PromHisr3 (Table 5, Section 2.2.1) to add RE 
sites BamHI and KpnI as well as a poly-Histidine tag (His-Tag, 6 amino acids in total) to the PCR 
product. The PCR products were run on a gel (Section 2.3.1) and the 361bp fragment was purified 
from the gel (Section 2.3.3). The purified PCR products were then cloned into pGem-T-Easy (Section 
2.6.1) to create the construct named pGemHsp60NHis3. About 4 µg of each plasmid DNA was used in 
a digestion to remove the insert from pGem-T-Easy with RE BamHI and KpnI (Section 2.3.9). The 
digestion products were run on a gel and the 359bp fragment was purified from the gel. Vector 
pDsRed (Appendix B.3), was digested with BamHI and KpnI, run on a gel, and the 3034bp vector 
fragment was purified and then dephosphorylated (Section 2.3.11). The digested and 
dephosphorylated DsRed vector was ligated (Section 2.3.12) to the inserts from the digested 
pGemHsp60NHis3 vectors and the resulting construct was called pDsRedHsp60NHisDsRed3. This 
places the DsRed gene, encoding for a tetrametic red fluorescent protein, under the control of the 
Hsp60 promoter and also adds an N-terminus His-tag to the DsRed gene. The ligation was 
electroporated into E. coli (Section 2.3.13.1) and plated on LB agar (Appendix A.2.7) containing 
ampicilin (Appendix A.1.1). PCR colony screening was done (Section 2.2.3) using ESAT6-f and 
Hsp60PromHisr3, colonies testing positive for the plasmid containing the plasmid with the correct size 
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insert (corresponding to 361bp band) were grown in liquid media (Section 2.1.2.1) containing 
ampicillin. Plasmid DNA was extracted and purified (Section 2.3.5) and the vectors were then sent for 
sequencing (Section 2.3.8) using primers ESAT6-f and Hsp60PromHisr3. The inserts were removed 
from the pDsRed vector by digestion with RE XbaI. The digests were run on a gel and the 1065bp 
fragment was purified. pSD21 (Appendix B.12) was digested with XbaI, run on a gel and the large 
molecular weight band was purified and dephosphorylated. The digested pSD21 DNA was ligated to 
the inserts of the digested Hsp60NHisDsRed3 products and the construct was named 
pSD21Hsp60DsRedNHis3. The ligations were electroporated into E. coli followed by a PCR colony 
screening for the Hsp60 promoter and DsRed gene insert using ESAT6-f and Hsp60PromHisr3. 
Colonies testing positive for the plasmid with the correct size insert (corresponding to the 1065bp 
band) were grown up in liquid media containing kanamycin (Appendix A.1.2). The plasmid DNA was 
purified from the liquid cultures and the plasmid constructs were verified by sequence analysis using 
primer pairs ESAT6-f and Hsp60PromHisr3. Figure 2.1a and 2.1b is an illustration of the main cloning 
steps used to create the construct pSD21Hsp60DsRedNHis. 
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pGEM-T Easy
3000bp
Amp
f1 ori
T T
ori
LacZ
pGemHsp60NHis3
3359bp
Amp
f1 ori
ori
His Tag
Hsp60 prom
KpnI
BamHI
 
pDsRed
3300bp
Amp
pUC ori
DsRed
Plac
BamHI
XbaI
XbaI
KpnI
DsRedHsp60NHis3
3657bp
Amp
pUC ori
DsRed
Plac
His Tag
Hsp60 prom
KpnI
XbaI
XbaI BamHI
 
Figure 2.1a Construction of pSD21Hsp60DsRedNHis. The PCR amplification product, consisting of 
the Hsp60promoter and a histidine tag for N-terminal protein fusions,  was cloned into pGem-T-Easy 
and was called pGemHsp60NHis3. pGemHsp60NHis3 was digested with BamHI and KpnI and the 
insert was ligated to the BamHI and KpnI digested pDsRed to give pDsRedHsp60NHis3. This places 
the DsRed gene under the control of the Hsp60 promoter and also creates an N-terminal His tag 
fusion to the DsRed gene. 
R 
R 
R R 
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Figure 2.1b Construction of pSD21Hsp60DsRedNHis (continued). DsRedHsp60NHis3 (shown in 
Figure 2.1a) was digested with XbaI and the resulting product consisting of the Hsp60 promoter and 
N-terminus His tagged DsRed gene was cloned into the XbaI site of expression vector pSD21 to 
create pSD21Hsp60DsRedNHis. 
 
2.6.3.2 Construction of P19KproHsp60DsRedNHis 
The P19Kpro vector (Appendix B.1) was digested (Section 2.3.9) with XbaI and run on a gel (Section 
2.3.1). The large molecular weight band was purified from the gel (Section 2.3.3) and 
dephosphorylated (Section 2.3.11). The XbaI digested P19Kpro vector was then ligated (Section 
2.3.12) to the liberated insert from the XbaI digested pDsRedHsp60DsRedNHis (Section 2.6.3.1) to 
create the vector P19KproHsp60DsRedNHis. The ligation was electroporated into E. coli (Section 
2.3.13.1). A PCR colony screening (Section 2.2.3) was performed using primers ESAT6-f and 
Hsp60promHisr-3 (Table 5, Section 2.2.1), to confirm the presence of plasmid containing the correct 
inserts. The colonies that tested positive for the plasmid with the correct insert (corresponding to the 
1065bp band, consisting of the Hsp60 promoter and DsRed gene) were grown up in liquid media 
(Section 2.1.2.1) containing hygromycin (Appendix A.1.3) and the plasmid DNA was purified (Section 
2.3.5). The constructs were then sequence analyzed (Section 2.3.8) using primers ESAT6-f and 
Hsp60promHisr-3. Figure 2.2 is a visual illustration of the main cloning steps used to create construct 
P19KproHsp60DsRedNHis. 
R R 
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Figure 2.2 Construction of P19KproHsp60DsRedNHis. The liberated insert from the XbaI digested 
pDsRedHsp60DsRedNHis (Section 2.6.3.1) was cloned into XbaI digested P19Kpro to create 
P19KproHsp60DsRedNHis.  
 
2.6.3.3 Construction of pSD21Hsp60DsRedCHis  
The Hsp60 promoter and the DsRed gene was PCR amplified (Section 2.2.2) from a previously 
constructed vector, pHsp60DsRed (Appendix B.4), with primer pairs ESAT6-f and DsRedHisr (Table 5, 
Section 2.2) to add a C-terminus His-tag as well as BamHI and XbaI RE sites. The PCR product was 
run on a gel (Section 2.3.1) and the 1065bp band was purified (Section 2.3.3). The PCR product was 
then cloned into pGem-T-Easy (Section 2.6.1) and the resulting construct was called 
pGemHsp60DsRedCHis. The insert was removed from pGem-T-Easy by digestion using BamHI and 
XbaI (Section 2.3.9), run on a gel and the 1059bp band was purified. pSD21 (Appendix B.12) was 
digested with BamHI and XbaI, run on a gel and the large molecular weight band was purified and 
dephosphorylated (Section 2.3.11). The digested and dephosphorylated pSD21 vector was ligated to 
the insert from the digested pGemHsp60DsRedCHis product and the construct was called 
pSD21Hsp60DsRedCHis. The ligation was electroporated into E. coli (Section 2.3.13.1) and plated 
onto LB solid media (Section 2.1.2.2) with kanamycin (Appendix A.1.2). A PCR colony screening 
(Section 2.2.3) was done and colonies testing positive for the plasmid with the correct insert size 
(corresponding to the 1065bp band) were grown in liquid culture (Section 2.1.2.1) with kanamycin. The 
R R 
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construct was then sequence verified (Section 2.3.8). Figure 2.3a and 2.3b is an illustration of the 
main cloning steps to create pSD21Hsp60DsRedCHis. 
pDsRedHsp60
3600bp
Amp
pUC ori
DsRed
Plac
KpnI
XbaI
XbaI BamHI
 
pGem-T-Easy
3000bp
Amp
f1 ori
T T
ori
LacZ
pGemHsp60DsRedCHis
4065bp
Amp
f1 ori
ori
Hsp60 prom
His Tag
DsRed
BamHI
XbaI
 
Figure 2.3a Construction of pSD21Hsp60DsRedCHis. The Hsp60 promoter and DsRed gene was 
PCR amplified from pDsRedHsp60 to add a C-term His-tag fusion to the PCR product. The PCR 
product was ligated to pGem-T-Easy and was called pGemHsp60DsRedCHis.  
R 
R 
R 
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Figure 2.3b Construction of pSD21Hsp60DsRedCHis (continued). Vector pGemHsp60DsRedCHis 
was digested with BamHI and XbaI and the liberated insert was ligated to BamHI and XbaI digested 
pSD21 to create pSD21Hsp60DsRedCHis. 
 
2.6.3.4 Construction of pACEHsp60DsRedCHis 
The 1059bp pGemHsp60DsRedCHis BamHI and XbaI digest product from Section 2.6.3.3 was also 
cloned into the expression vector pACE (Appendix B.2). The pACE vector was digested (Section 
2.3.9) with BamHI and XbaI (which removes the ACE promoter) and run on a gel (Section 2.3.1). The 
digested pACE vector (5315bp band) was purified from the gel (Section 2.3.3) and dephosphorylated 
(Section 2.3.11). The BamHI and XbaI digested pACE vector was then ligated (Section 2.3.12) to the 
liberated insert from the BamHI and XbaI digested pGemHsp60DsRedCHis (Section 2.6.3.3) to create 
the construct named pACEHsp60DsRedCHis. The ligation was electroporated into E. coli (Section 
2.3.13.1) and a PCR colony screening (Section 2.2.3) was done, using primers ESAT6-f and 
DsRedHisr (Table 5, Section 2.2.1). The colonies testing positive for the plasmid with the correct insert 
size (corresponding to the 1065bp band) were grown in liquid media (Section 2.1.2.1) containing 
ampicillin (Appendix A.1.1) and the plasmid DNA was purified (Section 2.3.5). The construct was then 
sequence analyzed (Section 2.3.8) using primers ESAT6-f and DsRedHisr (Table 5, Section 2.2.1). 
Figure 2.4 is a visual illustration of the main cloning steps used to create pACEHsp60DsRedCHis.  
R 
R 
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Figure 2.4 Construction of pACEHsp60DsRedCHis. The ACE promoter was removed from pACE 
with BamHI and XbaI. The insert from the BamHI and XbaI digested pGemHsp60DsRedCHis (Section 
2.6.3.3) was cloned into the BamHI and XbaI sites of pACE creating the construct 
pACEHsp60DsRedCHis. 
 
2.6.3.5 Construction of pSD21Int1DsRedNHis 
The intergenic region promoter element “Int1” (Section 2.6.2) was PCR amplified (Section 2.2.2) from 
H37Rv genomic DNA (Section 2.1.1) with the primers Rv1979-80f and Int1RFPr (Table 5, Section 
2.2.1) to add BamHI and KpnI RE sites as well as an His-tag for N-terminal protein fusions to the PCR 
product. The PCR product was run on a gel (Section 2.3.1) and the 254bp band was purified (Section 
2.3.3) and cloned into pGem-T-Easy (Section 2.6.1) to create the construct pGemInt1NHis. The insert 
was removed from pGem-T-Easy by digestion (Section 2.3.9) with BamHI and KpnI. The digest was 
R R 
R 
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run on a gel and the 254bp band was purified. pDsRed (Appendix B.3) was digested with BamHI and 
KpnI (Section 2.3.9), the digest product was run on a gel and the large molecular weight band was 
purified and then dephosphorylated (Section 2.3.11). The BamHI and KpnI digested pDsRed vector 
was ligated (Section 2.3.12) to the insert from the BamHI and KpnI digested pGemInt1NHis to create 
the construct pDsRedInt1DsRedNHis. The ligation was electroporated into E. coli (Section 2.3.13.1) 
and a PCR colony screening was done (Section 2.2.3) using primers Rv1979-80f and Int1RFPr. The 
colonies testing positive for the plasmid with the correct insert size (corresponding to the 254bp band) 
were grown up in liquid media (Section 2.1.2.1) containing ampicillin (Appendix A.1.1). The plasmid 
DNA was purified (Section 2.3.5) and sequence verified (Section 2.3.8) with primers Rv1979f and 
Int1RFPr. The pDsRedInt1DsRedNHis construct was then digested with XbaI to remove the promoter 
and DsRed gene. The digest was run on a gel and the 993bp band was purified. pSD21 (Appendix 
B.12) was digested with XbaI, the digest was run on a gel and the large molecular weight band was 
purified, dephosphorylated and was ligated to the XbaI digested insert from pDsRedInt1DsRedNHis to 
create the construct pSD21Int1DsRedNHis. The ligation was electroporated into E. coli and a PCR 
colony screening was done using primers Rv1979-80f and Int1RFPr to screen for colonies with the 
correct insert size (corresponding to the 993bp band). The colonies with plasmids containing the 
correct insert size were grown in liquid media containing kanamycin (Appendix A.1.2) and the plasmid 
DNA was purified. The constructs were sequenced with primers Rv1979-80f and Int1RFPr. Figure 
2.5a and 2.5b is a visual illustration of the main cloning steps used to create construct 
pSD21Int1DsRedNHis. 
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Figure 2.5a Construction of pSD21Int1DsRedNHis. The “int1” (intergenic region 1) promoter was 
PCR amplified to add a His-tag sequence for N-terminal protein fusions and was cloned into pGem-T-
Easy. The construct was named pGemInt1NHis. The insert was removed from pGem-T-Easy using 
BamHI and KpnI and was ligated into pDsRed to create pDsRedInt1DsRedNHis. 
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Figure 2.5b Construction of pSD21Int1DsRedNHis (continued). The promoter and DsRed gene 
was removed from pDsRed using XbaI and cloned into pSD21, this construct was named 
pSD21IntIDsRedNHis. 
 
2.6.3.6 Construction of pACEInt1DsRedCHis 
The intergenic region 1 promoter element 1 was PCR amplified (Section 2.2.2) using primers Rv1979-
80f and Rv1979-80r (Table 5, Section 2.2) from H37Rv genomic DNA (Section 2.1.1). The primers add 
BamHI and KpnI RE sites to the PCR product. The PCR product was run on a gel (Section 2.3.1) and 
the 233bp band was purified from the gel (Section 2.3.3). The purified PCR product was ligated to 
pGem-T-Easy (Section 2.6.1) and this was called pGemInt1. The insert was removed from pGem-T-
Easy by digestion with BamHI and KpnI (Section 2.3.9) and the digest was run on a gel, the 233bp 
band was then purified (Section 2.3.3). pDsRedHsp60DsRedCHis (Section 2.6.3.3) was digested with 
BamHI and KpnI to remove the Hsp60 promoter. The digested DNA was run on a gel and the large 
molecular weight band was purified and then dephosphorylated (Section 2.3.11). The digested 
pGemIntI fragment was then ligated (Section 2.3.12) to the BamHI and KpnI digested 
pDsRedHsp60DsRedCHis vector and was called pDsRedIntIDsRedCHis. The ligation was then 
electroporated into E. coli (Section 2.3.13.1) and plated onto LB agar plates (Appendix A.2.8) 
containing ampicillin (Appendix A.1.1). The colonies were PCR screened (Section 2.2.3) using primers 
Rv1979-80f and Rv1979-80r. Colonies testing positive for the 223bp band were then grown in liquid 
R 
R 
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media containing ampicillin and the plasmid DNA was subsequently purified (Section 2.2.5). The 
purified pDsRedIntIDsRedCHis DNA was then digested with BamHI and XbaI and the 993bp band 
was purified. BamHI and XbaI digested and dephosporylated pACE DNA from Section 2.6.3.4 was 
then ligated to the 993bp fragment from the BamHI and XbaI digest of pDsRedIntIDsRedCHis. The 
ligation product was named pACEIntIDsRedCHis and electroporated into E. coli, a PCR colony 
screening was done using primer pairs Rv1979-80f and DsRedHisr. The colonies containing plasmids 
testing positive for the correct insert size (corresponding to the 993bp band) were grown in liquid 
media (Section 2.1.2.1) containing hygromycin (Appendix A.1.2). A plasmid DNA extraction was 
performed on the liquid cultures and the construct was analyzed by sequencing (Section 2.3.8) using 
primers RV1979-80f, RV1979-80r and DsRedHisr. Figure 2.6 is a visual illustration of the main cloning 
steps to create construct pACEInt1DsRedCHis. 
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Figure 2.6 Construction of pACEInt1DsRedCHis. The initial PCR product was cloned into pGem-T-
Easy and was named pGemInt1. The Hsp60 promoter was removed from pACEHsp60DsRedCHis 
using BamHI and KpnI. The int1 promoter and His tag from pGemInt1NHis were cloned into the 
BamHI and KpnI digested pACEHsp60DsRedCHis to create pACEInt1DsRedCHis. 
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2.6.3.7 Construction of pSD21Hsp60mRFPNHis 
The mRFP1 gene was PCR amplified (Section 2.2) from the vector pRSETB (Appendix B.11) with the 
primers Hsp60mRFP1f2 and Hsp60mRFP1r2 (Table 5, Section 2.2.1) which add KpnI and SalI RE 
sites to the PCR product. The PCR product was run on a gel (Section 2.3.1), the 706bp band as 
purified (Section 2.3.3) and was subsequently cloned into pGem-T-Easy (Section 2.6.1) to create 
pGem1mRFP1. The insert was removed by digesting with RE KpnI and SalI (Section 2.3.9). The 
digest was run on a gel, and the 704bp band was purified from the gel. pGemHsp60NHis2 (Section 
2.6.3.1) was digested with KpnI and SalI, run on a gel, and the large molecular band was purified and 
dephosphoylated (Section 2.3.11). The purified mRFP1 insert from the KpnI and SalI digested 
pGem1mRFP2 was then ligated (Section 2.3.12) to the KpnI and SalI digested and dephosphorylated 
pGemHsp60NHis to create pGemHsp60mRFP1NHis2. The ligations were electroporated into E. coli 
(Section 2.3.13.1) and a PCR colony screening was done (Section 2.2.3) using primers 
Hsp60mRFP1f2 and Hsp60mRFP1r2. Colonies testing positive for the plasmid containing the correct 
insert size (corresponding to the 1060bp band) were grown up in liquid media (Section 2.1.2.1) 
containing ampicillin (Appendix A.1). A plasmid extraction was done (Section 2.3.5) and the construct 
was sequence verified (Section 2.3.8) using the primers Hsp60mRFP1f2 and Hsp60mRFP1r2. pSD21 
(Appendix B.12) was digested with BamHI and KpnI, run on a gel, the large molecular band was 
purified and the vector was dephosphorylated (Section 2.3.11). The BamHI and KpnI digested insert 
from pGem2Hsp60mRFPNHis consisting of the Hsp60 promoter and N-term His-tagged mRFP1 gene 
was ligated to the BamHI and KpnI digested and dephosphoylated pSD21 vector to create 
pSD21Hsp60mRFPNHis. The ligation was electroporated into E. coli and a PCR colony screening was 
done using primers ESAT6-f and Hsp60mRFP2r. Colonies testing positive for the correct insert size 
were selected and grown in liquid media containing kanamycin (Appendix A.1.2). The plasmid DNA 
was purified from the liquid culture (Section 2.3.5) and the construct was sequence verified (Section 
2.3.8) using primers ESAT6-f, Hsp60mRFP2f and Hsp60mRFP2r. Figure 2.7a and 2.7b is a visual 
illustration of the main cloning steps involved to create the construct pSD21Hsp60mRFPNHis. 
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Figure 2.7a Construction of pSD21Hsp60mRFPNHis. The mRFP1 gene was PCR amplified and 
cloned into pGem-T-Easy to create pGemmRFP. 
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Figure 2.7b Construction of pSD21Hsp60mRFPNHis (continued). The mRFP1 gene was removed 
by digestion with KpnI and SalI and was ligated to KpnI and SalI digested pGemHsp60NHis (Section 
2.6.3.1) to create pGemHsp60mRFP1NHis. The pGemHsp60mRFP1NHis vector was digested with 
BamHI and SalI and the liberated insert was cloned into pSD21 to create pSD21Hsp60mRFP1NHis. 
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2.6.3.8 Construction of p19KProp19KmRFPNHis 
The mRFP1 gene was PCR amplified (Section 2.2.2) to add an N-terminal His-tag. The PCR template 
used was vector pRSETB (Appendix B.11) with primer pairs that add RE sites HindIII and ClaI named 
P19Kmrfpf2 and P19Kmrfpr3 (Table 5, Section 2.2.1). The PCR product was run on a gel and the 
848bp band was purified (Section 2.3.3) and cloned into pGem-T-Easy (Section 2.6.1) to create 
pGemmRFPNHis. The PCR product was removed from pGemmRFPNHis by digesting with HindIII and 
ClaI (Section 2.3.9), the digested products were run on a gel and the 704bp band was purified. Vector 
p19Kpro (Appendix B.1) was digested with HindIII and ClaI, run on a gel, the large molecular band 
was purified and dephosphorylated (Section 2.3.11). The 704bp HindIII and ClaI digested insert from 
pGem5mRFPNHis was ligated to the HindIII and ClaI digested and dephosphorylated p19Kpro to 
create P19KproP19KmRFPNHis. The ligation was electroporated into E. coli (Section 2.3.12.1) and a 
PCR colony screening (Section 2.2.3) was done using primers P19Kmrfpf2 and P19Kmrfpr3. The 
colonies testing positive for the plasmid containing the correct insert size (corresponding to the 848bp 
band) were grown in liquid media (Section 2.1.2.1) containing kanamycin (Appendix A.1.2). A plasmid 
DNA extraction was done (Section 2.3.5) and the construct was sequence verified (Section 2.3.8) 
using primers P19Kmrfpf2 and P19Kmrfpr3. Figure 2.8 is a visual illustration of the main cloning steps 
involved to create the construct P19KmRFPNHisP19Kpro. 
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Figure 2.8 Construction of P19KproP19KmRFPNHis. A His-tagged mRFP1 gene was PCR 
amplified and cloned into pGem-T-Easy to create pGemmRFPNHis. The His-tagged mRFP gene was 
removed by digestion with HindIII and ClaI and cloned into HindIII and CalI digested P19Kpro to 
create P19KmRFPNHisP19Kpro. 
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2.6.3.9 Construction of pSD21Int1mRFPNHis 
pGemInt1NHis (Section 2.6.3.5) was sequenced (Section 2.3.8) with the primers SP6 and T7 (Table 5, 
Section 2.2.1) to verify the orientation of the Int1 promoter and His tag in pGem-T-easy. Constructs 
with an orientation such that it places the His tag coding orientation towards the SP6 side were 
digested (Section 2.3.9) with KpnI and SalI, run on a gel (Section 2.3.1), the large molecular band was 
purified (Section 2.3.3) and dephosphorylated (Section 2.3.11). The KpnI and SalI digested 
pGemInt1NHis was then ligated (Section 2.3.12) to the KpnI and SalI digested pGemmRFP1 from 
Section 2.6.3.8 and was named pGemInt1mRFPNHis. The ligation was electroporated into E. coli 
(Section 2.3.13.1) and a PCR colony screening (Section 2.2.3) was done using primers Int1F and 
Hsp60mRFP1r2 (Table 5, Section 2.2.1). Colonies testing positive for the plasmid containing the 
correct insert size (corresponding to the 989bp band) were then picked and grown in liquid media 
(Section 2.1.2.1) containing ampicillin (Appendix A.1.1), followed by plasmid DNA extraction (Section 
2.3.5). The purified plasmid DNA was then digested with BamHI and SalI, run on a gel and the 983bp 
band was then purified. pSD21 (Appendix B.12) was digested with BamHI and SalI, run on a gel, the 
large molecular band was purified and dephosphorylated. The digested pSD21 vector was then ligated 
to the BamHI and SalI digested 983bp fragment from pGemInt1mRFPNHis and was named 
pSD21Int1mRFPNHis. The ligation was electroporated into E. coli and a PCR colony screening was 
done using primers Int1F and Hsp60mRFP1r2, colonies testing positive for the plasmid containing the 
correct insert size (corresponding to the 989bp band) were grown in liquid culture containing 
kanamycin (Appendix A.1.2) and their plasmid DNA was extracted and sequence verified using 
primers Int1F and Hsp60mRFP1r2. Figure 2.9 is a visual illustration of the main cloning steps to create 
pSD21Int1mRFPNHis. 
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Figure 2.9 Construction of pSD21Int1mRFPNHis. The mRFP1 gene was removed from 
pGemmRFP and was cloned into the KpnI/SalI sites of pGemIntNHis. The Int1 promoter as well as 
His-tagged mRFP1 gene was removed by KpnI and SalI and cloned into the KpnI and SalI sites of 
pSD21. 
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2.6.3.10 Construction of pDMN1mRFPNHis 
Expression vector pDMN1 (Appendix B.10) was digested with HindIII and HpaI (Section 2.3.9), run on 
a gel (Section 2.3.1) and the large molecular size band was purified from a gel (2.3.3) and 
dephosphorylated (Section 2.3.11). The mRFP1 gene was PCR amplified (Section 2.2) from pRSETB 
(Appendix B.11) using primers RCMRFPF and RCMRFPR (Table 5, Section 2.2.1) and subsequently 
cloned into pGem-T-Easy (Section 2.6.1). The insert was removed from pGem-T-Easy by digestion 
with HindIII and HpaI (Section 2.3.9), was run on a gel, the 708bp mRFP1 gene was purified from the 
gel. The HindIII and HpaI digested mRFP1 gene was then ligated (Section 2.3.12) to the HindIII and 
HpaI digested pDMN1 vector. The ligation was electroporated into E. coli (Section 2.3.13.1) and plated 
on LB agar (Appendix A.2.8) containing kanamycin (Appendix A.1.2). A PCR colony screening 
(Section 2.2.3) was performed using the above-mentioned primer pair. Colonies positive for the 
plasmid containing the crorrect insert size (corresponding to the 706bp band) were selected and 
grown in LB media containing kanamycin and used for plasmid DNA extraction (Section 2.3.5). Figure 
2.10 is a visual illustration of the main cloning steps to construct pDMNmRFPNHis. 
pDMN1
4941bp
Kan       
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repB
Psmyc
RBS D
terminator
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RBS D
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Figure 2.10 Construction of pDMN1mRFPNHis. The mRFP1 gene was PCR amplified from 
pRSETB to add RE sites HindIII and HpaI and was cloned into the HindIII and HpaI RE sites of 
pDMN1. 
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2.6.3.11 Construction of pJem15Hsp60NHis 
pJem15 (Appendix B.6) was digested with BamHI and KpnI (Section 2.3.9), run on a gel (Section 
2.3.1) and the large molecular band was purified (Section 2.3.3) and dephosphorylated (Section 
2.3.11). The digested vector was then ligated (Section 2.3.12) to the 361bp BamHI and KpnI digestion 
product from pGemHsp60NHis (Section 2.6.3.1), consisting of the Hsp60 promoter and a sequence 
for an N-term His tag. The ligation was then electroporated into E. coli (Section 2.3.13.1) and a PCR 
colony screening (Section 2.2.3) was done using primers ESAT6-f and Hsp60PromHisr3 (Table 5, 
Section 2.6.3.1). Colonies testing positive for the plasmid containing the correct insert size 
(corresponding to the 361bp band) were then grown in liquid media (Section 2.1.2.1) containing 
ampicillin (Appendix A.1.1). A plasmid DNA extraction was then done (Section 2.3.5) and the 
constructs were sequence verified (Section 2.3.9) using the above-mentioned primer pair. Figure 
2.11a is a visual illustration of the main cloning steps to create pJem15Hsp60NHis. 
pJem15
9446bp
LacZ
 Kan
BamHIKpnI
  
pJem15Hsp60NHis
9807bp
LacZ
Kan
Hsp60 Prom
His tag BamHI
KpnI
 
Figure 2.11a Construction of pJem15Hsp60NHis. The Hsp60 promoter and His tag was removed 
from pGemHsp60NHis3 (Section 2.6.3.1) using BamHI and KpnI and was ligated into BamHI and KpnI 
digested pJem15. 
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A second cloning method was applied to create pJem15Hsp60NHis due to cloning difficulties which 
made use of PCR to replace a stop codon (situated between the LacZ gene and promoter start codon) 
with a start codon in order to allow N-term His-tag fusions. A portion of the LacZ gene as well as a 
region upsteam of the LacZ gene was PCR amplified from pJem15 (Appendix B.6) using primers 
LacZFusion-f2 and LacZFusion-r (Table 5, Section 2.2.1). The PCR product, named “LacZfusion”, was 
run on a gel (Section 2.3.1), the 1195bp band was purified (Section 2.3.3) and cloned into pGem-T-
Easy (Section 2.6.1). The 1187bp insert was excised by RE digest with KpnI and EcoRV and was 
cloned into the KpnI and EcoRV sites of pJem15 to restore N-Term His tag fusion to the LacZ Gene. 
Figure 2.11b is a visual illustration of the cloning method to construct pJem15Hsp60NHis2: 
 
pJem15Hsp60NHis2
9807bp
LacZ
Kan
Hsp60 Prom
His tag BamHI
KpnIEcoRV
 
Figure 2.11b. Construction of pJem15Hsp60NHis2. A portion of the LacZ gene was PCR amplified, 
replacing a stop codon with a start codon on the PCR product. This product was then cloned into 
pGem-T-Easy, excised with KpnI and EcoRV and subsequently cloned into KpnI and EcoRV digested 
pJem15Hsp60NHis to create pJemHsp60NHis2. 
 
 
 
 
 
KpnI Start codon LacZ segment EcoRV 
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2.6.3.12 Construction of pJem15Int1NHis 
The Int1 promoter was PCR amplified (Section 2.2.2) from M. tb H37Rv DNA using primers Int1LacZF 
and Int1LacZR (Table 5, Section 2.2.1) which add BglII RE sites to the product. The product was run 
on a gel (Section 2.3.1) and the 289bp band was excised and purified (Section 2.3.3). The purified 
PCR product was cloned into pGem-T-Easy (Section 2.6.1) and excised with BglII (Section 2.3.9). 
pJem15 (Appendix B.6) was partially digested with BglII (Section 2.3.10), run on a gel (Section 2.3.1), 
the large molecular band was purified (Section 2.3.3) and dephosphorylated (Section 2.3.11). The 
digested Int1 promoter was ligated to the BglII digested pJem15 vector (Section 2.3.12) and 
electroporated into E. coli (Section 2.3.13.1). A PCR colony screening (Section 2.2.3) was done using 
the above-mentioned primer pair, colonies testing positive for the plasmid containing the correct insert 
size (corresponding to the 289bp band) were grown in liquid media (Section 2.1.2.1) containing 
kanamycin (Appendix A.1.2). A plasmid DNA extraction was then done (Section 2.3.5) and the 
constructs were sequence verified (Section 2.3.8) using the above-mentioned primer pair. Figure 2.12 
is a visual illustration of the main cloning steps to create pJem15Int1NHis. 
pJem15
9446bp
LacZ
Kan
BglII
BglII
 
Int1pJem15NHis
9725bp
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His tag
BglII
BglII
 
Figure 2.12 Construction of pJem15Int1NHis. The Int1 promoter was PCR amplified, cloned into 
pGem-T-Easy and subsequently cloned into pJem15 to create Int1pJem15NHis. 
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2.6.4 Construction of reporter cosmids 
The optimal promoter/reporter protein/affinity tag combination (as constructed in Section 2.6.3) was to 
be ligated to mycobacterial genomic DNA with the end goal of creating a recombinant reporter 
mycobacteriophage. The methodology of lambda packaging was chosen due to the vast increase in 
transformation efficiency in comparison to electroporation. Selected reporter constructs were thus 
transferred to cosmids to allow for lambda packaging as well as antibiotic selection of recombinant 
clones. Several cloning approaches were attempted to ensure the successful creation of a suitable 
reporter cosmid for cloning into a mycobacteriophage. The N-term His-tagged reporter gene mRFP1 
and the promoter pSmyc was chosen to be transferred into a suitable cosmid and the various cloning 
methodologies are listed in Table 18. 
 
Table 18. List of reporter cosmids constructed. 
Construct Name
Reporter 
Gene Promoter Affinity tag
Expression 
vector
Antibiotic 
resistance Section
pYub412mRFPPvuI mRFP1 pSmyc N-term His tag pYub412.2 Ampicillin 2.6.4.1
pYub412mRFPSapI mRFP1 pSmyc N-term His tag pYub412.2 Ampicillin 2.6.4.2
pYub412mRFPNdeIBglII mRFP1 pSmyc N-term His tag pYub412.2 Ampicillin 2.6.4.3
pDMN1LCosmRFP mRFP1 pSmyc N-term His tag pDMN1 Kanamycin 2.6.4.4
pYubmRFP mRFP1 pSmyc N-term His tag pYub412 Ampicillin 2.6.4.5
pYubSSmRFP mRFP1 pSmyc N-term His tag pYub412 Ampicillin 2.6.4.6
pYub412LacZ LacZ pSmyc N-term His tag pYub412 Ampicillin 2.6.4.7
 
 
2.6.4.1 Construction of pYub412mRFPPvuI 
The pSmyc promoter along with the mRFP1 gene was PCR amplified from the vector 
pDMN1mRFPNHis (Section 2.6.3.10) with the primer pair mRFPreporter1-f and mRFPreporter1-r 
(Table 5, Section 2.2.1) which add PvuI RE sites to the PCR product. The PCR product was run on a 
gel (Section 2.3.1) and the 955bp band was purified (Section 2.3.3) The PCR product was cloned into 
pGem-T-Easy (Section 2.6.1) and named pGempSmycmRFP. The insert was removed by digesting 
with PvuI (Section 2.3.9), the digested DNA was run on a gel and subsequently the 949bp band was 
purified from the gel. pYub412 (Appendix B.14) was digested with BclI to remove a previous insert 
from the cosmid, the digested DNA was then run on a gel, the 8.5kb DNA band was removed and 
purified and then self-ligated (Section 2.3.12). The self-ligated DNA was then electroporated into E. 
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coli (Section 2.3.13.1) and plated onto LB agar plates (Appendix A.2.8) containing both ampicillin and 
hygromycin (Appendix A.1.1 and A.1.3 respectively). A single colony was selected and grown in LB 
media (Section 2.1.2.1) containing ampicillin and hygromycin, thereafter a cosmid DNA extraction was 
done (Section 2.3.6). The purified DNA was then digested with PvuI, run on a gel, the digested 
molecular size band (as determined by running controls along the digest) was purified and 
dephosphorylated (Section 2.3.11). The 949bp PvuI liberated DNA fragment from pGempSmycmRFP 
was then ligated to PvuI digested pYub412, electroporated into E. coli and plated out on LB agar 
containing hygromycin (ampicillin was no longer added since the cloning site used was situated inside 
the ampicillin resistance gene coding sequence). The resulting colonies were PCR screened using the 
above-mentioned primer pair and the cosmid DNA was extracted (Section 2.3.6). Figure 2.15 is a 
visual illustration of the main cloning steps involved to create the construct pYub412mRFPPvuI. 
pYub412
8562bp
Amp
OriE
cosBcosA
attP
int
Hyg
PvuI
pYub412.2mRFPPvuI
9512bp
mRFP1
OriE
cosB
cosAattP
int
Hyg
psmyc prom
His tag
PvuI
PvuI
 
Figure 2.15. The pSmyc promoter as well as the mRFP1 gene was PCR amplified from 
pDMNmRFPNHis to add PvuI RE sites and this was cloned into PvuI digested pYub412 to create 
pYub412mRFPPvuI 
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2.6.4.2 Construction of pYub412mRFPSapI 
The cloning steps for construction of pYub412mRFPSapI were the same as for pYub412mRFPPvuI 
(Section 2.6.4.1) except that the primer set used was RepTm4SapF2 and RepTm4SapR which add 
SapI RE sites to the PCR product. The PCR product size, however, differed and was 967bp. 
Additionally the resultant SapI digest was 955bp. This places the reporter construct downstream of the 
E. coli origin of replication and inserted it into the beginning of the first cos site (“cos B”). Subsequent 
digests thus made use of SapI instead of PvuI and the sequencing similarly made use of 
RepTm4SapF2 and RepTm4SapR. Figure 2.16 is a visual illustration of the final cloning product 
pYub412mRFPSapI. 
pYub412
8562bp
Amp
OriE
cosBcosA
attP
int
Hyg
SapI
pYub412.2mRFPSapI
9529bp
Amp
OriE
cosBcosA
attP
int
Hyg
mRFP
pSmyc promoter
His tag
 
Figure 2.16 Construction of pYub412mRFPSapI. The pSmyc promoter as well as the mRFP1 gene 
was PCR amplified from pDMNmRFPNHis to add SapI RE sites and this was cloned into SapI 
digested pYub412 to create pYub412mRFPSapI. 
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2.6.4.3 Construction of pYub412mRFPNdeIBglII 
The pSmyc promoter along with the mRFP1 gene was PCR amplified (Section 2.2) from the vector 
pDMNmRFPNHis (Section 2.6.3.10) with the primer pair RepNdeFixF and RCMRFPR (Table 5, 
Section 2.2.1) which PCR amplifies a product with HindIII and HpaI RE sites but without an NdeI site, 
simplifying downstream cloning that make use of these RE sites. The product was cloned into pGem-
T-easy (Section 2.6.1) and named pGemmRFPNdeFix and subsequently excised by RE digestion 
using HindIII and HpaI (Section 2.3.9). The digestion was then run on a gel (Section 2.3.1) and the 
716p product was excised and purified from the gel (Section 2.3.3). The purified fragment was then 
ligated to HindIII and HpaI digested pDMN1 (as derived from Section 2.6.3.10). The ligation product, 
named pDMNmRFPNHisNdeIfix, was electroporated into E. coli (Section 2.3.13.1) and a PCR colony 
screening (Section 2.2.3) was done using the above-mentioned primer pair. Colonies testing positive 
for the plasmid containing the correct insert size (corresponding to the 716bp band) were grown in 
liquid media (Section 2.1.2.1) containing kanamycin (Appendix A.1.2) and subsequently their plasmid 
DNA was extracted (Section 2.3.5). The purified DNA was then used as template for a PCR reaction 
using primer pairs D29repF and D29repR (which add NdeI and BglII RE sites to the PCR product). 
The PCR product was cloned into pGem-T-Easy and named pGemmRFPNHisNdeIfix. The insert was 
removed by digesting with NdeI and BglII. The digest was run on a gel and purified from the gel. 
pYub412 (Appendix B.14) was digested with NdeI and BglII, run on a gel, and the large molecular 
band was purified and dephosphoylated (Section 2.3.11). The 713bp NdeI and BglII digest fragment 
liberated from pGemmRFPNdeFix was then ligated to the NdeI and BglII digested pYub412 and 
electroporated into E. coli. The electroporation was plated out on LB agar containing ampicillin and 
hygromycin. Colonies were PCR screened using the primer pair D29repF and D29repR, and positive 
colonies were grown in LB media containing ampicillin and hygromycin. A cosmid DNA extraction was 
subsequently performed (Section 2.3.6). Figure 2.17a and 2.17b is a visual illustration of the main 
cloning steps to create pYub412mRFPNdeIBglII. 
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pDMNmRFPNHisNdeIfix
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Figure 2.17a Construction of pYub412mRFPNdeIBglII. The pSmyc promoter and mRFP gene was 
PCR amplified from pDMNmRFPNHis to add HindIII and HpaI sites as well as to remove an NdeI site 
in the mRFP1 gene. This insert was then cloned into the HindIII and HapI sites of pDMN1 to create 
pDMNmRFPNHisNdeIfix. The pSmyc promoter and mRFP gene was PCR amplified from 
pDMNmRFPNHisNdeIfix to add NdeI and BglII RE sites to the product and cloned into pGem-T-Easy 
to create pGemmRFPNHisNdeIfix.  
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Figure 2.17b Construction of pYub412mRFPNdeIBglII (continued). The pSmyc promoter and 
mRFP gene was excised from pGemmRFPNHisNdeIfix (Figure 2.17a) and cloned into the NdeI and 
BglII sites of pYub412 to create pYub412mRFPNHisNdeIBglII.  
 
2.6.4.4 Construction of pDMNLCosmRFP 
Due to cloning technicalities using pYub412, an additional vector was constructed to act as a shuttle 
cosmid. Vector pDMNmRFPNHis (Section 2.6.3.10) was digested (Section 2.3.9) with MluI and XbaI 
to remove the mycobacterial origin of replication. The digest was run on a gel (Section 2.3.1) and the 
large molecular band was purified (Section 2.3.3) and dephosphorylated (Section 2.3.11). A lambda 
cos site was PCR amplified from pYub412 (Appendix B.13) using primer pair LambdaCosF and 
LambdaCosR (Table 5, Section 2.2.1) which added XbaI and Mlu sites as well as one PacI site to the 
product. The PCR product was then cloned into pGem-T-Easy (Section 2.6.1) and the lambda cos 
fragment was excised by XbaI and Mlu digestion. The digested DNA was run on a gel and the 330bp 
fragment was excised and purified form the gel. The digested lambda cos fragment was then ligated 
(Section 2.3.12) to the digested pDMNmRFPNHis DNA and electroporated into E. coli (Section 
2.3.13.1). A PCR colony screening (Section 2.2.3) was done using the above-mentioned primer pair. 
Colonies testing positive for the plasmid containing the correct insert size (corresponding to the 330bp 
band) fragment were grown in liquid media (Section 2.1.2.1) containing kanamycin (Appendix A.1.2) 
and used for cosmid DNA extraction (Section 2.3.6). Figure 2.18 a visual illustration of the main 
cloning steps involved in creating pDMN1LCosmRFP.  
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Figure 2.18 Construction of pDMNLCosmRFP. pDMNmRFPNHis was digested with Mlu and XbaI, 
removing the mycobacterial origin of replication genes repB and repA. The Lambda Cos site from 
pYub412 was PCR amplified to add RE sites MluI, XbaI and one PacI site to the PCR. The PCR 
product was cloned into pGem-T-Easy, excised using XbaI and MluI and then cloned into MluI and 
XbaI digested pDMNmRFPNHis to create pDMNLCosmRFP. 
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2.6.4.5 Construction of pYubmRFP  
pYub412 (Appendix B.14) was digested with SalI and EcoRV (Section 2.3.9), the digest was run on a 
gel (Section 2.3.1) and the 4968bp fragment was purified (Section 2.3.3) and dephosphorylated 
(Section 2.3.11). This digest removes the integration site AttP and the integration gene Int as well as 
the Hygromycin resistance gene. The N-term His-tagged mRFP1 gene along with the pSmyc promoter 
was PCR amplified (Section 2.2) from pDMNmRFPNHis (Section 2.6.3.10) using the primer pair 
Rep4SalIF and Rep4EcoRVR (Table 5, Section 2.2.1) which add SalI and EcoRV RE sites to the PCR 
product. The 955bp PCR product was then cloned into pGem-T-easy (Section 2.6.1) and 
subsequently excised by digestion with SalI (partial digest) and EcoRV. The digest was run on gel and 
the 951bp fragment was purified from the gel. The SalI and EcoRV digested pYub412 was then ligated 
to the 951bp SalI and EcoRV fragment from pGem-T-Easy. A PCR colony screening (Section 2.2.3) 
was done using the above-mentioned primer pair and colonies testing positive for the cosmid 
containing the correct insert size (corresponding to the 951bp band) were picked and cultured in liquid 
media (Section 2.1.2.1) and used for cosmid DNA extraction (Section 2.3.6). The cosmid was then 
sequenced (Section 2.3.9) using the above-mentioned primer pair. Figure 2.19 is a visual illustration of 
the main cloning steps to create pYubmRFP. 
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Figure 2.19 Construction of pYubmRFP. pYub412 was digested with SalI and EcoRV to remove the 
hygomycin resistance and int genes as well as the attP integration site. The N-term His-tagged 
mRFP1 gene and pSmyc promoter was PCR amplified to add SalI and EcoRV RE sites. The PCR 
product was cloned into pGem-T-easy and subsequently removed by the same RE`s (partial digest 
using SalI) and cloned into pYub412 (digested with SalI and EcoRV) to create pYubmRFP. 
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2.6.4.6 Construction of pYubSSmRFP 
pYubmRFP (Section 2.6.4.5) was further reduced in size by digesting with SapI and MluI (Section 
2.3.9) which removes non-essential DNA including one of the two lambda cos sites. Since these RE 
sticky ends were not compatible, Klenow enzyme was used to fill in the 5` overhangs and to remove 3` 
overhangs to form blunt ends suitable for ligation. One microgram of digested DNA, 2 µl 10X Klenow 
filling buffer (Appendix A.3.17) and 1U Klenow enzyme (roche) was incubated for 15 min at 37°C. The 
enzyme was then deactivated by incubation at 65°C for 10 min. The blunt ends were ligated (Section 
2.3.12) and electroporated into E. coli (Section 2.3.13.1) and plated on LB agar media containing 
ampicillin (Appendix A.1.1). Colonies were picked and grown in liquid media (Section 2.1.2.1) 
containing ampicillin. The cosmid DNA was then extracted (Section 2.3.6) and run on a gel along with 
pYubmRFP DNA, which had not been cut with SapI and MluI. Size reduction was indicative of 
successful digestion, Klenow filling and ligation. The new smaller cosmid was named pYubSSmRFP. 
The original pYubmRFP has a size of 5919bp whereas the modified pYubSSmRFP is 3887bp, giving 
a 2032bp size reduction, and yielding a reporter cosmid more suitable for lambda packaging when 
ligated to mycobacteriophage DNA. Figure 2.20 is a visual illustration of the main cloning steps to 
create pYubSSmrfp. 
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Figure 2.20 Construction of pYubSSmrfp. pYubmRFP was digested with SapI and MluI and then 
treated with Klenow enzyme, followed by self-ligation to create the size-reduced pYubSSmRFP. 
 
2.6.4.7 Construction of pYub412LacZ 
Due to the large size of the LacZ gene, pYub412SSmRFP (Section 2.6.4.6) was chosen as cloning 
vector since it was maximally reduced in size (due to lambda packaging size constraints). The SalI 
and EcoRV RE sites were selected as cloning sites due to previous successful cloning into these RE 
sites (Section 2.6.4.5). However, due to the presence of multiple SalI and EcoRV cutting sites in both 
the pSmyc promoter and LacZ PCR product, a three-way-cloning methodology was adopted.  
 
pYub412SSmRFP was used as PCR template and the pSmyc promoter was PCR amplified (Section 
2.2) with primer pair PromsmycF and PromsmycR (Table 5, Section 2.2.1) to add SalI and NotI RE 
sites. The PCR removed an existing SalI site and replaced it with a NotI site. The PCR product was 
then run on a gel (Section 2.3.1) and the 253bp band was purified (Section 2.3.3). The PCR product 
was then cloned into pGem-T-Easy (Section 2.6.1) and named pGempSmycSalINotI. Thereafter, it 
was excised by digesting with SalI and NotI, the digest was run on a gel and the 246bp band was 
purified. The LacZ gene was then PCR amplified from pJem15 (Appendix B.6) using primer pair 
LacZNotIF and LacZEcoRVR, which added RE sites NotI and EcoRV to the product. The PCR product 
was run on a gel, the 3065bp fragment was purified, cloned into pGem-T-Easy and named 
pGemlacZNotIEcoRV. The LacZ gene was then excised by doing a partial digest (Section 2.3.10) and 
R R 
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the 3060bp fragment was purified. The 3060bp digested LacZ fragment was then ligated to the 253bp 
pSmyc fragment as described in Section 2.3.12, (however a ratio of 1:1 was used instead of 1:3) and 
the resulting product was named SalIpsmycNotILacZEcoRV. pYub412SSmRFP was then digested 
with SalI and EcoRV, run on a gel, the large molecular size band was purified and dephosphorylated 
(Section 2.3.11). SalIpsmycNotILacZEcoRV was ligated into the digested pYub412SSmRFP and 
electroporated into E. coli (Section 2.3.13.1). A PCR colony screening was done using both primer 
sets listed above and colonies testing positive for the plasmid containing the correct insert sizes 
(corresponding to both the 253bp and 3060bp bands) were picked and grown in liquid media (Section 
2.1.2.1) containing ampicillin (Appendix A.1.1). A plasmid DNA extraction was then done (Section 
2.3.5) and the constructs were sequence verified using the above-mentioned primer pairs. Figure 2.21 
is a visual illustration of the main cloning steps to create pYub412psmycLacZ. 
 
The pSmyc promoter was PCR amplified to add SalI and NotI RE sites and cloned into pGem-T-Easy 
(not shown), the LacZ gene was PCR amplified to add NotI and EcoRV sites (and cloned into pGem-
T-Easy) 
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Figure 2.21a Construction of pYub412psmycLacZ. The pSmyc promoter and Histidine-tag was 
PCR amplified to add SalI and NotI sites to the product which was cloned into pGem-T-Easy to create 
pGempSmycSalINotI. Similarly, the LacZ gene was PCR amplified to add NotI and EcoRV sites to the 
product which was cloned into pGem-T-Easy and called pGemlacZNotIEcoRV. The two inserts were 
then excised and pGem-T-Easy and ligated to create SalIpsmycNotILacZEcoRV. 
 
 
 
SalI pSmyc NotI His LacZ EcoRV 
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Figure 2.21b Construction of pYub412psmycLacZ (continued). pYub412SSmRFP was digested 
with SalI and EcoRV to remove the pSmyc promoter and mRFP gene. The SalIpsmycNotILacZEcoRV 
ligation product (Figure 2.21a) was then cloned into the SalI and EcoRV digested pYubSSmRFP to 
create pYub412psmycLacZ. 
 
2.6.5 Construction of reporter mycobacteriophages 
2.6.5.1 Selection of suitable mycobacteriophage for cloning 
The choice of mycobacteriophage for cloning was limited due to several criteria. Firstly, the selected 
mycobacteriophage required M. tb in its natural host range so as to act as a TB diagnostic, as well as 
being able to infect M. smegmatis to allow the majority of amplification and cloning steps to take place 
outside of a biohazard level 3 facility. The selected mycobacteriophage genome also needs to be able 
to accommodate the additional space in its head capsid to allow for the reporter cosmid. This required 
the removal of non-essential DNA from the selected mycobacteriophage genome, as well as 
knowledge on potential cloning sites in the genome. Two approaches could be followed. (1) A novel 
mycobacteriophages could be screened for their host range, their genomes could be sequenced to 
obtain information on non-essential DNA and cloning sites, they could be size reduced and then used 
for cloning; (2) Previously constructed reporter mycobacteriophages could be utilized for cloning. Both 
these strategies were followed in this study to ensure that a suitable mycobacteriophage could be 
identified.  
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During this study, two mycobacteriophages were available to us for use as reporter 
mycobacteriophage - mycobacteriophage D29 and mycobacteriophage phAE142, kind gifts from Torin 
R. Weisbrod (HHMI, University of Pittsburgh, Department of Biological Sciences). Mycobacteriophage 
D29 is a well characterized mycobacteriophage of lytic nature which has been previously used both for 
plaque-based diagnostics as well as reporter mycobacteriophage-based diagnostics. Since 
mycobacteriophage D29 is wild-type it does not contain any excisable cosmids which would thus 
necessitate the removal of non-essential genomic DNA in order to accomodate a reporter cosmid as 
discussed in Section 2.6.5.2. A partial restriction enzyme digest method has previously been shown 
generate size reduced mycobacteriophages which retain their infectivity (Pearson,R.E. 1996). 
Mycobacteriophage phAE142 is a luciferase reporter mycobacteriophage which is derived from 
mycobacteriophage Tm4. Since the LRP contains an integrating luciferase cosmid, phAE142 offers 
the attractive cloning avenue of excising the existing luciferase cosmid and replacing it with a reporter 
cosmid from this study as discussed in Section 2.6.5.3.   
 
In order to obtain novel mycobacteriophages, an isolation procedure was performed on various soil 
samples from regions in South Africa as described in Section 2.4.1. Large scale stocks were created 
of each isolated mycobacteriophage as described in Section 2.4.2. The large scale stocks were then 
ultracentrifuged as described in Section 2.4.3. The phage-bands resulting from the ultracentrifugation 
were then dialysed to purifiy the mycobacteriophage samples as described in Section 2.4.4. To 
document their morphology, transmission electron microscopy was used as in Section 2.4.5 and, 
finally, their genomic DNA was extracted and purified as in Section 2.4.6. In order to determine if the 
novel mycobacteriophages were suitable for use as reporter mycobacteriophage, a host range check 
was performed by means of a spot test. A grid was drawn on large petri-dish plates containing 7H10 
(Appendix A.2.2). A lawn of M. smegmatis was created by spreading 120 µl of competent M. 
smegmatis (Section 2.1.2.8) onto the plate after which it was allowed to dry. The novel 
mycobacteriophages were then spotted onto the corresponding grid area by pippeting about 10-20 µl 
onto the plate and allowing the droplet to dry. This was done along with the controls of D29 and 
phAE142, which are known to infect both M. tb and M. smegmatis. The plates were sealed with 
parafilm and incubated for 12-24h at 37°C. If the novel mycobacteriophages lead to plaque production 
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on the lawn of M. smegmatis the titer was considered as suitable. Alternatively, a higher titer was 
prepared and the test was repeated. The process was repeated using both M. bovis BCG as well as 
with M. tb under P3 conditions. The culturing method was changed for M. tb and M. bovis BCG from 
that of M. smegmatis, due to the tendency of M. tb and M bovis BCG cells to clump. Tween-80 was 
added (0.05% (w/v) ,Sigma), and the culture time was extended to 14-20 days due to the slow growth 
rate of these species. Since Tween-80 interferes with the binding of mycobacteriophages to their 
mycobacterial hosts, the Tween was subsequently removed by a centrifugation step of the culture 
followed by resuspension in 7H9 media containing no Tween (repeated twice). The culture was then 
used for plaque testing as with M. smegmatis and the host range was recorded for the 
mycobacteriophages following 7-30 days incubation on 7H11 solid media (Appendix A.2.3). 
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2.6.5.2 Construction of D29 reporter mycobacteriophage 
Wild-type mycobacteriophage D29 DNA was electroporated into M. smegmatis (Section 2.3.13.2). 
Plaques were purified and used for DNA extraction as described in Section 2.4. The linear 
mycobacteriophage D29 DNA was self-ligated at a concentration of 250 µg/ml to create concatemers. 
The ligase was then inactivated by incubation at 65°C for 20 min. DNA concatemers were partially 
digested with restriction enzyme Sau3AI (Section 2.3.10). The digest was then run on a gel (made as 
described in Section 2.3.1 except for using Cambridge Seakem low melting point agarose at 0.4% gel 
concentration). The digested DNA was mixed with 6X loading buffer (Fermentas) and loaded onto the 
gel. Field inversion gel electrophoresis (FIGE) (Section 2.3.2) was then used to separate the DNA 
using a Hoefer Scientific Instruments (HSI) PC750 Pulse Controller using the following settings: 60V, 
18h, 50msec pulse, forward:reverse pulse ratio = 2.5:1. DNA fragments of 30-50kb were excised from 
the gel and phenol purified (Section 2.3.4). pYub412mRFP (Appendix B.14) was digested with BclI 
(Section 2.3.9) and ligated to the partially digested D29 DNA and used for lambda packaging (Section 
2.3.14). The resulting colonies were then PCR screened (Section 2.2.3) using primers Rep4SalIF and 
Rep4EvoRVR (Table 5, Section 2.2.1). Positive colonies were picked and grown in 100 ml LB media 
(Section 2.1.2.1) containing ampicillin (Appendix A.1.1). The culture was then used for cosmid DNA 
extraction (Section 2.3.6). The purified cosmid DNA was electroporated into competent M. smegmatis 
(Section 2.1.2.8) incubated for 30 min at 37°C and then plated out with top agar (Appendix A.2.4) on 
7H10 plates (Appendix A.2.7). The plates were observed for plaque formation after overnight 
incubation. Resulting plaques were picked and plaque purified (Section 2.4). Figure 2.22 illustrates the 
main cloning steps to create D29::pYub412mRFP. “lcos” indicates bacteriophage lambda cos 
recognition sites and “mcos” indicates mycobacteriophage cos recognition sites in the illustration 
below. 
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Figure 2.22a. Construction of D29 reporter mycobacteriophage. Mycobacteriophage D29 genomic 
DNA was self-ligated to create concatamers. The concatamers were partially digested with Sau3AI 
which yields various product sizes. The digested fragments were then separated on a FIDGE gel and 
fragments of 50-70kb were isolated and purified.  
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Figure 2.22b. Construction of D29 reporter mycobacteriophage (continued). D29 DNA (of 50 to 
70kb in size) which was digested with Sau3AI and purified (Figure 2.22a) was ligated to BclI digested 
pYub412mRFP to create D29::pYub412mRFP concatamers (BclI and Sau3AI overhangs are 
compatible). The concatamerized D29::pYub412mRFP DNA was packaged into phage lambda, 
packaging all the DNA from one “lcos” site to the next “lcos” site. 
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pYub412mRFP 
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Sau3AI digested D29 fragment 
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pYub412mRFP 
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pYub412mRFP 
 
Ligation 
Cleavage at bacteriophage lambda cos sites  
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Figure 2.22c. Construction of D29 reporter mycobacteriophage. The D29::pYub412mRFP DNA 
which was linearized by cleavage at lambda cos sites (Figure 2.22b) was packaged into 
bacteriophage lambda heads and used to transform E. coli. Upon infecting E. coli the DNA was 
circularized and replicates as a circular phasmid. The phasmid DNA was then extracted and used to 
transform M. smegmatis. After infecting M. smegmaits the D29::pYub412mRFP DNA was linearized 
by cleavage at “mcos” sites (mycobacteriophage cos sites). Expression of mycobacteriophage D29 
genes then lead to packaging of the recombinant DNA into mycobacteriophage heads and the 
production of a recombinant reporter mycobacteriophage. Resulting plaques were isolated and used 
for plaque purification yielding a high titer of recombinant mycobacteriophage D29::pYub412mRFP.  
 
 
lcos BclI mcos BclI mcos 
Cosmid pYub412mRFP 
Left arm of D29  Right arm of D29  
pYub412mRFP::D29 phasmid DNA 
linearized by mcos site cleavage 
following electroporation into M. 
smegmatis. 
 
Linear DNA is packaged into 
bacteriophage lambda heads 
Linear DNA is packaged into 
mycobacteriophage heads 
Bacteriophage lambda is used to transform E. coli and the phasmid DNA is 
purified. The phasmid DNA is then used to transform M. smegmatis.  
“Mcos” cleaved DNA is then packaged into 
mycobacteriophage heads 
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2.6.5.3 Construction of Tm4-based reporter mycobacteriophage  
Three cloning strategies were followed in the construction of a recombinant reporter 
mycobacteriophage based on Tm4. In the first method, the starting material was mycobacteriophage 
phAE142 which, was reported to contain a luciferase reporter cosmid flanked by PacI RE sites. 
However, no sequence data was available for this construct. DNA was extracted from the 
mycobacteriophage sample by means of phenol extraction (Section 2.3.4), the phAE142 DNA was 
then electroporated into competent M. smegmatis (Section 2.3.13.2). The cells were incubated at 
37°C for 20 min and then mixed with 4 ml top agar (Appendix A.2.4) and spread onto a 7H10 plate 
(Appendix A.2.2) and then incubated at 37°C overnight. Resulting plaques were picked and used to 
produce large scale stocks (Section 2.4.2.), the mycobacteriophages were then purified by 
ultracentrifugation (Section 2.4.3) followed by dialysis (Section 2.4.4) and their DNA was extracted by 
phenol/chloroform/Isoamyl alcohol DNA extraction (Sections 2.4.6). The purified DNA was digested 
(Section 2.3.9) with restriction enzyme PacI. The digested DNA was then run on a low melting point 
FIDGE gel (Section 2.3.2). The upper DNA band was extracted and purified from the gel by phenol 
extraction (Section 2.3.4). The purified phAE142 DNA was then ligated (Section 2.3.12) to reporter 
cosmids pDMNLCosmRFP (Section 2.6.4.4), pYubmRFP (Section 2.6.4.5), pYubSSmrfp (Section 
2.6.4.6) and pYub412LacZ (Section 2.6.4.7) using a 2 µg phage DNA to 1 µg cosmid DNA ratio in a 
total volume of 10 µl. The 10 µl ligation mixtures were then packaged into phage lamba and used to 
infect E. coli (Section 2.3.14). The infected E. coli was and grown on LB agar plates containing the 
appropriate antibiotics (ampicillin was used for phAE142::pYubmRFP, phAE142::pYubSSmrfp and 
phAE142::pYub412psmycLacZ and kanamycin was used for phAE142::pDMNmRFP). Subsequent 
colonies were then picked, PCR screened (Section 2.2.3) using the corresponding primer pairs to 
construct the cosmids (see Sections 2.6.4.4, 2.6.4.5, 2.6.4,6 and 2.6.4.7 for primer details and PCR 
product sizes) grown in 100 ml LB (containing the appropriate antibiotics listed above), the cosmid 
DNA was extracted (Section 2.3.6) and 2 µg of the purified DNA was electroporated into competent M. 
smegmatis, incubated for 30 min at 37°C and then plated out with top agar on 7H10 plates. The plates 
were observed for plaque formation after overnight incubation. Resulting plaques were purified and 
used to create high titer stocks of the recombinant mycobacteriophage.  
 
Stellenbosch University  http://scholar.sun.ac.za
124 
 
 
In a second method designed to override the possible size constrains of phage lambda, (since the 
Tm4 capsid can accommodate more than bacteriophage lambda), the ligation of RE digested 
phAE142 DNA to reporter cosmid was performed at high DNA concentrations (5 µg cosmid DNA : 10 
µg phAE142 DNA), precipitated by adding sodium acetate (Appendix A.3.38) and 95% ethanol 
(Appendix A.3.13) to the sample as described in Section 2.4.6, and resuspended in H20. Between one 
and two micrograms of the ligation was then electroporated into competent M. smegmatis as 
described in Section 2.3.13.2. Figure 2.23a, Figure 2.23b and Figure 2.23c is a visual illustration of the 
first cloning method to create phAE142::pYubmRFP, phAE142::pYubSSmrfp and 
phAE142::pYub412psmycLacZ, and phAE142::pDMNmRFP where “lcos” indicates bacteriophage 
lambda cos recognition sites and “mcos” indicates mycobacteriophage cos recognition sites. Similarly, 
Figure 2.24 is a visual illustration of the second cloning method. 
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Figure 2.23a Construction of Tm4-based reporter mycobacteriophage (method 1). phAE142 
DNA was electroporated into M. smegmatis and a plaque purification was performed to obtain large 
quantities of purified phAE142 DNA suitable for RE digests. The linear phAE142 DNA was 
concatamerized by self-ligation. The concatamerized DNA was digested with PacI (several other REs 
were also tried in separate instances) to remove the unknown cosmid from phAE142 to liberate Tm4. 
The large molecular band was purified following FIDGE and ligated to reporter cosmids to create 
concatamerized phAE142::pYubmRFP, phAE142::pYubSSmrfp, phAE142::pYub412psmycLacZ and 
phAE142::pDMNmRFP. 
 
 
 
 
 
 
 
 
 
phAE142 Genomic DNA phAE142 Genomic DNA phAE142 Genomic DNA 
Linear phAE142 DNA (unknown length) 
PacI linearized phAE142 (TM4) Unknown cosmid 
 
phAE142 concatamer 
mcos mcos 
mcos mcos mcos mcos 
PacI PacI PacI mcos PacI 
Linear phAE142 DNA was self-ligated and 
concatemerized  
phAE142 concatemers are linearized with PacI 
and the luciferase cosmid was excised 
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Figure 2.23b Construction of Tm4-based reporter mycobacteriophage (method 1, continued). 
The Tm4::cosmid concatemer DNA was cleaved at the lambda cos sites. The lambda cleaved DNA 
was then packaged into bacteriophage lambda. The recombinant bacteriophage lambda was then 
used to transform E. coli. Phasmid DNA was extracted from resultant colonies and used to transform 
M. smegmatis by electroporation.  
 
 
 
Cos site cleaved 
TM4::cosmid DNA   
PacI mcos PacI lcos PacI PacI lcos 
TM4 genome 
Reporter cosmid (see list above) 
 
Reporter cosmid (see list above) 
 
PacI mcos PacI lcos lcos 
TM4 genome 
Right segmant of reporter cosmid Left segment of reporter cosmid 
Tm4::Cosmid concatamer (shown as 
minimal as possible to remain viable) 
Tm4::cosmid concatemers are cleaved at 
lambda cos sites.  
Lambda cos site-cleaved DNA was packaged 
into bacteriophage lamba  
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Figure 2.23c. Construction of Tm4-based reporter mycobacteriophage (method 1, continued). 
Following electroporation into M. smegmatis the phasmid DNA circularizes and mycobacteriophage 
Tm4 lytic genes are expressed. This leads to expression of genes that lead to the recombinant 
mycbacteriophage cleaving its genome at mycobacteriophage cos sites and packages its DNA into 
mycobacteriophages to result in propagation of recombinant Tm4 mycobacteriophages. Plaques were 
then used to create high titer stocks of the recombinant mycobacteriophages.  
  
lcos BclI mcos BclI mcos 
Reporter cosmid  
Left arm of TM4 Right arm of TM4  
Reporter cosmid::TM4 
phasmid circular DNA 
linearized by mcos  site 
cleavage. 
lcos BclI lcos BclI mcos 
TM4 genome  
Right segment of reporter 
cosmid  Left segment of reporter 
cosmid 
 
The mcos site linearized recombinant phasmid 
is packaged into mycobacteriophages 
The circular phasmid DNA is linearized by 
mcos site cleavage 
Circular reporter phasmid 
DNA (shown linear) 
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Figure 2.24. Construction of Tm4-based reporter mycobacteriophage (method 2). Resitriction 
enzyme digested Tm4 DNA was ligated to digested cosmid DNA to create concatemers. The DNA 
was electroporated into M. smemgmatis where the DNA is circularized. The mycobacterial genes are 
expressed which leads to cleavage of the DNA at the mcos sites and packaging into 
mycobacteriophages to result in recombinant mycobacteriophages. A plaque purification is then 
performed to produce a high titer stock of the recombinant mycobacteriophages.  
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mycobacteriophages to result in recombinant 
mycobacteriophages 
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In the third method phAE142 DNA (phenol purified DNA from the first method was used) was first self-
ligated (Section 2.3.12) to form concatamers, 10 µl of the ligation was then used for lambda packaging 
(Section 2.3.14). Subsequent colonies were then picked and grown overnight (Section 2.1.2.1) in 100 
ml LB media containing ampicillin (Appendix A.1.1). The phasmid DNA was then extracted (Section 
2.3.6) and digested (Section 2.3.9) with PacI. The digested DNA was run on a low melting point 
FIDGE gel (Section 2.3.2) and the upper large molecular weight band was excised and phenol purified 
(Section 2.3.4). Reporter cosmids pDMNLCosmRFP (Section 2.6.4.4), pYubmRFP (Section 2.6.4.5), 
pYubSSmrfp (Section 2.6.4.6) and pYub412LacZ (Section 2.6.4.7) was then digested (Section 2.3.9) 
with PacI, run on a gel (Section 2.3.1), the large molecular size band was purified (Section 2.3.3), and 
ligated to the PacI digested and purified phasmid DNA using a 2 µg phage DNA to 1 µg cosmid DNA 
ratio in a total volume of 10 µl. The 10 µl ligation was then packaged in to phage Lamba and used to 
infect and transform E. coli (Section 2.3.14). Subsequent colonies were then PCR screened (Section 
2.2.3) using the primer pairs listed in Sections 2.6.4.4, 2.6.4.5, 2.6.4.6 and 2.6.4.7. Positive colonies 
were picked and grown in 100 ml LB containing ampicillin at 37°C overnight (Section 2.1.2.1). The 
cosmid DNA was then purified (Section 2.3.6) and 2 µg of the purified DNA was electroporated into 
competent M. smegmatis (Section 2.3.13.2). Resulting plaques were then picked and placed into 50 µl 
MP buffer again. A serial dilution was made of the selected plaques by placing 10 µl of the 50 µl 
plaque sample into 990 µl MP buffer (to create a 10-2 dilution) followed by sequentially placing 100 µl 
of the preceding sample into the next tube containing 900 µl MP buffer to create ten-fold dilutions 
down to 10-6. Five microliters of each titer was mixed with 250 µl competent M. smegmatis (Section 
2.1.2.8) for 20 min at 37°C and plated out on 7H10 plates along of 4 ml top agar (Appendix A.2.4) 
followed by overnight incubation at 37°C. The plate with the most confluent plaque pattern was then 
flooded with 4 ml MP buffer and incubated at 4°C overnight. The buffer was siphoned off with a 
syringe and filtered through a Millipore MILLEX®-GV polyvinylidene difluoride (PVDF) 0.22 µm filter 
unit. The filtered stock was then titered again (by testing various titers of the freshly filtered stock with 
250 µl competent M. smegmatis as above) to determine the optimal titer for confluence on a large 
Petri dish. This titer was used to create large scale stocks of the recombinant mycobacteriophage 
(Section 2.4.2). The amplified recombinant mycobacteriophage stock was ultra-centrifuged (Section 
2.4.3) and dialysed (Section 2.4.4) against MP buffer (Appendix A.3.23). The titer of the dialysed 
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mycobacteriophage was determined as described above. The recombinant mycobacteriophage was 
then used to test its expression in M. smegmatis and M. tb. Figure 2.25a, b, c and d is a visual 
illustration of the main cloning steps to construct Tm4::pYubmRFP, Tm4::pYubSSmrfp and 
Tm4::pYub412psmycLacZ, and Tm4::pDMNmRFP where “Lcos” indicated bacteriophage lambda cos 
recognition sites and “Mcos” indicate mycobacteriophage cos recognition sites. 
 
 
 
 
 
 
 
 
  
 
 
     
 
 
Figure 2.25a Construction of Tm4-based reporter mycobacteriophage (method 3). The linear 
phAE142 DNA was concatamerized by self-ligation. The phAE142 concatemers were cleaved at 
lambda Cos sites and packaged into bacteriophage lambda. The recombinant bacteriophage lambda 
was then used to transform E. coli and the phasmid DNA was extracted from resultant colonies.  
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Figure 2.25b Construction of Tm4-based reporter mycobacteriophage (method 3, continued). 
The purified circular phAE142 phasmid DNA was digested with PacI to linearize the DNA as well as to 
remove the unknown cosmid from phAE142 to yield the Tm4 genome with suitable RE sites for 
cloning. The large molecular weight band was purified following FIDGE and was ligated to reporter 
cosmids to create concatamerized Tm4::pYubmRFP, Tm4::pYubSSmrfp, Tm4::pYub412psmycLacZ 
and Tm4::pDMNmRFP.  
 
 
 
 
     
 
 
 
Figure 2.25c Construction of Tm4-based reporter mycobacteriophage (method 3, continued). 
The cosmid::mycobacteriophage DNA concatamer was cleaved at lambda cos sites, packaged into 
bacteriophage lambda and used to transform E. coli.  Colonies were PCR screened following 
packaging into E. coli, cosmid DNA extraction was performed on subcultures of colonies testing 
positive.  
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Figure 2.25d Construction of Tm4-based reporter mycobacteriophage (method 3, continued). 
The purified phasmid DNA was used to transform M. smegmatis after which the phasmid DNA was 
circularized. The lytic mycobacteriophage genes were then expressed followed by mcos site cleavage 
and packaging of the linear phasmid DNA into mycobacteriophages to result in recombinant 
mycobacteriophages. Resulting plaques were isolated and used for plaque purification yielding a high 
titer of recombinant mycobacteriophage.  
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2.7 Construct evaluation 
2.7.1 Evaluation of promoter probe constructs 
The ten promoter probe constructs (Section 2.6.2), construct pJem15Hsp60NHis (Section 2.6.3.11) as 
well as a positive control (using mycobacterial Pan promoter) was expressed in M. smegmatis in order 
to determine their relative promoter strengths. Each construct was electroporated into M. smegmatis 
(Section 2.3.13.2) and plated on solid media containing X-gal (Appendix A.3.49) and kanamycin 
(Appendix A.1.2). Single colonies were picked and used in a β-galactosidase assay (Section 2.5.5) to 
compare promoter strengths. The most suitable promoter was selected and used as promoter for 
certain reporter constructs (Sections 2.6.3.5, 2.6.3.6, 2.6.3.9 and 2.6.3.12). 
 
2.7.2 Evaluation of reporter constructs 
Each reporter construct (Sections 2.6.3.1 to 2.6.3.12) was expressed in M. smegmatis and protein 
expression was analysed. Each construct was electroporated into M. smegmatis (Section 2.3.13.2) 
and plated on solid media containing the appropriate antibiotics (Table 18, Section 2.6.3). Single 
colonies were picked and grown up in liquid media (Section 2.1.2.3) containing the appropriate 
antibiotics (Table 18, Section 2.6.3). Cell cultures were centrifuged at 4000 rpm in an Eppendorf 
Centrifuge 5810R for 15 min and the cell pellet was redissolved in 500 µl PBS (Appendix A.3.26). The 
cell resuspension was then ribolysed (Section 2.5.1) and 200 µl of the ribolysed sample was used in a 
His-Tag purification (Section 2.5.2) for constructs that have His-tags (Table 18, Section 2.6.3). 
Pictures were taken of the His-tag purified protein eluates and the His-tag purified proteins were also 
used to obtain their quantitative fluorescence readings using a fluorescence plate reader (Section 
2.5.3) The protein concentrations were determined (Section 2.5.4) of the ribolysed and His-tag purified 
samples were determined and equal amounts of protein was then used in a SDS-PAGE gel separation 
(Section 2.5.6), Western blot (Section 2.5.6.4) followed by His-tag detection with His-tag specific 
antibodies (Section 2.5.6.6).  
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2.7.3 Evaluation of reporter mycobacteriophages 
The performance of reporter mycobacteriophage Tm4::pYubSSmRFP was initially tested using M. 
smegmatis as host to investigate the role that several variables play on fluorescence expression. The 
first variable investigated was the possible nucleotide sequence variation between the progeny 
mycobacteriophage Tm4::pYubSSmRFP, particularly in the pSmyc promoter region. 20 progeny 
plaques were purified and used to create stocks. The stocks used in this instance were made by 
creating one plate with confluent plaque formation (as described in Section 2.4.2) per 
mycobacteriophage. 5 ml of MP buffer was added to each plate and incubated overnight at 4°C. The 
supernatant was then siphoned off and filter sterilized. The primer pair Rep4SalIF and Rep4EcoRVR 
(Table 5, Section 2.2.1) was used to PCR amplify the pSmyc promoter and mRFP1 gene which was 
subsequently sequenced for each of the 20 stocks. The 20 progeny mycobacteriophages were also 
tested to determine variations in fluorescence levels. The stocks of the 20 progeny 
mycobacteriophages were diluted to an equal concentration of 106 pfu/ml of which 200 µl from each 
was used to infect 200 µl of competent M. smegmatis followed by 24h incubation at 37°C. 300 µl of the 
infected cells were then transferred to a fluorescence micro-well plate and their relative fluorescence 
levels were measured as described in Section 2.5.3. Additionally 25 µl of each sample was pipetted 
onto a microscope slide, covered with a cover slip and visualized using a fluorescence microscope 
under oil immersion. The four best performing mycobacteriophages were then selected for further 
testiing, named mycobacteriophage Tm4:pYubSSmRFP 1.3, 6.3, R and 12 (referred to henceforth as 
mycobacteriophage 1.3, 6.3, R and 12).  
 
In order to determine the optimal concentration of mycobacteriophage to use, a large titer range was 
tested. The two mycobacteriophages (R and 12) were used to create a dilution range from undiluted to 
a 10-9 dilution. 100 µl of each dilution was used to infect 200 µl of competent M. smegmatis overnight 
and the resultant fluorescence was measured. After determining the optimal concentration of 
mycobacteriophge, these results were used to determine the optimal incubation time for maximal 
fluorescence by incubating the four mycobacteriophages (1.3, 6.3, R and 12) at their optimal 
concentration with 200 µl M. smemgmatis for 1h, 4h, 6h, 12h, 16h, 24h and 46h at 37°C followed by 
fluorescence measurement. Using the optimal incubation time and mycobacteriophage concentration, 
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infections consisting of 200 µl M. smegmatis and 70 µl of mycobacteriophage 1.3, 6.3, R and 12 were 
ribolysed and used for his-tag purification (Section 2.5.2) of the mRFP1 protein. The fluorescence 
levels of the eulates were compared with the euates derived from uninfected M. smemgmatis cultues. 
The reporter mycobacteriophages were then evaluated in M. tb as described below. 
 
M. tb strain H37Rv was grown in 7H9 (Appendix A.1) with an added 2 ml 20% Tween-80 (Appendix 
A.3.48) per liter of 7H9 at 37°C with shaking. A millilitre of culture was aliquoted into Eppendorf tubes, 
the cells were pelleted by centrifugation in an Eppendorf centrifuge 5415D for 5 min at 2000 rpm. The 
cells were then resuspended in 7H9 (without Tween). Two-hundred microliters from each tube was 
then transferred into a new Eppendorf tube and 100µl of a 109 pfu/ml reporter mycobacteriophage 
Tm4::pYubSSmRFP stock was added (except to the control tube) and incubated for 6 hours at 37°C. 
Three-hundred microliters of 4% paraformaldehyde (Appendix A.3.25) was added to each tube and 
incubated at room temperature for 90 min to ensure killing of the M. tb bacilli. The tubes were then 
centrifuged as above, resuspended in 300µl 7H9 and incubated at room temperature for 90 min. The 
tubes were centrifuged as above, resuspended in 400µl PBS (Appendix A.3.26). The tubes were 
centrifuged again, resuspened in 25µl PBS and then spread onto a labeled glass microscope slide, 
covered with a cover slip and examined using a fluorescence microscope with a 1000x magnification 
using oil immersion. To test the viability of His-tag purification to amplify the reporter signal, 200 µl 
competent M. smegmatis cells were incubated overnight at 37°C with 100 µl of the recombinant 
mycobacteriophage at various titers. The tube contents were then ribolysed (Section 2.5.1), His-tag 
purified (Section 2.5.2) and eluted in 100 µl elution buffer. The fluorescence of the eluates were tested 
by loading 100 µl of the eluates onto a 96-well fluorescence plate and thereafter measuring it using a 
modulus microplate reader as above (with ribolysed and His-tag purified M. tb as negative control).  
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Chapter 3 Results 
3.1 Promoter screening 
In order to identify additional mycobacterial promoters to be considered for reporter gene expression, 
10 potential promoter regions of the ESAT-6 gene cluster region 5 were investigated and their 
expression levels were compared with the Hsp60 promoter. Two promoter prediction software 
programs were used to analyze the ten selected regions designated “Int1” to “Int10” in the M. tb 
H37Rv ESAT-6 gene cluster 5. The bioinformatics programs NNPP and BPPROM (Section 2.6.2) 
generated results for these regions as shown in Table 20.  
 
Table 20. Promoter prediction results for NNPP and BPPROM software. “X” indicates that the 
software predicted the presence of a promoter. 
Intergenic region NNPP BPPROM
Int1 X X
Int2 X
Int3 X
Int4 X X
Int5 X
Int6 X
Int7 X X
Int8 X X
Int9
Int10 X X
Hsp60 X X
 
NNPP predicted promoters for intergenic regions Int1, Int3, Int4, Int5, Int6 Int7, Int8 and Int10 as well 
as the known Hsp60 promoter. BPPROM predicted promoters for intergenic regions Int, Int2, Int4, 
Int7, Int8, Int10 as well as the known Hsp60 promoter. The ten intergenic regions were successfully 
PCR amplified, cloned into pGem-T-easy and subsequently cloned into the promoter probe vector 
pJem15. Figure 3.1.1a shows the PCR amplification results for a subsection of the intergenic regions 
(Int2 Int3, Int4 and Int5, not all are shown for reasons of conciseness). Subsequent sequencing of the 
products revealed that the primer set for Int3 and Int9 amplified the incorrect sequences and new 
primer sets were thus designed for these regions. The correct PCR products can be seen in Figure 
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3.1.1b and c (utilizing new primer sets). Figure 3.1.2a and 3.1.2b show the excision of the intergenic 
regions from pGem-T-Easy and Figure 3.1.3 shows the successful PCR colony screening following the 
ligation of the intergenic regions into pJem15. A sub-section of intergenic regions are shown for 
reasons of conciseness. 
 
      
  
       
 
Figure 3.1.1 PCR amplification of intergenic regions from M. tb H37Rv ESAT-6 gene cluster 5. 
(a) Lane 1: GeneRuler 100bp DNA ladder plus, Lane 2&3: Int2 PCR product, Lane4&5: Int3 PCR 
product, Lane 6&7: Int4 PCR product, Lane 8: Int5 PCR product. (b) Lane 1: GeneRuler DNA ladder 
mix, Lane 2: PCR amplification of Int3 (please note that an irrelevant section of the gel image was 
removed for purposes of clarity) (c) Lane 1: GeneRuler DNA ladder mix, Lane 2: PCR amplification of 
Int9. 
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Figure 3.1.2 BamHI and KpnI excision of intergenic regions Int1, Int2, Int3, Int4, Int8 and Int9 
from pGem-T-Easy. (a) Lane 1: GeneRuler 100bp DNA ladder, Lane2: Int1 digest product, Lane 3: 
Int2 digest product. (b) Lane 1: molecular marker X, Lane 2: Int8 digest product, Lane 3: Int3 digest 
product as well as an unknown amplification product from the M. tb H37Rv genome due to use of 
primers with less than ideal specificity, Lane 4: Int4 digest product. (Please note that irrelevant 
sections of the gel images were removed for purposes of clarity)   
                                               
 
Figure 3.1.3 PCR colony screening for intergenic promoters following ligation to pJem15 and 
electroporation into E. coli. (a) Lane 1: GeneRuler DNA ladder mix, Lane 2: PCR product for Int3. 
(b) Lane 1: molecular marker X, Lane 2: PCR product for Int4. Two products can be seen due to non-
specific binding from one of the two primers, the lower band represents the correct size band. (Please 
note that irrelevant sections of the gel image was removed for purposes of clarity)  (c) Lane 1: 
molecular marker X, Lane 2: PCR product for Int5.  
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Sequencing results for the intergenic regions cloned into the promoter probe vector pJem15 showed 
that the inserts match the ten intergenic regions in the H37Rv genome sequence. Appendix C.1 shows 
the sequence information for the ten intergenic regions. The 10 sequence-verified promoter constructs 
were electroporated into M. smegmatis and plated together with X-gal in order to perform a visual test 
of promoter activity. Plates with a blue/green appearance indicated promoter activity by metabolizing 
the X-gal into its substrate (as in Figure 3.1.4). 
 
 
 
 
 
Figure 3.1.4. Int1 to Int10 plated onto solid media containing X-gal. Green/blue colonies indicate 
β- galactosidase activity and thus promoter activity. pJem15 was included as negative control and 
Hsp60 as positive control. Promoters Int1, Int2, Int3, Int5, Int7, Int8, Int10 and Hsp60 show promoter 
activity. 
  
Int1 Int2 Int3 
Int4 Int5 Int6 
Int7 Int8 Int9 
Int10 pJem15 negative control Hsp60 positive control 
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In order to quantify the promoter strengths of the intergenic regions a β-galactosidase assay was 
performed, which revealed the relative promoter strength of the 10 constructs. The promoter strengths 
of the 10 intergenic regions, relative to the Hsp60 promoter and a negative control (pJem15 lacking a 
promoter insert) are shown in Figure 3.1.5. The β-galactosidase assay indicated that Int1, Int2, Int5 
and Int8 are strong promoters relative to the Hsp60 promoter (in M. smegmatis). Int5, Int8 and Int10 
displayed variable promoter strength between β-galactosidase assays. In certain instances the Int10 
promoter was weaker than Int1 and in others it was stronger indicating that the promoter is not always 
active despite the similar growth conditions between cultures as well as between β-galactosidase 
assays. However, Int1 and Int2 displayed constantly high promoter activity indicating its suitability to 
drive expression of reporter genes. 
 
 
 
Figure 3.1.5.  β-Galactosidase activity indicating the relative promoter strength of the ten 
intergenic regions. The relative promoter strength for intergenic region Int to Int10 can be se seen 
compared to the Hsp60 promoter, the mycobacterial Pan promoter and negative control (vector 
pJem15 without a promoter element) and represents the data from 3 separate assays. The figure 
shows that Int1, Int2, Int5 and Int8 are strong promoters relative to the Hsp60 promoter. 
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3.2 Reporter constructs 
3.2.1 pSD21Hsp60DsRedNHis 
Construct pSD21Hsp60DsRedNHis was constructed to test expression of N-term His-tagged DsRed 
driven by the Hsp60 promoter in expression vector pSD21. Vector pSD21Hsp60DsRedNHis was 
constructed by cloning the N-term His-tagged DsRed gene, driven by the Hsp60 promoter, into 
expression vector pSD21 (as described in Section 2.6.3.1). The Hsp60 promoter was PCR amplified 
(the PCR product is shown in Figure 3.2.1.1), cloned into pGem-T-Easy and excised using BamHI and 
KpnI. Figure 3.2.1.1b shows the RE excision from pGem-T-Easy. The digested DNA was then cloned 
into the BamHI and KpnI digested pDsRed vector. Figure 3.2.1.2 shows the RE digest of pDsRed. 
 
  
            
        
Figure 3.2.1.1. PCR amplification and RE excition of the Hsp60 promoter from pGem-T-Easy. 
(a): PCR amplificiation of Hsp60 promoter with primers ESATRFPF and Hsp60PromHisR3 (Section 
2.2.1), Lane 1: molecular marker X, Lane 2: Hsp60 promoter PCR product. (b) RE excision of the 
Hsp60 promoter from pGem-T-Easy. Lane1: molecular marker X, Lane 2: BamHI and KpnI digest 
excision of the Hsp60 promoter from pGem-T-easy.  
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Figure 3.2.1.2 BamHI and KpnI digest of vector DsRed. Lane 1: molecular marker X, Lane 2: 
digest of pDsRed (Please note that irrelevant sections of the gel image were removed for purposes of 
clarity). 
 
The Hsp60 promoter was sucsesfully cloned into pDsRed and sequence analysis confirmed the 
correct sequence of the promoter. The Hsp60 promoter and DsRed gene was excised from pDsRed 
as shown in Figure 3.2.1.3a and cloned into the XbaI RE site of pSD21. Figure 3.2.13b shows a digest 
screening for the Hsp60 promoter and DsRed gene insert following cloning into pSD21.  
                     
  
Figure 3.2.1.3 RE excision of the Hsp60 promoter and DsRed gene from pDsRed and pSD21. (a) 
RE excision of the Hsp60 promoter and DsRed gene from pDsRed. Lane 1: molecular marker X, Lane 
2: XbaI digested pDsRedHsp60NHis (Section 2.6.3.1) excising the Hsp60 promoter and DsRed gene 
from pDsRed. (b) RE excision of the Hsp60 promoter and DsRed gene from pSD21. Lane 1: 
molecular marker X, Lane 2: XbaI digest screening of pSD21Hsp60DsRedNHis (Section 2.6.3.1) 
confirming the Hsp60 promoter and DsRed insert. 
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Vector pSD21DsRedHsp60NHis was subsequently sequence verified and electroporated into M. 
smegmatis to test the expression of the affinity-tagged DsRed fluorescent protein. Figure 3.2.1.4a 
shows the visible red signal from a cell pellet of a M. smegmatis culture containing the vector 
pSD21Hsp60DsRedNHis. Figure 3.2.1.4b shows the purified eluate following affinity chromatography 
performed on the cell pellet shown in Figure 3.2.1.4a. The visible signal from the eluate proves the 
functionality of the N-term His-tag to the DsRed protein. Figure 3.2.1.5 shows a fluorescence 
microscopy photograph of M. smegmatis cells containing the construct. The expression of the DsRed 
gene was however variable among transformants.  Picking of colonies with a red appearance (as well 
as PCR positive for the Hsp60 promoter and DsRed gene) led to subcultures with unpredictable 
expression profiles ranging from good expression to none.   
 
 
 
 
 
 
 
 
Figure 3.2.1.4. DsRed expression in M. smegmatis cells containing pSD21Hsp60DsRedNHis. (a) 
M. smegmatis cell pellet of a culture containing pSD21Hsp60DsRedNHis following overnight 
expression (b). Eluate of a His-tag purification performed on cell pellet shown in (a). 
(b) (a) 
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Figure 3.2.1.5. Fluorescence microscopy of M. smegmatis cells containing 
pSD21Hsp60DsRedNHis. Individual cells are visible following overnight expression of affinity-tagged 
DsRed.  
 
3.2.2 p19KProHsp60DsRedNHis  
Construct p19KProHsp60DsRedNHis was constructed to test expression of N-term His-tagged DsRed 
driven by the Hsp60 promoter using expression vector p19KPro. Construct p19KProHsp60DsRedNHis 
was constructed by cloning the Hsp60 promoter and N-Term His-tagged DsRed gene into vector 
p19KPro. The 1052bp fragment from Figure 3.2.1.3, consisting of the Hsp60 promoter and DsRed 
gene, was cloned into the XbaI RE site of p19KPro. Construct p19KProHsp60DsRedNHis did not 
display visibly red cell pellets, however the majority of the cultures had a supernatant which were 
visibly red. Despite the low level of red signal visible in the cell pellet, cells were easily detected using 
fluorescence microscopy as in Figure 3.2.2.  
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Figure 3.2.2. Fluorescence microscopy of a M. smegmatis culture containing vector 
p19KProHsp60DsRedNHis. Single cells are shown to be visible. 
 
3.2.3 pSD21Hsp60DsRedCHis 
Construct pSD21Hsp60DsRedCHis was constructed to test expression of C-term His-tagged DsRed 
driven by the Hsp60 promoter using expression vector pSD21. The construct pSD21Hsp60DsRedCHis 
consisted of the Hsp60 promoter, C-term His-tagged DsRed gene cloned into pSD21. The Hsp60 
promoter and DsRed gene was PCR amplified to add a C-term His-tag to the DsRed gene and this 
was cloned into pGem-T-Easy and subsequently subcloned into pSD21. Figure 3.2.3a shows the 
restriction enzyme excision of the promoter and reporter gene from pGem-T-Easy, Figure 3.2.3b 
shows the PCR colony screening following ligation to pSD21 and Figure 3.2.3c shows a digest 
screening for the promoter and reporter gene insert following ligation to pSD21. Expression of the C-
term His-tagged DsRed gene from transformants could not be detected for this construct in M. 
smegmatis despite being positive PCR for the insert (data not shown).  
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Figure 3.2.3. Cloning of the Hsp60 promoter and DsRed gene into pSD21 (a) BamHI and XbaI 
excision of the Hsp60 promoter and DsRed gene from pGem-T-Easy. Lane 1: molecular marker X, 
Lane 2: RE digest product for the promoter and reporter gene. (b) PCR colony screening for the 
Hsp60 promoter and DsRed gene insert following ligation to pSD21. Lane 1: molecular marker X, 
Lane 2: PCR product for the promoter and reporter gene. (c) BamHI and XbaI digest screening for the 
hsp60 promoter and DsRed gene following ligation to pSD21. Lane1: GeneRuler 100bp DNA ladder, 
Lane 2: promoter and reporter gene digest product (Please note that an irrelevant section of this gel 
image was removed for reasons of clarity). 
 
3.2.4 pACEHsp60DsRedCHis 
Construct pACEHsp60DsRedCHis was constructed to test expression of C-term His-tagged DsRed 
driven by the Hsp60 promoter using expression vector pACE. The construct pACEHsp60DsRedCHis 
was constructed by cloning the Hsp60 promoter and C-term His-tagged DsRed gene cloned into 
expression vector pACE (as described in Section 2.6.3.4). The Hsp60 promoter and C-term His-
tagged DsRed gene was excised from pGem-T-Easy as in Figure 3.2.3a (Section 3.2.3) and cloned 
into BamHI and XbaI digested pACE (Figure 3.2.4.1a). Figure 3.2.4.1b shows the PCR colony 
screening for the Hsp60 promoter and DsRed gene following ligation to pACE and electroporation into 
E. coli. Construct pACEHsp60DsRedCHis was successfully sequence verified and electroporated into 
M. smegmatis. Expression of DsRed was detectable compared to pSD21DsRedCHis, by means of 
fluorescence microscopy. Figure 3.2.4.2 shows a typical fluorescence microscopy result for M. 
smegmatis cells containing this construct. 
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Figure 3.2.4.1. Cloning of the Hsp60 promoter and DsRed Gene into vector pACE. (a) Digest 
excision of th promoter and reporter gene from pGem-T-Easy and RE digest of vector pACE. 
Lane 1: molecular marker X. Lane 2: BamHI and XbaI digest excising the Hsp60 promoter and DsRed 
gene fragment from pGem-T-Easy, Lane 3: BamHI and XbaI digest of pACE removing the ACE 
promoter. (b) PCR colony screening of transformants following ligation of the promoter and reporter 
gene to vector pACE.  Lane 1: molecular marker X. Lane 2: PCR colony screening for the Hsp60 
promoter and DsRed gene insert following electroporation of E. coli with construct 
pACEHsp60DsRedCHis. 
 
 
Figure 3.2.4.2. Fluorescent microscopy of M. smegmatis cells containing construct 
pACEHsp60DsRedCHis. A Large clump of cells can be seen with individual cells fluorescing brightly 
(one example shown by the arrow). 
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3.2.5 pSD21Int1DsRedNHis 
Construct pSD21Int1DsRedNHis was constructed to test expression of N-term His-tagged DsRed 
driven by the Int1 promoter using expression vector pSD21. The construct pSD21Int1DsRedNHis was 
constructed by cloning the Int1 promoter and N-terminus His-tagged DsRed gene cloned into 
expression vector pSD21. The Int1 promoter was PCR amplified (the product is shown in Figure 
3.2.5.1a), cloned into pGem-T-easy and subsequently excised using BamHI and KpnI (the digest 
product is shown in Figure 3.2.5.1b). The promoter was subsequently cloned into pDsRed after which 
both the promoter and reporter gene was excised and cloned into vector pSD21. Figure 3.2.5.1c 
shows the PCR colony screening results for the promoter and reporter gene following ligation into 
pSD21. This construct presented poor fluorescence visible in culture as well as under fluorescence 
microscopy (data not shown). 
 
        
Figure 3.2.5.1 Cloning of the Int1 promoter and DsRed gene into pSD21. (a) PCR amplification of 
the Int1 promoter. Lane 1: GeneRuler 100bp DNA ladder plus, Lane 2: PCR product for the Int1 
promoter. (b) BamHI and KpnI excision of promoter Int1 from pGem-T-Easy. Lane 1: Generuler DNA 
ladder Mix, Lane 2: digest product of the Int1 promoter from pGem-T-Easy. (c) PCR colony screening 
for the Int1 promoter following transformantion of E. coli with construct pSD21Int1DsRedNHis. Lane 1: 
GeneRuler DNA ladder mix, Lane 2: Int1 PCR product following PCR colony screening. 
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3.2.6 pACEInt1DsRedCHis 
Construct pACEInt1DsRedCHis was constructed to test expression of C-term His-tagged DsRed 
driven by the Int1 promoter using expression vector pACE. Construct pACEInt1DsRedCHis was 
constructed by cloning the Int1 promoter and C-term His-tagged DsRed gene into vector pACE. The 
int1 promoter, which was previously cloned into pGem-T-Easy (Section 3.1), was excised with BamHI 
and KpnI and cloned into pACEHsp60DsRedCHis which replaces the Hsp60 promoter with the Int1 
promoter. The PCR amplification product for the Int1 promoter can be seen in figure 3.2.6.1a. The 
BamHI and KpnI digest of pACEHsp60DsRedCHis can be seen in Figure 3.2.6.1a, lane 4. The PCR 
colony screening results can be seen for the completed construct using primers for the int1 promoter 
as in Figure 3.2.6.1b. Sequencing confirmed the successful cloning of the Int1 promoter and the 
construct was subsequently electroporated into M. smegmatis.  
Figure 3.2.6.2 shows the fluorescence micrsoscopy results for pACEInt1DsRedCHis in M. smegmatis.  
 
                               
Figure 3.2.6.1. Cloning of the Int1 promoter into pACEHsp60DsRedCHis. (a) BamHI and KpnI 
digest of pACEHsp6-DsRedCHis and pGemInt1. Lane1: Generuler DNA ladder mix. Lane 2&3: RE 
digest of construct pACEHsp6-DsRedCHis excising the Hsp60 promoter, Lane 4: RE digest of 
construct pGemInt1 excising the Int1 promoter. (b) PCR colony screening for the Int1 promoter. Lane 
1: GeneRuler 100bp DNA ladder plus, Lane 2: PCR colony screening for the Int1 promoter performed 
on tranformants containing construct pACEHsp60DsRedCHis. 
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Figure 3.2.6.2. Fluorescence microscopy results for M. smegmatis containing vector 
pACEInt1DsRedCHis. Individual cells are visible. 
 
 
3.2.7 pSD21Hsp60mRFPNHis 
Construct pSD21Hsp60mRFPNHis was constructed to test expression of N-term His-tagged mRFP1 
driven by the Hsp60 promoter using expression vector pSD21. The construct pSD21Hsp60mRFPNHis 
consisted of the Hsp60 promoter and N-term His-tagged mRFP1 gene cloned into expression vector 
pSD21 (as described in Section 2.6.3.7). Figure 3.2.7a shows the PCR amplification mRFP1, Figure 
3.2.7b shows the PCR colony screening for the mRFP1 gene following ligation to pGem-T-Easy and 
Figure 3.2.7c shows the successful excision of mRFP1 from pGem-T-Easy. The vector was sequence 
verified following cloning into pSD21, however mRFP1 expression was poor and variable. A small 
proportion of cells appeared fluorescent however the majority appeared non-fluorescent, the culture 
media however indicated fluorescence. Fluorescence microscopy could however not detect individual 
cells (results not shown). 
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Figure 3.2.7 PCR amplification and cloning of the mRFP1 gene. (a) PCR amplification of the 
mRFP1 gene from pRSETB. Lane 1: GeneRuler DNA ladder. Lane 2: PCR amplification of mRFP1.  
(b) PCR colony screening for the mRFP1 gene following ligation to pGem-T-Easy. Lane 1: GeneRuler 
DNA ladder mix, Lane 2: PCR colony screening product for the reporter gene. (c) KpnI and SalI 
excision of the mRFP1 insert from pGem-T-Easy. Lane 1: GeneRuler DNA ladder mix, Lane 2: Digest 
product consisting of the reporter gene. 
 
3.2.8 p19KProp19KmRFPNHis 
Construct p19KProp19KmRFPNHis was constructed to test expression of N-term His-tagged mRFP1 
driven by the p19K promoter using expression vector pSD21. Construct p19KProp19KmRFPNHis 
consisted of the N-term His-tagged mRFP1 gene cloned into vector p19KPro (as described in Section 
2.6.3.8). The mRFP1 gene was PCR amplified (as shown in Figure 3.2.9.1a), cloned into pGem-T-
Easy and subsequently cloned into vector p19KPro. Figure 3.2.8.1b shows the PCR colony screening 
for the mRFP1 gene following ligation into pGem-T-Easy and Figure 3.2.8.1c shows the HindIII and 
ClaI RE excision of the promoter and reporter gene from pGem-T-Easy. The construct was sequence 
verified and electroporated into M. smegmatis. Figure 3.2.8.2 shows the fluorescence microscopy for 
construct p19Kprop19KmRFP1NHis in M. smegmatis. 
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Figure 3.2.8.1. Cloning of the mRFP1 gene into pGem-T-Easy. (a) PCR amplification of the mRFP1 
gene. Lane 1: GeneRuler DNA ladder mix, Lane 2: mRFP1 PCR product. (Please note that irrelevant 
sections of this gel image was removed for clarity) (b) PCR colony screening for the mRFP1 gene 
following ligation to pGem-T-Easy. Lane 1: Generuler DNA ladder Mix, Lane 2: PCR colony screening 
PCR product for the mRFP1 gene. (c) HindIII and ClaI excision of the mRFP1 gene from pGem-T-
Easy. Lane 1 Generuler DNA ladder Mix, Lane 2: Digest product for mRFP1.   
 
Figure 3.2.8.2. Fluorescence microscopy of M. smegmatis cells containing construct 
p19Kprop19KmRFPNHis. Individual cells are visible.  
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3.2.9 pSD21Int1mRFPNHis 
Construct pSD21Int1mRFPNHis was constructed to test expression of N-term His-tagged mRFP1 
driven by the Int1 promoter using expression vector pSD21. Construct pSD21Int1mRFPNHis was 
constructed by cloning the Int1 promoter and N-term His-tagged mRFP1 gene into expression vector 
pSD21 (as described in Section 2.6.3.9). The mRFP1 gene which was cloned into pGem-T-Easy was 
excised using KpnI and SalI and successfully cloned into pGem-T-Easy which contained the Int1 
promoter and sequence for N-Term His-tag fusion (Figure 3.2.6.1, lane 4, shows the positive digest 
screening for the promoter). The promoter and mRFP1 gene was successfully removed from pGem-T-
Easy and cloned into pSD21 and confirmed by sequence analysis. Fluorescence was observed 
following electroporation into M. smegmatis as shown in 3.2.9. 
 
Figure 3.2.9. Fluorescence microscopy image of M. smegmatis cells containing construct 
pSD21Int1mRFPNHis. Individual cells are visible.  
 
3.2.10 pDMN1pSmycMRFPNHis 
Construct pDMN1pSmycMRFPNHis was constructed to test expression of N-term His-tagged mRFP1 
driven by the pSmyc promoter using expression vector pDMN1. Construct pDMN1pSmycMRFPNHis 
was constructed by cloning the pSmyc promoter and N-term His-tagged mRFP1 gene into expression 
vector pDMN1 (as described in Section 2.6.3.10). The mRFP1 gene was successfully PCR amplified, 
cloned into pGem-T-Easy and successfully excised by RE HindIII and HpaI. Vector pDMN1, which 
contains the pSmyc promoter, was digested with HindIII and HpaI which removed the GFP gene as 
shown in Figure 3.2.10.1a. The mRFP1 gene was cloned into pDMN1 which was confirmed by PCE 
colony screening as shown in Figure 3.2.10.2b. Figure 3.2.10.2 shows the fluorescence microscopy 
results of M. smegmatis cells containing construct pDMN1pSmycMRFPNHis. Constitutive and high 
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levels of mRFP1 expression was observed from all cultures containing construct 
pDMN1pSmycRFPNHis which indicated that this construct was superior to others tested in this study. 
 
                       
Figure 3.2.10.1. Cloning of mRFP1 into pDMN1. (a) RE digest of vector pDMN1. Lane 1: shows 
Generuler DNA ladder Mix, Lane 2:  Digest product for pDMN1. (b) PCR colony screening for the 
mRFP1 gene following ligation to pDMN1. Lane 1: Generuler DNA ladder Mix, Lane 2: PCR product 
for mRFP1.  
 
Figure 3.2.10.2. Fluorescence microscopy of M. smegmatis transformed with 
pDMN1pSmycmRFPNHis. Individual cells are detectable.  
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3.2.11 pJem15Hsp60LacZNHis 
Construct pJem15Hsp60LacZNHis was constructed to test expression of the N-term His-tagged LacZ 
gene driven by the pSmyc promoter using promoter probe vector pJem15. Construct 
pJem15Hsp60LacZNHis was constructed to test expression of N-term His-tagged mRFP1 driven by 
the pSmyc promoter using expression vector pDMN1. Construct pJem15Hsp60LacZNHis was 
constructed by cloning the Hsp60 promoter and N-Term His-tagged LacZ gene into promoter probe 
vector pJem15 (as described in Section 2.6.3.11). The Hsp60 promoter was cloned into pGem-T-
Easy, and subsequently subcloned into pJem15 using BamHI and KpnI. Figure 3.2.11a shows a PCR 
colony screening for the Hsp60 promoter following ligation to vector pJem15. This initial construct 
(pJem15Hsp60NHis, Section 2.6.3.11) required further cloning steps to remove an existing stop codon 
upstream of the Hsp60 promoter region in order to allow affinity-tag fusions to the LacZ gene (as 
described in Section 2.6.3.11). To achieve this goal, PCR was used to amplify the region containing 
the stop codon by means of a different primer set, which replaced the stop codon with a start codon. 
The PCR product was successfully PCR amplified (as shown in Figure 3.2.11b) and cloned into the 
EcoRV RE site of pJem15Hsp60NHis. Figure 3.2.11c shows the PCR colony screening for the insert. 
Construct pJem15Hsp60LacZNHis was sequence verified and electroporated into M. smegmatis. The 
cell lysate as well as his-tag purified eluate from M. smegmatis cells containing the construct resulted 
in a colorimetric reaction with X-gal substrate was added indicating the functionality of both the LacZ 
gene and affinity-tag. Figure 3.2.11d shows the visible colorimetric reaction.  
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Figure 3.2.11. Construction of pJem15Hsp60LacZNHis in M. smegmatis. (a) PCR colony 
screening for the Hsp60 promoter following cloning into pJem15. Lane 1: Generuler DNA ladder Mix, 
Lane 2: PCR product for the promoter. (b) PCR amplification product for the stop codon region from 
pJem15Hsp60NHis. Lane 1: Generuler DNA ladder Mix, Lane 2: PCR amplification product for the 
region to be cloned into pJem15Hsp60NHis. (c) PCR colony screening for the insert following ligation 
to pJem15Hsp60LacZNHis. Lane 1: GeneRuler 100bp DNA ladder plus, Lane 2: PCR colony 
screening PCR product for the insert. (d) Eppendorf tube containing X-gal substrate mixed with his-tag 
purified eluate performed on the WCL of M. smegmatis cells containing pJem15Hsp60LacZNHis, 3h 
incubation. 
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Construct pJem15Int1LacZNHis was constructed to test expression of the N-term His-tagged LacZ 
gene driven by the Int1 promoter using promoter probe vector pJem15. Construct 
pJem15Int1LacZNHis was constructed by cloning the Int1 promoter into expression vector pJem15 (as 
described in Section 2.6.3.12). The Int1 promoter was PCR amplified to add BglII RE sites to the PCR 
product (as in Figure 3.2.12a). The PCR product was successfully cloned into pGem-T-Easy as shown 
by the PCR colony screening in Figure 3.2.12b. Figure 3.2.12c shows the partial digest products for 
pJem15 using BglII, which was ligated to the Int1 promoter. Following transformation of M. smegmatis 
with construct pJem15Int1LacZNHis, no detectable β-galactosidase activity could be observed by 
means of substrate addition to either the WCL or his-tag purification eluate (data not shown). It is thus 
possible that the partial digest performed on pJem15 excised DNA from the LacZ gene in turn 
removed functionality of the expressed enzyme. 
 
                                               
Figure 3.2.12. Cloning of pJem15Int1LacZNHis. (a) PCR amplification of the Int1 promoter adding 
flanking BglII RE sites to the product. Lane: Generuler DNA ladder Mix, Lane 2: PCR product for the 
Int1 promoter. (b) PCR colony screening for the Int1 promoter following ligation to pGem-T-Easy. Lane 
1: Generuler DNA ladder Mix, Lane 2: PCR product for the Int1 promoter. (c) BglII partial digest of 
vector pJem15. Lane 1: Generuler DNA ladder Mix, Lane 2: Partial digest products for vector pJem15. 
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3.3 Reporter cosmids 
3.3.1 pYub412mRFPPvuI 
Construct pYub412mRFPPvuI was constructed to act as shuttle cosmid for transferral of the pSmyc 
promoter and mRFP1 gene to a suitable mycobacteriophage. Construct pYub412mRFPPvuI was 
constructed by cloning the pSmyc promoter and N-term His-tagged mRFP1 gene into the PvuI RE site 
of pYub412 which clones the construct into the ampicillin resistance gene of pYub412. The pSmyc 
promoter and His-tagged mRFP1 gene was successfully PCR amplified as in Figure 3.3.1a, cloned 
into pGem-T-Easy (Figure 3.3.1b shows the PCR colony screening result, however the gel image 
shown shows a smear, in addition to the correct band, due to a combination DNA overloading and 
incorrect imaging settings) and excised using PvuI (as shown in Figure 3.3.1c). Cloning of the insert 
into PvuI digested pYub412 led to no viable transformants on several attempts indicating that 
insertions into the PvuI RE site of pYub412 disrupted expression of essential genes. The proximity of 
the RE site to the E. coli origin of replication suggests that this is possible. 
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Figure 3.3.1. PCR amplification and cloning of the pSmyc promoter and mRFP1 gene into 
pYub412. (a) PCR amplification of the pSmyc promoter and His-tagged mRFP1 gene insert from 
pSmycmRFPNHispDMN1. Lane 1 GeneRuler 1kb DNA ladder, Lane 2: PCR product for the promoter 
and reporter gene. (b) PCR colony screening for the pSmyc promoter and mRFP1 gene insert 
following ligation to pGem-T-Easy. Lane 1: GeneRuler DNA ladder mix, Lane 2: PCR colony screening 
PCR product for the promoter and reporter gene. (c) PvuI RE excision of the pSmyc promoter and 
mRFP1 gene insert from pGem-T-Easy. Lane 1: GeneRuler DNA ladder mix, Lane 2: Digest products 
for pGemInt1mRFPNHis using PvuI. Several bands (1780bp, 1220bp, 1096bp, 949bp and 139bp) can 
be seen due to either partial digest of the construct or due to the presence of multiple cutting sites in 
the construct, the 955bp band corresponds to the pSmyc promoter and mRFP1 gene insert as 
indicated. 
 
3.3.2 Cloning of pYub412mRFPSapI 
Construct pYub412mRFPSapI was constructed to act as shuttle cosmid for transferral of the pSmyc 
promoter and mRFP1 gene to a suitable mycobacteriophage. Construct pYub412mRFPSapI was 
constructed by cloning the pSmyc promoter and N-term His-tagged mRFP1 gene into the SapI RE site 
of pYub412 which places the reporter construct into the ampicillin gene (as described in Section 
2.6.4.2). The pSmyc promoter and mRFP1 gene was successfully PCR amplified (as shown in Figure 
3.3.2a). The PCR product was cloned into pGem-T-Easy and excised using RE SapI (as shown in 
Figure 3.3.2c). The promoter and reporter gene insert was cloned into the SapI RE digested vector 
pYub412 (shown in Figure 3.3.2b). Electroporation of the pYub412mRFPSapI construct did not yield 
any viable transformants, which suggests that the insertion of the reporter construct disrupted 
essential genes. 
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Figure 3.3.2. Cloning of the pSymc promoter and mRFP1 gene into the SapI RE site of pYub412. 
(a) PCR amplification of the pSmyc promoter and mRFP1 gene adding SapI RE sites to the product. 
Lane 1 GeneRuler DNA ladder Mix, Lane 2: PCR product for the pSmyc promoter and mRFP1 gene. 
(Please note that an irrelevant section of this gel image was removed for clarity). (b) RE digest of 
pYub412. Lane 1: GeneRuler DNA ladder mix, Lane2: pYub412 undigested, Lane 3: pYub412 
digested with SapI, Lane 4: pYub412 digested with SalI and EcoRV, Lane 5: pYub412 digested with 
NdeI and BglII (c). SapI RE excision of the pSmyc promoter and mRFP1 gene from pGem-T-Easy. 
Lane 1: GeneRuler DNA ladder mix, Lane 2: SapI excision of the promoter and reporter gene from 
pGem-T-Easy. The band above the 955bp band represents the digest product spanning the natural 
SapI RE site in pGem-T-Easy to the SapI RE site in the insert which is visible due to incomplete digest 
and represents a band of about 1400bp. 
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3.3.3 pYub412mRFPNdeIBglII  
Construct pYub412.2mRFPNdeIBglII was constructed by cloning the pSmyc promoter and N-term His-
tagged mRFP1 gene into the NdeI and BglII RE sites of pYub412 (as described in Section 2.6.4.3). 
This removes a portion of the integrase gene and cloned the reporter construct between the 
hygromycin and lambda cos genes. The pSmyc promoter and mRFP1 gene was successfully PCR 
amplified (as shown in Figure 3.3.3a) and cloned into pGem-T-Easy (Figure 3.3.3b shows the PCR 
colony screening result for the pSmyc promoter and mRFP1 gene insert). The insert was subsequently 
excised with HindIII and HpaI (as shown in Figure 3.3.3c) and cloned into vector pDMN1. The 
promoter and reporter gene insert was PCR amplified to add NdeI and BglII RE sites (as shown in 
Figure 3.3.3d) and cloned into pGem-T-Easy. Thereafter the promoter and reporter gene was cloned 
into the NdeI and BglII digested vector pYub412 (as shown in 3.2.2d and Figure 3.3.3e), however, no 
viable colonies were observed following electroporation into E. coli, indicating that essential genes 
were disrupted by means of this cloning method.      
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Figure 3.3.3. Construction of pYub412mRFPNdeIBglII. (a) PCR amplification of the pSmyc 
promoter and mRFP1 gene adding HindIII and HpaI RE sites to the product. Lane 1: GeneRuler DNA 
ladder mix, Lane 2: PCR product for the promoter and reporter gene. (b) PCR colony screening for the 
pSmyc promoter and mRFP1 gene following ligation into pGem-T-Easy. Lane 1 GeneRuler DNA 
ladder mix, Lane 2: PCR colony screening product for the promoter and reporter gene. (c) HindIII and 
HpaI RE digest excising the pSmyc promoter and mRFP1 insert from pGem-T-Easy. Lane 1: 
GeneRuler DNA ladder mix, Lane 2: Digest product for the promoter and reporter gene. (d) PCR 
amplification of the pSmyc promoter and mRFP1 gene following ligation to vector pDMN1 using 
primers to add NdeI and BglII RE sites. Lane 1 GeneRuler DNA ladder mix, Lane 2: PCR product for 
the promoter and reporter gene. (e) NdeI and BglII digest of vector pYub412. Lane 1: GeneRuler DNA 
ladder mix, Lane 2: Digest product for the pYub412. (Please note that an irrelevant section of this gel 
image was removed for clarity). 
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3.3.4 pDMNLCosmRFP  
Construct pDMNLCosmRFP was constructed by cloning a lambda cos site from pYub412 into the XbaI 
and MluI RE sites of pDMN1 (as described in Section 2.6.4.4). The cloning method excised the 
mycobacterial origin of replication from pDMN1 and replaced it with a lambda cos site. This method 
created a novel reporter cosmid for cloning into mycobacteriophage. The lambda cos site from 
pYub412 was PCR amplified and cloned into pGem-T-Easy, excised by XbaI and MluI (as shown in 
Figure 3.3.4) and cloned into pDMN1pSmycmRFPNHis (as described in Section 2.6.3.10). The 
construct was sequence verified by using primers specific for the inserted cos site which revealed that 
the cos site was successfully cloned into the reporter construct. Lambda packaging of the cosmid 
ligated to mycobacteriophage DNA failed to produce viable transformants. The reason for the 
packaging failure was initially unclear; however excision of the luciferase containing cosmid from 
phAE142 (as shown in Figure 3.4.3.3a, Section 3.4.3) revealed that cosmid pDMNLCosmRFP is 
considerably larger than the luciferase containing cosmid. This suggests that the failure of 
pDMNLCosmRFP to be packaged together with mycobacteriophage DNA is due to size constraints of 
bacteriophage lambda and that a smaller reporter cosmid would be needed to successfully package. 
This was later confirmed by the successful packaging of a significantly smaller reporter cosmid  
(pYubSSmRFP1, section 3.3.6). Further investigation was halted due to success using other cosmid 
constructs. 
 
                   
Figure 3.3.4. XbaI and MluI digest of the Lambda cos insert following ligation to pGem-T-Easy. 
Lane 1: GeneRuler DNA ladder mix, Lane 3: Lambda cos site PCR product. 
400bp 
300bp 
200bp 
330bp Lambda Cos 
PCR product 
500bp 
(d) 
   1         2         3           
Stellenbosch University  http://scholar.sun.ac.za
164 
 
 
3.3.5 pYubmRFP 
Construct pYubmRFP was constructed by cloning the pSmyc promoter and N-term His-tagged mRFP1 
gene into the SalI and EcoRV RE sites of pYub412 which removes the hygromycin gene and 
integrase genes from pYub412 (as described in Section 2.6.4.5). The pSmyc promoter and mRFP1 
gene was successfully PCR amplified (as in Figure 3.3.5a) and cloned into pGem-T-Easy to add SalI 
and EcoRV RE sites to the product. The insert was excised from pGem-T-Easy (as shown in Figure 
3.3.5b) and cloned into SalI and EcoRV digested pYub412 (as shown in Figure 3.2.2c, Section 3.3.2) 
which was verified by PCR colony screening (as shown in Figure 3.3.5c). The construct was sequence 
verified and used for cloning into mycobacteriophage phAE142. 
 
                                    
Figure 3.3.5. Cloning of the pSmyc promoter and mRFP1 gene into pYub412. (a) PCR 
amplification of the pSmyc promoter and mRFP1 gene from pDMN1 to add SalI and EcoRV RE sites. 
Lane 1: GeneRuler DNA ladder mix, Lane2: PCR product for the promoter and reporter gene. (b) 
EcoRV and SalI RE excision of the pSmyc promoter and mRFP1 gene from pGem-T-Easy. Lane 1 
GeneRuler DNA ladder mix, Lane 2: Promoter and reporter gene digest product. (c) PCR colony 
screening for the pSmyc promoter and mRFP1 gene following ligation to pYub412. Lane 1: GeneRuler 
DNA ladder mix, Lane 2: PCR colony screening product for the promoter and reporter gene. 
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3.3.6 pYubSSmrfp 
Construct pYubSSmrfp consisted performing a size reduction on construct pYubmRFP (Section 
3.3.5).The pYubmRFP construct was successfully reduced in size by removing non-essential DNA by 
digesting with SapI and MluI. The cosmid was treated with klenow enzyme (since the two RE sites 
used were not compatible), ligated and electroporated. A cosmid DNA extraction was performed on 
cultures of transformants. The new cosmid, designated pYubSSmrfp was 2032bp smaller than 
pYubmRFP and was used for cloning into mycobacteriophage phAE142. pYub412mRFP and 
pYub412SSmRFP was run on a gel together which confirmed the size reduction (as shown in Figure 
3.3.6).  
 
      
Figure 3.3.6. Gel electrophoresis of pYubmRFP and pYubSSmRFP. Lane 1: GeneRuler DNA 
ladder mix, Lane 2: pYubmRFP, Lane 3: pYubSSmRFP. 
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3.4 Construction of reporter mycobacteriophages 
3.4.1 Selection of suitable mycobacteriophages for cloning 
Twenty-one novel South African mycobacteriophages were evaluated for their ability to infect M. tb, as 
a surrogate for their usefulness in a TB diagnostic. Their capability to infect M. tb was tested, in three 
separate experiments, by means of a spot test followed by incubation of up to 2 weeks. It was, 
however, found that their host ranges did not include M. tb as suggested by the lack of clearing or 
plaque formation following the spot test. This was furthermore apparent, since the 3rd spot test made 
use of a high titer of each purified mycobacteriophage (obtained by means of CsCl ultracentrifugation) 
and included the addition of CaCl2, a co-factor that influences the ability of certain 
mycobacteriophages to infect their hosts. Since mycobacteriophage D29 and phAE142 were available 
to us and were previously demonstrated to infect M. tb, they were selected for use in this study to 
create reporter mycobacteriophages. 
 
3.4.2 Construction of D29 reporter mycobacteriophage 
Mycobacteriophage D29 was obtained as wild type and required a size reduction in order to 
accommodate the additional DNA from a reporter cosmid to create a reporter mycobacteriophage. 
Several steps were taken to produce a size reduced mycobacteriophage D29. Mycobacteriophage 
D29 was propagated and its DNA was extracted (Section 2.4). The main cloning strategy for D29 (as 
discussed in Section 2.6.5.2) requires concatemerization of D29 genomic DNA followed by partial 
digestion to remove non-essential DNA from the D29 genome. This method was used to allow 
sufficient space to accommodate a reporter cosmid whilst maintaining a suitable size for lambda 
packaging. The D29 DNA was successfully self-ligated to form concatamers (as shown in Figure 
3.4.2.1a). Phenol extraction and purification of the concatamerized DNA from agarose gels, followed 
by subsequent gel electrophoresis showed that both concatemers and linear genomic DNA was 
visible. Repeated isolation and purification (of up to three repeats) of the concatamerized DNA band 
consistently led to both linear and concatamers being visible following gel electrophoresis. This 
indicated that the purification step possibly shears some of the concatamerized DNA, or that a large 
amount of linear DNA fails to separate from the concatamerized DNA despite extensive a FIGE run 
time. The purified concatameric DNA was partially digested (as shown in Figure 3.4.2.1b) and DNA of 
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between 40 and 70Kb was purified from the gel. The purified DNA was ligated to BclI digested 
pYubmRFP DNA and lambda packaged into E. coli. This led to do production of a vast amount of PCR 
positive colonies when screening for the pYubmRFP cosmid (as showin in Figure 3.4.2.1c), however 
subsequent cosmid DNA extraction and electroporation into M. smegmatis led to no visible plaques. 
This indicated that the DNA which was packaged did not contain the essential genes required by D29 
for infectivity and replication.  
 
                                                       
Figure 3.4.2.1. D29 self-ligation and partial digest. (a) FIDGE of self-ligated D29 genomic DNA 
displaying both concatamerized and linear DNA. Lane 1: GeneRuler DNA ladder mix, Lane 2: D29 
DNA. (b) Partial digest of concatemerized D29 DNA with Sau3AI. Lane 1: Undigested D29 DNA, Lane 
2-6: digested D29 DNA, 3µg of DNA per well, digested for 20 min with a serial dilution of RE Sau3AI 
from lane 2 to lane 6. (c) PCR colony screening for the pYubmRFP cosmid following ligation to 
partially digested D29 DNA and lambda packaging. Lane 1: GeneRuler DNA ladder mix, Lane 2: PCR 
colony screening product for the promoter and reporter gene from pYubmRFP. 
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3.4.3 Construction of Tm4 reporter mycobacteriophage 
Mycobacteriophage Tm4 was available to us in the form of reporter mycobacteriophage phAE142 
which contains a luciferase containing cosmid which was to be replaced with a cosmid from this study. 
Three cloning strategies were followed to create a Tm4-based reporter mycobacteriophage (as 
described in Section 2.6.5.3). In the first method, phAE142 was initially electroporated into M. 
smegmatis followed by plaque purification to obtain suitable quantities of phAE142 DNA for use. 
Electroporation of phAE142 DNA successfully led to plaque formation and enabled CsCl purification 
and DNA extraction. However, no RE map of the existing luciferase containing cosmid in phAE142 
was available. A large number of RE digests were performed in order to excise the luciferase 
containing cosmid from phAE142, including REs that the creators of phAE142 commonly utilized in 
related publications (such as XbaI, NotI, NheI and PacI). RE digest with these enzymes did not led to 
additional detectable DNA bands despite several attempts with varying concentrations as well as 
incubation times. Figure 3.4.3.1a shows PacI RE digest products for phAE142 and Figure 3.4.3.1b 
shows a NotI RE digest of phAE142. These two gel images show no detectable difference between 
the digested and undigested DNA, independent of the concentration of genomic DNA used (which was 
tested using concentrations ranging from 0.5µg to 15µg). These results indicate that these cutting sites 
did not exist in the purified phAE142 DNA obtained as per the first method. However, following 
numerous DNA extractions from phAE142 and RE digests of the DNA, it was eventually observed that 
a feint band, possibly corresponding to the luciferase cosmid, was observed when RE PacI and NotI 
was used (as shown in Figure 3.4.3.1c). The bands for both the PacI and NotI digested phAE142 DNA 
were purified, ligated to pYubmRFP and lambda packaged. Subsequent PCR colony screening 
showed several colonies to be positive as in Figure 3.4.3.2a, however none of the colonies possessed 
DNA capable of producing plaques when electroporated into M. smegmatis. This reason for this was 
initially unclear. It was possible that the failure to package was due to size constrains during lambda 
packaging. It was also possible that the failure to package resulted from a failure of the DNA to ligate, 
possibly resulting from mutations or deletions in the phAE142 DNA. This was suspected to be the 
case since it has been reported that propagation of phAE142 requires a special strain of M. 
smegmatis in order to avoid mutations (Bardarov,S.,Jr 2003}. It could thus be that only a small subset 
of the phAE142 DNA did not undergo mutations or have deletions, which would correspond to the 
Stellenbosch University  http://scholar.sun.ac.za
169 
 
 
poor digest efficiency and the feint band observed. The amount of successfully digested DNA would 
thus not be sufficient to outcompete the amount of pYubmRFP concatamer packaging leading to 
copious amounts of PCR positive colonies (using primers for the cosmid) containing no 
mycobacteriophage DNA. Despite screening more than 1000 colonies by means of PCR, the pooled 
PCR positive DNA did not result in any detectable plaque formation. Use of the first method thus 
proved inefficient and a second method was utilized in order to obtain a reporter mycobacteriophage.  
 
In the second method, which was designed to override the size constraints of lambda packaging (as 
described in Section 2.6.5.3), direct electroporation of the ligation product of pYubmRFP and 
mycobacteriophage DNA was performed using large quantities of DNA (2µg). Plaques were 
subsequently observed and PCR plaque screening showed several positive plaques as in Figure 
3.4.3.2b. However, subsequent plaque purification, DNA extraction and gel electrophoresis revealed 
that the ligation failed and that the PCR positive plaques were due to the excessive amount of DNA on 
the plate causing false positive PCR results. The failure of the second method to create a Tm4-based 
reporter mycoacteriophage suggested that the reason was either due to size constraints of the Tm4 
mycobacteriophage head capsid or due to mutations or deletions in the phAE142 DNA which removes 
the required RE cutting sites.  
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Figure 3.4.3.1. Mycobacteriophage phAE142 digests. (a): phAE142 DNA comparison of digested 
and undigested DNA. Lane 1: PacI digested phAE142 DNA, Lane 2: Undigested DNA, Lane 3: self-
ligated phAE142 DNA. (b) phAE142 digested to remove existing luciferase cosmid with NotI. Lane 1-
3: Digested phAE142 DNA indicating no visible excised cosmid. (c) phAE142 digest with PacI and 
NotI. Lane 1: phAE142 digested with PacI, a feint band is visible corresponding to between 2500bp 
and 3500bp, Lane 2: GeneRuler DNA ladder Mix, Lane 3: phAE142 NotI digest, a feint band, similar to 
that in lane 1, is visible.  
                                                     
Figure 3.4.3.2. PCR colony and plaque screening for the pYubmRFP cosmid following method 1 
and 2. (a) PCR plaque screening for the pYubmRFP cosmid using primers for the pSmyc promoter 
and mRFP1 gene insert following ligation to phAE142 DNA and lambda packaging from method 1. 
Lane 1: Generuler DNA ladder mix, Lane 2-3: PCR plaque screening product for the promoter and 
reporter gene. (b) PCR plaque screening for pYubmRFP following ligation to phAE142 and 
electroporation into M. smegmatis for method 2.  
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The third cloning method to create a Tm4-based reporter mycobacteriophage was designed to 
circumvent the possibility of selective pressure and mutation of the necessary RE sites (as described 
in Section 2.6.5.3). Mycobacteriophage phAE142 DNA was self-ligated to create concatamers and 
was successfully lambda packaged into E. coli. Cosmid DNA was extracted from transformants and 
showed the correct size matching the genome size of phAE142 when run on a gel. Additionally the 
purified DNA led to plaque formation when electroporated into M. smegmatis. By propagating the 
mycobacteriophage DNA in E. coli and working with the DNA as a circular phasmid, instead of as a 
mycobacteriophage this circumvented the possible selective pressures leading to mutations or 
deletions when propagated in mycobacteria. The purified phAE142 DNA was digested with PacI which 
successfully removed the existing luciferase cosmid from phAE142 to release the Tm4 genome (as 
show in in Figure 3.4.3.3a). The PacI digested Tm4 DNA was successfully recovered from the gel, 
purified, ligated to pYubmRFP and lambda packaged. Several colonies were PCR positive for the 
reporter cosmid (as shown in Figure 3.4.3.3b), however electroporation of the purified DNA into M. 
smegmatis did not led to plaque formation. A possible reason for the failure to package the 
pYubmRFP and phAE142 ligation could be due to size constrains of lambda packaging. This was 
apparent since the cosmid which was excised from phAE142 by PacI RE digest (as in shown in Figure 
3.4.3.3a) is considerably smaller than pYubmRFP. For this reason pYubSSmRFP was created which 
was further size reduced by 2031bp compared to pYubmRFP. Subsequent ligation of PacI digested 
pYubSSmRFP to phAE142 (named Tm4::pYubSSmRFP) followed by lambda packaging led to a 
substantial increase in PCR positive colonies as in Figure 3.4.3.3c. A phasmid DNA extraction was 
performed on cultures of the PCR positive colonies which led to the successful formation of plaques 
when electroporated into M. smegmatis. Subsequent plaque purification yielded a high titer stock of 
the novel reporter mycobacteriophage Tm4::pYubSSmRFP. 
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Figure 3.4.3.3a. Cloning of Tm4::pYubSSmRFP. (a) PacI digest of mycobacteriophage phAE142. 
Lane 1: pYub412 DNA (high concentration), Lane 2: GeneRuler DNA ladder mix, Lane 3: Undigested 
self-ligated phAE142 DNA, Lane 4: PacI digest of self-ligated phAE142 DNA, the luciferase containing 
cosmid can be seen excised from the genomic DNA. (b) PCR colony screening for the pYubmRFP 
cosmid following ligation to PacI digested phAE142 DNA and lambda packaging. Lane 1: GeneRuler 
DNA ladder mix, Lane 2: PCR colony screening product for the promoter and reporter gene. (c) PCR 
colony screening for the pYubSSmRFP cosmid following ligation to PacI digested phAE142 DNA and 
lambda packaging. Lane 1: GeneRuler DNA ladder mix. Lane 2: PCR colony screening product for the 
promoter and reporter gene. 
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3.5. Evaluation of reporter mycobacteriophage Tm4::pYubSSmRFP 
The preliminary evaluation Tm4::pYubSSmRFP made use of a 96-well format fluorescence plate 
reader as well as fluorescence microscopy to test three aspects of the reporter mycobacteriophage 
important for its function and suitability as a reporter mycobacteriophage. These aspects were (1) 
variation in mRFP1 expression between isolates, (2) the optimal titer, and (3) change in fluorescence 
levels as a function of time. In order to test for variation in expression between isolates of 
Tm4::pYubSSmRFP, 20 isolates were purified and investigated for fluorescence expression variation. 
Fluorescence measurements performed on M. smegmatis cells infected with Tm4::pYubSSmRFP 
revealed that there was some level of variation as shown in Figure 3.5.1. It should be noted that these 
results represent a single experiment and results need to be interpreted with caution. However, each 
sample had fluorescence levels considerably higher than the negative control consisting of uninfected 
M. smegmatis cells allowed to grow for a period equal to the infection and incubation time.  
 
Figure 3.5.1. Relative fluorescence as detected by fluorescence plate reader for 20 isolates of 
reporter mycobacteriophage Tm4::pYubSSmRFP following infection of M. smegmatis cells 
compared to uninfected M. smegmatis allowed a replicating time equal to the infection and 
incubation time for the reporter mycobacteriophage. The X-axis shows the Isolate name and the 
Y-axis shows the fluorescence level. Mycobacteriophage isolates 12 and 18 to 20 show the highest 
levels of fluorescence. 
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In order to determine if the level of variation observed between the 20 isolates was due to mutations in 
the pSmyc promoter or mRFP1 gene, the promoter and reporter gene was PCR amplified and 
sequenced. However, sequencing results revealed that there were no mutations or deletions in the 
amplified and sequenced regions. M. smegmatis, when cultured in the absence of Tween-80, has a 
high tendency to clump, which in turn makes accurate pipetting difficult. It is possible that the observed 
variations in the fluorescence levels for the 20 isolates could be to inadvertently using varying 
amounts of M. smegmatis due to pipetting inaccuracy. In order to investigate this, varying amounts of 
M. smegmatis was infected with a set amount of Tm4::pYubSSmRFP and the fluorescence levels 
were observed as shown in Figure 3.5.2 (note that this represents a single experiment and these 
results should be considered with caution). The result from Figure 3.5.2 appear to indicate a trend 
between fluorescence levels and the amount of M. smegmatis used for the infected cells, which 
suggests that inaccurate pipetting is likely to be the reason for the variations observed between the 20 
isolates as in Figure 3.5.1. Figure 3.5.2 also indicates that, although M. smegmatis has some 
background fluorescence levels, the fluorescence levels do not substantially increase as the amount 
of cells increase.   
 
Figure 3.5.2. Fluorescence levels resulting from increasing amounts of M. smegmatis infected 
with a constant amount of Tm4::pYubSSmRFP. The X-axis indicates the amount of microliters of 
competent M. smegmatis which is infected by 20 µl of a 107 pfu/ml sample of Tm4::pYubSSmRFP. 
The Y-axis indicates the fluorescence level. 
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The second aspect that was investigated was the optimal titer to produce maximum fluorescence. To 
this goal, a large titer range was tested. Two mycobacteriophage isolates (12 and 20, see Figure 
3.5.1) were used to create a dilution range from 109 pfu/ml to 1 pfu/ml. 100 µl of each dilution was 
used to infect 200 µl of competent M. smegmatis cells with overnight incubation and the resultant 
fluorescence. The resultant fluorescence is shown in Figure 3.5.3. These results indicate that the 
highest concentration, corresponding to 109 pfu/ml, correspond the highest fluorescence levels 
observed.  
 
Figure 3.5.3. M. smegmatis fluorescence levels following 24h incubation with a titer range of 
mycobacteriophage Tm4::pYubSSmRP (Isolate 18 and 19). The X-axis indicates the dilution 
exponent used of a 109 pfu/ml stock of the two isolates. The Y axis shows the fluorescence level 
corresponding to the dilution used (where 0 indicates undiluted or 109 pfu/ml and -9 indicates 1pfu/ml. 
Note that these results indicate data from a single experiment and needs to be considered with 
caution. 
 
The third aspect that was investigated was the optimal incubation time for maximal fluorescence. This  
was determined using four mycobacteriophages (12, 18, 19. and 20). A total of 70 µl for each 109 
pfu/ml stock was used to infect 200 µl of M. smegmatis cells for 3, 5, 8, 9 and 46h at 37°C, after which 
fluorescence readings were taken using a fluorescence plate reader. Figure 3.5.4 shows the results 
for this time-frame, which show detectable fluorescence levels as early as 3h and with a peak of more 
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than 46h. It was also possible to detect fluorescence from individual cells as early as 5h using 
fluorescence microscopy as shown in Figure 3.5.5 
 
Figure 3.5.4. Fluorescence levels over time following infection of M. smegmatis by 
mycobacteriophage Tm4:pYubSSmRFP. Mycobacteriophage 1, 2, 3 and 10 was used to infect 300 
µl of M. smegmatis and incubated for 0h, 3h, 5h, 8h, 9h and 46h followed by fluorescence 
measurement as described in Section 2.5.3, the dotted lines indicate uninfected M. smegmatis as 
negative controls. Note that these results were generated from a single experiment and need to be 
interpreted with caution. 
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Figure 3.5.5 Fluorescence microscopy of M. smegmatis cells following 5h infection and 
incubation with Tm4::pYubSSmRFP. (a), (b) and (c) M. smegmatis cells infected with three 
different isolates of Tm4::pYubSSmRFP, individual cells are visible on each slide. (d) 
Uninfected M. smegmatis cells. 
 
Using the optimal parameters from Figures 3.5.3 and 3.5.4, a 24h infection and incubation time 
together with a titer of 109 pfu/ml was tested on M. smegmatis using four mycobacteriophages together 
with uninfected M. smegmatis as negative control. Figure 3.5.6 shows the resulting fluorescence 
measurements, which indicate that the fluorescence levels resulting from the infected cells were 
clearly discernible from the uninfected cells. It also shows that 24h of M. smegmatis proliferation does 
not result in a very large increase in background fluorescence. However, it should be kept in mind that 
the M. smegmatis cells in the infected cells would not be proliferating to such an extent as the 
uninfected cells due to cellular lysis due to mycobacteriophage infection and replication. It can also be 
seen from Figure 3.5.6 that the reporter phage infected samples have up to 3 to 8 times the 
expression levels of the negative samples, suggesting that Tm4::pYubSSmRFP may perform 
favourably for use as a diagnostic.  
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(d) 
(c) 
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Figure 3.5.6. Relative fluorescence following infection of M. smegmatis with 
mycobacteriophage Tm4::pYubSSmRFP (Isolates 12, 18, 19 and 20). M. smegmatis cultures of 
10ml each were used for infection followed by 24h incubation along with 2 negative controls consisting 
of uninfected M. smegmatis cultured for 24h. An amount of 300 µl of each sample was loaded onto a 
fluorescence plate reader and used to quantify fluorescence (as described in Section 2.5.3). Isolate 18 
showed about 5 times the background expression levels of M. smegmatis cultured for 24h and more 
than 8 times the expression levels of an M. smegmatis culture of 1h. Note that this data represents a 
single experiment and needs to be interpreted with caution. 
 
The ability to detect M. smegmatis cells, following infection with mycobacteriophage 
Tm4::pYubSSmRFP, by means of affinity chromatography and fluorescence measurement was also 
tested using several isolates (as shown in Figure 3.5.7). Figure 3.5.7 indicated that the fluorescence 
levels of His-tag purified eluates of M. smegmatis cultures infected with Tm4:pYubSSmRFP was up to 
7 times higher than that from uninfected M. smegmatis. This shows that the new diagnostic avenue by 
means of chromatography and fluorescence detection shows promise and generates results which are 
clearly discernible from negative controls.  
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Figure 3.5.7. Fluorescence levels from His-tag purified eluates performed on M. smegmatis 
cells infected with isolates of Tm4::pYubSSmRFP (Isolate 1, 2, 3, 4, 5, 12, 19 and 20). A his-tag 
purification performed on a water sample as well as on uninfected M. smegmatis cells was included as 
negative controls. Note that this data represents a single experiment and needs to be interpreted with 
caution. 
 
A protocol was developed for testing Tm4::pYubSSmRFP in M. tb H37RV (as described Appendix 
D.1). A high titer (109 pfu/ml) of Tm4::pYubSSmRFP was used to test for expression of fluorescence in 
M. tb following 6h infection and incubation. The samples were tested for fluorescence development 
using fluorescence microscopy as shown in Figure 3.5.7. The samples had been processed and 
stored for 4 weeks prior fluorescence microscopy which indicates that fluorescence levels are stable 
for extensive periods of time, despite the harsh paraformaldehyde treatment step. Furthermore, 3 
different tests with paraformaldehyde treatment of the M. tb mycobacteriophage-infected cells, showed 
total killing of all cells in the sample which was confirmed by culture testing on MGIT for up to 4 weeks. 
This shows that the samples may be processed outside of a biohazard facility following 
paraformaldehyde treatment. Unfortunately the relative fluorescence of M. tb cells infected with 
Tm4::pYubSSmRFP compared to uninfected cells was not determined due to time constraints. 
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Figure 3.5.8. Fluorescence microscopy of M. tb cells following 6h infection with 
Tm4::pYubSSmRFP. (a), (b) and (c) M. tb infected with three different isolates of 
Tm4::pYubSSmRFP. Fluorescence can be seen following infection and 6h incubation, 90 min 
paraformaldehyde treatment and 4 weeks of storage at 4°C prior to microscopy. (d) Negative control 
consisting of uninfected M. tb cells (a large clump) showing no fluorescence or auto-fluorescence.  
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Chapter 4 Discussion 
The continuous spread of M. tb is the source of major mortality and morbidity world-wide (World 
Health Organization, 2009a). One third of the world has been estimated to be infected with this 
pathogen (Corbett et al., 2003, World Health Organization, 2009a). Furthermore, the emergence of 
drug resistant strains is a new cause for concern, with MDR- and XDR-TB spreading globally and 
having been reported in as many as 58 countries around the world (World Health Organization, 2010). 
Drug treatment of TB is problematic since the treatment regimens spans over extended periods of time 
of between 6 and 8 months for drug sensitive TB and 18 to 24 months for MDR-TB (World Health 
Organization, 2009a). Patients are also liable to relapse following successful treatment, which leads to 
an increased risk of drug resistance (World Health Organization, 2009b). The current lack of effective 
anti-TB drugs presents a large problem in the control of the M. tb epidemic. Diagnostics are thus 
required to effectively detect and treat infected individuals before extensive transmission can take 
place. However, current routine diagnostics are not fulfilling this role effectively. Culture is the current 
gold standard TB diagnostic which is time consuming and requires biohazard facilities which are not 
ideal for field use. Smear microscopy is another widely-used TB diagnostic but it is insensitive. 
Additionally, current novel rapid TB diagnostics are out of reach for resource poor settings due to 
infrastructure, cost and skills requirements. Bacteriophage-based technology offers several 
advantages which could lead to simple, rapid and field-useable diagnostic technologies for bacterial 
detection. Mycobacteriophages have previously been investigated for use in M. tb diagnostics. 
However, these diagnostics have impractical requirements for field use, such as expensive reporter 
signal detection equipment, biohazard facilities and skilled staff. In this study, the construction of an 
affinity-tagged fluorescent reporter mycobacteriophage is described, which was engineered to act as a 
rapid TB diagnostic, offering an improvement on previous mycobacteriophage-based TB diagnostics. 
The construction of this reporter mycobacteriophage consisted of several steps. First, several 
mycobacterial promoters were screened for their suitability to drive expression of reporter genes, and 
the most optimal promoters were selected for further analyses. Secondly, various combinations of 
promoters, reporter genes, affinity tags and expression vectors were compared to establish which 
construct presented the most optimal and stable expression. The most suitable plasmid construct was 
then selected and the promoter, reporter gene and affinity tag from this construct was transferred to a 
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cosmid in preparation for transferral to a suitable mycobacteriophage. Thirdly, in order to construct a 
novel reporter mycobacteriophage, several mycobacteriophages were investigated for suitability. 
Reporter cosmids were cloned into the most suitable mycobacteriophage, which lead to the production 
of a novel reporter mycobacteriophage capable of detecting M. tb.  
 
4.1 Promoter screening 
Several promoters were investigated for use in the initial reporter plasmid constructs to drive 
expression of reporter genes, including the Hsp60, p19K, and pSmyc promoters. Additionally, 10 
intergenic regions from M. tb H37Rv ESAT-6 gene cluster 5 were evaluated for the presence of 
promoters in silico as well as in vivo. Two promoter prediction software programs, “NNPP” and 
“BPPROM” were used to analyze the 10 intergenic regions as described in Section 2.6.2. The results 
of these programs did not fully correspond, with “NNPP” predicting more potential promoters within the 
10 intergenic regions than “BPPROM”. The promoter prediction software detected several of the 
promoters identified in the in vitro results; however two of the strongest promoters (“Int 2” and “Int 5”), 
as detected by the β-galactosidase assay, were only detected by one of the two programs, 
respectively. The software, however, could only act as an additional tool to help include promoter 
regions for screening and does not provide suitable evidence to exclude a region. The 10 intergenic 
regions were cloned into promoter probe vector pJem15 and used for promoter activity screening by 
transforming M. smegmatis and by plating onto solid media containing X-gal. Blue / green colonies 
indicated β-galactosidase activity and thus promoter activity. Figure 3.1.4 showed that “Int1”, “Int2”, 
“Int3”, “Int5”, “Int7”, “Int8” and “Int10” have detectable promoter activity using the plating method. A β-
galactosidase assay was performed and revealed the relative promoter strength for the intergenic 
regions as shown in Figure 3.1.5. This figure shows that “Int1”, “Int2”, “Int5” and “Int8” are strong 
promoter elements relative to the Hsp60 promoter. These results were in accordance with the β-
galactosidase activity observed on the solid media containing X-gal, with the exception of “Int10”, 
which is a relatively weak promoter according to the β-galactosidase assays. Promoter “Int1” was 
specifically chosen for use in the subsequently constructed reporter constructs since it has strong 
promoter strength, yet slightly weaker than the Hsp60 promoter. The reason for aiming to select a 
promoter weaker than Hsp60 was to avoid mutations and deletions which have previously been shown 
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to occur in very strong promoters such as Hsp60 and mycobacteriophage L5 pLeft promoters (Al 
Zarouni & Dale, 2002, Bardarov et al., 2003).    
 
4.2 Reporter plasmid constructs 
Mycobacterial plasmid expression vectors were initially used in order to test the various promoter, 
reporter gene and affinity tag combinations in M. smegmatis, of which the best reporter construct 
would be cloned into a suitable cosmid and subsequently transferred to a suitable mycobacteriophage. 
Table 18 (Section 2.6.3) shows a list of the reporter plasmids constructed during this study and the 
various combinations of promoters, reporter genes and affinity tags within these. These constructs are 
discussed below and grouped according to the specific reporter genes utilized (first DsRed, thereafter 
mRFP1 and lastly LacZ constructs). 
 
4.2.1 pSD21Hsp60DsRedNHis 
To construct pSD21Hsp60DsRedNHis, the Hsp60 promoter and N-Term His-tagged DsRed gene were 
cloned into expression vector pSD21 (as described in Section 2.6.3.1). The results are shown in 
Section 3.2.1. Expression of DsRed from this construct in M. smegmatis (as well as in E. coli) was 
exceptionally high in certain instances, with cell pellets and His-tag purified eluates being visibly red to 
the naked human eye (as displayed in Figure 3.2.1.4a and b, respectively). However, the construct 
displayed unstable expression profiles after subculturing of the visibly red cultures containing construct 
pSD21Hsp60DsRedNHis. A several-fold decrease in visual red signal was observed in cell pellets, as 
well as in His-Tag purified eluates, despite similar culture conditions to the parent culture. This is likely 
due to the excessively strong promoter activity of the Hsp60 promoter, which leads to mutations and / 
or deletions in the promoter itself (Al Zarouni & Dale, 2002). A recent study also reported unreliable 
expression of DsRed in M. smegmatis using the Hsp60 promoter and suggested that frame-shift 
mutations could also be the cause (Carroll,P. 2010). Although the majority of cell pellets (grown from 
PCR positive colonies) displayed little visual red signal to the human eye, several of the cultures had a 
culture supernatant with visible red colour indicating possible cellular export of DsRed. However, as 
export of DsRed has not been reported in the literature, and due to the size of the tetramer, this is less 
likely. A more probable explanation for the visibly red supernatant could be due to cellular lysis of cells 
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expressing DsRed, releasing DsRed into the supernatant. In this study we observed that cultures 
(containing pSD21Hsp60DsRedNHis) which had a visibly red cell pellet following centrifugation often 
did not have a red supernatant. Conversely, it was also found that cultures (containing 
pSD21Hsp60DsRedNHis) with a red supernatant often did not have a red cell pellet. This mutual 
exclusion seems to indicate that DsRed is only released in certain cultures, notwithstanding the fact 
that culturing conditions were exactly the same. It is not clear whether this is due to active secretion or 
due to lysis of the cells. Considering the previously reported unstable expression in constructs that 
make use of the Hsp60 promoter, it is possible that this is also the case for the unstable expression 
from pSD21Hsp60DsRedNHis (Al Zarouni & Dale, 2002). In certain instances, expression of DsRed 
was not observed for the pellet or supernatant at all, despite positive PCR colony screening results for 
the pSD21Hsp60DsRedNHis construct. This further supports that expression from this promoter 
construct is unstable. Despite the variable visual results, fluorescence microscopy of samples with a 
red supernatant or red cell pellet revealed the presence of individual fluorescing cells (as displayed in 
Figure 3.2.1.5). The unreliable expression of construct pSD21Hsp60DsRedNHis makes it an 
unsuitable construct for the purpose of this study and further use of it was discontinued.  
 
4.2.2 p19KProHsp60DsRedNHis 
To construct p19KProHsp60DsRedNHis, the Hsp60 promoter and N-term His-tagged DsRed gene 
was cloned into vector p19KPro (as described in Section 2.6.3.2). The results for this construct are 
shown in Section 3.2.2. The expression of DsRed from M. smegmatis cultures containing construct 
p19KProHsp60DsRedNHis was similar to the expression observed for some of the cultures containing 
construct pSD21Hsp60DsRedNHis (discussed in Section 4.2.1). The similarity was that culture 
supernatants (from M. smegmatis cultures containing p19KProHsp60DsRedNHis) were frequently 
(almost consistently) red with cell pellets which were not visibly red. It is unclear whether this could be 
due to cellular lysis or due to export of the DsRed protein. However, as stated in Section 4.2.1, this 
has not been previously reported for DsRed and is less likely due to the large size of the DsRed 
tetramer. Despite the lack of a visibly red cell pellet, it was possible to detect single cells by means of 
fluorescence microscopy as displayed in Figure 3.2.2. Since none of the cell pellets were visibly red, it 
appears as though p19KProHsp60DsRedNHis could offer a worse expression level of DsRed than 
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pSD21Hsp60DsRedNHis. However, fluorescence microscopy showed that single fluorescent cells 
could be detected for most of the cultures, thus suggesting an increased stability in expression 
compared to pSD21Hsp60DsRedNHis. Furthermore, the frequently red supernatants also suggest 
increased expression of DsRed compared to DsRed expression from pSD21Hsp60DsRedNHis. A 
factor to take into account, when analysing the expression results from p19KProHsp60DsRedNHis, is 
the possible role of the p19k promoter which remains intact following construction of 
p19KProHsp60DsRedNHis as displayed in Figure 2.2. The Hsp60 promoter and DsRed gene was 
cloned into a single cutting site of p19Kpro. Thus, theoretically in half of the constructs the Hsp60 
promoter and DsRed gene should be in the same orientation as the p19K promoter. The p19K 
promoter could thus potentially act synergistically with the Hsp60 promoter to yield increased promoter 
strength, increasing expression of DsRed. Additionally, the p19K promoter could perhaps grant 
promoter activity leading to DsRed expression in constructs with mutations or deletions in the Hsp60 
promoter (as discussed in Section 4.2.1) which might explain the increased stability in expression over 
pSD21Hsp60DsRedNHis. However, it could also be argued that the possible additional promoter 
strength granted by the p19K promoter could further increase the occurrence of mutations and 
deletions in the Hsp60 promoter due to the increased combined promoter strength. It is unclear as to 
the exact reason for the less than ideal expression levels from construct p19KProHsp60DsRedNHis. 
However, due to the superior expression levels of reporter genes from other constructs made in this 
study, it was decided to discontinue further use of this construct for the purpose of this study.  
 
4.2.3 pSD21Hsp60DsRedCHis 
To construct pSD21Hsp60DsRedCHis, the Hsp60 promoter and C-term His tagged DsRed gene was 
cloned into vector pSD21 (as described in Section 2.6.3.3). The results are shown in Section 3.2.3. M. 
smegmatis cultures containing pSD21Hsp60DsRedCHis displayed no detectable expression of DsRed 
by means of fluorescence microscopy. The reason for the lack of DsRed expression is not clear. It 
would have been expected that pSD21Hsp60DsRedCHis would have similar expression to 
pSD21Hsp60DsRedNHis (Section 4.2.1) especially since the culture conditions used were exactly the 
same. As discussed in Section 4.2.1 and 4.2.2, use of the Hsp60 promoter lead to some cultures with 
no detectable DsRed expression which could also be the case for pSD21Hsp60DsRedCHis. 
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Interestingly, when the Hsp60 promoter, together with the C-terminal His-tagged DsRed gene, was 
excised from pSD21Hsp60DsRedCHis and cloned into vector pACE (which had its existing pACE 
promoter removed), the expression of DsRed was restored (as discussed in Section 4.2.4). Since 
transferral of the exact same promoter and affinity tagged reporter gene construct to another 
expression vector restored DsRed expression, it suggests that vector pSD21 contains some element 
which prevented optimal expression of DsRed. The lack of DsRed expression from construct 
pSD21Hsp60DsRedCHis made this construct unsuitable for further use in this study and its use was 
discontinued.  
 
4.2.4 pACEHsp60DsRedCHis 
To construct pACEHsp60DsRedCHis, the Hsp60 promoter and C-term His tagged DsRed gene was 
cloned into vector pACE (as described in Section 2.6.3.4). The results are shown in Section 3.2.4. The 
expression of DsRed was consistently high between cultures of M. smegmatis containing 
pACEHsp60DsRedCHis and single cells could be detected by fluorescence microscopy (as displayed 
in Figure 3.2.4.2). It is unclear why construct pACEHsp60DsRedCHis, despite its dependence on the 
Hsp60 promoter for DsRed expression, had more stable expression that previous constructs which 
utilized the Hsp60 promoter (as discussed in Sections 4.2.1, 4.2.2 and 4.2.3). One concern regarding 
the construct pACEHsp60DsRedCHis was the possibility that due to its situation at the C-terminus of 
DsRed, the affinity tag could be non-functional. It was previously suggested that C-terminal protein 
fusions to the DsRed tetramer could be non-functional (Yarbrough et al., 2001). However, the C-
termini of DsRed monomers are partially exposed to solvent (Yarbrough et al., 2001), making it 
possible for small protein fusions, such as affinity tags, to remain functional as long as they are 
exposed to solvent. In this study, His-tag purification performed on the WCL of M. smegmatis 
containing pACEHsp60DsRedCHis resulted in an eluate which displayed fluorescence levels several-
fold higher than the His-tag purified eluate of a control containing the same vector without a His-tag, 
indicating functional C-terminal His-tags. Furthermore, DsRed is an obligate tetramer and only 
fluoresces optimally when it this form (Yarbrough et al., 2001). It is thus not possible that the 
fluorescence observed was due to monomers or due to poorly fluorescing dimers (Yarbrough et al., 
2001), which suggests that the His-tags fused to the tetramer did not affect tetramerization of DsRed. 
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The results for pACEHsp60DsRedCHis indicate that it is a suitable construct to consider for transferral 
into a cosmid vector. However, use of the Hsp60 promoter was considered less than ideal, as 
previously described, and thus use of pACEHsp60DsRedCHis was discontinued in favour of other 
superior constructs developed in this study.  
 
4.2.5 pSD21Int1DsRedNHis 
In order to address the poor and variable performance of the Hsp60 promoter, this promtoer was 
replaced with the Int1 promoter identified in the promoter analysis (discussed in Section 4.1). The 
expression from this construct was expected to correlate to the promoter analysis results for the Int1 
promoter from the promoter analysis results as described in Section 4.1.1. However, since this 
promoter has not previously been described in literature its performance in expressing fluorescent 
proteins was unknown. To construct pSD21Int1DsRedNHis, the Int1 promoter and N-term His-tagged 
DsRed gene was cloned into vector pSD21 (as described in Section 2.6.3.5). The results are shown in 
Section 3.2.5. Interestingly, despite the good expression from this promoter in the promoter probe 
vector, the expression levels of DsRed were poor in M. smegmatis cultures containing 
pSD21Int1DsRedNHis. The reason for this is uncertain as construct pSD21Int1DsRedNHis is the 
same as construct pSD21Hsp60DsRedNHis except for the difference in promoter. The results from the 
comparative promoter analysis showed that the Int1 promoter was somewhat weaker than the Hsp60 
promoter (shown in Figure 3.1.5, Section 3.1). Furthermore, use of the Int1 promoter should 
theoretically provide a more stable and reliable expression of DsRed as discussed in Section 4.1. This 
was in fact shown to be the case in another construct. Construct pACEInt1DsRedCHis (discussed in 
Section 4.2.6) showed high levels of DsRed expression when utilizing the Int1 promoter (see Section 
4.2.6). This once again indicates potential problems with the use of expression vector pSD21. Later 
analyses also showed that expression vector pSD21 gave problematic expression in constructs 
pSD21Hsp60DsRedNHis (Section 4.2.1), pSD21Hsp60DsRedCHis (Section 4.2.3) and 
pSD21Hsp60mRFPNHis (Section 4.2.8). As discussed in Section 4.2.3, transfer of the Hsp60 
promoter and His-tagged DsRed gene from pSD21Hsp60DsRedCHis (which had poor DsRed 
expression, Section 4.2.3) to expression vector pACE (to create pACEHsp60DsRedCHis, Section 
4.2.4) restored expression of DsRed. All of these results thus suggest that the use of vector pSD21 
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potentially leads to problems in expression of these reporter genes. Given this, the Int1 promoter was 
also tested in other constructs (Sections 4.2.6, 4.2.10 and 4.2.15) and showed better expression 
activity. Thus, construct pSD21Int1DsRedNHis was not further utilized in this study.  
 
4.2.6 pACEInt1DsRedCHis 
To construct pACEInt1DsRedCHis, the Int1 promoter and C-term His-tagged DsRed gene was cloned 
into vector pACE (as described in Section 2.6.3.6). The results are shown in Section 3.2.6. Expression 
levels of DsRed from M. smegmatis cultures containing pACEInt1DsRedCHis were high and single 
cells could be detected using fluorescence microscopy as in Figure 3.2.6.2. His-tag purification 
performed on the WCL of M. smegmatis cells containing construct pACEInt1DsRedCHis lead to an 
eluate with fluorescence levels several-fold higher than a negative control. These results 
corresponded to the results obtained with construct pACEHsp60DsRedCHis (Section 4.2.4) which 
show that a 6 amino-acid C-terminal fusion to the DsRed tetramer, such as a His-tag, remains 
functional and is thus exposed to the solvent. These results also show that the Int1 promoter is a 
strong promoter which drives expression of DsRed to a level which enables single-cell detection by 
means of fluorescence microscopy. Due to the strong promoter activity of Int1 in construct 
pACEInt1DsRedCHis, it is thus likely that the poor expression from construct pSD21Int1DsRedNHis 
(discussed in Section 4.2.5) is attributable to the use of the pSD21 vector. The expression of DsRed 
from construct pACEInt1DsRedCHis indicated that it would be suitable for further use in downstream 
cloning and transfer into mycobacteriophage. However, pACEInt1DsRedCHis was not utilized further 
in this study due to the superior performance of other constructs (discussed later in this chapter).   
 
4.2.7 pSD21Hsp60mRFPNHis 
To construct pSD21Hsp60mRFPNHis, the Hsp60 promoter and N-term His-tagged mRFP1 gene was 
cloned into vector pSD21 (as described in Section 2.6.3.7). The results are shown in Section 3.2.7. A 
low level of fluorescence was detected among some of the M. smegmatis cultures containing 
construct pSD21Hsp60mRFPNHis. However, the expression of mRFP1 from this construct matched 
the unstable expression of DsRed from pSD21Hsp60DsRedNHis (as discussed in Section 4.2.1). 
Other constructs from this study, which also utilized the Hsp60 promoter, also displayed poor 
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expression of their reporter genes (see Sections 4.2.1, 4.2.2, 4.2.3 and 4.2.5). This supports the 
previous observation in this study that the Hsp60 promoter results in unstable reporter gene 
expression. However, constructs in pSD21 also showed poor performance regardless of which 
promoter was used (see Section 4.2.1, 4.2.3, 4.2.5, with the exception of Section 4.2.4), so that the 
vector could also contribute to the poor performance. It is thus possible that constructs which utilize 
both the Hsp60 promoter and pSD21 are at highest risk to have poor expression. In fact, all constructs 
which utilized both the Hsp60 promoter in combination with vector pSD21 had expression ranging 
from poor to none (see discussion of these constructs in Sections 4.2.1, 4.2.5 as well as this section). 
Due to the poor mRFP1 expression observed from pSD21Hsp60mRFPNHis, its further use in thus 
study was discontinued.  
 
4.2.8 p19KProp19KmRFPNHis 
To construct p19kProp19kmRFPNHis, an N-term His-tagged mRFP1 gene was cloned into vector 
p19KPro, placing the mRFP1 gene under control of the p19K promoter (Section 2.6.3.8). Expression 
was expected to be stable due to favourable results from previous studies using this promoter 
(Dave,J.A. 2002). The results are shown in Section 3.2.8. Expression of mRFP1 from M. smegmatis 
cultures containing construct p19kProp19kmRFPNHis was consistently stable among cultures and 
sub-cultures containing p19kProp19kmRFPNHis. The cultures did not, however, lead to a visibly red 
cell pellet or eluates following His-tag purification. Despite the lack of a visibly red cell pellet, single 
cells were easily detected using fluorescence microscopy, as displayed in Figure 3.2.8.2. It thus 
appears as though the p19Kpro is not a suitably strong promoter for further use in this study. Despite 
the expression levels of mRFP1 being consistent among cultures, the expression levels were not as 
high as other constructs from this study. Thus the use of p19kProp19kmRFPNHis was discontinued.  
 
4.2.9 pSD21Int1mRFPNHis 
To construct pSD21Int1mRFPNHis, the Int1 promoter and N-term His tagged mRFP1 gene was 
cloned into vector pSD21 (as described in Section 2.6.3.9). The results are shown in Section 3.2.10. 
Expression levels of mRFP1 were stable in cultures of M. smegmatis containing vector 
pSD21Int1mRFPNHis and single cells were easily detected using fluorescence microscopy (as 
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displayed in Figure 3.2.9). In this study, constructs that utilized the Int1 promoter lead to superior 
(higher and more stable) expression compared to constructs that utilized the Hsp60 promoter (with the 
exception of pSD21Int1DsRedNHis as discussed in Section 4.2.5).  The Int1 promoter is thus a good 
candidate promoter for use in a reporter construct due to its consistent levels of expression and 
stability. However, due to the superior performance of other constructs, use of pSD21Int1mRFPNHis 
was discontinued.  
 
4.2.10 pDMN1pSmycmRFPNHis 
To construct pDMN1pSmycMRFPNHis, the N-term His tagged mRFP1 gene was cloned into pDMN1 
(as described in Section 2.6.3.10). This promoter was previously shown to drive strong and stable 
expression of fluorescent proteins in M. smegmatis (Carroll,P. 2010). The results from this study are 
shown in Section 3.2.10. pDMN1pSmycMRFPNHis displayed high levels of mRFP1 expression in all 
cultures and sub-cultures of M. smegmatis cells containing the construct. Single fluorescing cells were 
identifiable in all cultures and sub-cultures containing this construct. This indicated stable and 
constitutive expression from the pSmyc promoter contained in this construct (in contrast to earlier 
constructs which utilized the Hsp60 promoter). The superior expression of mRFP1 observed from this 
construct makes the promoter and reporter gene combination an appropriate construct for transferral 
to a cosmid and subsequently into a mycobacteriophage. Additionally, cultures of 
pDMN1pSmycMRFPNHis also gave a visibly red eluate following His-tag purification performed on the 
WCL, proving that this construct would be useful for concentration of reporter signal. All these factors 
made pDMN1pSmycMRFPNHis the most suitable reporter construct for transferral into 
mycobacteriophage and it was thus selected to be cloned into a cosmid and subsequently into 
mycobacteriophages.   
 
4.2.11 pJem15Hsp60LacZNHis  
To construct pJem15Hsp60LacZNHis, the Hsp60 promoter and N-term His-tagged LacZ gene was 
cloned into pJem15 (as described in Section 2.6.3.11). The results are shown in Section 3.2.11. The 
expression of LacZ the gene, and functionality of the His-tag fusion, was shown by first performing a 
His-tag purification on the WCL of cells containing the construct, followed by addition of X-gal which 
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resulted in a colorimetric reaction (as shown in figure 3.2.11d). Construct pJem15Hsp60LacZNHis 
proved to be a suitable construct for further use in this study, however, its use was discontinued due to 
favourable results from other constructs. 
  
 
4.2.12 pJem15Int1LacZNHis 
To construct pJem15Int1LacZNHis, the Int1 promoter and C-term His-tagged LacZ gene was cloned 
into pJem15 (as described in Section 2.6.3.12). The results are shown in Section 3.2.12. A His-tag 
purification performed on the WCL of M. smegmatis cells containing construct pJem15Int1LacZNHis 
produced an eluate which did not lead to a colorimetric signal after the addition of X-gal as with 
construct pJem15Hsp60LacZNHis (discussed in Section 4.2.11). It is possible that the partial digest 
performed on pJem15 lead to removal of DNA from the LacZ gene which inactivated the enzyme. The 
construct was thus not suitable for further consideration in this study and was not further utilized.   
 
4.3 Cosmid constructs 
The optimal and most stable expression of a reporter gene was observed from construct 
pDMNpSmycmRFPNHis (Section 4.2.10), consisting of the pSmyc promoter and N-term His-tagged 
mRFP1 gene cloned into expression vector pDMN1. This promoter and reporter gene combination 
was selected to be sub-cloned into a suitable cosmid in order to allow Lambda packaging together 
with mycobacteriophage DNA to create a novel reporter mycobacteriophage. This brings two 
limitations into play, the head capsid size of bacteriophage lambda and the mycobacteriophage head 
capsid size of the selected mycobacteriophage limit the amount of DNA that can be stored. The 
theoretical maximum size that the head capsid of bacteriophage lambda can accommodate has been 
determined to be between 38 and 52 kb (Chauthaiwale,V.M. 1992). This means that the ligation 
product between mycobacteriophage DNA and cosmid DNA cannot exceed this amount in order to 
allow lambda packaging. In turn, the mycobacteriophage head capsid can only accommodate 52,797 
bp for mycobacteriophage Tm4 and 49 136 bp for mycobacteriophage D29 (Pedulla,M.L. 2003). The 
integrating cosmid pYub412 (Appendix B.11) was used for the majority of cloning attempts.  A non-
integrating version of this cosmid was also created. Furthermore, a new cosmid was constructed, 
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based on expression vector pDMN1 (Appendix B.8). Table 19 (Section 2.6.4) shows a list of the 
cosmid constructs created in this study. 
 
4.3.1 pYub412mRFPPvuI 
Integrating reporter cosmid pYub412mRFPPvuI consisted of the mRFP1 gene driven by the pSmyc 
promoter, cloned into the PvuI RE site of pYub412 (as described in Section 2.6.4.1). The results are 
shown in Section 3.3.1. Construct pYub412mRFPPvuI failed to produce viable transformants following 
lambda packaging into E. coli. It is unclear why this construct failed to produce viable transformants. 
The cloning disrupted the ampicillin resistance gene, but since the PvuI RE site is situated only about 
halfway into the ampicillin resistance gene, it would be unlikely to disrupt any essential genes. 
Additionally, disruption of the ampicillin resistance gene on its own could not be the explanation, as it 
would leave the role of selectable marker to the intact hygromycin resistance gene. The only plausible 
explanation for the lack of viable transformants (other than incorrect RE map information) could be 
that the E. coli origin of replication makes use of promoter read-through from the ampicillin resistance 
gene. It is possible that this origin of replication is disrupted by insertion of the reporter construct into 
the PvuI RE site. This assumption is substantiated by the fact that the origin of replication is situated 
directly adjacent to the ampicillin resistance gene. This construct was thus found to be unsuitable for 
the purpose of this study and additional RE sites of pYub412 were investigated for use in constructing 
a more suitable reporter cosmid. 
 
4.3.2 pYub412mRFPSapI 
Integrating reporter cosmid pYub412mRFPPvuI was constructed by cloning of the N-terminal His-
tagged mRFP1 gene driven by the pSmyc promoter into the SapI RE site of pYub412 (as described in 
Section 2.6.4.2). The results are shown in Section 3.3.2. Construct pYub412mRFPSapI failed to 
produce viable transformants following electroporation into E. coli. A possible reason for the lack of 
viable transformants following ligation of the reporter construct into the SapI site of pYub412 might be 
ligation failure. This would result from using incompatible DNA overhangs during the ligation step. In 
order to clone an insert into a SapI RE site it is necessary to have the exact sequence information of 
the SapI RE site since the entire DNA overhangs are not dependent on the SapI RE recognition site 
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and are determined by the specific DNA target site. However, since the overhangs of the digested 
promoter and reporter gene insert were complementary to the SapI digested overhangs of pYub412, 
according to the sequence information available on pYub412, it was unclear why the DNA failed to 
ligate. Furthermore, since the SapI RE site is situated in a non-essential region in the pYub412 
cosmid, it is unlikely that the insert disrupted any essential genes. Due to the failure of this construct to 
produce viable transformants following ligation, further use of it was discontinued.  
 
4.3.3 pYub412mRFPNdeIBglII 
Cosmid vector pYub412 was modified from an integrating cosmid to an episomal consmid by 
restriction digesting with NdeI and BglII which removed the AttP site as well as a part of the integrase 
gene. The episomal reporter cosmid pYub412mRFPPvuI was constructed by cloning the N-terminal 
His-tagged mRFP1 gene driven by the pSmyc promoter into the NdeI and BglII RE sites (as described 
in Section 2.6.4.3). The results are shown in Section 3.3.3. Construct pYub412mRFPNdeIBglII failed 
to produce viable transformants following electroporation into E. coli. It is not clear why no viable 
colonies were observed following electroporation of the construct into E. coli. The region excised from 
pYub412, and replaced by the pSmyc promoter and mRFP1 gene, contained non-essential DNA 
according to the vector map (Appendix B.12). Nevertheless, other RE sites were available and utilized 
in this study in order to construct a functional reporter cosmid (as discussed later in this section). Thus 
pYub412mRFPNdeIBglII was not further utilized in this study.  
 
4.3.4 pDMNLCosmRFP  
Granted that pYub412mRFPPvuI, pYub412mRFPSapI and pYub412mRFPNdeIBglII (discussed in 
Section 4.3.1, 4.3.2, and 4.3.3 respectively) were found to be unsuitable for the purposes of this study. 
Construction of a novel cosmid based on the selected reporter plasmid (pDMNpSmycmRFPNHis) was 
attempted. Episomal reporter cosmid pDMNLCosmRFP consisted of the construct 
pDMNpSmycmRFPNHis (see Section 4.2.10) with a (minimally size reduced) lambda cos site cloned 
into it (as described in Section 2.6.4.4). The results are shown in Section 3.3.4. The construct was 
successfully cloned, however, failed to lambda package together with mycobacteriophage DNA. The 
reason why the construct failed to produce viable colonies following ligation to mycobacteriophage 
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DNA and lambda packaging was initially unclear. This was especially the case since the recombinant 
reporter cosmid possessed all the features required for lambda packaging (an E. coli origin of 
replication, selectable marker and lambda cos site). Failure of similarly-sized cosmids to package 
along with mycobacteriophage DNA in this study later revealed that the most likely reason for 
packaging failure of this construct was due to size constraints of the lambda head capsid. It was 
shown that the cosmid pYubmRFP (Section 4.3.5) also did not successfully package, however, a size 
reduced version of it (pYubSSmRFP, Section 4.3.6) could successfully be lambda packaged. It was 
not possible to further reduce the size of this cosmid extensively, so unfortunately the functionality of 
the minimally size reduced lambda cos site used in pDMNLCosmRFP could thus not be tested in this 
study. Due to the failure of the novel reporter cosmid to be packaged along with mycobacteriophage 
DNA into E. coli, the pDMNLCosmRFP cosmid was not further utilized in this study. 
 
4.3.5 pYubmRFP 
As with construct pYub412mRFPNdeIBglII (Section 4.3.3), cosmid vector pYub412 was again 
modified from an integrating cosmid to an episomal cosmid by restriction digestion, this time with SalI 
and EcoRV, which removed a larger region including the hygromycin resistance gene, the AttP site as 
well as the whole integrase gene. Episomal reporter cosmid pYub412mRFPPvuI was constructed by 
cloning the N-terminal His-tagged mRFP1 gene driven by the pSmyc promoter into the SalI and 
EcoRV RE sites (as described in Section 2.6.4.5). The results are shown in Section 3.3.5. Due to the 
removal of the large region, and the insertion of only a small construct, the resulting cosmid was 
considerably size reduced compared to pYub412. It was envisaged that this could result in a cosmid 
small enough to be accompanied together with mycobacteriophage DNA in phage lamba heads during 
lambda packaging into E. coli. Despite the removal of the non-essential genes, the cosmid could, 
however, still not be lambda packaged together with mycobacteriophage DNA due to size constraints. 
It seemed that the construct still needed to be much smaller to allow packaging. According to Figure 
3.4.3.3a (Section 3.4.3), which displays the excision of the existing luciferase reporter cosmid from 
phAE142, the existing luciferase reporter cosmid was in fact considerably smaller than pYubmRFP 
(~4500bp compared to 5919bp). Thus, our reporter cosmid needed to be smaller than around 4500bp 
in order to ensure that the size constraints of bacteriophage lambda do not prevent packaging. For this 
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purpose, a further size reduced version of pYubmRFP was constructed as discussed in the following 
section (Section 4.3.6). 
 
4.3.6 pYubSSmRFP 
The size reduced cosmid pYub412mRFPPvuI was constructed by further removal of a 2032bp region 
of non-essential DNA, leaving the construct with only one remaining functional lamba cos site (as 
described in Section 2.6.4.6). The results are shown in Section 3.3.6. Although a double cos site 
improves lambda packaging efficiency, only one site is necessary, and the priority was to create a 
cosmid of the right physical size to allow lambda packaging. Thus, the reduced packaging efficiency 
due to using only one cos site was an acceptable trade off. However, this cosmid did have one 
drawback in that expression of mRFP1 from the cosmid construct in M. smegmatis could not be 
tested. The reason for this was that the only remaining selectable marker in pYubSSmRRP was the 
ampicillin resistance marker, to which M. smegmatis is resistant. This meant that M. smegmatis cells 
containing the construct could not be selectively propagated in liquid or solid media, since both 
transformed and non-transformed cells would replicate equally well. However, favorable results were 
previously observed for the reporter plasmid containing the same DNA sequence for the promoter and 
reporter gene (pDMNpSmycmRFPNHis, Section 4.2.10). The reporter cosmid pYubSSmrfp was used 
for cloning into mycobacteriophage as described in Section 4.4.  
 
4.4 Reporter mycobacteriophages 
4.4.1 Selection of a suitable mycobacteriophage for cloning 
The choice of mycobacteriophage plays a large role in the dynamics and performance of a reporter 
assay based on mycobacteriophage detection technology. Lysogenic mycobacteriophages will 
integrate into the host cells and will lead to gradual buildup of reporter signal, enabling single cell 
detection. Lytic mycobacteriophages, however, will lead to the rapid expression of reporter protein, but 
also host lysis and phage replication, rapidly leading to progeny phage buildup and new cycles of 
infection. Host lysis is the most suitable scenario for affinity-tagged mRFP1 expression prior to 
purification of reporter protein. Twenty-one novel South African mycobacteriophages isolated from soil 
samples, as well as mycobacteriophages D29 and Tm4 were considered for cloning to create a 
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reporter mycobacteriophage. Host range analyses indicated that the novel mycobacteriophages were 
not capable of infecting and replicating in M. tb and were found to be limited to M. smegmatis and 
possibly other unidentified soil mycobacteria. These were thus not found to be suitable for the purpose 
of this study. According to the literature there are currently 26 mycobacteriophages (the entire cluster 
K as well as mycobacteriophage L5 and D29) which are known to infect fast and slow growing 
mycobacteria and currently 223 genomes mycobacteriophages in genbank. This gives the rough 
estimate that about 1 in ten mycobacteriophages can infect fast and slow growing mycobacteria. It is 
thus unfortunate that the 21 mycobacteriophages screened in this study could only infect M. 
smegmatis. Their host range could, however, include other mycobacteria which have not been 
screened for in this study. Both D29 and Tm4 were found to be suitable since they are both lytic 
mycobacteriophages capable of infecting M. tb. Furthermore, their use as reporter 
mycobacteriophages has previously been demonstrated (Dusthackeer et al., 2008, Pearson et al., 
1996). The dynamics of reporter protein expression is further influenced by the choice between an 
integrative or an episomally replicating cosmid for cloning into the mycobacteriophage. However, in 
this study only episomal cosmids could successfully be utilized due to size constraints. Incidentally, 
episomal reporter cosmids would be preferable since it would lead to rapid build-up of progeny 
mycobacteriophage and exponential signal amplification. In contrast, integrative reporter 
mycobacteriophage would lead to strong expression, but lower levels of lysis, and thus less 
extracellular reporter signal suitable for affinity purification-based signal detection.  
 
In order to construct a recombinant mycobacteriophage, several approaches can be followed. If 
insertion site sequence information is available and if size constrains allow, recombination offers a 
relatively easy method of creating a recombinant mycobacteriophage. However, recombination was 
not utilized in this study since D29 DNA was wild-type and required a size reduction in order to 
accommodate additional DNA, making recombination unsuitable. Also, recombination could not be 
used for Tm4 since information on the insertion site of the existing luciferase cosmid (which had to be 
excised to disable luciferase expression as well as to allow space for the new cosmid) was not 
available. Self-ligation of the cosmid and mycobacteriophage followed by electroporation into E. coli or 
M. smegmatis offers a low efficiency alternative (compared to the lambda packaging method). A third 
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method for construction of recombinant mycobacteriophage is excision of non-essential 
mycobacteriophage DNA, followed by ligation to a suitable reporter cosmid, and thereafter the use of 
lambda packaging to create a reporter phasmid. Lambda packaging requires that the DNA which is 
targeted for packaging contain a lambda cos site and must be of suitable size (not too small or too 
large in order to be accommodated in the lambda phage heads). In addition, an E. coli origin of 
replication and a selectable marker needs to be present on the target DNA. However, ligation into the 
mycobacteriophage genome would naturally have to be into a non-essential region as well as into a 
region flanked by the mycobacteriophage cos sites to avoid cleavage excision after transfer into a 
mycobacterial host following activation of the mycobacteriophage lytic machinery. Additionally, the 
total size of the cosmid and mycobacteriophage DNA would also have to be of a suitable size to be 
accommodated in the mycobacteriophage heads (in addition to the lambda phage heads).  
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4.4.2 D29 reporter mycobacteriophage 
Mycobacteriophage D29 DNA was obtained as wild-type DNA which would not be able to 
accommodate additional DNA in the D29 head capsid. A restriction enzyme size reduction strategy 
was adopted which makes use of partial RE digest and cloning of large (yet size reduced) DNA 
fragments into reporter cosmid pYubmRFP followed by lambda packaging. This method removed non-
essential DNA from the D29 genome and replaced it with a reporter cosmid selected in this study. The 
cloning method is shown in Section 2.6.5.2 and the results are shown in Section 4.4.2. Working with 
linear double stranded mycobacteriophage DNA proved to be difficult, in particular obtaining large 
quantities of partially digested D29 DNA. Several attempts were made to construct a viable 
mycobacteriophage by ligating partially digested D29 DNA to digested pYubmRFP. Several hundreds 
of transformant colonies, resulting from lambda packaging of the ligations into E. coli, were PCR 
screened and DNA was extracted from colonies testing positive. However, transformation of the 
extracted DNA into M. smegmatis did not result in the production of a recombinant 
mycobacteriophage. Although the DNA packaged was large (as detected by cosmid DNA extraction 
and gel electrophoresis) the essential genes for infectivity and the lytic cycle must have been lost 
during the partial RE digest. To avoid the size constraints of phage lambda packaging, we attempted 
to electroporate the cosmid and partially-digested D29 DNA ligation directly into M. smegmatis, but 
this proved to be equally time consuming and unsuccessful. In order to achieve success with the RE 
size reduction method, clearly inordinate amounts of colonies would have to be further screened, 
which could potentially be simplified by resorting to Southern blotting to detect positive colonies. 
However, since several hundred colonies yielded no viable reporter mycobacteriophages by PCR, it 
was unlikely that a different screening method would provide a solution to the lack of viable 
recombinant mycobacteriophages. Granted the amount of time required to screen additional hundreds 
of colonies and / or plaques by either PCR or Southern blotting, other cloning methods proved to be 
superior to obtain a novel reporter mycobacteriophage, as discussed in Section 4.4.3.  
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4.4.3 Tm4 mRFP mycobacteriophage 
Mycobacteriophage Tm4 was obtained in the form of phAE142, a luciferase reporter 
mycobacteriophage utilizing the L5 promoter to drive firefly luciferase from an unknown cosmid. 
phAE142 contains RE sites which could be utilized to excise the luciferase-containing cosmid and 
allows the possibility to replace it with another reporter cosmid. This method offers, in principle, a 
simplified cloning strategy over the D29 RE size reduction method (discussed in Section 4.4.1). Initial 
RE digest attempts to excise the luciferase cosmid appeared to excise a faint band of DNA. However, 
ligation of a reporter cosmid to the presumably digested DNA failed to produce viable transformants 
(Section 3.3). Additionally, attempts to directly electroporate the ligation between the cosmid and the 
(presumably) digested mycobacteriophage DNA failed to produce viable mycobacteriophage (Section 
3.3). It was later revealed that mutations or deletions were most likely present in luciferase cosmid. 
According to literature, the luciferase cosmid has been reported to have mutations or deletions when 
phAE142 is propagated in wild-type M. smegmatis, and requires a special strain of M. smegmatis 
which expresses an L5 promoter repressor (Bardarov et al., 2003). However, the special strain of M. 
smegmatis was unavailable.  
 
Thus, an alternative methodology was devised to obtain adequate amounts of phAE142 without the 
presence of mutations or deletions. Instead of propagating the DNA as mycobacteriophage, which 
subjects the DNA to selective pressures leading to mutations or deletions, the linear 
mycobacteriophage DNA was instead self-ligated and lambda packaged into E. coli. This allowed 
handling of the mycobacteriophage DNA in the form of circular phasmid DNA in E. coli, which was of 
benefit, as the L5 promoter is not active in the E. coli host. As such, a phasmid DNA extraction was 
performed on the DNA which yielded purified phAE142 DNA without, to our knowledge, mutations or 
deletions. This method preserved the RE sites in the unknown luciferase cosmid DNA sequence which 
subsequently allowed the successful excision of the luciferase cosmid and the release of the PacI-
digested Tm4 genome (as shown in Figure 3.4.3.3a). The minimally size reduced reporter cosmid 
pYubSSmRFP (as discussed in Section 4.3.6) was cloned into the PacI RE site of PacI-digested 
mycobacteriophage Tm4 and was successfully lambda packaged. Colonies testing PCR positive were 
cultured and a phasmid DNA extraction was performed on the cultures. The electroporation of the 
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purified phasmid DNA successfully lead to plaque formation, after which plaque purification was 
performed to obtain a large amount of recombinant Tm4::pYubSSmRFP stock. The novel reporter 
mycobacteriophage Tm4::pYubSSmRFP was then tested in both M. smegmatis and M. tb as 
described in Section 4.5. 
 
4.5 Evaluation of reporter mycobacteriophage Tm4::pYubSSmRFP 
Novel reporter mycobacteriophage Tm4::pYubSSmRFP consisted of the episomal reporter cosmid 
pYubSSmRFP (as discussed in Section 4.3.6) cloned into the PacI RE site of mycobacteriophage 
Tm4. Mycobacteriophage Tm4::pYubSSmRFP was initially tested in M. smegmatis in order to evaluate 
its performance. The preliminary evaluation made use of a 96-well format fluorescence plate reader as 
well as fluorescence microscopy to test three aspects of the reporter mycobacteriophage important for 
its function and suitability as a reporter mycobacteriophage. These aspects were (1) variation in 
mRFP1 expression between isolates, (2) the optimal titer, and (3) change in fluorescence levels as a 
function of time. The results are shown in Section 3.5.  
 
In order to determine if there was any variation in mRFP1 expression between isolates of 
Tm4::pYubSSmRFP, isolates were diluted to the same titer and used to infect M. smegmatis. Figure 
3.5.1 displays the fluorescence levels observed, which indicated that some level of variation exists 
between different isolates. However, this variation was not significant since the expression from each 
isolate was considerably higher than that of uninfected M. smegmatis cells. Furthermore, good 
expression of mRFP1 was observed using fluorescence microscopy which leads to the detection of 
individual cells of M. smegmatis as shown in Figure 3.5.5. Possible explanations for the level of 
variation could possibly due to mutations in the genomes of the isolates or due to unanticipated 
variance in the conditions of infection. It is also possible that some level of variation may be attributed 
to variance in the growth stages of the M. smegmatis cells. Sequencing of the pSmyc promoter and 
mRFP1 reporter gene did not show any mutations or deletions in the 20 isolates which lead to two 
conclusions. First, if mutations or deletions are responsible for the observed expressional variance, 
then these mutations must reside elsewhere in the Tm4 genome. Secondly, the lack of mutations and 
deletions suggest that Tm4:pYubSSmRFP is more stable than phAE142 (Bardarov et al., 2003) during 
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propagation in wild-type M. smegmatis which simplifies large scale production of the reporter 
mycobacteriophage Tm4::pYubSSmRFP for wide-spread use in diagnostics. Other than mutations or 
deletions, the remaining source for variation is due to variations during the infection of each M. 
smegmatis sample either by variations in the titer ranges of the mycobacteriophage isolates or due to 
variations in the amount of M. smegmatis used for infection or a combination of these aspects. 
Variations in the titer ranges could arise due to the inherent level of inaccuracy of titer ranges due to 
the downstream amplification of pipetting errors. Furthermore, considering that the M. smegmatis 
cultures used for infection were cultured in the absence of Tween-80 (leading to clumping of cells), it is 
possible that some level of variation occurred between samples during pipetting uneven amounts of 
cells. This is apparent since Figure 3.5.2 (Section 3.5) shows that fluorescence levels from infected 
cells are strongly associated with the amount of M. smegmatis cells used. It is thus likely that a 
combination of these two sources of variation is at play to yield the fluorescence variations in Figure 
3.5.1.  
 
In order to determine the optimal titer of Tm4::pYubSSmRFP to yield maximum expression of mRFP1, 
alarge dilution range was tested, ranging from 109pfu/ml to 1 pfu/ml as shown in Figure 3.5.3. The 
optimal fluorescence was observed from the undiluted samples corresponding to a concentration of 
109 pfu/ml.  Interestingly, one of the samples had a higher fluorescence at a concentration of 108 
pfu/ml compared to 109 pfu/ml. This could be due to an excessively high MOI leading to LO occurring.  
 
In order to determine how the fluorescence levels changed as a function of time, infection of M. 
smegmatis cultures with mycobacteriophage Tm4::pYubSSmRFP were performed over various time 
frames as shown in Figure 3.5.4. Figure 3.5.4 shows that an increase in fluorescence levels can be 
detected as early as 3h with a maximum fluorescence at more than 46h. It was also possible to detect 
single fluorescing cells by means of fluorescence microscopy by as early as 5h following infection of 
M. smegmatis (as shown in Figure 3.5.5). This roughly corresponded to the maturation time required 
for mRFP1 of about 6h (Campbell et al., 2002). According to Figure 3.5.4, the highest fluorescence is 
between 8 and 46h. However, these results indicate that an incubation time of between 6-8h yields the 
fastest incubation time for an easily discernible result compared to the negative controls. Four isolates 
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of Tm4::pYubSSmRFP were selected and used to infect M. smegmatis cells using the suitably optimal 
incubation time of 24h (as shown in Figure 3.5.4) and the optimal titer of 108pfu/ml to 109pfu/ml (as 
shown in Figure 3.5.3). The results are shown in Figure 3.5.6, which indicates that the isolate at a 
concentration 109pfu/ml had significantly higher fluorescence values that those at 108pfu/ml. Thus 
109pfu/ml is the optimal titer for maximum fluorescence. Additionally, isolate 18 showed fluorescence 
levels which were more than 8 times that of uninfected M. smegmatis cells which were cultured for 1h, 
and about 5 times higher than M. smegmatis cells which were allowed to grow for 24h. This shows 
that Tm4::pYubSSmRFP infected cells would show a considerably higher fluorescence level 
compared to contaminant bacteria with background fluorescence levels equal to that of a 24h M. 
smegmatis culture. The ability to detect the presence of Tm4::pYubSSmRFP infected M. smegmatis 
cells by means of affinity chromatography was also investigated (as described in Section 2.7.3). 
Figure 3.5.7 shows the resultant fluorescence levels following fluorescence reading of the his-tag 
purified eluates which show that the eluates have up to 7 times higher fluorescence levels than the 
eluate of uninfected M. smegmatis which provides a diagnostic avenue with a high level of 
discrimination. 
 
The performance of the Tm4::pYubSSmRFP reporter mycobacteriophage was also tested in M. tb 
using the protocol listed in Appendix C.1. Using a MOI of 109 pfu/ml and overnight infection and 
incubation, single M. tb cells were able to be detected by means of fluorescence microscopy as shown 
in Figure 3.5.8. This indicates that the reporter cosmid pYubSSmRFP was successfully cloned into the 
Tm4 genome and that the reporter mycobacteriophage Tm4::pYubSSmRFP was able to infect M. tb 
and express the reporter gene mRFP1 under control of the pSmyc promoter. These results also show 
that Tm4::pYubmRFP offers single cell detection of M. tb after only 6h incubation with the reporter 
mycobacteriophage. Furthermore, 3 different tests with formaldehyde treatment of the M. tb 
mycobacteriophage-infected cells, for 90 min each, showed that no viable cells remained in the 
samples. This was confirmed by culture testing on MGIT for up to 4 weeks after the 90 min treatment. 
Additionally, despite 4 weeks of storage at 4°C of the formaldehyde treated samples, individual cells 
could still be detected by means of fluorescence microscopy (as displayed in Figure 3.5.8). This shows 
that the analysis of the sample may be performed outside of a biohazard facility, following the 90 min 
Stellenbosch University  http://scholar.sun.ac.za
203 
 
 
paraformaldehyde treatment, due to the very efficient bactericidal effect of the paraformaldehyde, 
which increases its usefulness to settings without specialized biohazard facilities. Furthermore, the 
four week results showed that the samples do not have to be processed immediately following 
formaldehyde treatment, which is an improvement on luciferase assays in which the reporter signal 
degrades as soon as the substrate and ATP is consumed. As culture testing is not necessary in this 
protocol, it could decrease the total diagnostic time for the assay to an estimated 8h. However, it is 
possible to increase the sensitivity of the assay by a brief 24h selective culture step by incubating the 
sample together with the 21 mycobacteriophages isolated in this study as they have been shown to 
not include M. tb in their host range (as described in Appendix D). The selective culture and detection 
of M. tb protocol is described in Section C.2). The assay offers the distinct advantage of signal 
concentration which is an improvement on existing mycobacteriophage-based TB diagnostics. His-tag 
purification of the samples following infection with Tm4::pYubSSmRFP provides a rapid and simple 
diagnostic avenue. In summary, the TB diagnostic based on Tm4::pYubSSmRFP provides a simpler 
diagnostic method to existing mycobacteriophage based assays without the need for P3 facilities, 
which makes the assay more suitable for field use.  
 
4.6 Conclusion  
Construction of the novel reporter mycobacteriophage Tm4::pYubSSmRFP led to the construction of 
several intermediates consisting of varying promoter, reporter gene, affinity tag and expression vector 
combinations. Initial constructs were evaluated using plasmid expression vectors. The combination of 
promoter and affinity tagged reporter protein which lead to the highest and most stable expression of 
the reporter gene was subsequently cloned into a cosmid to allow lambda packaging together with 
mycobacteriophage DNA. Several reporter cosmids were in turn cloned into mycobacteriophage Tm4 
and analyzed for functionality. This lead to the successful production of novel reporter 
mycobacteriophage Tm4::pYubSSmRFP. The reporter mycobacteriophage Tm4::pYubSSmRFP was 
able to detect both M. smegmatis and M. tuberculosis using a multi-plate fluorescence reader as well 
as by detecting single cells using fluorescence microscopy. The optimal MOI was determined to be 
109 pfu/ml which lead to detectable fluorescence levels after 3h with optimal expression between 24 to 
46h. Incubation for a period of between 6 and 8h appeared to give the fastest results with a definitive 
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result compared to the negative controls. This corresponded to the maturation time required for 
mRFP1 of about 6h (Campbell et al., 2002). Fluorescence was stable following formaldehyde 
treatment and 4 weeks storage at 4°C. This is an extensive time window for detection compared to 
luciferase assays which only produce a detectable signal in the presence of ATP and substrate. This 
extensive time-frame eases logistics for the assay and adds to the versatility of the diagnostic. 
Additionally, analysis of the sample may be performed outside of a biohazard facility after fixing of the 
cells due to the bactericidal effect of the paraformaldehyde treatment step. The assay further offers 
the distinct advantage of signal concentration through the histidine affinity tag which is an 
improvement on existing mycobacteriophage-based TB diagnostics.  
 
4.7 Future directions 
In this study we developed a novel reporter mycobacteriophage that could detect single cells of M. tb 
by means of fluorescence microscopy, and also present a novel concept whereby the signal can be 
concentrated by means of affinity chromatography. Future studies should investigate the sensitivity 
and specificity presented by the novel reporter mycobacteriophage Tm4::pYubSSmRFP performed on 
clinical samples by means of fluorescence detection following affinity chromatography. Improvement 
on novel reporter mycbacteriophage Tm4::pYubSSmRFP could provide an even more suitable 
reporter mycobacteriophage for M. tb detection. Future studies to improve the characteristics of 
Tm4::pYubSSMRFP should investigate and compare the use of various combinations of M. tb specific 
promoters, reporter genes, affinity tags, mycobacteriophages as well as means of detection.  
 
Use of mycobacteriophages which are specific for M. tb could offer a reporter mycobacteriophage with 
a specificity of 100%. However, construction of such a reporter mycobacteriophage, utilizing the 
methods described in this study, would require propagation of the mycobacteriophage in M. tb which 
presents an extensive biohazard risk. Use of a mycobacteriophage with a slightly wider host range 
could potentially decrease the biohazard risk, such as mycobacteriophage DS6A which is specific to 
the M. tb complex (REDMOND & CATER, 1960). Another means to derive a reporter 
mycobacteriophage with a high specificity for M. tb is to utilize M. tb specific promoters which are not 
active in other mycobacteria. It is also possible to increase the sensitivity of reporter 
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mycobacteriophage assays by investigating the use of other reporter genes. Enzymatic reactions in 
particular offer a very high amount of reporter signal production for a relatively low amount of reporter 
protein (enzyme), for example β-galactosidase enzymes. Use of a reporter bacteriophage which 
makes use of ice-nucleation genes as reporter could also provide a useful diagnostic method. Use of 
ice-nucleation genes as reporters offers a single-tube reaction which is simple and highly sensitive 
with the main drawback of requiring accurate temperature control devices. Finally, use of affinity-tag 
purification offers a natural solution to the problem that contaminant bacteria could express similar 
reporter genes through a affinity chromatography purification step. The use of biotin as affinity-tag, in 
particular, should be investigated in future studies due to its strong binding to streptavidin.  
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Appendix A - Solutions 
A.1 Antibiotic stock solutions 
Antibiotic name Concentration
Amount per 
ml of culture 
media Conditions
A.1.1 Ampicillin 50mg/ml 1µl/ml
Made up in water, filter 
sterilised*, stored at -20°C
A.1.2 Kanamycin 50mg/ml 1µl/ml
Made up in water, filter 
sterilised*, stored at 4°C
A.1.3 Hygromycin B 50mg/ml 2µl/ml
Made up in water, filter 
sterilised*, stored at 4°C
A.1.4 Tetracyclin 50mg/ml 10µl/ml
Made up in methanol, filter 
sterilised*, stored at -20°C
 
* using a Sterillin 0.22µm PVDF filter unit 
 
A.2 Culture Media 
A.2.1 7H9 
Dissolve 21g of Middlebrook 7H9 media in 900ml H2O, add 3ml glycerol and autoclave for 20 min at 
121°C. Once cooled to about 45°C, add 100ml Middlebrook Oleic-Acid-Albumin-Dextrose-Catalase 
(OADC, Appendix A.2.8). 
 
A.2.2 7H10 plates 
Dissolve 19g of Middlebrook 7H10 media in 900ml H2O, add 5ml glycerol and autoclave for 20 min at 
121°C. Once cooled to about 40°C, add 100ml Middlebrook Oleic-Acid-Albumin-Dextrose-Catalase 
(OADC, Appendix A.2.8) and the appropriate antibiotic(s). Slowly mix the media and pour onto plates. 
Allow the plates to set and immediately use or stored upside down at 4°C for up to 4 weeks.  
 
A.2.3 7H11 plates 
Dissolve 21g of Middlebrook 7H11 media in 900ml H2O, add 3ml glycerol and autoclave for 20 min at 
121°C. Once cooled to about 45°C, add 100 ml Middlebrook Oleic-Acid-Albumin-Dextrose-Catalase 
(OADC, Appendix A.2.8) and the appropriate antibiotic(s). Slowly mix the media and pour onto plates. 
Allowed the plates to set and immediately use or store upside down at 4°C for up to 4 weeks. 
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A.2.4 Top Agar 
Dissolve 4.7g of Middlebrook 7H9 broth and 7g Bacto agar (Difco) in 1L H2O and autoclave for 20 min 
at 121°C. Once cooled to about 45°C, add CaCl2 to a concentration of 1mM and use immediately. 
 
A.2.5 Kircheners medium 
Dissolve 3g Na2HPO, 4g KH2PO4, 1.07g MgSO4.7H2O,  2.5g Trisodiumcitrate and 5g Asparagine in 
980ml distilled H2O, add 20ml Glycerol and autoclave 20 min at 121°C. 
 
A.2.6 Lysogeny Broth (LB) 
Dissolve 10g Bacto-tryptone, 5g Yeast Extract and 5g NaCl in distilled H2O, fill to 1L and autoclave for 
20 min at 121°C. Once cooled to room temperature, add the appropriate antibiotics prior to use. 
 
A.2.7 Lysogeny Broth (LB) agar plates 
Dissolve 10g Bacto-tryptone, 5g Yeast Extract, 5g NaCl and 12g Bacto-agar in distilled H2O, fill to 1L 
and autoclave for 20 min at 121°C. Once cooled to about 45°C, add the appropriate antibiotics, slowly 
mix the media and pour onto plates. Allow the plates to set and use immediately use or store upside 
down at 4°C for up to 4 weeks.  
 
A.2.8 Oleic Acid-albumin-Dextrose Catalase (OADC) 
Middlebrook OADC enrichment for mycobacterial growth media, supplied as a 100ml liquid (Merck). 
 
A.2.9 Super Optimal Broth (SOB) medium 
Dissolve 2g Bacto-tryptone, 0.5g yeast extract, 0.496g NaCl and 0.186g KCl in 900ml H2O, adust the 
pH to pH7 and fill to 1L. Aliquote the media into 10ml autoclavable tubes and autoclave for 20 min at 
121°C 
 
A.2.10 Super Optimal broth with Catabolite repressor (SOC) medium 
Add 200µl filter-sterilized glucose and 100µl filter-sterilized MgCl2 to 10ml of SOB. 
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A.3 Buffers and solutions 
A.3.1 Acid alcohol (3%) 
Add 30ml 1M HCL to 970ml 95% ethanol 
 
A.3.2 Acrylamide-bisacrylamide (30%) 
Dissolve 30g Acrylamide and 0.8g Bis-acrylamide in 100ml H2O, filter the solution through a Whatman 
filter paper (no.1) and store at 4°C in the absence of light. 
 
A.3.3 Ammonium persulphate (APS) (10%w/v) 
Dissolve 1g (NH4)2S2O8 in H2O and fill to 10ml, use immediately or store for up to one week at 4°C. 
 
A.3.4 Ammonium Sulfate (Saturated) 
Dissolve 80g ammonium sulfate in 100ml H2O by mixing the solution for 5 hours. Siphon off the 
saturated solution from the undissolved crystals and store at room temerature. 
 
A.3.5 Blocking buffer 
Dissolve 20g Fat free milk powder in 200ml of TBS-T wash buffer (Appendix A.3.43) together with 2g 
BSA and 4ml 5M Azide (NaN3). Use immediately or store the solution at 4oC. 
 
A.3.6 Bromophenol Blue (0.75%) 
Dissolve 75mg Bromophenol Blue in 10ml H2O. 
 
A.3.7 BSA blocking buffer (1%) 
Dissolve 1g BSA in 100ml PBS-T buffer (Appendix A.3.27). 
 
A.3.8 Carbol Fuchsin (ZN Staining) 
Dissolve 10g basic fuchsin, 50g phenol in H2O, add 100ml absolute ethanol and fill to solution to 1L. 
Filter the solution using a Whatman paper (no.1) before use. 
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A.3.9 Coomassie blue staining solution 
Dissolve 2.5g Coomassie blue (Merck) in 450ml methanol and add 100ml acetic acid. Filter the 
solution using Whatman paper (no.1) before use. 
 
A.3.10 Destaining solution 
Add 50ml Glycerol, 187.5ml Glacial acetic acid and 125ml Methanol to 637.5ml distilled H2O. 
 
A.3.11 EDTA (0.5M) 
Dissolve 186.12g EDTA in 800ml H2O, adjust pH to pH8.0, fill to 1L and autoclave for 20 min at 121°C. 
 
A.3.12 Ethanol (70%) 
Add 30ml distilled and autoclaved sterile H2O to 70ml 100% ethanol (merk) and store at -20°C 
 
A.3.13 Ethanol (95%) 
Add 5 ml distilled and autoclaved H2O to 95ml 100% ethanol (merk) and store at -20°C. 
 
A.3.14 Ethidium Bromide stock solution 
Dissolve 10mg ethidium bromide in 1ml TE buffer (Appendix A.3.43) 
 
A.3.15 Glycerol (10%) 
Add 100ml Glycerol to 900ml H2O and autoclave for 20 min at 121°C. 
 
A.3.16 Isopropyl-β-D-thiogalactoside (IPTG, 0.1M) 
Dissolve 238mg IPTG in 10ml water and filter sterilize the solution. 
 
A.3.17 Klenow filling buffer (10X) 
Make up 33µM dNTPs, 10mM Tris-HCl, 50mM NaCl, 10mM MgCl2 and 1mM Dithiothreitol in sterile 
autoclaved H2O and adjust the pH to pH7.9. 
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A.3.18 Maltose (1%) 
Dissolve 1g Maltose in 100ml distilled and autoclaved H2O and filter sterilize the solution using a 
0.22µm filter. 
 
A.3.19 Methylene Blue 
Dissolve 0.3g methylene blue in 100ml distilled and autoclaved H2O. 
 
A.3.20 Mg solution (100X) 
Add 1ml 1M MgCl2 (Appendix A.3.21), 3.1674ml β-mercaptoethanol (sigma) to 5.8326ml distilled and 
autoclaved H2O. 
 
A.3.21 MgCl2 (1M) 
Supplied as a 1M solution (sigma). 
 
A.3.22 MgSO4 (1M) 
Dissolve 12.03g MgSO4 in 100ml water and filter purifyie the solution using a 0.22µm filter.  
 
A.3.23 Mycobacteriophage (MP) buffer 
Add 25ml 1M Tris (pH 7.6, Appendix A.2.48), 4.35g NaCl, 0.47g MgCl2 and 0.11g CaCl2 to 475ml H2O 
and filter sterilize the solution using a 0.22µm filter. 
 
A.3.24 ONPG (o-nitrophenyl-b-D-galactopyraniside, 1X) 
Dissolve 4mg ONPG in 1ml 0.1M phosphate buffer (Appendix A.3.32). 
 
A.3.25 Paraformaldehyde (4%) 
Dissolve 4g Paraformaldehyde in 100ml distilled and autoclaved H2O and stored the solution in a foil-
covered container in the absence of light. 
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A.3.26 PBS (phosphate buffered saline) pH 7.4 
Dissolve 8g NaCl, 0.2g of KCl, 1.44g Na2HPO4 and 0.24g KH2PO4 in 900ml H2O, fill to 1L and 
autoclave for 20min at 121°C. 
 
A.3.27 Phage dilution buffer 
Make up 10mM Tris-HCL, 100mM NaCl and 10mM MgCl2 in 1L H2O and autoclave 20 min at 121°C. 
 
A.3.28 Phenol (buffer equilibrated) 
Add Sigma buffer equilibration mixture to phenol as per provider instruction (sigma), incubate the 
solution at room temperature for 2-4 hours and store in a foil-coverd container in the absence of light 
at 4°C.  
 
A.3.29 Phenol:Chloroform 
Add an equal amount of Phenol (Appendix A.3.27) to chloroform in a glass container, store in a foil-
covered container at 4°C.  
 
A.3.30 Phenol:Chloroform:Isoamyl alcohol (PCI, 25:24:1) 
Add 250ml Phenol (Appendix A.3.29), 240ml chloroform and 10ml isoamyl alcohol to a glass container 
covered with foil and store at 4°C. 
 
A.3.31 Phosphate buffer (0.1M, pH 7) 
Dissolve 1.61g Na2HPO4.7H2O and 0.55g NaH2PO4.H2O in 80ml distilled H2O, adjust the pH to pH7 
and fill the solution to 100ml. 
 
A.3.32 Ponceau Red dye 
Dissolve 2g Ponceau S, 30g trichloracetic acid and 30g sulfosalicylic acid in 100ml H2O. 
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A.3.33 Proteinase K 
Supplied as 100mg powder (promega). Make up to 2µg/ml using sterile autoclaved H2O, use 
immediately or store as frozen aliquots at -20°C.  
 
A.3.34 Proteinase K buffer (10X) 
Add 25ml 1M Tris-HCl (pH 7.6, Appendix A.3.46) and 25ml 0.5M EDTA (pH 8.0, Appendix A.3.11) to 
200ml sterile autoclaved H2O and autoclave to solution for 20 min at 121°C. 
 
A.3.35 Sample Reducing buffer (2X) 
Add 3.4ml 1M Tris-HCl (pH6.8, Appendix A.3.47), 2ml glycerol, 3ml SDS (20% m/v), 0.5ml 
Bromophenol Blue (0.75%), 0.2ml EDTA (0.5M, Appendix A.3.11) and 1ml β-mercatoethanol to 10ml 
tube and store at 4°C. 
 
A.3.36 SDS (Sodium dodecyl sulfate, 10% m/v)  
Dissolve 10g SDS in 900ml distilled and autoclaved H2O, adjust the pH to pH7.2 and fill to 1L.  
 
A.3.37 SDS-PAGE Running buffer  
Dissolve 6g Tris and 28.8g glycine in 1.5L H2O, add 20ml SDS (10%) and fill to 2L with H2O. 
 
A.3.38 Sodium Acetate (3M) 
Dissolve 40.8g Sodium Acetate (merck) in 100ml H2O. 
 
A.3.39 Sodium Borate Buffer (SB) 
Dissove 19.1g di-Sodium tetraborate decahydrate (merk) in 500ml distilled H2O to yied a 10X solution. 
Add 100ml of the 10X stock to 900ml distilled H2O to yield a 1X working solution. 
 
A.3.40 Sodium Carbonate (1M) 
Dissolve 1,06g Sodium Carbonate (merck) in 10ml distilled H2O.  
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A.3.41 TBS-T (Tris Buffered Saline Tween) buffer 
Add 20ml Tris (1M, ph7.6 Appendix A.3.48), 16.01g NaCl2 and  2ml Tween 20 to 1.5L H2O, make up 
the solution to 2L. 
 
A.3.42 Transfer buffer  
Dissolve 3.03 g of Tris (25 mM), 14.4 g Glycine (192 mM) and 200 ml Methanol (20%) in 700ml H2O 
and make up the solution to 1L. Store at 4°C.  
 
A.3.43 Tris-EDTA buffer (TE) 
Make up 10mM Tris and 1mM EDTA in 1L H2O, adjust pH to pH7.5 and autoclave for 20 min at 121°C.  
 
A.3.44 Tris-Acetic-acid-EDTA (TAE buffer) 
Dissolve 242g Tris base in 750 mL H2O, add 57.1 ml glacial acetic acid and 100 mL of 0.5 M EDTA 
(pH 8.0), (Appendix A.3.12) and adjust the volume to 1L.  
 
A.3.45 1M Tris-HCl pH 6.8, 
Dissolve 121.1g Tris in 900 ml H2O, adjust the pH to pH6.8 and make up the solution to 1L. 
 
A.3.46 1M Tris-HCl pH 7.6,  
Dissolve 121.1g Tris in 900 ml H2O, adjust the pH to pH7.6 and make up the solution to 1L. 
 
A.3.47 1.5 M Tris-HCl; pH 8.8 
Dissolve 90.75g Tris in 400ml H2O, adjusted the pH to to pH 8.8 and make up the solution to 500ml. 
 
A.3.48 Tween (20%) 
Add 20ml Tween 80 to 80ml H2O and filter sterilize. 
 
A.3.49 X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) 
Dissolve 250mg X-gal (Sigma) in 10ml dimethylsulfoxide (DMSO). 
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Appendix B - Vector maps 
B.1 p19Kpro 
p19Kpro
5499bp
Hyg
ALori
19kDa prom
BamHI
ClaI
HindIII
 
 
P19Kpro is a mycobacterial expression vector with hygromycin resistance. It contains a promoter 
region from M. tuberculosis H37Rv chromosomal DNA which is upstream of the 1 kDa antigen gene, 
(Ashbridge et al., 1989). The promoter drives expression in mycobacterial hosts such as M. tb and M. 
smegmatis. Additionally it contains the the ALori origin of replication which is derived from M. fortuitum 
pAL5000 plasmid and is functional in both E. coli and mycobacteria, enabling cloning steps in E. coli 
host. The p19Kpro plasmid was constructed by Dr. Koen de Smet (Imperial College Medical School at 
St Mary`s, London, UK) and used with permission from Dr. Douglas Young (Imperial College Medical 
School at St Mary`s, London, UK).  
 
 
 
 
R 
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B.2 pACE 
pACE
8191bp
ALori
Hyg
ACE promoter
XbaI
BamHI
ClaI
 
pACE is a mycobacterial expression vector with hygromycin resistance. The vector contains a 3kb 
region upstream of the acetamidase gene from M. smegmatis, (Mahenthiralingam et al., 1993). The 
vector allows concentration dependant acetamide-inducible expression from the ACE promoter 
situated in the 3kb region. The vector contains the ALori origin of replication enabling replication in E. 
coli and mycobacteria. The pACE plasmid was constructed by Dr. Koen de Smet (Imperial College 
Medical School at St Mary`s, London, UK) and used with permission from Dr. Douglas Young (Imperial 
College Medical School at St Mary`s, London, UK).  
 
 
 
 
 
 
 
 
R 
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B.3 pDsRed 
pDsRed
3300bp
Amp
pUC ori
DsRed
Plac
BamHI
XbaI
XbaI
KpnI
 
pDsRed (clonetech) is a prokaryotic expression vector which encodes the red fluorescent protein 
DsRed. DsRed, isolated from coral of the discosoma genus, has an excitation maximum of 558nm and 
emission maximum of 583nm. The DsRed gene in pDsRed is cloned in frame with the Plac promoter 
allowing expression in E. coli. The vector contains a high copy number origin of replication as well as a 
gene for ampicillin resistance.  
 
 
 
 
 
 
 
 
R 
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B.4 pHsp60promDsRed 
pDsRedHsp60
3600bp
Amp
pUC ori
DsRed
Plac
KpnI
XbaI
XbaI BamHI
 
pDsRedHsp60 contains the Hsp60 promoter cloned into vector pDsRed (Appendix B.3) using the 
restriction enzyme sites BamHI and KpnI. The gene for the fluorescent protein, DsRed, is cloned in 
frame with the Hsp60 promoter enabling expression in E. coli.  
 
 
 
 
 
 
 
 
 
 
 
R 
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B.5 pGem-T-Easy 
pGEM-T Easy
3000bp
Amp
f1 ori
T T
ori
LacZ
 
The Promega pGEM-T-Easy vector is a linear (shown circular) T-cloning vector for cloning PCR 
products with overhanging deoxyadenine base pairs as generated by DNA-polymerases without 
proofreading activity. The vector contains overhangs of 3` thiamine (T) which bind to the 
deoxyadenine overhangs on the PCR product which to form a circular construct. The plasmid contains 
T7 and SP6 RNA polymerase promoters on two multiple cloning sites which flank the PCR product 
cloning site. The insertion site is within the coding region of β-galactosidase, insertional inactivation of 
β-galactosidase allows colour screening of recombinant clones on plates containing X-gal (Appendix 
B.3.49). The vector also contains an E. coli high copy number origin of replication and an ampicillin 
resistance gene (AmpR).  
 
 
 
 
 
T7 
NotI 
EcoRI 
 
EcoRI 
NotI 
Sp6 
R 
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B.6 pJem15 
1
pJem15
9446bp
LacZ
Kan
BamHIKpnI
NdeI
 
pJem15 is a mycobacterial promoter probe plasmid vector used for relative quantification of promoter 
activity. The vector has a multiple cloning site upstream of the lacZ gene which allows promoter 
activity to be determined by detection of LacZ expression by β-galactosidase activity assay. The 
vector contains the kanamycin resistance marker (KanR) as well as an origin of replication enabling 
cloning in E. coli host. The pJem15 promoter probe vector was obtained from and used with 
permission from Dr. Brigitte Gicquel (Institute Pasteur). 
 
 
 
 
 
 
 
R 
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B.7 pMB154Hsp60 
 
pMB154
4758bp
oriE
oriM
KanHsp60 promoter
groEL
 
pMB154 is an E. coli - mycobacteria shuttle vector with kannamycin resistance. pMB154 used in this 
study was constructed previously to contain the Hsp60 promoter in frame with the first 3 amino acids 
from M. tb H37RV Esat6 gene cluster 5 (N.C Gey van Pittius, unpublished results). The vector 
contains origins of replication for both mycobacteria and E. coli. 
 
 
 
 
 
 
 
R 
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B.8 pRC 
pRC
4941bp
Kan
oriE
repA
repB
Hsp60prom
RBS D
terminator
GFP
HpaI
XbaI
EcoRI
HindIII
KpnI
 
pRC is a mycobacterial expression vector containing GFP (green fluorescent protein) cloned 
downstream of the mycobacterial Hsp60 promoter and a ribosome binding site. Additionally the vector 
makes use of a terminator sequence downstream of the GFP gene. The vector contains genes for 
kannamycin resistance as well as E. coli and mycobacterial origins of replication enabling cloning in E. 
coli host. The vector was a kind gift, and used under permission, from Dr. Ros Chapman (University of 
Cape Town, infectious diseases).  
 
 
 
 
 
 
 
R 
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B.9 pDMN1 
pDMN1
4941bp
Kan
oriE
repA
repB
Psmyc
RBS D
terminator
GFP
HpaI
XbaI
EcoRI
HindIII
KpnI
 
pDMN1 is a mycobacterial expression vector containing GFP (green fluorescent protein) cloned 
downstream of the strong constitutive mycobacterial promoter Psmyc which has been previously 
described, (Mailaender et al., 2004), (Kaps et al., 2001). The GFP gene is flanked by a ribosomal 
binding site as well as a terminator sequence. The vector contains genes for kannamycin resistance 
as well as origin of replication sequences for mycobacteria and E. coil enabling cloning on E. coli host. 
The vector was a kind gift, and used under permission, from Dr. Ros Chapman (University of Cape 
Town, infectious diseases).  
 
 
 
 
 
 
 
R 
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B.10 pRSETBmRFP 
pRSETBmRFP
2900bp
AmppUC
F1 ori
Prom T7
mRFP1
His tag
 
pRSETBmRFP is a prokaryotic expression vector which utilizes the inducible T7 promoter to express 
histidine tagged mRFP1 (monomeric red fluorescent protein). Utilizing bacterial strain 
BL21(DE3)pLysS to encode T7 RNA polymerase strong expression can be achieved. The vector 
contains a gene for ampicillin resistance as well an E. coli origin of replication. The vector is used with 
permission from Roger Y. Tsien (Howard Hughes Medical Institute, USA). 
 
. 
 
 
 
 
 
 
R 
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B.11 pSD21 
pSD21
4503bp
Kan
oriE
oriM
Hsp60 promoter
XbaI
BamHI
 
pSD21 is a mycobacterial expression vector that contains the mycobacterial hsp60 promoter. The 
vector has a kanamycin resistance marker, mycobacterial as well as E. coli origins of replication (oriM 
and oriE respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
R 
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B.12 pYub412 
1
pYub412
8562bp
Amp
Ori E
Hyg
int
attP
cos A
cos B
AatII (74)
ApaLI (321)
Alw44I (321)
ScaI (512)
XorII (624)
PvuI (624)
MstI (770)
VspI (818)
ApaLI (1567)
Alw44I (1567)
SapI (2009)
Eco47III (2020)
MstI (2210)
Eco47III (2552)
MluI (2962)
MfeI (3465)
XbaI (3734)NheI (3750)
MluI (4044)MfeI (4547)
SalI (4830)
BalI (5155)
MscI (5155)
NdeI (5248)
BamHI (5442)
Bsp1407I (5679)
SphI (5810)
MstII (5928)
SauI (5928)
Bsu36I (5928)
CvnI (5928)
BglII (5955)
SunI (6203)
SplI (6203)
AvrII (6422)
MscI (6497)
BalI (6497)
EspI (6769)
Bpu1102I (6769)
FseI (6807)
XmaI (6845)
SmaI (6847)
XmaI (6911)
SmaI (6913)
AccIII (6972)
BspMII (6972)
AatII (7182)
SalI (7190)
FseI (7281)
DraIII (7453)
SunI (7660)
SplI (7660)
BspMII (7689)
AccIII (7689)
SgrAI (7782)
EcoICRI (7804)
Ecl136II (7804)
SstI (7806)
SacI (7806)
PflMI (8108)
SphI (8412)
EcoRV (8424)
PacI (8497)
BclI (8507)
BamHI (8513)
PacI (8523)
 
pYub412 is an PacI-excisable integrative cosmid cloning vector. The vector contains both ampicillin 
and hygromycin resistance. The cosmid also contains the mycobacteriophage L5 attachement site 
(attP), the L5 integrase gene (int) which allows stable integration into the mycobacteriophage L5 
attachment site (attB) of the mycobacterial chromosome, (Lee et al., 1991). As such the vector is a 
suicide vector in mycobacteria and can only replicate in E. coli 
  
R 
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Appendix C – TB Diagnostic protocols 
C.1 TB diagnostic protocol including culture testing 
Protocol for detecting M. tuberculosis with the reporter mycobacteriophage Tm4::pYubSSmRFP 
1. Culture M. tuberculosis sample in 7H9 OADC + Tween  
2. Aliquot 1 ml of culture to 2 tubes 
3. Centrifuge the tubes and resuspend the pellets in in 7H9-OADC without Tween  
4. Aliquot 200µl from each tube into a new tube 
5. Add 100µl of a 109 pfu/ml stock of Tm4::pYubSSmRFP to all tubes, except the control tube. 
6. Incubate the tube for 6h at 37°C. 
7. Add 300µl of paraformaldehyde (4% in PBS) 
10. Leave at room temperature for 90 min to ensure killing of the bacteria. 
11. Centrifuge, resuspend the pellet in 400µl PBS 
12. Centrifuge, resuspend the pellet in 30µl PBS.  
13. Spread 15µl onto a labeled glass microscope slide, cover with a coverslip and store at 4°C until 
step 14 shows that no viable cells remain in the sample. 
14. Use 15ul of the cells to inoculate a fresh MGIT culture and culture for 4 weeks, if no viable cells 
are detected, proceed to step 15. 
15. Examine slides with fluorescence microscope, 100x objective with oil immersion.  
 
 
 
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
227 
 
 
C.2 Optimized TB diagnostic protocol 
1. Decontaminate sputum sample with NaOH and subsequently neutralize with HCL. 
2. Incubate the M. tuberculosis sample in 7H9 0ADC + Tween together with a cocktail of 21    novel 
South African mycobacteriophages for 24h.  
3. Centrifuge the sample and resuspend the pellet in 100µl 7H9-0AD without Tween.  
4. Infect the samples with 100µl of a 109 PFU Tm4::pYubSSmRFP mycobacteriophage stock and 
incubate for 6 hours 37°C. 
5. Add 300µl paraformaldehyde (4% in Phosphate Buffered Saline) and incubate for 90 min. 
6. Centrifuge the sample and resuspend the pellet in 400µl PBS. 
8. Centrifuge the sample and resuspend the pellet in 50µl PBS.  
9. Detect fluorescence by a fluorescence plate reader, or by detecting a red signal on a Nickel coated 
membrane. 
 
Figure C.1 is a visual illustration of the optimized diagnostic. 
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Figure C.1.  Diagram illustrating the diagnostic procedure for detecting M. tb with 
mycobacteriophage Tm4::pYubSSmRFP. 
Sodium 
peroxide 
added 
HCL 
added 
Patient sputum sample is 
collected in an airtight 
sealable tube 
Phage cocktail of 21 
novel South African 
mycobacteriophages 
added 
Mycobacteriophage 
Tm4::pYubSSmRFP 
added and incubated 
for 6h 
Paraformaldehyde 
added  
Strip containing nickel 
added and briefly 
incubated 
Strip 
visualized  
Stellenbosch University  http://scholar.sun.ac.za
229 
 
 
 
 
 
Appendix D – ADDITIONAL WORK DONE 
 
The isolation, characterization and comparative genomics of novel South African 
mycobacteriophages from soil samples 
 
D.1 Introduction 
Mycobacteria, especially Mycobacterium tuberculosis the causative agent of tuberculosis, pose a serious 
health threat worldwide. Mycobacteriophages are mycobacterium specific phages that are naturally 
occurring and have been isolated from various niches such as soil or even human sources. Various 
mycobacteriophages have been isolated, characterized, sequenced and investigated on a genetic level, 
however none originate from South Africa, a country with an extremely high TB burden. 
Mycobacteriophages have proven useful as molecular tools to manipulate mycobacteria, such as through 
generating knockouts, site specific integration, recombineering, improved transformation, novel 
transposon delivery vehicles and opportunity to investigate novel means of combating the organism. This 
includes drug development as well as rapid and cheap diagnostics. Isolation, characterization and 
comparative genomic analysis of novel mycobacteriophages offer further tools to address and investigate 
pathogenic mycobacteria. 
 
D.2 Aim 
The aim of this study is to isolate novel mycobacteriophages originating from South African soil samples, 
to characterize them by electron microscopy, to determine their host range, to extract and sequence their 
genomic DNA and to perform comparative genomics on their genomes.   
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D.3 Methods 
D.3.1 Purification and DNA extraction. 
Soil samples were collected from various regions in South Africa and tested for the presence of 
mycobacteriophages using indicator strain M.smegmatis as described in Section 2.4.1. Resulting plaques 
were then purified to create large stocks as described in Section 2.4.2. The mycobacteriophages where 
then purified from the large stocks by utracentrifugation (as described in Section 2.4.3) after which the 
resulting mycobacteriophage band was used for dialysis (as described in Section 2.4.4). The purified 
mycobacteriophage samples were then investigated by means of electron microscopy (as described in 
Section 2.4.4) and their genomic DNA was extracted (as described in Section 2.4.6). Each 
mycobacteriophage tested for its ability to infect M. tb by means of a spot test (as described in Section 
2.4.1). Additionally, the mycobacteriophages were used for whole sequencing, and genome annotation 
and comparative genomcis. 
 
D.3.2 Sequencing and genome annotation 
Novel South African mycobacteriophages that were isolated from soil and used for DNA extraction 
(Section 2.4) were sent for whole genome sequencing at the Texas A&M University using an Illumina with 
de novo assembly in collaboration with Prof. Thomas Ioerger. Several bioinformatics tools and 
parameters were used to annotate the novel South African mycobacteriophages, as described below.  
 
An initial genome sequence homology search was done using the NCBI blast website: 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome) and the closest matching 
mycobacteriophage data was stored for each novel genome. Positional annotation was performed using 
the annotation software “DNA Master” (available on the website: http://en.bio-
soft.net/dna/dnamaster.html). DNA Master was used with the following parameters: The default 
translation table was set to “Bacteria and Plant Plastid”, the codons ATG, GTG as well as TTG was added 
as start codons. The “auto-annotate” feature was used for preliminary positional annotation using NCBI 
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blast searches. The settings used for the “auto-annotate” feature were as follows: Aragorn was used to 
document tRNA`s, open reading frames were analysed with both Glimmer and GeneMark (GeneMark  
 
calls were favoured), “examine and learn gene features” was selected, “Perform BLAST search on nr 
database” was selected with the restrictions of saving hits with E-values less than 10-3, however 1 hit was 
saved regardless of E-value and the number of hits was limited to 50. Open reading frames were 
predicted using Glimmer, which is embedded into the DNA Master suite. GeneMark was used to identify 
putative open reading frames ((http://opal.biology.gatech.edu/GeneMark/genemark_prok_gms_plus.cgi). 
The host selection parameter was set to mycobacteria. tRNAScan SE (Version 1.21) was used to predict 
potential tRNA genes (http://lowelab.ucsc.edu/tRNAscan-SE/). Aragorn (Version 1.2.28.c) was also used 
for tRNA prediction as well as for tmRNA (the software is accessible from the DNA Master suite). Frame 
Shift Finder was used to detect programmed translational frameshifts 
(http://chainmail.bio.pitt.edu/~junxu/webshift.html). M. tuberculosis was used as the coding potential 
model and RBS model, and the other settings were left as default. 
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D.4 Results 
21 mycobacteriophages were isolated from various regions in South Africa. Plaque morphology showed a 
wide degree of variation. Transmission electron microscopy performed on the first two 
mycobacteriophages revealed them to be siphoviridae with typical head and tail properties. Figure D.1 
shows the TEM images for the first two mycobacteriophages isolated. The host range of the 21 
mycobacteriophages excluded M. bovis BCG and M.tb according to host range tests performed by spot 
testing. Field inversion gel electrophoresis indicates the genomes of the novel mycobacteriophages 
ranged between 50kb and 120kb which is within the range of previously isolated mycobacteriophags. 
Whole genome sequencing and annotation of the first South African mycobacteriophage, to be 
sequenced at the time, was successfully completed with sequencing of the others underway. The first 
fully sequenced South African mycobacteriophage was named mycobacteriophage Luiperd. It has a 
genome of 54885bp (~55KB), GC content of 65.4% and is in cluster I. Luiperd shows high levels of 
similarity to mycobacteriophage Che9c (with regions of >95% similarity) and with 47 (out of 83) open 
reading frames (ORFs) closely matching those of Che9c. 9 ORFs with no genbank matches were found, 
4 of which contain conserved protein predictions according to BLASTp (3 belong to the XRE family 
transcriptional regulators and one contains NrdH-redoxin (NrdH)). 15 ORFs were found to be more 
closely related to bacterial genes than mycobacteriophage genes. tRNAScan revealed no tRNA`s in the 
genome. Luiperd also appears to have a divergent lysin B with only 42% BLASTP identities to a known 
mycobacteriophage lysin B (mycobacteriophage Giles). Table D.1 shows a list of the annotated open 
reading frames in Luiperd and Figure D.2 shows a visual illustration of the genome map of Luiperd. 
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Figure D.1 TEM images of two novel mycobacteriophages isolated from soil samples. (a) and (b) 
TEM image of a novel mycobacteriophage of lytic nature. (c) and (d) TEM images of a novel 
mycobacteriophages of lysogenic nature.  
 
 
 
(c) 
(a) 
(d) 
(b) 
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Table D.1 Annotation of open reading frames in novel South African mycobacteriophage Luiperd. 
Product Closest Match Predicted function based on DNA homology 
gp1 Che9c gp1   
gp2 Che9c gp2 Terminase 
gp3     
gp4 Che9c gp4 Portal 
gp5 Che9c gp5 Prohead Protease 
gp6 Che9c gp6 Capsid 
gp7 Che9c gp7   
gp8 Che9c gp8   
gp9 Che9c gp9   
gp10 Che9c gp10   
gp11 Che9c gp11   
gp12 Che9c gp12   
gp13 Che9c gp13   
gp14 M. smegmatis Hypothetical protein smegmatis 2145 
gp15 Che9c gp15 Tape measure protein 
gp16 Che9c gp16   
gp16a Che9c gp16a   
gp17 Che9c gp17   
gp18 Brujita gp19   
gp19 Che9c gp18   
gp20 Che9c gp19   
gp21 Marinobacter aquaeolei Fis family Transcriptional regulator? 
gp22 Qyrzula gp31   
gp23 Che9c gp22   
gp24 Pipefish gp36   
gp25 Che9c gp24   
Stellenbosch University  http://scholar.sun.ac.za
235 
 
 
 
 
 
gp26 Che9c gp25 Lysin A? (Contains putative peptidoglycan binding domain) 
gp27 Brujita gp30 Lysin B 
gp28 Tm4 gp31   
gp29 Tm4 gp33   
gp30 predator gp39   
gp31 Actinomyces urogenitalis Hypotherical protein Actinomyces urogenitalis DSM 15434 
gp32 Actinomyces urogenitalis DNA-methyltransferase? 
gp33 Thermofilum pendens methyltransferase type 11? 
gp34 Sphaerobacter thermophilus  Hypothetical protein 
gp35 Sphaerobacter thermophilus transferase, transferring glycosyl groups?  
gp36 Rhodococcus equi  gp43 family protein 
gp37 Rhodococcus equi Hypothetical protein 
gp38 Che9c gp35 PPE superfamily, Antigenic varation for host? 
gp39 Che9c gp36   
gp40 Che9c gp38 H37RV LpqJ 
gp41 Che9c gp39   
gp42 Che9c gp41 phiLC3 phage Integrase 
gp43 Che9c gp42 Actinobacteria protein superfamily DUF3263  
gp44 Che9c gp43   
gp45   transcriptional regulator, XRE family 
gp46   transcriptional regulator, XRE family 
gp47 Streptomyces DNA-damage-inducible protein D  
gp48 Che9c gp50 transcription regulator, HTH MerR-SF superfamily 
gp49 Che9c gp51   
gp50 Corynebacterium matruchotii hypothetical protein CORMATOL_00734 
gp51   LuxR family transcriptional regulator? 
gp52 Giles gp41   
gp53     
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gp54 Streptomyces lividans 
transcriptional regulator, required for differentiation and 
sporulation. 
gp55 Brujita gp44   
gp56 Che9c gp58   
gp57 Brujita gp48 YqaJ-like viral recombinase domain, Exonuclease 
gp58 Brujita gp49 Recombination and repair recT superfamily 
gp59     
gp60 Che9c gp62   
gp61   NrdH-redoxin (NrdH) 
gp62 Salinibacter ruber methyl-accepting chemotaxis protein 
gp63 ctinomyces sp. oral taxon  glutaredoxin, NrdH-redoxin 
gp64 Wee gp74   
gp65 Beggiatoa sp. PS sensor signal transduction histidine kinase? 
gp66 Che9c gp67   
gp67 Che9c gp68 RADICAL SAM superfamily 
gp68 Brujita gp60   
gp69 
Trypanosoma brucei 
gambiense conserved hypothetical protein 
gp70 Che9c gp71   
gp71 Che9c gp72   
gp72 Che9c gp73   
gp73 Che9c gp75   
gp74 Angelica gp3   
gp75     
gp76 Che9c gp77   
gp77 Che9c gp78   
gp78 Che9c gp79   
gp79 Che9c gp80   
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gp80 Che9c gp81   
gp81 Che9c gp82   
gp82 Che9c gp83   
gp83 Che9c gp84   
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Figure D.2 Visual illustration of the open reading 
frames in mycobacteriophage Luiperd. 
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D.5 Discussion  
Twenty-one novel South African mycobacteriophages were isolated from soil samples. Transmission 
electron microscopy of two of the mycobacteriophages revealed that are siphoviridae with head and tail 
lengths similar to previously described mycobacteriophages. Field inversion gel electrophoresis showed 
them to have genome sizes within the range of previously published mycobacteriphages. Each has been 
submitted for whole genome sequencing, one of which has been fully annotated, named 
mycobacteriophage Luiperd, the first South African mycobacteriophage to be sequenced. Comparative 
genomics showed that Luiperd has a high degree of similarity to mycobacteriophage Che9c, originating 
from Chenai, India. Luiperd, however, was isolated from a historically barren and unpopulated area in the 
Karoo landscape in the Western cape of South Africa. The proximity of the two regions suggest that it is 
improbable that there was trafficking of soil, mycobacteria or mycobacteriophages between the regions, 
which makes the degree of genome similarity surprising. However, geographical distance is not a good 
indicator of genome diversity since samples taken in close proximity have been known to differ to a large 
extent. A high level of conservation in structurally encoding genes (head, tail, capsid, tape-measure etc.) 
between Che9c and Luiperd was observed and a total of 47 out of 83 ORFs closely match those of 
Che9c. The lack of divergence in structural genes is a typical occurrence. Luiperd also contains ORFs 
that contain novel genes not in the Genbank database as well as several genes not common to 
mycobacteria or mycobacteriophages which suggests a high rate of divergence in DNA encoding for non-
structural components (see Table D.1 and figure D.3 for a list of ORFs found in Luiperd).  Luiperd has 
given us initial insight to South African mycobacteriophage genome diversity; further comparative 
genomics will provide deeper insight as to their diversity. This could potentially populate Genbank with 
several novel mycobacteriophage genes since the majority of genbank mycobacteriophages originate for 
Japan, India and USA. Investigation of the unique attributes in the novel genomes of mycobacteriophages 
could offer further insight and novel tools for the understanding and manipulation of mycobacterial 
genetics as well as potential new drug treatments and diagnostics for mycobacterial infections.  
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Appendix E – Sequence data  
E.1 Intergenic regions in ESAT-6 gene cluster region 5 
 
The following shows the sequence data for the 10 intergenic regions from the M. tb H37Rv gene cluster 
region 5, the primer binding locations are shown in bold. 
 
Int1: Rv1779c-80 
>M. tuberculosis H37Rv genome: 421 bp - region from 2014379 bp to 2014799 bp 
cgctcgccgagttcgcgccagtgtccgccgccgagccaggtaagcagcccctcgattccggacacggccgagcgctgctcagcatattcgtgg
gcgcacatgagactgaaaacacctcctgctggtcaagcctggcaggcccccgcccgacacaccgaatcgaagcggccccttgtggtgttgttcac
aactgcgcgagagatgacgcagatcacgtcgcggctgcccagccgaatcctcagcgagttcaatgtcaaaattaccgcggcgcgagcggatca
gcggccattatggcaggtgacgtgagacggtatacacctatgcaaaatcacgactacgttacctacgaagagttcggccgcagattcttcgaggt
agcagttaccccggaccgcgtcgccgccgcgtttgccgacatcgc 
 
Int2: Rv1781-82 
>M. tuberculosis H37Rv genome: 465 bp - region from 2017376 bp to 2017840 bp 
gcctcggagaccagcacctgccggccagtccagtccgtgtactcggtggcaatgccgaatcgtcgggcaagttcgaccagcgaaggcgcgag
ctcggtcatgtcgcccatcttgcgtccggcacccgtgtgcgggcgagcgcaggaatctgagccttccgtcagcacagcacggttggctaccgaaca
ccactacgttgcaggtcaacgaggtagactgcggagcggacagttccacaggcggactcggtcattcgccgctaccatgcccagtgaagacacg
acgaatccttgggggatccgcgcagtggcaaatacccaggtcaatgtccaggtgttctgagcagaccggaaggtgatctagcgtggctgaaga
gagccgcgggcagcgggggtcggggtatggccttgggttgtccacgcggacccaggtaaccggttatcagttcctggcgcgtcgaaccgc 
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Int3: Rv1783 – 84  
>M. tuberculosis H37Rv genome: 671 bp - region from 2020119 bp to 2020734 bp 
catttcggtgactcgcggcggcacgacgcggcgggtaacgcgcggatggtctacacctcggttcgtgagtttgccgcagagcaagccgaattat
tcgcgggccgtggttctttcacgcctcgacacgcgagttcgtcggcgcagaccccgaccccgcacaccgtgatcatcgccgacgtcgacgatccgc
aatgggagtacgtgatcagcgccgagggtgtcgacggggtgacgttcttcgacctgaccggctcttcgatgtggactgacatcccggagcggaagc
tgcagttcgacaagaccggcgtgatcgaggcgctgccccgcgaccgcgacacctggatggtgatcgacgacaaggcttggttcttcgctctcaccg
accaagtcagcatcgccgaggcagaagagttcgcgcagaagctggcgcagtggcggctggctgaggcctatgaagagatcggccagcgggtt
gcccacattggtgcccgagacatctagtcctactacgggattgacgatcctggcaacatcgacttcgactcgctgtgggctagccggaccgacac
catgggacggtcgcgattgcgggcgccgttcggtaatcgctccgacaacggcgagctgctgttcttggatatgaaatcgctcgacgaaggcggcg
acggccc 
 
Int4: Rv1786-87 (PPE25) 
>M. tuberculosis H37Rv genome: 471 bp - region from 2024931 bp to 2025401 bp 
cagagcacgaggtgcggcccgaggacatgcagctgaccagagacggtgtggccgcttgccccgaaatggcgctcatcctcgaggaggacga
cgcggactgacgattccgggtcataccacaaaattaacgctggccaaacgatcgtttacgaggaatgaatatttggcgtcatcggcgctggaggcc
ggtattgcaatctaatgtgttttctatgcaacagttgcgcagcgacgccgttatcgactagcggtgctatattcggcgccttttcgatgccgagcgcgcgt
ctcgttggccacgtttggtggcaatgctcatcagggctcatccggatcgccaacgcgatcgtgtgtggagagggaggactggttggacttcggggc
gttaccgccggagatcaattcgggccgtatgtattgcggtccggggtcggggccgatgctggctgcggccgcggcctgggacggggt 
 
Int5: Rv1787-88 (PPE25/PE18) 
>M. tuberculosis H37Rv genome: 280 bp - region from 2026298 bp to 2026577 bp 
Gactgccgctagggtcgcggatcactcggcgtagcggcgcctttgcccaccgatatgggttccgtcacagtgtggttgcccgcccgccatcggcc
ggataacgccatgacctcagctcggcagaaatgacaatgctcccaaaggcgtgagcacccgaagacaactaagcaggagatcgcatgtcgtt
tgtgactacccaaccagaagcactggcggcggcggccggcagtctgcagggaatcggctccgcattgaacgcccagaatgcggctgcggcgac 
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Int6: Rv1789-90 (PPE26/PPE27) 
>M. tuberculosis H37Rv genome: 655 bp - region from 2027871 bp to 2028525 bp 
tgttgggcggcctgccgctagctggtgcgggcggggccggcgcgggtccacgctacggattccgtcccaccgtcatggctcgcccacccttcgc
cggatagtcgctgccgcaacgtattaacgcgccggcctcggctggtgtggtccgctgcgggtggcaattggtcggcgccgagatctcggtgggttatt
tgcggtgggattttttcccgaagccgggttcagcaccggatttcctaacggtcccgcgactcaacggcaccgcgccgtcagcaagttccggtggtgtt
gatcgcggtatccatgcaggtggtgatggcgcggcgagactggtcgtgtgcgctgaagcacagggtacttggcggttgtggctcccgggatgtagct
ggccgcccaacgtcccgcagcgtcggggtcagcggcggagcagcacggcgatttagcctcacaaccgagcagctagctcgcgtttcccagcgg
ctcaatccccgtcgagccattgaaaggcacctcagatgtcgtttgcgactccgcaaccggagaaagggttcggaatggacttcggggcgttaccg
ccggagatcaattcgggccgtatgtattgcggtccggggtcggggccgatgctggctgcggccgcggcctgggacggggt 
 
Int7: Rv1790-91 (PPE27/PE19) 
>M. tuberculosis H37Rv genome: 628 bp - region from 2029377 bp to 2030004 bp 
gaggcataccgctggcgagagcggggcggcgtacgggcgccttcgctcaccgatacgggt 
tccgccacagcgtgattacccggtctccgtcggcgggatagctttcgatccggtctgcgcggccgccggaaatgctgcagatagcgatcgaccg
cgccggtcggtaaacgccgcacacggcactatcaatgcgcacggcgggcgttgatgccaaattgaccgtcccgacggggctttatctgcggcaag
atttcatccccagcccggtcggtgggccgataaatacgctggtcagcgcgactcttccggctgaattcgatgctctgggcgcccgctcgacgccgag
tatctcgagtgggccgcaaacccggtcaaacgctgttactgtggcgttaccacaggtgaatttgcggtgccaactggtgaacacttgcgaacgggtg
gcatcgaaatcaacttgttgcgttgcagtgatctactctcttgcagagagccgttgctgggattaattgggagaggaagacagcatgtcgttcgtgac
cacacagccggaagccctggcagctgcggcggcgaacctacagggtattggcacgacaatgaacgcccagaacgcggccgcggctgc 
 
Int8: Rv1791-92 (PE19/esxM) 
>M. tuberculosis H37Rv genome: 345 bp - region from 2030103 bp to 2030447 bp 
cccaggccgcggccattcacgaaatgttcgtgaacacgctggtggccagttctggctcatacgcggccaccgaggcggccaacgcagccgctg
ccggctgaacgggctcgcacgaacctgctgaaggagagggggaacatccggagttctcgggtcaggggttgcgccagcgcccagccgattcag
ctatcggcgtccataacagcagacgatctaggcattcagtactaaggagacaggcaacatggcctcacgttttatgacggatccgcatgcgatgc
gggacatggcgggccgttttgaggtgcacgcccagacggtggaggacgaggctcgccggatgtg 
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Int9: Rv1793-94 (esxN/1794) 
>M. tuberculosis H37Rv genome: 289 bp - region from 2030878 bp to 2031166 bp 
aggtgatctacgagcaggccaacgcccacgggcagaaggtgcaggctgccggcaacaacatggcgcaaaccgacagcgccgtcggctcc
agctgggcctaaaactgaacttcagtcgcggcagcacaccaaccagccggtgtgctgctgtgtcctgcagttaactagcactcgaccgctgaggt
agcgatggatcaacagagtacccgcaccgacatcaccgtcaacgtcgacggcttctggatgcttcaggcgctactggatatccgccacgttgcgc
ctgagttacg 
 
Int10: Rv1794-95 
>M. tuberculosis H37Rv genome: 473 bp - region from 2031868 bp to 2032340 bp 
tggctatctgcccggctaccccgcagttggtgcaagtaggagtgaagaccgttttggatacactgccctacggcgagtggaaaacacacagcag
agtatgacgccagggcgtgaaacccgaagtacaacaacaaatttgagcatcagatacaacccagatacgtacagggcaaattgctctagaatcg
actgcaatactgcaaggcaaggtcaaccacaacgatttggtcgcgaggcaaggcaaatgaaatcggagttagtcgagccgcagctcccggtgg
gctaccgcgcctcggtgcctacaccgacggagctccccgcgccactgaagccacggtgtaacacgtttgccatggcagggggtacaggacgat
gaccgcagtagctgacgcacctcaggctgacattgagggtgtggcatcgccccaggctgtcgtcgtgggcgtcatggccggcgaaggcgtccag
atcgg 
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